data_1tey_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tey _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 1.5800000000000001 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 1.1200000000000001 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.9299999999999999 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.9199999999999999 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.95999999999999996 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 2.0600000000000001 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 HG21 ' HH ' ' A' ' 111' ' ' TYR . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.5700000000000001 110.112 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 2.1800000000000002 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 1.5700000000000001 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.74 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.776 ' HB2' HE21 ' A' ' 23' ' ' GLN . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.9199999999999999 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.69999999999999996 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 1.04 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 1.1399999999999999 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.726 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.45000000000000001 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 1.0700000000000001 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.85999999999999999 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.68000000000000005 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.776 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.6 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.71 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 1.1499999999999999 111.377 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 1.1100000000000001 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.34000000000000002 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77000000000000002 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.84999999999999998 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 1.24 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.8300000000000001 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 2.0899999999999999 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 2.1600000000000001 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.9500000000000002 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.8799999999999999 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.95 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92000000000000004 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.54000000000000004 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.79 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.457 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 1.1299999999999999 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 1.52 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.812 ' HH ' HH12 ' A' ' 137' ' ' ARG . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.91000000000000003 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 1.1499999999999999 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.71 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 1.3600000000000001 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 2.0 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.0899999999999999 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.8300000000000001 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.8200000000000001 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.8500000000000001 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.72 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.78 111.299 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.3100000000000001 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.49 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.8600000000000001 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.95 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 65' ' ' VAL . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 1.4099999999999999 109.913 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.41999999999999998 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.66000000000000003 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 1.7 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 1.03 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 1.0800000000000001 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.38 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 3.3199999999999998 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.81999999999999995 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.475 ' HG3' ' HG1' ' A' ' 27' ' ' THR . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 2.3599999999999999 109.985 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.46000000000000002 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.71 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.66000000000000003 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 20.8 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.77 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 1.24 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.1299999999999999 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 1.1399999999999999 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.89000000000000001 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.23 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.68000000000000005 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.55000000000000004 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 2.1600000000000001 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 1.1399999999999999 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 1.002 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 1.2 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.79 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 1.002 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.9399999999999999 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.1499999999999999 110.578 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 1.28 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.8100000000000001 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 1.3200000000000001 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 1.1000000000000001 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 1.3100000000000001 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 1.1299999999999999 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.74 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.74 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 1.1599999999999999 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 1.0900000000000001 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.9300000000000002 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.59999999999999998 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.3100000000000001 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.5900000000000001 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.34999999999999998 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 1.1299999999999999 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.3700000000000001 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 1.0700000000000001 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.31 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.521 ' HB2' HG12 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.91000000000000003 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 1.2 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.516 HG23 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.8500000000000001 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.73 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.94999999999999996 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 1.1599999999999999 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.916 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.2400000000000002 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.408 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.8600000000000001 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 1.3999999999999999 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.3999999999999999 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.8399999999999999 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.1899999999999999 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.3700000000000001 111.304 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.2 111.753 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.5299999999999998 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 2.6099999999999999 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.576 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.79000000000000004 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.489 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.57999999999999996 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.97 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 2.5 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 1.4299999999999999 110.458 -171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.916 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.812 HH12 ' HH ' ' A' ' 44' ' ' TYR . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 3.5299999999999998 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.95999999999999996 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.588 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 1.21 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 1.6000000000000001 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 1.1200000000000001 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.8500000000000001 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 2.5 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.81999999999999995 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.7999999999999998 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.76 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 1.2 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.46 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.53000000000000003 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 4.04 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 1.3200000000000001 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.8 109.848 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.3199999999999998 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.4900000000000002 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.8900000000000001 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 111.209 0.077 . . . . 2.0800000000000001 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.562 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 1.5800000000000001 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 1.1200000000000001 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.9299999999999999 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.9199999999999999 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.95999999999999996 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.77 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 2.0600000000000001 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.5700000000000001 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 2.1800000000000002 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 1.5700000000000001 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.74 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.9199999999999999 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.69999999999999996 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 1.04 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 1.1399999999999999 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.45000000000000001 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 1.0700000000000001 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.657 ' ND2' HH21 ' A' ' 137' ' ' ARG . 0.0 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.0699999999999998 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.85999999999999999 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.68000000000000005 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 7.5 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.71 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 1.1499999999999999 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 1.1100000000000001 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.34000000000000002 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77000000000000002 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.84999999999999998 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 1.24 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.562 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.8300000000000001 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.1800000000000002 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 2.0899999999999999 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 2.1600000000000001 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.673 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.9500000000000002 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.8799999999999999 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.95 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92000000000000004 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.54000000000000004 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.79 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.539 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 1.1299999999999999 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.669 ' HB ' HD13 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 1.52 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.582 ' HE1' HG13 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.91000000000000003 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 1.1499999999999999 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.46999999999999997 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.611 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.71 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 1.3600000000000001 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 2.0 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.0899999999999999 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.8300000000000001 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.459 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.8200000000000001 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.8500000000000001 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.72 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD23 ' HG3' ' A' ' 79' ' ' PRO . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.78 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.3100000000000001 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.49 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.8600000000000001 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.95 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 1.4099999999999999 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.41999999999999998 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.66000000000000003 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.636 ' HB ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 1.7 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 1.03 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 1.0800000000000001 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.38 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 3.3199999999999998 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.81999999999999995 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 2.3599999999999999 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.46000000000000002 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.71 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.66000000000000003 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.77 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 1.24 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.1299999999999999 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 1.1399999999999999 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.89000000000000001 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.23 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.68000000000000005 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.55000000000000004 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 2.1600000000000001 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 1.1399999999999999 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 1.2 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.79 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.83 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.9399999999999999 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 1.1499999999999999 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 1.28 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.8100000000000001 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 1.3200000000000001 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 1.1000000000000001 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 1.3100000000000001 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.9199999999999999 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.537 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 1.1299999999999999 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.74 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.74 110.717 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 1.1599999999999999 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 1.0900000000000001 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.9300000000000002 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.59999999999999998 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.3100000000000001 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.5900000000000001 110.5 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.512 ' HB3' HG12 ' A' ' 151' ' ' ILE . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.34999999999999998 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 1.1299999999999999 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.433 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.31 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.91000000000000003 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 1.2 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.582 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.8500000000000001 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.73 109.478 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.94999999999999996 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.793 ' HH ' ' H ' ' A' ' 131' ' ' ASP . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 1.1599999999999999 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 1.4299999999999999 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.2400000000000002 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.8600000000000001 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 1.3999999999999999 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.3999999999999999 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.8399999999999999 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.1899999999999999 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.3700000000000001 110.451 165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.2 112.539 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.5299999999999998 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 2.6099999999999999 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.79000000000000004 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.793 ' H ' ' HH ' ' A' ' 117' ' ' TYR . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.646 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.57999999999999996 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.97 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 2.5 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 1.4299999999999999 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.6299999999999999 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.934 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.95999999999999996 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.934 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 1.21 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 1.6000000000000001 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 1.1200000000000001 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.8500000000000001 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 2.5 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.81999999999999995 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.7999999999999998 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.76 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 1.2 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.46 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.53000000000000003 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 4.04 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 1.3200000000000001 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.8 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.3199999999999998 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.4900000000000002 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.8900000000000001 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 2.0800000000000001 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 1.5800000000000001 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.45 HG22 HD13 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 1.1200000000000001 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.9299999999999999 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.9199999999999999 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.95999999999999996 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.3 t30 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 2.0600000000000001 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.5700000000000001 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 2.1800000000000002 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 1.5700000000000001 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.74 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.9199999999999999 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.69999999999999996 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.629 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 1.04 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 1.1399999999999999 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.45000000000000001 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 1.0700000000000001 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.0699999999999998 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.85999999999999999 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.68000000000000005 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.713 HE21 ' HB2' ' A' ' 12' ' ' LEU . 2.8 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.71 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 1.1499999999999999 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 1.1100000000000001 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.34000000000000002 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77000000000000002 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.84999999999999998 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 1.24 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.8300000000000001 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 2.0899999999999999 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 2.1600000000000001 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.9500000000000002 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.95 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.687 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92000000000000004 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.54000000000000004 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.79 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 1.1299999999999999 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 1.52 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.91000000000000003 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 1.1499999999999999 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.46999999999999997 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.626 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.71 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 1.3600000000000001 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 2.0 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.0899999999999999 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.8300000000000001 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.595 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.8200000000000001 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.577 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.8500000000000001 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.72 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.78 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.3100000000000001 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.49 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.8600000000000001 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.687 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.95 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 1.4099999999999999 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.41999999999999998 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.66000000000000003 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 1.7 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 1.03 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 1.0800000000000001 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.38 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 3.3199999999999998 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.81999999999999995 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 2.3599999999999999 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.46000000000000002 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.71 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.66000000000000003 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.459 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.77 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 1.24 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.1299999999999999 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 1.1399999999999999 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.89000000000000001 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.493 ' CB ' HD12 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.23 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.68000000000000005 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.55000000000000004 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD12 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 2.1600000000000001 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 1.1399999999999999 110.418 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 1.2 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.79 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.757 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 1.1499999999999999 111.481 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 1.28 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.8100000000000001 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 1.1000000000000001 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 HG22 ' A' ' 113' ' ' VAL . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 1.3100000000000001 107.973 173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.9199999999999999 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 1.1299999999999999 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.74 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.74 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 1.1599999999999999 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 1.0900000000000001 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.459 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.9300000000000002 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.59999999999999998 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.3100000000000001 109.51 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.5900000000000001 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.34999999999999998 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 1.1299999999999999 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.3700000000000001 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 1.0700000000000001 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.31 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.91000000000000003 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.455 ' O ' HD12 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 1.2 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.8500000000000001 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HD13 ' A' ' 140' ' ' LEU . 2.3 m120 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.73 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.94999999999999996 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 1.1599999999999999 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.734 HG21 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 1.4299999999999999 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.2400000000000002 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.8600000000000001 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 1.3999999999999999 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.3999999999999999 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.8399999999999999 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.1899999999999999 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.3700000000000001 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.2 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.5299999999999998 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 2.6099999999999999 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.79000000000000004 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.57999999999999996 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.97 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 2.5 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 1.4299999999999999 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.734 ' HB2' HG21 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.6299999999999999 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 3.5299999999999998 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.95999999999999996 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.61 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 1.21 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 112' ' ' TYR . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 1.6000000000000001 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 1.1200000000000001 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.8500000000000001 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 2.5 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.81999999999999995 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.7999999999999998 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 1.2 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.46 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.53000000000000003 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 4.04 109.3 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 1.3200000000000001 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.8 110.075 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.616 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.3199999999999998 109.744 -170.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.459 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.4900000000000002 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 7.3 p30 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.8900000000000001 109.416 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.491 0.186 . . . . 2.0800000000000001 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.539 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 1.5800000000000001 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 1.1200000000000001 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.9299999999999999 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.9199999999999999 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.95999999999999996 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.659 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 2.0600000000000001 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.5700000000000001 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.796 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.1800000000000002 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 1.5700000000000001 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.977 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.74 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.9199999999999999 110.05 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.69999999999999996 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 1.04 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 1.1399999999999999 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.45000000000000001 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 1.0700000000000001 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.0699999999999998 109.694 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.85999999999999999 111.971 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.565 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.4 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.71 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.977 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 1.1499999999999999 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 1.1100000000000001 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.34000000000000002 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77000000000000002 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.84999999999999998 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 1.24 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.8300000000000001 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.1800000000000002 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 2.0899999999999999 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 2.1600000000000001 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.9500000000000002 109.432 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.8799999999999999 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.95 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.634 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92000000000000004 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.54000000000000004 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.643 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.79 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 1.1299999999999999 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 1.52 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.91000000000000003 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 1.1499999999999999 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.595 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.46999999999999997 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.537 ' CB ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.71 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 1.3600000000000001 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 2.0 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.0899999999999999 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.8300000000000001 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.8200000000000001 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.8500000000000001 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.72 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.78 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.3100000000000001 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.49 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.8600000000000001 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.95 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.41999999999999998 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.66000000000000003 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 1.7 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 1.03 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 1.0800000000000001 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.38 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 3.3199999999999998 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.81999999999999995 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 2.3599999999999999 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.46000000000000002 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.71 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.66000000000000003 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 23.5 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.77 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 1.24 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.1299999999999999 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.1399999999999999 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.89000000000000001 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.23 110.952 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.68000000000000005 112.134 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.55000000000000004 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 83' ' ' LEU . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 2.1600000000000001 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 1.1399999999999999 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 1.2 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.79 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.9399999999999999 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' O ' HD23 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 1.1499999999999999 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 1.28 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.8100000000000001 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 1.3200000000000001 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.528 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 1.1000000000000001 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 1.3100000000000001 108.297 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.9199999999999999 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 1.1299999999999999 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.74 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.74 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 1.1599999999999999 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.488 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 1.0900000000000001 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.9300000000000002 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.59999999999999998 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.3100000000000001 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.5900000000000001 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.34999999999999998 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 1.1299999999999999 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.3700000000000001 109.402 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 1.0700000000000001 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.91000000000000003 110.18 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.485 ' HH ' ' HD2' ' A' ' 145' ' ' ARG . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.2 110.027 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.625 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.8500000000000001 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.73 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.94999999999999996 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.693 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 1.1599999999999999 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 1.4299999999999999 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.2400000000000002 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.8600000000000001 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 1.3999999999999999 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.3999999999999999 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.8399999999999999 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.1899999999999999 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.3700000000000001 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.2 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.5299999999999998 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 2.6099999999999999 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.693 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.653 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.57999999999999996 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.97 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 2.5 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 1.4299999999999999 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.8 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.6299999999999999 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.625 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 3.5299999999999998 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.95999999999999996 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 1.21 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 1.6000000000000001 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 1.1200000000000001 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.8500000000000001 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 2.5 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.81999999999999995 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HD2' ' HH ' ' A' ' 112' ' ' TYR . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.7999999999999998 109.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.76 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 1.2 108.937 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.46 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.53000000000000003 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 4.04 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 1.3200000000000001 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.8 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.526 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.3199999999999998 108.576 -171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.4900000000000002 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.8900000000000001 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.69 -0.485 . . . . 2.0800000000000001 109.69 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.977 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 1.5800000000000001 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.691 HG23 HD22 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 1.1200000000000001 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.9299999999999999 110.249 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.9199999999999999 109.76 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.95999999999999996 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.77 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 2.0600000000000001 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.5700000000000001 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 2.1800000000000002 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 1.5700000000000001 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.74 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.9199999999999999 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.69999999999999996 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 1.04 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 1.1399999999999999 112.39 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.666 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.45000000000000001 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 1.0700000000000001 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.0699999999999998 108.162 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.85999999999999999 113.225 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.68000000000000005 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.633 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 10.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.71 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HB3' HG22 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 1.1499999999999999 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.34000000000000002 109.461 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77000000000000002 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.84999999999999998 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 1.24 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.977 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.8300000000000001 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.1800000000000002 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD22 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 2.0899999999999999 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 2.1600000000000001 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.69 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.9500000000000002 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.95 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.636 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92000000000000004 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.54000000000000004 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.593 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.79 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 1.1299999999999999 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 1.52 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.91000000000000003 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 1.1499999999999999 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.46999999999999997 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.628 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.71 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 1.3600000000000001 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 2.0 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.0899999999999999 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.8300000000000001 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.615 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.8200000000000001 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.8500000000000001 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.72 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.78 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.593 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.49 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.8600000000000001 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.95 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 1.4099999999999999 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.41999999999999998 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.66000000000000003 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 1.7 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 1.03 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 1.0800000000000001 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.38 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 3.3199999999999998 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.81999999999999995 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 2.3599999999999999 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.46000000000000002 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.71 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.66000000000000003 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.9 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 1.24 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.89000000000000001 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.23 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.68000000000000005 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.55000000000000004 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 2.1600000000000001 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 1.2 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.79 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.77 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' O ' HD22 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 1.1499999999999999 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 1.28 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.8100000000000001 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.669 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 1.3200000000000001 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 1.1000000000000001 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 1.3100000000000001 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.9199999999999999 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 1.1299999999999999 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.74 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HB3' HD13 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.74 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 1.1599999999999999 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.69 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 1.0900000000000001 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.9300000000000002 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.59999999999999998 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.3100000000000001 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.5900000000000001 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.34999999999999998 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 1.1299999999999999 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.3700000000000001 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 1.0700000000000001 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.31 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.91000000000000003 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 1.2 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.8500000000000001 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.73 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.414 ' HB3' HD22 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.94999999999999996 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 1.4299999999999999 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.2400000000000002 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.8600000000000001 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 1.3999999999999999 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.3999999999999999 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.8399999999999999 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.1899999999999999 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.808 ' HB3' HG12 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.3700000000000001 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.2 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.632 HG11 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.5299999999999998 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.632 ' HD2' HG11 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 2.6099999999999999 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.591 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.79000000000000004 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.666 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.57999999999999996 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.97 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 2.5 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 1.4299999999999999 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.6299999999999999 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 3.5299999999999998 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.95999999999999996 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 1.21 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 1.6000000000000001 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 1.1200000000000001 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.8500000000000001 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 2.5 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.81999999999999995 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.7999999999999998 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.76 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 1.2 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.46 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.53000000000000003 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 4.04 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 1.3200000000000001 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.8 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 156' ' ' ASN . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.3199999999999998 107.958 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.4900000000000002 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.524 HD22 ' HB3' ' A' ' 154' ' ' GLU . 1.9 p30 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.8900000000000001 109.737 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.654 0.264 . . . . 2.0800000000000001 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 1.5800000000000001 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 1.1200000000000001 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.9299999999999999 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.9199999999999999 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.95999999999999996 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 2.0600000000000001 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.5700000000000001 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 2.1800000000000002 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 1.5700000000000001 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.74 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.9199999999999999 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.69999999999999996 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 1.04 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 1.1399999999999999 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.45000000000000001 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 1.0700000000000001 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.0699999999999998 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.85999999999999999 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.68000000000000005 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.71 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 1.1100000000000001 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.34000000000000002 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.84999999999999998 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 1.24 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.1800000000000002 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 2.0899999999999999 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 2.1600000000000001 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.9500000000000002 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.8799999999999999 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.95 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92000000000000004 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.54000000000000004 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.79 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 1.1299999999999999 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 1.52 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HE1' HG13 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.91000000000000003 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 1.1499999999999999 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.46999999999999997 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.71 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 1.3600000000000001 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.621 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 2.0 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.0899999999999999 112.08 -170.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.8300000000000001 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.8200000000000001 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.616 HG21 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.78 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.3100000000000001 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.49 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.8600000000000001 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 1.4099999999999999 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.41999999999999998 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.66000000000000003 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 1.7 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 1.03 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.38 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 3.3199999999999998 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.81999999999999995 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.419 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 2.3599999999999999 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.46000000000000002 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.71 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.66000000000000003 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.77 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 1.24 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.1299999999999999 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.625 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.89000000000000001 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.23 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.68000000000000005 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.55000000000000004 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.413 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 2.1600000000000001 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 1.1399999999999999 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 1.2 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.79 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 1.1499999999999999 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 1.28 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.8100000000000001 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.623 HG21 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 1.3200000000000001 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 1.1000000000000001 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 1.3100000000000001 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.9199999999999999 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.473 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 1.1299999999999999 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.74 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.74 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 1.1599999999999999 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 1.0900000000000001 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.9300000000000002 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.59999999999999998 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.3100000000000001 110.011 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.5900000000000001 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.34999999999999998 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 1.1299999999999999 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.3700000000000001 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 1.0700000000000001 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.31 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.91000000000000003 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 1.2 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.601 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.8500000000000001 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.73 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.94999999999999996 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 1.1599999999999999 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.965 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 1.4299999999999999 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.2400000000000002 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.8600000000000001 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 1.3999999999999999 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.3999999999999999 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.8399999999999999 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.1899999999999999 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.3700000000000001 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.2 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.5299999999999998 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 2.6099999999999999 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.559 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.79000000000000004 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.57999999999999996 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.97 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 2.5 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 1.4299999999999999 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.965 ' HB2' HG23 ' A' ' 118' ' ' THR . 5.0 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.6299999999999999 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.585 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 3.5299999999999998 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.95999999999999996 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.585 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 1.21 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 1.6000000000000001 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.8500000000000001 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 2.5 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.81999999999999995 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.7999999999999998 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.76 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 1.2 109.432 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.46 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.53000000000000003 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 4.04 109.677 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 110.33 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.8 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.526 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.3199999999999998 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.4900000000000002 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.8900000000000001 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.337 -0.246 . . . . 2.0800000000000001 110.337 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.783 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 1.5800000000000001 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.707 HG23 HD22 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 1.1200000000000001 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.836 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.9299999999999999 109.89 177.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.9199999999999999 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.95999999999999996 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 2.0600000000000001 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.5700000000000001 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 2.1800000000000002 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.428 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 1.5700000000000001 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.74 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.9199999999999999 109.714 167.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.69999999999999996 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 1.04 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 1.1399999999999999 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.696 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.45000000000000001 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 1.0700000000000001 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.0699999999999998 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.85999999999999999 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.68000000000000005 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.71 110.809 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.702 ' HB2' HD12 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 1.1499999999999999 111.424 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 1.1100000000000001 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77000000000000002 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.84999999999999998 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.542 HD11 ' HB1' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 1.24 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.783 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.8300000000000001 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.1800000000000002 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.707 HD22 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 2.0899999999999999 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 2.1600000000000001 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.9500000000000002 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.561 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.8799999999999999 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.857 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.95 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92000000000000004 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.54000000000000004 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.79 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 1.1299999999999999 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 1.52 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.91000000000000003 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 1.1499999999999999 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.46999999999999997 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.71 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 1.3600000000000001 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 2.0 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.0899999999999999 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.8300000000000001 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.8200000000000001 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.607 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.8500000000000001 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.72 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.582 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.78 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.3100000000000001 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.8600000000000001 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.95 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 1.4099999999999999 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.41999999999999998 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.66000000000000003 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.857 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 1.7 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 1.03 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 1.0800000000000001 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.38 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 3.3199999999999998 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.81999999999999995 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 2.3599999999999999 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.46000000000000002 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.71 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.66000000000000003 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.77 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 1.24 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.1299999999999999 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 1.1399999999999999 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.582 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.89000000000000001 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.23 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.68000000000000005 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.55000000000000004 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD13 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 2.1600000000000001 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 1.1399999999999999 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.491 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 1.2 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.79 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.9399999999999999 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 1.1499999999999999 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 1.28 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.8100000000000001 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.637 HG23 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 1.3200000000000001 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 1.1000000000000001 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 1.3100000000000001 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.9199999999999999 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 1.1299999999999999 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.74 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.74 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 1.1599999999999999 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 1.0900000000000001 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.9300000000000002 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.59999999999999998 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.3100000000000001 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.5900000000000001 110.569 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.34999999999999998 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 1.1299999999999999 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.3700000000000001 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 1.0700000000000001 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.31 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.91000000000000003 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 1.2 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.8500000000000001 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.73 110.019 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.94999999999999996 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 1.1599999999999999 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.478 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 1.4299999999999999 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.2400000000000002 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.8600000000000001 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 1.3999999999999999 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.3999999999999999 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.8399999999999999 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.1899999999999999 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.3700000000000001 111.73 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.2 113.008 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.5299999999999998 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 2.6099999999999999 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.79000000000000004 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.57999999999999996 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.97 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 2.5 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 1.4299999999999999 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.9 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.6299999999999999 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 3.5299999999999998 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.95999999999999996 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 1.21 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 1.6000000000000001 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 1.1200000000000001 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.8500000000000001 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 2.5 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.81999999999999995 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.7999999999999998 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.76 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 1.2 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.46 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.53000000000000003 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 4.04 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 1.3200000000000001 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.8 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.3199999999999998 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.4900000000000002 109.762 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.8900000000000001 109.611 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.141 0.496 . . . . 2.0800000000000001 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.492 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 1.5800000000000001 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 1.1200000000000001 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.771 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.9299999999999999 110.193 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.9199999999999999 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.95999999999999996 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.695 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 2.0600000000000001 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.5700000000000001 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 2.1800000000000002 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 1.5700000000000001 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.954 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.74 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.9199999999999999 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.69999999999999996 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.719 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 1.04 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 1.1399999999999999 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.45000000000000001 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 1.0700000000000001 111.358 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.85999999999999999 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.68000000000000005 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.954 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 25.3 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.71 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.773 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.437 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 1.1499999999999999 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.34000000000000002 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77000000000000002 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.84999999999999998 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 1.24 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 2.0899999999999999 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 2.1600000000000001 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.9500000000000002 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.8799999999999999 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.95 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92000000000000004 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.54000000000000004 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.79 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 1.1299999999999999 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 1.52 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.91000000000000003 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.637 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.46999999999999997 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.574 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.71 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 1.3600000000000001 109.131 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 2.0 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.0899999999999999 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.8300000000000001 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.8200000000000001 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.637 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.8500000000000001 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.72 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.78 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.3100000000000001 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.597 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.49 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.8600000000000001 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.95 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.41999999999999998 112.085 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.66000000000000003 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 1.7 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 1.03 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 1.0800000000000001 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.38 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 3.3199999999999998 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 2.3599999999999999 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.46000000000000002 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.71 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.66000000000000003 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.1 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.77 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 1.24 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.1299999999999999 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 1.1399999999999999 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.632 ' HG3' HD22 ' A' ' 57' ' ' LEU . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.89000000000000001 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.23 110.911 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.68000000000000005 112.324 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.55000000000000004 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 2.1600000000000001 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 1.1399999999999999 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 1.2 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.79 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.9399999999999999 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 1.1499999999999999 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 1.28 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.8100000000000001 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.593 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 1.3200000000000001 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 1.1000000000000001 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 1.3100000000000001 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.706 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.9199999999999999 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 1.1299999999999999 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.74 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.74 109.988 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.471 ' HG1' ' HG2' ' A' ' 105' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 1.1599999999999999 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 1.0900000000000001 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.9300000000000002 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.59999999999999998 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.3100000000000001 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' HG2' ' HG1' ' A' ' 100' ' ' THR . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.5900000000000001 110.33 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 1.1299999999999999 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.3700000000000001 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 1.0700000000000001 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.31 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.91000000000000003 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.8500000000000001 110.978 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 14.8 m120 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.73 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.94999999999999996 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.796 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 1.1599999999999999 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 1.4299999999999999 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.2400000000000002 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.8600000000000001 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.514 HD21 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 1.3999999999999999 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.3999999999999999 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.8399999999999999 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.1899999999999999 110.921 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HG3' HG13 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.3700000000000001 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG3' HD21 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.2 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.5299999999999998 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 2.6099999999999999 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.796 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.79000000000000004 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.507 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.57999999999999996 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.97 110.684 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 1.4299999999999999 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.6299999999999999 108.683 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 3.5299999999999998 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 11' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 1.21 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 1.6000000000000001 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 1.1200000000000001 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.8500000000000001 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 2.5 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.81999999999999995 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.7999999999999998 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.76 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 1.2 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.46 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.53000000000000003 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 4.04 109.183 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 1.3200000000000001 109.916 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.8 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.3199999999999998 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.4900000000000002 109.334 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.8900000000000001 109.733 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.867 0.321 . . . . 2.0800000000000001 111.867 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 1.5800000000000001 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 1.1200000000000001 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.9299999999999999 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.9199999999999999 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.95999999999999996 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 2.0600000000000001 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.5700000000000001 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 2.1800000000000002 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 1.5700000000000001 110.531 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.851 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.74 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.843 ' OD1' ' HB ' ' A' ' 139' ' ' ILE . 1.6 m120 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.9199999999999999 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.69999999999999996 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 1.04 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 1.1399999999999999 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.686 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.45000000000000001 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.561 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 1.0700000000000001 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.85999999999999999 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.68000000000000005 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.851 HE21 ' HB2' ' A' ' 12' ' ' LEU . 4.8 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.71 110.243 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.568 ' HG2' HG11 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 1.1499999999999999 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 1.1100000000000001 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.34000000000000002 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77000000000000002 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.84999999999999998 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 1.24 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.8300000000000001 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.1800000000000002 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.9500000000000002 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.8799999999999999 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.95 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HA ' HD11 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92000000000000004 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.54000000000000004 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.79 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 1.1299999999999999 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.879 HG12 HG21 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.91000000000000003 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.668 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 1.1499999999999999 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.555 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.46999999999999997 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.656 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.71 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 1.3600000000000001 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 2.0 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.0899999999999999 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.8300000000000001 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.529 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.8200000000000001 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.8500000000000001 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.879 HG21 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.72 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.78 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.49 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.8600000000000001 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.95 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 1.4099999999999999 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.41999999999999998 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.66000000000000003 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 1.7 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 1.03 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 1.0800000000000001 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.38 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 3.3199999999999998 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.81999999999999995 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 2.3599999999999999 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.46000000000000002 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.71 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.66000000000000003 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.6 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.77 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 1.24 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.1299999999999999 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 1.1399999999999999 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.89000000000000001 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.23 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.68000000000000005 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.55000000000000004 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 1.1399999999999999 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.656 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 1.2 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.79 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.9399999999999999 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 1.1499999999999999 111.672 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 1.28 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.8100000000000001 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.668 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 1.3200000000000001 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 1.1000000000000001 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 1.3100000000000001 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.9199999999999999 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 1.1299999999999999 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.74 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.74 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 1.1599999999999999 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 1.0900000000000001 109.238 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.9300000000000002 111.166 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.59999999999999998 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.3100000000000001 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.5900000000000001 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CZ ' ' SG ' ' A' ' 99' ' ' CYS . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.34999999999999998 111.56 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 1.1299999999999999 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.3700000000000001 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 1.0700000000000001 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.91000000000000003 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 1.2 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.8500000000000001 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.73 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.94999999999999996 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 1.1599999999999999 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 1.4299999999999999 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.2400000000000002 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.8600000000000001 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 1.3999999999999999 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.3999999999999999 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.8399999999999999 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.1899999999999999 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.3700000000000001 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.2 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.5299999999999998 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 2.6099999999999999 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.79000000000000004 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.535 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.57999999999999996 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.97 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 2.5 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 1.4299999999999999 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.6299999999999999 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.686 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 3.5299999999999998 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.95999999999999996 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.843 ' HB ' ' OD1' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 1.21 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 1.6000000000000001 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 1.1200000000000001 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.8500000000000001 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 2.5 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.81999999999999995 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.7999999999999998 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.76 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 1.2 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.46 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.53000000000000003 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 4.04 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 1.3200000000000001 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.8 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.506 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.3199999999999998 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.444 ' C ' HD21 ' A' ' 156' ' ' ASN . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.4900000000000002 110.668 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.444 HD21 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.8900000000000001 108.984 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 110.858 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 1.5800000000000001 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 1.1200000000000001 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.9299999999999999 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.9199999999999999 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.95999999999999996 109.921 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 2.0600000000000001 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.5700000000000001 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 2.1800000000000002 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 1.5700000000000001 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.674 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.74 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.9199999999999999 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.69999999999999996 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 1.04 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 1.1399999999999999 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.626 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.45000000000000001 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 1.0700000000000001 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.0699999999999998 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.85999999999999999 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.68000000000000005 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.674 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.5 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.71 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.49 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 1.1100000000000001 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.34000000000000002 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.858 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77000000000000002 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.84999999999999998 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 1.24 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.8300000000000001 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.1800000000000002 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 2.0899999999999999 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 2.1600000000000001 110.646 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.9500000000000002 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.8799999999999999 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.95 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.54000000000000004 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.61 ' HD2' HD11 ' A' ' 43' ' ' ILE . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.79 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 1.1299999999999999 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.61 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 1.52 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.91000000000000003 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 1.1499999999999999 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.46999999999999997 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.556 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.71 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 1.3600000000000001 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.546 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 2.0 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.0899999999999999 111.202 -173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.8300000000000001 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.8200000000000001 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.57 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.8500000000000001 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.72 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.78 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.61 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.49 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.95 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 1.4099999999999999 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.41999999999999998 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.66000000000000003 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 1.7 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 1.03 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 1.0800000000000001 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.38 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.858 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 3.3199999999999998 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.81999999999999995 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 2.3599999999999999 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.46000000000000002 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.71 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.481 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.66000000000000003 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.77 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.24 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' HD22 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.1299999999999999 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 1.1399999999999999 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.89000000000000001 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.68000000000000005 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.55000000000000004 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 2.1600000000000001 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 1.1399999999999999 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 1.2 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.79 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.9399999999999999 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 1.1499999999999999 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 1.28 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.8100000000000001 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.654 HG23 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 1.3200000000000001 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 1.1000000000000001 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 1.3100000000000001 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.9199999999999999 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 1.1299999999999999 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.74 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB3' HD12 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.74 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 1.1599999999999999 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HH ' ' H ' ' A' ' 35' ' ' SER . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 1.0900000000000001 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.46 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.9300000000000002 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.59999999999999998 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.3100000000000001 109.599 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.5900000000000001 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.34999999999999998 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 1.1299999999999999 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.3700000000000001 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 1.0700000000000001 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.31 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.91000000000000003 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 12.9 m120 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.73 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.94999999999999996 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.691 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 1.1599999999999999 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 1.4299999999999999 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.2400000000000002 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.8600000000000001 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 1.3999999999999999 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.3999999999999999 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.8399999999999999 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.1899999999999999 110.509 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.3700000000000001 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.2 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.5299999999999998 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 2.6099999999999999 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.691 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.79000000000000004 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.97 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 2.5 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 1.4299999999999999 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.666 ' HB2' HG22 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.6299999999999999 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 3.5299999999999998 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 7.5 t30 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.95999999999999996 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 1.21 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 1.6000000000000001 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 1.1200000000000001 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.8500000000000001 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.5 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.7999999999999998 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.76 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 1.2 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.46 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.53000000000000003 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 4.04 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 1.3200000000000001 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.8 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HB2' HD21 ' A' ' 156' ' ' ASN . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.3199999999999998 109.069 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.437 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.4900000000000002 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.451 HD21 ' HB2' ' A' ' 154' ' ' GLU . 47.2 m-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.8900000000000001 110.487 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.721 0.296 . . . . 2.0800000000000001 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 1.5800000000000001 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 1.1200000000000001 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.9299999999999999 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.9199999999999999 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.95999999999999996 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.75 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 2.0600000000000001 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.5700000000000001 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 2.1800000000000002 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 1.5700000000000001 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.74 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.9199999999999999 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.69999999999999996 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 1.04 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.757 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 1.1399999999999999 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.745 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.45000000000000001 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 1.0700000000000001 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.0699999999999998 108.762 173.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.85999999999999999 112.996 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.834 HE21 ' HB2' ' A' ' 12' ' ' LEU . 9.1 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.71 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.918 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 1.1499999999999999 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 1.1100000000000001 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.477 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.34000000000000002 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77000000000000002 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.84999999999999998 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 1.24 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.1800000000000002 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 2.0899999999999999 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 2.1600000000000001 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.9500000000000002 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.8799999999999999 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.95 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92000000000000004 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.54000000000000004 109.475 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.79 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 1.1299999999999999 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 1.52 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.91000000000000003 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.572 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1499999999999999 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.46999999999999997 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.71 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 1.3600000000000001 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 2.0 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.0899999999999999 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.8300000000000001 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.8200000000000001 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.8500000000000001 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.72 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.78 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.4 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.49 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.8600000000000001 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.95 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 1.4099999999999999 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.41999999999999998 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.66000000000000003 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 1.7 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 1.03 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 1.0800000000000001 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.38 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 3.3199999999999998 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.81999999999999995 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 2.3599999999999999 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.46000000000000002 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.71 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.66000000000000003 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.77 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 1.24 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.1299999999999999 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 1.1399999999999999 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.89000000000000001 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.23 110.772 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.68000000000000005 111.948 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.55000000000000004 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 2.1600000000000001 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 1.1399999999999999 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 1.2 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.79 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.78 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.9399999999999999 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 1.1499999999999999 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 1.28 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.8100000000000001 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.572 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 1.3200000000000001 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 1.1000000000000001 110.542 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 1.3100000000000001 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.9199999999999999 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 1.1299999999999999 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.501 HG22 HD11 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.74 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.74 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 1.1599999999999999 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.716 ' CE1' HD22 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 1.0900000000000001 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.455 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.9300000000000002 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.59999999999999998 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.3100000000000001 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.5900000000000001 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.34999999999999998 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 1.1299999999999999 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.3700000000000001 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.31 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.91000000000000003 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 1.2 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.8500000000000001 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.73 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.413 ' HB3' HD23 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.94999999999999996 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.934 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 1.1599999999999999 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 1.4299999999999999 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.2400000000000002 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.8600000000000001 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 1.3999999999999999 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.3999999999999999 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.8399999999999999 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.1899999999999999 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.3700000000000001 111.809 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.2 112.07 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.5299999999999998 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 2.6099999999999999 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.934 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.79000000000000004 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.57999999999999996 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.97 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 2.5 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 1.4299999999999999 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.644 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.6299999999999999 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 3.5299999999999998 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.95999999999999996 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 1.21 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 1.6000000000000001 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.417 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 1.1200000000000001 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.8500000000000001 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 2.5 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.81999999999999995 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.7999999999999998 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.76 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 1.2 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.46 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.53000000000000003 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 4.04 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 1.3200000000000001 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.8 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.3199999999999998 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.4900000000000002 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.8900000000000001 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.895 0.379 . . . . 2.0800000000000001 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.88 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 1.1200000000000001 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.9299999999999999 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.9199999999999999 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.95999999999999996 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.6 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.2 t-20 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.5700000000000001 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 2.1800000000000002 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 1.5700000000000001 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.74 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 4.6 p30 -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.9199999999999999 110.443 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.69999999999999996 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 1.04 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 1.1399999999999999 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.45000000000000001 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 1.0700000000000001 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.0699999999999998 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.85999999999999999 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.68000000000000005 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.659 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.4 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.71 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.929 ' HG3' HD22 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 1.1100000000000001 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.34000000000000002 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.8 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77000000000000002 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.84999999999999998 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 1.24 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.88 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.1800000000000002 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.662 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 2.0899999999999999 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 2.1600000000000001 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.9500000000000002 111.026 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.8799999999999999 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.769 ' HG ' HG23 ' A' ' 65' ' ' VAL . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.95 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92000000000000004 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.54000000000000004 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.79 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 1.1299999999999999 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.902 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 1.52 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.91000000000000003 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 1.1499999999999999 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.46999999999999997 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.867 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.71 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.783 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 1.3600000000000001 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 2.0 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.0899999999999999 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.8300000000000001 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.8200000000000001 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.8500000000000001 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.72 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.78 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.3100000000000001 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.435 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.49 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.8600000000000001 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.859 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 1.4099999999999999 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.41999999999999998 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.66000000000000003 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 1.7 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 1.03 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 1.0800000000000001 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.38 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 3.3199999999999998 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 2.3599999999999999 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.46000000000000002 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.71 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.66000000000000003 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 48.6 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.77 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 1.24 110.149 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.1299999999999999 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 1.1399999999999999 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.89000000000000001 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.23 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.68000000000000005 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.55000000000000004 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 2.1600000000000001 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 1.1399999999999999 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.867 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 1.2 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.79 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.9399999999999999 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 1.1499999999999999 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 1.28 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.8100000000000001 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.599 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 1.3200000000000001 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 1.1000000000000001 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 1.3100000000000001 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.9199999999999999 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 1.1299999999999999 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.74 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.74 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 1.1599999999999999 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.761 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 1.0900000000000001 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.761 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.9300000000000002 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.59999999999999998 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.3100000000000001 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.34999999999999998 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 1.1299999999999999 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.3700000000000001 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 1.0700000000000001 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.31 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.91000000000000003 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 1.2 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.8500000000000001 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.73 109.312 175.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.466 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.94999999999999996 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 1.1599999999999999 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 1.4299999999999999 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.2400000000000002 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.8600000000000001 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 1.3999999999999999 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.3999999999999999 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.8399999999999999 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.1899999999999999 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.3700000000000001 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.2 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.5299999999999998 110.338 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 2.6099999999999999 109.751 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.466 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.79000000000000004 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.65 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.57999999999999996 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.97 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 2.5 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 1.4299999999999999 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.6299999999999999 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 3.5299999999999998 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.95999999999999996 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.725 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 1.21 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 1.6000000000000001 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 1.1200000000000001 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.8500000000000001 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 2.5 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.81999999999999995 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.7999999999999998 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.76 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 1.2 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.46 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.53000000000000003 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 4.04 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.3200000000000001 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.8 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.469 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.3199999999999998 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.4900000000000002 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.8900000000000001 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 2.0800000000000001 109.782 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 1.5800000000000001 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 1.1200000000000001 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.9299999999999999 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.9199999999999999 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.95999999999999996 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 2.0600000000000001 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.5700000000000001 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 2.1800000000000002 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 1.5700000000000001 110.077 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.74 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.968 ' HB2' HE21 ' A' ' 23' ' ' GLN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.9199999999999999 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.69999999999999996 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 1.04 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 1.1399999999999999 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.45000000000000001 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 1.0700000000000001 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.0699999999999998 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.85999999999999999 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.68000000000000005 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.968 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.0 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.71 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG2' HG21 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 1.1499999999999999 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 1.1100000000000001 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.34000000000000002 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77000000000000002 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.84999999999999998 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 1.24 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.8300000000000001 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.497 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 2.0899999999999999 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 2.1600000000000001 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.9500000000000002 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.493 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.8799999999999999 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.95 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92000000000000004 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.54000000000000004 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.79 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.734 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 1.1299999999999999 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 1.52 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.91000000000000003 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 1.1499999999999999 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.594 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.46999999999999997 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.776 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.71 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 1.3600000000000001 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.776 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 2.0 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.0899999999999999 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.8300000000000001 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.8200000000000001 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.8500000000000001 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.72 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG21 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.78 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.3100000000000001 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.49 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.8600000000000001 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.95 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 1.4099999999999999 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' OD1' ' A' ' 37' ' ' ASP . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.41999999999999998 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.66000000000000003 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 1.7 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 1.03 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0800000000000001 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.38 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 3.3199999999999998 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.81999999999999995 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 2.3599999999999999 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.46000000000000002 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.497 HG21 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.71 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.734 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.66000000000000003 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.2 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 1.24 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.1299999999999999 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 1.1399999999999999 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.89000000000000001 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.23 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.68000000000000005 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.55000000000000004 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 2.1600000000000001 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 1.1399999999999999 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.831 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 1.2 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.79 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.831 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.9399999999999999 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 1.1499999999999999 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 1.28 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.8100000000000001 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 1.3200000000000001 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 1.1000000000000001 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 1.3100000000000001 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.9199999999999999 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 1.1299999999999999 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.74 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.497 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.9300000000000002 110.833 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.59999999999999998 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.5900000000000001 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.5 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.34999999999999998 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 1.1299999999999999 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.3700000000000001 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 1.0700000000000001 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.31 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.91000000000000003 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 1.2 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.8500000000000001 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 174.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.409 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.94999999999999996 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 1.1599999999999999 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 1.4299999999999999 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.2400000000000002 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.8600000000000001 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 1.3999999999999999 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.3999999999999999 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.8399999999999999 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.1899999999999999 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.3700000000000001 111.877 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.2 111.794 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.5299999999999998 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 2.6099999999999999 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.667 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.79000000000000004 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.621 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.57999999999999996 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.97 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 2.5 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 1.4299999999999999 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.6299999999999999 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.552 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 3.5299999999999998 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.95999999999999996 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 1.21 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.6000000000000001 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 1.1200000000000001 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.8500000000000001 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 2.5 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.81999999999999995 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.7999999999999998 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.76 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 1.2 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.46 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.53000000000000003 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 4.04 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 106' ' ' PHE . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 1.3200000000000001 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.8 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.514 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.3199999999999998 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.4900000000000002 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.8900000000000001 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 2.0800000000000001 111.054 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 1.5800000000000001 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 1.1200000000000001 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.9299999999999999 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.95999999999999996 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 2.0600000000000001 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.5700000000000001 108.668 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.8 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 2.1800000000000002 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 1.5700000000000001 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.683 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.74 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 12' ' ' LEU . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.9199999999999999 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.69999999999999996 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 1.04 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 1.1399999999999999 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.45000000000000001 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 1.0700000000000001 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.0699999999999998 108.672 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.85999999999999999 113.377 -174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.68000000000000005 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.683 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.7 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.71 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.8 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 1.1499999999999999 110.931 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 1.1100000000000001 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.652 ' HG ' HG11 ' A' ' 65' ' ' VAL . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.84999999999999998 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 1.24 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.8300000000000001 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.1800000000000002 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 2.0899999999999999 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 2.1600000000000001 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.9500000000000002 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.8799999999999999 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.95 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HA ' HD11 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92000000000000004 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.54000000000000004 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.79 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 1.1299999999999999 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.654 HG12 HG21 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 1.52 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.91000000000000003 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 1.1499999999999999 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.582 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.46999999999999997 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.71 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 1.3600000000000001 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 2.0 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.0899999999999999 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.8300000000000001 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.582 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.8500000000000001 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.72 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.49 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.8600000000000001 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.95 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 1.4099999999999999 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.41999999999999998 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.66000000000000003 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.652 HG11 ' HG ' ' A' ' 30' ' ' CYS . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 1.7 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 1.03 113.441 -171.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 1.0800000000000001 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.38 111.936 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 3.3199999999999998 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.81999999999999995 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 2.3599999999999999 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.46000000000000002 110.046 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.71 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.66000000000000003 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.0 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.77 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.1299999999999999 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.1399999999999999 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.89000000000000001 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.23 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.68000000000000005 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.55000000000000004 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 2.1600000000000001 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.517 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 1.1399999999999999 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 1.2 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.79 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.9399999999999999 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 1.1499999999999999 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 1.28 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.8100000000000001 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.638 HG21 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 1.3200000000000001 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 1.1000000000000001 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 1.3100000000000001 108.983 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.9199999999999999 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.553 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 1.1299999999999999 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.74 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.74 110.251 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 1.1599999999999999 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 1.0900000000000001 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.9300000000000002 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.59999999999999998 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.3100000000000001 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.5900000000000001 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.34999999999999998 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 1.1299999999999999 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.3700000000000001 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 1.0700000000000001 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.31 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.91000000000000003 110.823 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 1.2 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.8500000000000001 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.73 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 1.1599999999999999 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 1.4299999999999999 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.2400000000000002 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.8600000000000001 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 1.3999999999999999 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.3999999999999999 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.8399999999999999 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.1899999999999999 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.3700000000000001 111.262 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.2 111.689 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.5299999999999998 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 2.6099999999999999 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.79000000000000004 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.716 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.57999999999999996 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.97 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 2.5 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 1.4299999999999999 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.558 ' HB2' HG21 ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.6299999999999999 108.452 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 3.5299999999999998 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.95999999999999996 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 1.21 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 1.6000000000000001 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 1.1200000000000001 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.8500000000000001 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 2.5 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.7999999999999998 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 1.2 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.46 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.53000000000000003 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 4.04 110.045 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 1.3200000000000001 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.8 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.438 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.3199999999999998 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.4900000000000002 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.8900000000000001 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.666 0.269 . . . . 2.0800000000000001 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 1.1200000000000001 109.415 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.612 ' HB2' HD12 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.9299999999999999 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.9199999999999999 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.95999999999999996 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 9.5 t30 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 2.0600000000000001 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.414 HG11 ' HH ' ' A' ' 111' ' ' TYR . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.5700000000000001 109.302 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 2.1800000000000002 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 141' ' ' ALA . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 1.5700000000000001 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.74 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.756 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.588 ' OD1' HG11 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.69999999999999996 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.565 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 1.04 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 1.1399999999999999 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.45000000000000001 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 1.0700000000000001 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.565 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.0699999999999998 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.85999999999999999 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.676 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.68000000000000005 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.756 HE21 ' HB2' ' A' ' 13' ' ' ASP . 8.3 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.71 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.568 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 1.1499999999999999 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 1.1100000000000001 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77000000000000002 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.84999999999999998 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 1.24 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.8300000000000001 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.1800000000000002 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 2.0899999999999999 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 2.1600000000000001 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.9500000000000002 109.582 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.8799999999999999 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.95 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92000000000000004 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.54000000000000004 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.79 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 1.1299999999999999 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HG12 HG23 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 1.52 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.91000000000000003 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.55 HG23 ' HB ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 1.1499999999999999 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.71 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 1.3600000000000001 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.616 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 2.0 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.0899999999999999 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.8300000000000001 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.8200000000000001 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.603 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.8500000000000001 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG23 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.72 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.78 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.49 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.8600000000000001 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.95 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 1.4099999999999999 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.41999999999999998 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.66000000000000003 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 1.7 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 1.03 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 1.0800000000000001 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.38 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 3.3199999999999998 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.81999999999999995 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 2.3599999999999999 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.46000000000000002 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.71 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.66000000000000003 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.77 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 1.24 110.18 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.1299999999999999 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 1.1399999999999999 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.89000000000000001 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.23 111.991 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.68000000000000005 112.207 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.55000000000000004 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 2.1600000000000001 110.741 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 1.1399999999999999 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 1.2 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.79 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.661 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.9399999999999999 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 1.1499999999999999 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 1.28 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.8100000000000001 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 1.3200000000000001 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 1.1000000000000001 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.3100000000000001 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.9199999999999999 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 1.1299999999999999 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.74 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.74 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 1.1599999999999999 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.808 ' HH ' ' HB2' ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 1.0900000000000001 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.9300000000000002 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.59999999999999998 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.3100000000000001 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.34999999999999998 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 1.1299999999999999 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.3700000000000001 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 1.0700000000000001 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.509 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.31 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.425 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.91000000000000003 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 1.2 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.73 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' HD23 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.94999999999999996 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.592 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 1.1599999999999999 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 1.4299999999999999 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.2400000000000002 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.8600000000000001 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 1.3999999999999999 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.3999999999999999 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.8399999999999999 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.1899999999999999 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.521 ' HB3' HG12 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.3700000000000001 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.2 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.5299999999999998 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 2.6099999999999999 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.592 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.79000000000000004 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.57999999999999996 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.97 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 2.5 109.802 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 1.4299999999999999 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.6299999999999999 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.442 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 3.5299999999999998 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.95999999999999996 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.517 HD12 ' ND2' ' A' ' 14' ' ' ASN . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 1.21 109.919 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 1.6000000000000001 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.612 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.8500000000000001 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 2.5 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.81999999999999995 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.7999999999999998 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.76 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 1.2 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.46 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.53000000000000003 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 4.04 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 1.3200000000000001 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.8 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.3199999999999998 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.4900000000000002 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.8900000000000001 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 2.0800000000000001 112.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 1.5800000000000001 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 1.1200000000000001 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.9299999999999999 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.9199999999999999 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.95999999999999996 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 2.0600000000000001 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.5700000000000001 109.782 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 2.1800000000000002 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 1.5700000000000001 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.74 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.9199999999999999 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.69999999999999996 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 1.04 110.499 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 1.1399999999999999 114.275 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.45000000000000001 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 1.0700000000000001 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.0699999999999998 108.945 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.85999999999999999 112.702 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.68000000000000005 109.126 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.3 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.71 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 1.1499999999999999 111.451 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 1.1100000000000001 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.34000000000000002 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77000000000000002 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.84999999999999998 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 1.24 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.8300000000000001 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.1800000000000002 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 ' CG1' ' A' ' 65' ' ' VAL . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 2.0899999999999999 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 2.1600000000000001 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.9500000000000002 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.528 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.8799999999999999 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.95 109.904 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' A' ' 41' ' ' LYS . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92000000000000004 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.54000000000000004 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.79 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 1.1299999999999999 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 1.52 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.91000000000000003 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 1.1499999999999999 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.46999999999999997 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.982 ' HG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.71 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 1.3600000000000001 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.0899999999999999 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.8300000000000001 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.588 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.8200000000000001 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.588 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.72 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.78 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.49 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.8600000000000001 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.95 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 1.4099999999999999 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.41999999999999998 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.66000000000000003 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' CG1' HD21 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 1.7 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 1.03 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 1.0800000000000001 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.38 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 3.3199999999999998 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.81999999999999995 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 2.3599999999999999 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.46000000000000002 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.71 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.66000000000000003 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.77 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 1.24 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.1299999999999999 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 1.1399999999999999 110.548 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.89000000000000001 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.23 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.68000000000000005 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.55000000000000004 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 2.1600000000000001 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 1.1399999999999999 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 1.2 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.79 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 1.12 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.9399999999999999 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 1.1499999999999999 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 1.28 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.8100000000000001 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.558 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 1.3200000000000001 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 1.1000000000000001 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 1.3100000000000001 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.9199999999999999 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.614 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 1.1299999999999999 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.74 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.74 109.639 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 1.1599999999999999 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 1.0900000000000001 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.9300000000000002 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.59999999999999998 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.467 HE22 ' ND2' ' A' ' 152' ' ' ASN . 21.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.3100000000000001 110.033 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.5900000000000001 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.34999999999999998 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 1.1299999999999999 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.4 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.3700000000000001 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 1.0700000000000001 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.31 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.91000000000000003 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 1.2 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.8500000000000001 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.73 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.94999999999999996 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.651 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 1.1599999999999999 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 1.4299999999999999 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.2400000000000002 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.673 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.8600000000000001 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 1.3999999999999999 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.3999999999999999 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.8399999999999999 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.1899999999999999 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.621 ' HB3' HG12 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.3700000000000001 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.2 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.5299999999999998 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 2.6099999999999999 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.651 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.79000000000000004 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' H ' ' HH ' ' A' ' 117' ' ' TYR . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.579 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.57999999999999996 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.532 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.97 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 2.5 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 1.4299999999999999 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.435 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 3.5299999999999998 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.95999999999999996 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 1.21 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 1.6000000000000001 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 1.1200000000000001 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.8500000000000001 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 2.5 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.81999999999999995 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.7999999999999998 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.76 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.4 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 1.2 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.46 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.53000000000000003 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 4.04 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 1.3200000000000001 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.467 ' ND2' HE22 ' A' ' 104' ' ' GLN . 7.7 p30 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.8 109.657 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.473 ' HZ3' HD23 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.3199999999999998 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.4900000000000002 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.8900000000000001 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 109.876 -0.416 . . . . 2.0800000000000001 109.876 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.759 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 1.5800000000000001 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 1.1200000000000001 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.9299999999999999 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.9199999999999999 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 2.0600000000000001 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.5700000000000001 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 1.5700000000000001 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.74 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 15' ' ' PRO . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.9199999999999999 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.69999999999999996 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.736 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 1.04 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 1.1399999999999999 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.45000000000000001 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 1.0700000000000001 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.0699999999999998 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.85999999999999999 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.68000000000000005 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.739 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.71 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 1.1499999999999999 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 1.1100000000000001 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.34000000000000002 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.84999999999999998 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 1.24 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.759 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.8300000000000001 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.1800000000000002 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 2.0899999999999999 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.9500000000000002 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.8799999999999999 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.492 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.95 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92000000000000004 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.45 ' CZ3' HG23 ' A' ' 26' ' ' ILE . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.54000000000000004 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.79 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.566 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 1.1299999999999999 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.626 HG13 HG21 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 1.52 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.91000000000000003 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HB ' HG21 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 1.1499999999999999 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.46999999999999997 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.66 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.71 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 1.3600000000000001 108.704 168.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 2.0 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.0899999999999999 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.8300000000000001 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.558 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.8200000000000001 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.8500000000000001 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.626 HG21 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.72 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.78 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.49 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.95 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 1.4099999999999999 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.41999999999999998 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.66000000000000003 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.06 ' HB ' HD22 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 1.7 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 1.03 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 111.42 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.38 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 3.3199999999999998 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.81999999999999995 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 2.3599999999999999 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.46000000000000002 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.71 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.66000000000000003 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.77 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 1.24 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.1299999999999999 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 1.1399999999999999 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.57 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.89000000000000001 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.23 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.68000000000000005 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.55000000000000004 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 2.1600000000000001 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 1.1399999999999999 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.66 ' HG2' ' HG ' ' A' ' 47' ' ' SER . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 1.2 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.79 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.599 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.9399999999999999 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 1.1499999999999999 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 1.28 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.8100000000000001 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 1.3200000000000001 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 1.1000000000000001 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 1.3100000000000001 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.9199999999999999 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.566 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 1.1299999999999999 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.74 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.74 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.1599999999999999 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.534 ' HH ' ' HB2' ' A' ' 34' ' ' LEU . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 1.0900000000000001 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.9300000000000002 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.59999999999999998 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.421 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 26.8 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.3100000000000001 109.85 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.5900000000000001 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.34999999999999998 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 1.1299999999999999 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.3700000000000001 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 1.0700000000000001 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.31 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.91000000000000003 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 1.2 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.526 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.73 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.491 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.94999999999999996 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.727 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 1.1599999999999999 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 1.4299999999999999 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.2400000000000002 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.8600000000000001 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 1.3999999999999999 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.3999999999999999 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.8399999999999999 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.1899999999999999 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.3700000000000001 110.937 169.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.2 111.19 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.5299999999999998 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 2.6099999999999999 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.727 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.79000000000000004 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.686 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.57999999999999996 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.447 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 2.5 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 1.4299999999999999 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.6299999999999999 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 3.5299999999999998 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.95999999999999996 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.452 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.21 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 1.6000000000000001 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 1.1200000000000001 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 2.5 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.81999999999999995 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.7999999999999998 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.76 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 1.2 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.46 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.53000000000000003 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 4.04 109.418 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.421 ' HB ' ' NE2' ' A' ' 104' ' ' GLN . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 1.3200000000000001 110.58 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.8 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.638 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.3199999999999998 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.4900000000000002 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.8900000000000001 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.057 0.456 . . . . 2.0800000000000001 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.902 ' HZ3' ' HG3' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 1.5800000000000001 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 1.1200000000000001 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.9299999999999999 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.9199999999999999 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.95999999999999996 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.542 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 2.0600000000000001 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.5700000000000001 109.909 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 2.1800000000000002 110.412 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 1.5700000000000001 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.74 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.794 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.9199999999999999 111.381 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.69999999999999996 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 1.04 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 1.1399999999999999 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.45000000000000001 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 1.0700000000000001 111.634 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.0699999999999998 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.85999999999999999 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.68000000000000005 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.794 HE21 ' HB2' ' A' ' 13' ' ' ASP . 16.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.71 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 1.1499999999999999 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 1.1100000000000001 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.34000000000000002 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77000000000000002 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.84999999999999998 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 1.24 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.902 ' HG3' ' HZ3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.8300000000000001 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.1800000000000002 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.82 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 2.0899999999999999 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 2.1600000000000001 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.8799999999999999 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.95 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92000000000000004 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.428 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.54000000000000004 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.79 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 1.1299999999999999 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.603 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 1.52 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.443 ' HE1' HG13 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.91000000000000003 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 1.1499999999999999 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.602 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.46999999999999997 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.912 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.71 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 1.3600000000000001 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 2.0 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.0899999999999999 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.8300000000000001 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.912 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.8200000000000001 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.602 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.8500000000000001 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.78 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.3100000000000001 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.617 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.49 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.8600000000000001 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.95 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 1.4099999999999999 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.41999999999999998 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.66000000000000003 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 1.7 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 1.03 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 1.0800000000000001 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.38 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 3.3199999999999998 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.81999999999999995 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 2.3599999999999999 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.46000000000000002 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.71 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.492 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.66000000000000003 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.77 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 1.24 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.1299999999999999 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 1.1399999999999999 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 57' ' ' LEU . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.89000000000000001 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.672 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.23 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.68000000000000005 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.55000000000000004 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.672 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 2.1600000000000001 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 1.1399999999999999 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG3' ' CB ' ' A' ' 47' ' ' SER . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 1.2 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.79 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.9399999999999999 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 1.1499999999999999 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 1.28 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.8100000000000001 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 1.3200000000000001 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 1.1000000000000001 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 1.3100000000000001 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.687 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.9199999999999999 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 1.1299999999999999 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.74 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.74 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 1.1599999999999999 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 1.0900000000000001 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.59999999999999998 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.471 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.3100000000000001 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.5900000000000001 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.34999999999999998 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 1.1299999999999999 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.496 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.3700000000000001 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 1.0700000000000001 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.91000000000000003 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 1.2 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.443 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.8500000000000001 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.73 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' HD22 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.774 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 1.1599999999999999 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 1.4299999999999999 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.2400000000000002 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.8600000000000001 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 1.3999999999999999 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.3999999999999999 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.8399999999999999 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.1899999999999999 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.3700000000000001 111.825 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.2 112.005 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.5299999999999998 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 2.6099999999999999 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.79000000000000004 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.57999999999999996 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 2.5 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 135' ' ' LEU . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 1.4299999999999999 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.5 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.6299999999999999 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 3.5299999999999998 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.95999999999999996 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 1.21 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 1.6000000000000001 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 1.1200000000000001 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.8500000000000001 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 2.5 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.81999999999999995 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.7999999999999998 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.76 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 1.2 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.46 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.53000000000000003 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 4.04 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 1.3200000000000001 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.853 HD22 ' HA ' ' A' ' 155' ' ' ASP . 6.2 t30 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.8 110.427 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.3199999999999998 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.853 ' HA ' HD22 ' A' ' 152' ' ' ASN . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.4900000000000002 111.502 -166.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.8900000000000001 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 2.0800000000000001 110.373 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 1.5800000000000001 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 1.1200000000000001 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.9299999999999999 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.9199999999999999 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.95999999999999996 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 2.0600000000000001 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.5700000000000001 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 2.1800000000000002 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 1.5700000000000001 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.74 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.9199999999999999 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.69999999999999996 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 1.04 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 1.1399999999999999 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.45000000000000001 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 1.0700000000000001 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.0699999999999998 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.85999999999999999 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.68000000000000005 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.739 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.71 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.868 ' HG2' HG23 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 1.1499999999999999 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.34000000000000002 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77000000000000002 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.84999999999999998 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 1.24 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.8300000000000001 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.1800000000000002 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 2.0899999999999999 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 2.1600000000000001 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.9500000000000002 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.8799999999999999 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.412 HD11 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.95 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92000000000000004 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.412 ' NE1' HD11 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.54000000000000004 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.63 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.79 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.627 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 1.1299999999999999 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 1.52 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.91000000000000003 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 1.1499999999999999 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.46999999999999997 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.549 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.71 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 1.3600000000000001 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 2.0 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.0899999999999999 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.8300000000000001 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.641 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.8200000000000001 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.8500000000000001 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.72 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.78 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.3100000000000001 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.63 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.49 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.8600000000000001 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.95 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 1.4099999999999999 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.41999999999999998 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.66000000000000003 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 1.7 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 1.03 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 1.0800000000000001 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.38 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 3.3199999999999998 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.81999999999999995 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 2.3599999999999999 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.46000000000000002 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.868 HG23 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.71 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.66000000000000003 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.77 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 1.24 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.1299999999999999 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 1.1399999999999999 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.89000000000000001 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.23 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.68000000000000005 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.55000000000000004 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 1.1399999999999999 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 1.2 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.79 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.711 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.9399999999999999 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 1.1499999999999999 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 1.28 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.8100000000000001 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 1.3200000000000001 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 1.1000000000000001 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 1.3100000000000001 108.436 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.7 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.9199999999999999 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 1.1299999999999999 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.74 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.74 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 1.1599999999999999 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 1.0900000000000001 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.9300000000000002 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.59999999999999998 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3100000000000001 109.751 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.5900000000000001 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.34999999999999998 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.419 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 1.1299999999999999 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.3700000000000001 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 1.0700000000000001 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.31 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.91000000000000003 110.121 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 1.2 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.8500000000000001 110.819 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.73 109.079 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.94999999999999996 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 1.1599999999999999 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 1.4299999999999999 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.2400000000000002 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.8600000000000001 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 1.3999999999999999 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.3999999999999999 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.8399999999999999 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.1899999999999999 111.353 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.3700000000000001 111.671 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.2 112.267 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.5299999999999998 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 2.6099999999999999 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.79000000000000004 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.57999999999999996 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 2.5 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 1.4299999999999999 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.3 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.6299999999999999 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 3.5299999999999998 109.978 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.95999999999999996 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 1.21 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 1.6000000000000001 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 1.1200000000000001 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.8500000000000001 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 2.5 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.81999999999999995 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.7999999999999998 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.76 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 1.2 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.46 110.553 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.53000000000000003 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 4.04 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 1.3200000000000001 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.8 109.915 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.3199999999999998 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.47 ' C ' HD21 ' A' ' 156' ' ' ASN . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.4900000000000002 108.968 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.8900000000000001 109.669 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 2.0800000000000001 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 1.5800000000000001 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 1.1200000000000001 110.331 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.9299999999999999 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.9199999999999999 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.676 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.0 t-20 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 2.0600000000000001 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.5700000000000001 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 2.1800000000000002 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 1.5700000000000001 109.376 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.744 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.74 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.403 ' HB2' HE21 ' A' ' 23' ' ' GLN . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.439 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.9199999999999999 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.69999999999999996 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 1.04 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 1.1399999999999999 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.45000000000000001 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 1.0700000000000001 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.776 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.0699999999999998 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.85999999999999999 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.68000000000000005 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.744 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.0 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.71 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.504 HD12 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 1.1499999999999999 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.676 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 1.1100000000000001 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77000000000000002 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.84999999999999998 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 1.24 108.557 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.688 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD22 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 2.0899999999999999 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 2.1600000000000001 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.9500000000000002 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.8799999999999999 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.95 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92000000000000004 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.54000000000000004 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.79 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 1.1299999999999999 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 1.52 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.542 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.91000000000000003 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 1.1499999999999999 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.46999999999999997 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.655 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.71 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 1.3600000000000001 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 2.0 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.0899999999999999 111.189 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.8300000000000001 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.8200000000000001 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.8500000000000001 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.826 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.72 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.621 HD23 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.78 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.3100000000000001 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.49 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.95 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 1.4099999999999999 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.41999999999999998 112.17 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.66000000000000003 110.243 -14.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 1.7 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 1.03 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.38 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 3.3199999999999998 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.81999999999999995 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 2.3599999999999999 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.46000000000000002 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.71 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.66000000000000003 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.428 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 25.2 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.77 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 1.24 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.1299999999999999 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 1.1399999999999999 113.794 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.89000000000000001 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.535 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.23 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.68000000000000005 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.55000000000000004 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.535 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 2.1600000000000001 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.1399999999999999 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.678 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 1.2 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.79 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.9399999999999999 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 1.1499999999999999 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 1.28 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.8100000000000001 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.417 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 1.3200000000000001 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 1.1000000000000001 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 1.3100000000000001 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.9199999999999999 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 1.1299999999999999 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.74 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.476 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.74 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 1.1599999999999999 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.5 ' CE1' HD22 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 1.0900000000000001 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.474 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.9300000000000002 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.59999999999999998 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.3100000000000001 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.5900000000000001 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.494 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.34999999999999998 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 1.1299999999999999 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 96' ' ' LEU . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.3700000000000001 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.0700000000000001 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.31 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.91000000000000003 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.749 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 1.2 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.8500000000000001 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.73 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.689 HD21 HD11 ' A' ' 135' ' ' LEU . 10.0 m120 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.94999999999999996 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 1.1599999999999999 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 1.4299999999999999 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.8600000000000001 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 1.3999999999999999 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.3999999999999999 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.8399999999999999 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.3700000000000001 110.68 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.2 111.463 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.5299999999999998 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 2.6099999999999999 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.715 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.79000000000000004 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.716 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.57999999999999996 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.97 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 2.5 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.689 HD11 HD21 ' A' ' 115' ' ' ASN . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 1.4299999999999999 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.586 ' HB2' HG21 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.6299999999999999 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.945 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 3.5299999999999998 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.95999999999999996 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.945 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 1.21 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 1.6000000000000001 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.8500000000000001 109.524 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 2.9 t-20 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 2.5 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.81999999999999995 112.105 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.749 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.7999999999999998 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.76 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 1.2 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.46 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.53000000000000003 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 4.04 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.494 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 1.3200000000000001 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.8 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.3199999999999998 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.4900000000000002 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.8900000000000001 110.096 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' HE1' ' HD1' ' A' ' 153' ' ' TRP . 26.9 ptm . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.514 0.197 . . . . 3.2599999999999998 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 31' ' ' ILE . . . -74.29 135.82 42.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 111.013 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 1.5800000000000001 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 1.1200000000000001 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.9299999999999999 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.9199999999999999 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.95999999999999996 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 2.0600000000000001 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 HG21 ' HH ' ' A' ' 111' ' ' TYR . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.5700000000000001 110.112 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 2.1800000000000002 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 1.5700000000000001 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.74 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.776 ' HB2' HE21 ' A' ' 23' ' ' GLN . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.9199999999999999 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.69999999999999996 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 1.04 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 1.1399999999999999 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.726 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.45000000000000001 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 1.0700000000000001 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.85999999999999999 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.68000000000000005 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.776 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.6 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.71 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 1.1499999999999999 111.377 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 1.1100000000000001 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.34000000000000002 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77000000000000002 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.84999999999999998 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 1.24 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.8300000000000001 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 2.0899999999999999 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 2.1600000000000001 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.9500000000000002 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.8799999999999999 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.95 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92000000000000004 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.54000000000000004 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.79 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.457 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 1.1299999999999999 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 1.52 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.812 ' HH ' HH12 ' A' ' 137' ' ' ARG . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.91000000000000003 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 1.1499999999999999 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.722 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.71 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 1.3600000000000001 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 2.0 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.0899999999999999 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.8300000000000001 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.8200000000000001 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.8500000000000001 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.72 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.78 111.299 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.3100000000000001 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.511 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.49 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.8600000000000001 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.95 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 65' ' ' VAL . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 1.4099999999999999 109.913 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.41999999999999998 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.66000000000000003 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 1.7 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 1.03 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 1.0800000000000001 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.38 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 3.3199999999999998 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.81999999999999995 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.475 ' HG3' ' HG1' ' A' ' 27' ' ' THR . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 2.3599999999999999 109.985 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.46000000000000002 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.71 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.66000000000000003 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 20.8 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.77 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 1.24 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.1299999999999999 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 1.1399999999999999 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.89000000000000001 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.23 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.68000000000000005 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.55000000000000004 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 2.1600000000000001 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 1.1399999999999999 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 1.002 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 1.2 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.79 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 1.002 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.9399999999999999 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.1499999999999999 110.578 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 1.28 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.8100000000000001 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 1.3200000000000001 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 1.1000000000000001 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 1.3100000000000001 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.9199999999999999 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 1.1299999999999999 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.74 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.74 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 1.1599999999999999 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 1.0900000000000001 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.9300000000000002 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.59999999999999998 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.3100000000000001 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.5900000000000001 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.34999999999999998 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 1.1299999999999999 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.3700000000000001 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 1.0700000000000001 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.31 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.521 ' HB2' HG12 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.91000000000000003 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 1.2 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.516 HG23 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.8500000000000001 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.73 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.94999999999999996 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.576 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 1.1599999999999999 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.916 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 1.4299999999999999 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.2400000000000002 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.408 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.8600000000000001 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 1.3999999999999999 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.3999999999999999 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.8399999999999999 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.1899999999999999 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.3700000000000001 111.304 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.2 111.753 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.5299999999999998 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 2.6099999999999999 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.576 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.79000000000000004 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.489 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.57999999999999996 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.97 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 2.5 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 1.4299999999999999 110.458 -171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.916 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.812 HH12 ' HH ' ' A' ' 44' ' ' TYR . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 3.5299999999999998 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.95999999999999996 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.588 HG22 HG12 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 1.21 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 1.6000000000000001 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 1.1200000000000001 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.8500000000000001 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 2.5 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.81999999999999995 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.7999999999999998 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.76 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 1.2 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.46 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.53000000000000003 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 4.04 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 1.3200000000000001 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.8 109.848 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.3199999999999998 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.4900000000000002 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.8900000000000001 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.573 ' HE1' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.765 0.283 . . . . 3.2599999999999998 111.765 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.88 -84.63 0.41 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.416 -0.514 . . . . 2.0800000000000001 111.209 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.562 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 1.5800000000000001 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 1.1200000000000001 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.9299999999999999 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.9199999999999999 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.95999999999999996 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.77 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 2.0600000000000001 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.5700000000000001 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 2.1800000000000002 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 1.5700000000000001 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.74 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.9199999999999999 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.69999999999999996 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 1.04 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 1.1399999999999999 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.45000000000000001 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 1.0700000000000001 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.657 ' ND2' HH21 ' A' ' 137' ' ' ARG . 0.0 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.0699999999999998 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.85999999999999999 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.68000000000000005 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 7.5 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.71 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 HD11 HD12 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 1.1499999999999999 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 1.1100000000000001 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.34000000000000002 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77000000000000002 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.84999999999999998 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 1.24 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.562 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.8300000000000001 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.1800000000000002 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 2.0899999999999999 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 2.1600000000000001 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.673 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.9500000000000002 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.8799999999999999 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.95 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92000000000000004 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.54000000000000004 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.79 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.539 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 1.1299999999999999 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.669 ' HB ' HD13 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 1.52 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' HE1' HG13 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.91000000000000003 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 1.1499999999999999 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.46999999999999997 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.611 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.71 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 1.3600000000000001 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 2.0 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.0899999999999999 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.8300000000000001 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.459 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.8200000000000001 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.8500000000000001 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.72 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD23 ' HG3' ' A' ' 79' ' ' PRO . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.78 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.3100000000000001 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.49 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.8600000000000001 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.95 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 1.4099999999999999 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.41999999999999998 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.66000000000000003 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.636 ' HB ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 1.7 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 1.03 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 1.0800000000000001 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.38 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 3.3199999999999998 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.81999999999999995 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 2.3599999999999999 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.46000000000000002 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.71 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.66000000000000003 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.77 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 1.24 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.1299999999999999 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 1.1399999999999999 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.89000000000000001 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.23 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.68000000000000005 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.55000000000000004 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 2.1600000000000001 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 1.1399999999999999 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.83 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 1.2 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.79 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.83 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.9399999999999999 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 1.1499999999999999 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 1.28 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.8100000000000001 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 1.3200000000000001 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 1.1000000000000001 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 1.3100000000000001 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.9199999999999999 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.537 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 1.1299999999999999 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.74 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.74 110.717 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 1.1599999999999999 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 1.0900000000000001 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.9300000000000002 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.59999999999999998 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.3100000000000001 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.5900000000000001 110.5 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.34999999999999998 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 1.1299999999999999 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.433 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 1.0700000000000001 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.31 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.91000000000000003 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 1.2 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.582 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.8500000000000001 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.73 109.478 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.94999999999999996 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.793 ' HH ' ' H ' ' A' ' 131' ' ' ASP . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 1.1599999999999999 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 1.4299999999999999 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.2400000000000002 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.8600000000000001 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 1.3999999999999999 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.3999999999999999 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.8399999999999999 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.1899999999999999 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.3700000000000001 110.451 165.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.2 112.539 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.5299999999999998 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 2.6099999999999999 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.79000000000000004 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.793 ' H ' ' HH ' ' A' ' 117' ' ' TYR . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.646 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.57999999999999996 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.97 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 2.5 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 1.4299999999999999 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.635 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.6299999999999999 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.934 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 3.5299999999999998 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.95999999999999996 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.934 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 1.21 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 1.6000000000000001 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 1.1200000000000001 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.8500000000000001 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 2.5 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.81999999999999995 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.7999999999999998 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.76 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 1.2 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.46 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.53000000000000003 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 4.04 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.512 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 1.3200000000000001 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.8 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.486 ' HE1' ' HE2' ' A' ' 1' ' ' MET . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.3199999999999998 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.4900000000000002 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.8900000000000001 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.729 ' HE2' ' HA ' ' A' ' 150' ' ' HIS . 8.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.365 0.126 . . . . 3.2599999999999998 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -64.2 107.99 1.45 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 2.0800000000000001 110.788 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 1.5800000000000001 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG22 HD13 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 1.1200000000000001 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.9299999999999999 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.9199999999999999 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.95999999999999996 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.3 t30 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 2.0600000000000001 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.5700000000000001 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 2.1800000000000002 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 1.5700000000000001 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.74 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.9199999999999999 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.69999999999999996 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.629 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 1.04 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 1.1399999999999999 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.45000000000000001 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 1.0700000000000001 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.0699999999999998 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.85999999999999999 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.68000000000000005 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.713 HE21 ' HB2' ' A' ' 12' ' ' LEU . 2.8 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.71 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 1.1499999999999999 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 1.1100000000000001 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.34000000000000002 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77000000000000002 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.84999999999999998 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 1.24 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.8300000000000001 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 2.0899999999999999 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 2.1600000000000001 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.9500000000000002 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.95 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.687 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92000000000000004 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.54000000000000004 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.79 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 1.1299999999999999 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 1.52 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.91000000000000003 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG23 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 1.1499999999999999 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.46999999999999997 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.626 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.71 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 1.3600000000000001 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 2.0 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.0899999999999999 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.8300000000000001 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.595 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.8200000000000001 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.577 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.8500000000000001 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.72 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.78 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.3100000000000001 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.49 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.8600000000000001 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.687 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.95 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 1.4099999999999999 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.41999999999999998 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.66000000000000003 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 1.7 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 1.03 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 1.0800000000000001 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.38 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 3.3199999999999998 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.81999999999999995 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 2.3599999999999999 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.46000000000000002 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.71 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.66000000000000003 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.459 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.77 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 1.24 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.1299999999999999 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 1.1399999999999999 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.89000000000000001 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.493 ' CB ' HD12 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.23 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.68000000000000005 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.55000000000000004 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD12 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 2.1600000000000001 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 1.1399999999999999 110.418 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 1.2 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.79 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.757 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 1.1499999999999999 111.481 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 1.28 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.8100000000000001 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 1.1000000000000001 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 HG22 ' A' ' 113' ' ' VAL . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 1.3100000000000001 107.973 173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.9199999999999999 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 1.1299999999999999 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.74 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.74 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 1.1599999999999999 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.58 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 1.0900000000000001 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.459 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.9300000000000002 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.59999999999999998 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.3100000000000001 109.51 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.5900000000000001 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.34999999999999998 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 1.1299999999999999 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.3700000000000001 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 1.0700000000000001 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.31 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.91000000000000003 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.455 ' O ' HD12 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 1.2 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.8500000000000001 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HD13 ' A' ' 140' ' ' LEU . 2.3 m120 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.73 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.94999999999999996 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 1.1599999999999999 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.734 HG21 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 1.4299999999999999 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.2400000000000002 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.8600000000000001 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 1.3999999999999999 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.3999999999999999 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.8399999999999999 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.1899999999999999 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.3700000000000001 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.2 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.5299999999999998 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 2.6099999999999999 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.79000000000000004 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.57999999999999996 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.97 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 2.5 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 1.4299999999999999 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.734 ' HB2' HG21 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.6299999999999999 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 3.5299999999999998 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.572 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.95999999999999996 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.61 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 1.21 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 112' ' ' TYR . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 1.6000000000000001 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 1.1200000000000001 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.8500000000000001 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 2.5 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.81999999999999995 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.7999999999999998 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.76 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 1.2 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.46 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.53000000000000003 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.729 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 22.0 t-160 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 4.04 109.3 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 1.3200000000000001 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.8 110.075 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.616 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.3199999999999998 109.744 -170.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.459 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.4900000000000002 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 7.3 p30 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.8900000000000001 109.416 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 4.7 ppp? . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.807 0.337 . . . . 3.2599999999999998 110.806 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 139.89 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.323 -0.398 . . . . 2.0800000000000001 110.508 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' HZ2' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 1.5800000000000001 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 1.1200000000000001 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.9299999999999999 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.9199999999999999 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.95999999999999996 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.659 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 2.0600000000000001 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.5700000000000001 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.796 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.1800000000000002 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 1.5700000000000001 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.977 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.74 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.9199999999999999 110.05 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.69999999999999996 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 1.04 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 1.1399999999999999 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.45000000000000001 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 1.0700000000000001 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.0699999999999998 109.694 175.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.85999999999999999 111.971 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.68000000000000005 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.565 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.4 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.71 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.977 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 1.1499999999999999 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 1.1100000000000001 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.34000000000000002 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77000000000000002 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.84999999999999998 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 1.24 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.8300000000000001 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.1800000000000002 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 2.0899999999999999 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 2.1600000000000001 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.9500000000000002 109.432 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.8799999999999999 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.95 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.634 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92000000000000004 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.54000000000000004 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.643 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.79 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 1.1299999999999999 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 1.52 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.91000000000000003 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.632 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 1.1499999999999999 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.595 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.46999999999999997 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.537 ' CB ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.71 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 1.3600000000000001 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 2.0 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.0899999999999999 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.8300000000000001 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.8200000000000001 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.8500000000000001 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.72 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.78 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.3100000000000001 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.49 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.8600000000000001 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.95 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.41999999999999998 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.66000000000000003 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 1.7 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 1.03 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 1.0800000000000001 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.38 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 3.3199999999999998 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.81999999999999995 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 2.3599999999999999 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.46000000000000002 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.71 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.454 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.66000000000000003 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 23.5 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.77 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 1.24 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.1299999999999999 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.1399999999999999 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.89000000000000001 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.23 110.952 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.68000000000000005 112.134 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.55000000000000004 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 83' ' ' LEU . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 2.1600000000000001 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 1.1399999999999999 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 1.2 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.79 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.9399999999999999 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' O ' HD23 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 1.1499999999999999 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 1.28 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.8100000000000001 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.632 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 1.3200000000000001 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.528 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 1.1000000000000001 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 1.3100000000000001 108.297 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.9199999999999999 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 1.1299999999999999 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.74 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.74 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 1.1599999999999999 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.488 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 1.0900000000000001 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.9300000000000002 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.59999999999999998 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.3100000000000001 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.5900000000000001 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.34999999999999998 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 1.1299999999999999 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.3700000000000001 109.402 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 1.0700000000000001 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.91000000000000003 110.18 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.485 ' HH ' ' HD2' ' A' ' 145' ' ' ARG . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.2 110.027 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.625 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.8500000000000001 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.73 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.94999999999999996 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.693 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 1.1599999999999999 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 1.4299999999999999 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.2400000000000002 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.8600000000000001 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 1.3999999999999999 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.3999999999999999 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.8399999999999999 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.1899999999999999 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.3700000000000001 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.2 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.5299999999999998 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 2.6099999999999999 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.693 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.79000000000000004 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.653 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.57999999999999996 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.97 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 2.5 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 1.4299999999999999 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.8 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.6299999999999999 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.625 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 3.5299999999999998 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.95999999999999996 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 1.21 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 1.6000000000000001 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 1.1200000000000001 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.8500000000000001 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 2.5 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.81999999999999995 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' HD2' ' HH ' ' A' ' 112' ' ' TYR . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.7999999999999998 109.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.76 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 1.2 108.937 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.46 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.53000000000000003 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 4.04 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 1.3200000000000001 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.8 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.526 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.3199999999999998 108.576 -171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.4900000000000002 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.8900000000000001 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' MET . 26.7 ttp . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.499 0.666 . . . . 3.2599999999999998 110.234 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -79.53 127.82 32.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.69 -0.485 . . . . 2.0800000000000001 109.69 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.977 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 1.5800000000000001 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.691 HG23 HD22 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 1.1200000000000001 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.9299999999999999 110.249 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.9199999999999999 109.76 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.95999999999999996 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.77 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 2.0600000000000001 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.5700000000000001 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 2.1800000000000002 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 1.5700000000000001 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.633 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.74 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.9199999999999999 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.69999999999999996 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 1.04 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 1.1399999999999999 112.39 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.666 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.45000000000000001 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 1.0700000000000001 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.0699999999999998 108.162 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.85999999999999999 113.225 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.68000000000000005 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.633 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 10.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.71 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.476 ' HB3' HG22 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 1.1499999999999999 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.1100000000000001 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.34000000000000002 109.461 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77000000000000002 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.84999999999999998 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 1.24 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.977 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.8300000000000001 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.1800000000000002 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD22 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 2.0899999999999999 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 2.1600000000000001 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.69 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.9500000000000002 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.95 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.636 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92000000000000004 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.54000000000000004 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.593 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.79 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 1.1299999999999999 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 1.52 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.91000000000000003 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 1.1499999999999999 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.46999999999999997 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.628 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.71 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 1.3600000000000001 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 2.0 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.0899999999999999 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.8300000000000001 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.615 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.8200000000000001 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.8500000000000001 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.72 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.78 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.593 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.49 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.8600000000000001 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.95 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 1.4099999999999999 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.41999999999999998 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.66000000000000003 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.837 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 1.7 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.586 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 1.03 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 1.0800000000000001 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.38 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.717 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 3.3199999999999998 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.81999999999999995 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 2.3599999999999999 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.46000000000000002 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.71 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.66000000000000003 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.9 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.77 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 1.24 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.89000000000000001 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.23 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.68000000000000005 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.55000000000000004 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 2.1600000000000001 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 1.2 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.79 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.77 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' O ' HD22 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 1.1499999999999999 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 1.28 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.8100000000000001 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.669 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 1.3200000000000001 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 1.1000000000000001 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 1.3100000000000001 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.9199999999999999 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 1.1299999999999999 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.74 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HB3' HD13 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.74 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 1.1599999999999999 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.69 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 1.0900000000000001 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.9300000000000002 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.59999999999999998 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.3100000000000001 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.5900000000000001 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.34999999999999998 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 1.1299999999999999 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.3700000000000001 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 1.0700000000000001 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.31 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.91000000000000003 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 1.2 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.8500000000000001 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.73 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.414 ' HB3' HD22 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.94999999999999996 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.591 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 1.4299999999999999 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.2400000000000002 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.8600000000000001 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 1.3999999999999999 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.3999999999999999 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.8399999999999999 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.1899999999999999 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.808 ' HB3' HG12 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.3700000000000001 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.2 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.632 HG11 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.5299999999999998 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.632 ' HD2' HG11 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 2.6099999999999999 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.591 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.79000000000000004 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.666 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.57999999999999996 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.97 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 2.5 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 1.4299999999999999 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.6299999999999999 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.629 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 3.5299999999999998 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.95999999999999996 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 1.21 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 1.6000000000000001 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 1.1200000000000001 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.8500000000000001 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 2.5 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.81999999999999995 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.7999999999999998 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.76 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 1.2 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.46 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.53000000000000003 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 4.04 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 1.3200000000000001 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.8 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.414 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 156' ' ' ASN . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.3199999999999998 107.958 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.4900000000000002 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.524 HD22 ' HB3' ' A' ' 154' ' ' GLU . 1.9 p30 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.8900000000000001 109.737 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 150' ' ' HIS . 22.6 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.689 0.281 . . . . 3.2599999999999998 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.16 131.9 35.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 2.0800000000000001 110.518 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 1.5800000000000001 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 1.1200000000000001 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.9299999999999999 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.9199999999999999 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.95999999999999996 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 2.0600000000000001 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.5700000000000001 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 2.1800000000000002 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 1.5700000000000001 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.74 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.9199999999999999 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.69999999999999996 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 1.04 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 1.1399999999999999 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.45000000000000001 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 1.0700000000000001 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.0699999999999998 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.85999999999999999 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.68000000000000005 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.71 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 1.1100000000000001 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.34000000000000002 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.84999999999999998 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 1.24 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.1800000000000002 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 2.0899999999999999 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 2.1600000000000001 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.9500000000000002 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.8799999999999999 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.95 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92000000000000004 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.54000000000000004 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.79 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 1.1299999999999999 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 1.52 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HE1' HG13 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.91000000000000003 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 1.1499999999999999 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.46999999999999997 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.71 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 1.3600000000000001 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.621 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 2.0 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.0899999999999999 112.08 -170.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.8300000000000001 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.8200000000000001 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.616 HG21 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.72 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.78 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.3100000000000001 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.49 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.8600000000000001 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.95 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 1.4099999999999999 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.41999999999999998 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.66000000000000003 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 1.7 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 1.03 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.38 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 3.3199999999999998 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.81999999999999995 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.419 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 2.3599999999999999 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.46000000000000002 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.71 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.66000000000000003 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.77 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 1.24 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.1299999999999999 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.625 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.89000000000000001 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.23 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.68000000000000005 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.55000000000000004 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.413 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 2.1600000000000001 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 1.1399999999999999 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 1.2 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.79 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 1.1499999999999999 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 1.28 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.8100000000000001 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.623 HG21 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 1.3200000000000001 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 1.1000000000000001 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 1.3100000000000001 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.9199999999999999 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.473 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 1.1299999999999999 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.74 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.74 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 1.1599999999999999 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 1.0900000000000001 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.9300000000000002 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.59999999999999998 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.3100000000000001 110.011 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.5900000000000001 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.34999999999999998 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 1.1299999999999999 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.3700000000000001 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 1.0700000000000001 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.31 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.91000000000000003 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 1.2 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.601 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.8500000000000001 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.73 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.94999999999999996 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 1.1599999999999999 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.965 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 1.4299999999999999 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.2400000000000002 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.8600000000000001 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 1.3999999999999999 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.3999999999999999 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.8399999999999999 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.1899999999999999 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.3700000000000001 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.2 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.5299999999999998 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 2.6099999999999999 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.559 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.79000000000000004 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.57999999999999996 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.97 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 2.5 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 1.4299999999999999 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.965 ' HB2' HG23 ' A' ' 118' ' ' THR . 5.0 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.6299999999999999 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.585 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 3.5299999999999998 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.95999999999999996 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.585 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 1.21 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 1.6000000000000001 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.8500000000000001 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 2.5 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.81999999999999995 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.7999999999999998 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.76 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 1.2 109.432 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.46 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.53000000000000003 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.459 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 62.7 m80 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 4.04 109.677 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 110.33 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.8 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.526 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.3199999999999998 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.4900000000000002 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.8900000000000001 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.803 ' HE1' ' HD1' ' A' ' 153' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.95 0.405 . . . . 3.2599999999999998 110.1 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 31' ' ' ILE . . . -104.36 135.01 46.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.552 -0.294 . . . . 2.0800000000000001 110.337 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.783 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 1.5800000000000001 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.707 HG23 HD22 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 1.1200000000000001 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.836 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.9299999999999999 109.89 177.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.9199999999999999 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.95999999999999996 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 2.0600000000000001 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.5700000000000001 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 2.1800000000000002 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.428 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 1.5700000000000001 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.74 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.9199999999999999 109.714 167.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.69999999999999996 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 1.04 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 1.1399999999999999 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.696 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.45000000000000001 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 1.0700000000000001 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.0699999999999998 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.85999999999999999 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.68000000000000005 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.71 110.809 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.702 ' HB2' HD12 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 1.1499999999999999 111.424 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 1.1100000000000001 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77000000000000002 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.84999999999999998 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.542 HD11 ' HB1' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 1.24 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.783 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.8300000000000001 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.1800000000000002 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.707 HD22 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 2.0899999999999999 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 2.1600000000000001 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.9500000000000002 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.561 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.8799999999999999 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.857 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.95 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92000000000000004 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.54000000000000004 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.79 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 1.1299999999999999 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 1.52 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.91000000000000003 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 1.1499999999999999 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.607 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.46999999999999997 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.71 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 1.3600000000000001 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 2.0 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.0899999999999999 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.8300000000000001 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.536 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.8200000000000001 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.607 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG3' HD13 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.8500000000000001 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.72 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.78 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.3100000000000001 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.49 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.8600000000000001 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.95 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 1.4099999999999999 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.41999999999999998 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.66000000000000003 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.857 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 1.7 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 1.03 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 1.0800000000000001 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.493 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.38 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 3.3199999999999998 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.81999999999999995 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 2.3599999999999999 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.46000000000000002 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.71 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.66000000000000003 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.77 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 1.24 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.1299999999999999 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 1.1399999999999999 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.582 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.89000000000000001 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.23 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.68000000000000005 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.55000000000000004 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD13 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 2.1600000000000001 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 1.1399999999999999 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.491 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 1.2 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.79 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.9399999999999999 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 1.1499999999999999 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 1.28 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.8100000000000001 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.637 HG23 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 1.3200000000000001 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 1.1000000000000001 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 1.3100000000000001 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.9199999999999999 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 1.1299999999999999 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.74 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.74 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 1.1599999999999999 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 1.0900000000000001 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.9300000000000002 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.59999999999999998 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.3100000000000001 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.5900000000000001 110.569 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.34999999999999998 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 1.1299999999999999 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.3700000000000001 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 1.0700000000000001 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.31 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.91000000000000003 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 1.2 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.8500000000000001 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.73 110.019 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.94999999999999996 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 1.1599999999999999 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.478 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 1.4299999999999999 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.2400000000000002 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.8600000000000001 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 1.3999999999999999 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.3999999999999999 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.8399999999999999 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.1899999999999999 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.3700000000000001 111.73 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.2 113.008 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.5299999999999998 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 2.6099999999999999 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.79000000000000004 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.57999999999999996 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.97 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 2.5 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 1.4299999999999999 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.9 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.6299999999999999 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 3.5299999999999998 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.95999999999999996 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 1.21 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 1.6000000000000001 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 1.1200000000000001 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.8500000000000001 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 2.5 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.81999999999999995 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.7999999999999998 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.76 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 1.2 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.46 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.53000000000000003 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 4.04 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 1.3200000000000001 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.8 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.803 ' HD1' ' HE1' ' A' ' 1' ' ' MET . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.3199999999999998 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.4900000000000002 109.762 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.8900000000000001 109.611 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.628 ' HE2' ' HE1' ' A' ' 153' ' ' TRP . 14.2 ptt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.484 0.183 . . . . 3.2599999999999998 111.325 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.03 21.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.141 0.496 . . . . 2.0800000000000001 111.994 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 1.5800000000000001 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 1.1200000000000001 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.771 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.9299999999999999 110.193 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.9199999999999999 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.95999999999999996 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.695 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 2.0600000000000001 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.5700000000000001 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 2.1800000000000002 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 1.5700000000000001 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.954 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.74 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.9199999999999999 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.69999999999999996 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.719 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 1.04 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 1.1399999999999999 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.45000000000000001 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 1.0700000000000001 111.358 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.85999999999999999 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.68000000000000005 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.954 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 25.3 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.71 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.773 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.437 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 1.1499999999999999 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.34000000000000002 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77000000000000002 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.84999999999999998 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 1.24 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 2.0899999999999999 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 2.1600000000000001 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.9500000000000002 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.8799999999999999 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.95 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92000000000000004 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.54000000000000004 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.79 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 1.1299999999999999 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 1.52 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.91000000000000003 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.637 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.46999999999999997 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.574 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.71 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 1.3600000000000001 109.131 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 2.0 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.0899999999999999 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.8300000000000001 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.8200000000000001 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.637 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.8500000000000001 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.72 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.78 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.3100000000000001 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.597 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.49 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.8600000000000001 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.95 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.41999999999999998 112.085 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.66000000000000003 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 1.7 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 1.03 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 1.0800000000000001 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.38 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 3.3199999999999998 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 2.3599999999999999 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.46000000000000002 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.71 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.66000000000000003 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.1 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.77 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 1.24 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.1299999999999999 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 1.1399999999999999 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.632 ' HG3' HD22 ' A' ' 57' ' ' LEU . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.89000000000000001 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.23 110.911 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.68000000000000005 112.324 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.55000000000000004 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 2.1600000000000001 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 1.1399999999999999 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 1.2 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.79 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.9399999999999999 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' O ' HD23 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 1.1499999999999999 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 1.28 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.8100000000000001 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.593 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 1.3200000000000001 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 1.1000000000000001 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 1.3100000000000001 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.706 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.9199999999999999 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 1.1299999999999999 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.74 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.74 109.988 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.471 ' HG1' ' HG2' ' A' ' 105' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 1.1599999999999999 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 1.0900000000000001 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.9300000000000002 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.59999999999999998 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.3100000000000001 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' HG2' ' HG1' ' A' ' 100' ' ' THR . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.5900000000000001 110.33 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 1.1299999999999999 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.3700000000000001 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 1.0700000000000001 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.31 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.91000000000000003 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.8500000000000001 110.978 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 14.8 m120 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.73 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.94999999999999996 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.796 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 1.1599999999999999 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 1.4299999999999999 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.59 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.2400000000000002 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.8600000000000001 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.514 HD21 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 1.3999999999999999 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.3999999999999999 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.8399999999999999 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.1899999999999999 110.921 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HG3' HG13 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.3700000000000001 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG3' HD21 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.2 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.5299999999999998 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 2.6099999999999999 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.796 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.79000000000000004 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.507 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.57999999999999996 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.97 110.684 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 1.4299999999999999 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.6299999999999999 108.683 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 3.5299999999999998 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.95999999999999996 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 11' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 1.21 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.458 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 1.6000000000000001 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 1.1200000000000001 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.8500000000000001 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 2.5 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.81999999999999995 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.7999999999999998 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.76 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 1.2 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.46 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.53000000000000003 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 4.04 109.183 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.501 ' H ' ' HE3' ' A' ' 1' ' ' MET . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 1.3200000000000001 109.916 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.8 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.628 ' HE1' ' HE2' ' A' ' 1' ' ' MET . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.3199999999999998 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.4900000000000002 109.334 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.8900000000000001 109.733 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HE1' ' HE1' ' A' ' 153' ' ' TRP . 43.3 ttp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.383 -0.229 . . . . 3.2599999999999998 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.53 -84.47 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.8 -0.36 . . . . 2.0800000000000001 111.867 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 1.5800000000000001 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 1.1200000000000001 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.9299999999999999 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.9199999999999999 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.95999999999999996 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 2.0600000000000001 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.5700000000000001 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 2.1800000000000002 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 1.5700000000000001 110.531 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.851 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.74 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.843 ' OD1' ' HB ' ' A' ' 139' ' ' ILE . 1.6 m120 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.9199999999999999 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.69999999999999996 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 1.04 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 1.1399999999999999 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.686 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.45000000000000001 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.561 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 1.0700000000000001 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.85999999999999999 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.68000000000000005 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.851 HE21 ' HB2' ' A' ' 12' ' ' LEU . 4.8 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.71 110.243 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.568 ' HG2' HG11 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 1.1499999999999999 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 1.1100000000000001 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.34000000000000002 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77000000000000002 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.84999999999999998 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 1.24 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.8300000000000001 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.1800000000000002 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 2.0899999999999999 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 2.1600000000000001 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.9500000000000002 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.8799999999999999 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.95 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HA ' HD11 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92000000000000004 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.54000000000000004 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.79 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 1.1299999999999999 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.879 HG12 HG21 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.91000000000000003 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.668 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 1.1499999999999999 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.555 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.46999999999999997 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.656 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.71 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 1.3600000000000001 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 2.0 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.0899999999999999 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.8300000000000001 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.529 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.8200000000000001 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.8500000000000001 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.879 HG21 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.72 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.78 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.49 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.8600000000000001 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.95 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 1.4099999999999999 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.41999999999999998 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.66000000000000003 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 1.7 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 1.03 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 1.0800000000000001 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.38 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 3.3199999999999998 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.81999999999999995 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 2.3599999999999999 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.46000000000000002 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.71 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.66000000000000003 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.6 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.77 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 1.24 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.1299999999999999 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 1.1399999999999999 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.89000000000000001 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.23 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.68000000000000005 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.55000000000000004 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 2.1600000000000001 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 1.1399999999999999 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.656 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 1.2 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.79 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.9399999999999999 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 1.1499999999999999 111.672 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 1.28 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.8100000000000001 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.668 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 1.3200000000000001 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 1.1000000000000001 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 1.3100000000000001 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.9199999999999999 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 1.1299999999999999 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.74 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.74 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 1.1599999999999999 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 1.0900000000000001 109.238 172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.9300000000000002 111.166 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.59999999999999998 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.3100000000000001 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.5900000000000001 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CZ ' ' SG ' ' A' ' 99' ' ' CYS . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.34999999999999998 111.56 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 1.1299999999999999 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.3700000000000001 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 1.0700000000000001 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.31 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.512 ' HB2' HG22 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.91000000000000003 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 1.2 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.8500000000000001 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.73 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.94999999999999996 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 1.1599999999999999 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 1.4299999999999999 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.2400000000000002 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.8600000000000001 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 1.3999999999999999 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.3999999999999999 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.8399999999999999 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.1899999999999999 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.3700000000000001 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.2 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.5299999999999998 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 2.6099999999999999 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.79000000000000004 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.535 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.57999999999999996 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.97 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 2.5 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 1.4299999999999999 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.6299999999999999 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.686 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 3.5299999999999998 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.95999999999999996 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.843 ' HB ' ' OD1' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 1.21 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 1.6000000000000001 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 1.1200000000000001 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.8500000000000001 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 2.5 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.81999999999999995 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.7999999999999998 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.76 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 1.2 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.46 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.53000000000000003 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 4.04 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 1.3200000000000001 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.8 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.59 ' HE1' ' HE1' ' A' ' 1' ' ' MET . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.3199999999999998 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.444 ' C ' HD21 ' A' ' 156' ' ' ASN . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.4900000000000002 110.668 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.444 HD21 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.8900000000000001 108.984 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.472 0.177 . . . . 3.2599999999999998 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -78.75 122.78 26.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 110.858 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 1.5800000000000001 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 1.1200000000000001 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.9299999999999999 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.9199999999999999 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.95999999999999996 109.921 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 2.0600000000000001 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.5700000000000001 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 2.1800000000000002 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 1.5700000000000001 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.674 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.74 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.571 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.9199999999999999 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.69999999999999996 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 1.04 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 1.1399999999999999 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.626 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.45000000000000001 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 1.0700000000000001 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.0699999999999998 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.85999999999999999 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.68000000000000005 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.674 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.5 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.71 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.49 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 1.1100000000000001 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.34000000000000002 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.858 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77000000000000002 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.84999999999999998 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 1.24 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.8300000000000001 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.1800000000000002 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 2.0899999999999999 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 2.1600000000000001 110.646 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.9500000000000002 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.8799999999999999 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.95 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.54000000000000004 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.61 ' HD2' HD11 ' A' ' 43' ' ' ILE . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.79 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 1.1299999999999999 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.61 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 1.52 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.91000000000000003 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 1.1499999999999999 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.46999999999999997 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.556 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.71 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 1.3600000000000001 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.546 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 2.0 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.0899999999999999 111.202 -173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.8300000000000001 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.8200000000000001 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.57 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.8500000000000001 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.72 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.78 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.61 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.49 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.8600000000000001 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.95 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 1.4099999999999999 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.41999999999999998 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.66000000000000003 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 1.7 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 1.03 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 1.0800000000000001 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.38 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.858 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 3.3199999999999998 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.81999999999999995 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 2.3599999999999999 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.46000000000000002 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.71 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.481 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.66000000000000003 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.77 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.24 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' O ' HD22 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.1299999999999999 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 1.1399999999999999 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.89000000000000001 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.68000000000000005 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.55000000000000004 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 2.1600000000000001 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.574 HD12 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 1.1399999999999999 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 1.2 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.79 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.9399999999999999 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 1.1499999999999999 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 1.28 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.8100000000000001 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.654 HG23 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 1.3200000000000001 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 1.1000000000000001 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 1.3100000000000001 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.9199999999999999 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 1.1299999999999999 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.74 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HB3' HD12 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.74 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 1.1599999999999999 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HH ' ' H ' ' A' ' 35' ' ' SER . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 1.0900000000000001 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.46 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.9300000000000002 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.59999999999999998 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.3100000000000001 109.599 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.5900000000000001 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.34999999999999998 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 1.1299999999999999 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.3700000000000001 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 1.0700000000000001 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.31 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.91000000000000003 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 12.9 m120 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.73 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.94999999999999996 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.691 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 1.1599999999999999 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 1.4299999999999999 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.2400000000000002 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.8600000000000001 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 1.3999999999999999 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.3999999999999999 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.8399999999999999 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.1899999999999999 110.509 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.3700000000000001 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.2 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.5299999999999998 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 2.6099999999999999 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.691 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.79000000000000004 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.97 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 2.5 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 1.4299999999999999 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.666 ' HB2' HG22 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.6299999999999999 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.571 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 3.5299999999999998 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 7.5 t30 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.95999999999999996 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 1.21 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 1.6000000000000001 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 1.1200000000000001 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.8500000000000001 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.5 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.81999999999999995 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.7999999999999998 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.76 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 1.2 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.46 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.53000000000000003 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 4.04 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.511 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 1.3200000000000001 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.8 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HB2' HD21 ' A' ' 156' ' ' ASN . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.3199999999999998 109.069 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.437 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.4900000000000002 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.451 HD21 ' HB2' ' A' ' 154' ' ' GLU . 47.2 m-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.8900000000000001 110.487 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 tmm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.431 -0.211 . . . . 3.2599999999999998 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . -51.12 115.98 1.8 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.152 -0.476 . . . . 2.0800000000000001 110.936 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 1.5800000000000001 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 1.1200000000000001 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.9299999999999999 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.9199999999999999 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.95999999999999996 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.75 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 2.0600000000000001 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.5700000000000001 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 2.1800000000000002 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 1.5700000000000001 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.74 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.9199999999999999 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.69999999999999996 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 1.04 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.757 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 1.1399999999999999 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.745 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.45000000000000001 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 1.0700000000000001 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.0699999999999998 108.762 173.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.85999999999999999 112.996 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.834 HE21 ' HB2' ' A' ' 12' ' ' LEU . 9.1 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.71 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.918 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 1.1499999999999999 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 1.1100000000000001 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.477 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.34000000000000002 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77000000000000002 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.84999999999999998 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 1.24 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.1800000000000002 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD22 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 2.0899999999999999 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 2.1600000000000001 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.9500000000000002 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.8799999999999999 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.95 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.643 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92000000000000004 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.54000000000000004 109.475 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.79 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.581 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 1.1299999999999999 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 1.52 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.91000000000000003 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.572 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 1.1499999999999999 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.46999999999999997 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.71 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 1.3600000000000001 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 2.0 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.0899999999999999 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.8300000000000001 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.8200000000000001 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.8500000000000001 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.72 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.78 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.4 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.49 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.8600000000000001 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.95 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 1.4099999999999999 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.41999999999999998 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.66000000000000003 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 1.7 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 1.03 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 1.0800000000000001 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.38 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 3.3199999999999998 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.81999999999999995 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 2.3599999999999999 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.46000000000000002 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.71 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.66000000000000003 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.77 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 1.24 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.1299999999999999 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 1.1399999999999999 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.89000000000000001 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.23 110.772 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.68000000000000005 111.948 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.55000000000000004 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 2.1600000000000001 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 1.1399999999999999 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.78 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 1.2 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.79 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.78 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.9399999999999999 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 1.1499999999999999 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 1.28 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.8100000000000001 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.572 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 1.3200000000000001 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 1.1000000000000001 110.542 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 1.3100000000000001 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.9199999999999999 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 1.1299999999999999 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.501 HG22 HD11 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.74 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.74 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 1.1599999999999999 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.716 ' CE1' HD22 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 1.0900000000000001 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.455 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.9300000000000002 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.59999999999999998 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.3100000000000001 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.5900000000000001 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.34999999999999998 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 1.1299999999999999 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.3700000000000001 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 1.0700000000000001 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.31 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.91000000000000003 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 1.2 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.8500000000000001 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.73 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.413 ' HB3' HD23 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.94999999999999996 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.934 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 1.1599999999999999 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.644 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 1.4299999999999999 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.2400000000000002 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.8600000000000001 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 1.3999999999999999 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.3999999999999999 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.8399999999999999 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.1899999999999999 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.3700000000000001 111.809 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.2 112.07 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.5299999999999998 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 2.6099999999999999 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.934 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.79000000000000004 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.57999999999999996 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.97 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 2.5 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 1.4299999999999999 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.644 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.6299999999999999 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 3.5299999999999998 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.95999999999999996 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 1.21 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 1.6000000000000001 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.417 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 1.1200000000000001 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.8500000000000001 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 2.5 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.81999999999999995 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.7999999999999998 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.76 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 1.2 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.46 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.53000000000000003 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 4.04 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 1.3200000000000001 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.8 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.3199999999999998 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.4900000000000002 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.8900000000000001 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.905 0.383 . . . . 3.2599999999999998 110.887 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.64 133.41 39.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 2.0800000000000001 110.849 -175.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.88 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 1.1200000000000001 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.9299999999999999 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.9199999999999999 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.95999999999999996 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.6 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.2 t-20 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.5700000000000001 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 2.1800000000000002 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 1.5700000000000001 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.74 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 4.6 p30 -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.9199999999999999 110.443 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.69999999999999996 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 1.04 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 1.1399999999999999 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.45000000000000001 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 1.0700000000000001 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.0699999999999998 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.85999999999999999 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.68000000000000005 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.659 ' HB3' HD21 ' A' ' 12' ' ' LEU . 47.4 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.71 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.929 ' HG3' HD22 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 1.1100000000000001 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.34000000000000002 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.8 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77000000000000002 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.84999999999999998 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 1.24 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.88 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.1800000000000002 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.662 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 2.0899999999999999 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 2.1600000000000001 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' H ' ' HH ' ' A' ' 101' ' ' TYR . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.9500000000000002 111.026 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.8799999999999999 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.769 ' HG ' HG23 ' A' ' 65' ' ' VAL . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.95 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.859 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92000000000000004 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.54000000000000004 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.79 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 1.1299999999999999 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.902 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 1.52 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.91000000000000003 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 1.1499999999999999 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.46999999999999997 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.867 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.71 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.783 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 1.3600000000000001 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.429 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 2.0 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.0899999999999999 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.8300000000000001 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.545 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.8200000000000001 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.8500000000000001 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.72 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.78 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.3100000000000001 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.435 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.49 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.8600000000000001 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.859 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 1.4099999999999999 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.41999999999999998 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.66000000000000003 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 1.7 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 1.03 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 1.0800000000000001 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.38 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 3.3199999999999998 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 2.3599999999999999 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.46000000000000002 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.71 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.66000000000000003 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 48.6 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.77 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 1.24 110.149 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.1299999999999999 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 1.1399999999999999 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.89000000000000001 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.23 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.68000000000000005 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.55000000000000004 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 2.1600000000000001 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 1.1399999999999999 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.867 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 1.2 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.79 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.9399999999999999 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 1.1499999999999999 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 1.28 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.8100000000000001 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.599 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 1.3200000000000001 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 1.1000000000000001 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 1.3100000000000001 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.9199999999999999 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 1.1299999999999999 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.74 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.74 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 1.1599999999999999 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.761 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 1.0900000000000001 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.761 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.9300000000000002 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.59999999999999998 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.3100000000000001 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.34999999999999998 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 1.1299999999999999 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.3700000000000001 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 1.0700000000000001 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.31 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.91000000000000003 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 1.2 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.8500000000000001 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.73 109.312 175.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.466 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.94999999999999996 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 1.1599999999999999 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 1.4299999999999999 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.2400000000000002 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.8600000000000001 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 1.3999999999999999 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.3999999999999999 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.8399999999999999 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.1899999999999999 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.3700000000000001 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.2 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.5299999999999998 110.338 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 2.6099999999999999 109.751 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.466 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.79000000000000004 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.65 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.57999999999999996 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.97 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 2.5 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 1.4299999999999999 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.6299999999999999 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 3.5299999999999998 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.95999999999999996 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.725 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 1.21 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 1.6000000000000001 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 1.1200000000000001 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.8500000000000001 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 2.5 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.81999999999999995 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.7999999999999998 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.76 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 1.2 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.46 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.53000000000000003 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 4.04 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.3200000000000001 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.8 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.469 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.3199999999999998 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.4900000000000002 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.8900000000000001 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.6 ' HE3' ' O ' ' A' ' 151' ' ' ILE . 10.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.31 0.1 . . . . 3.2599999999999998 110.966 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.34 103.49 6.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 2.0800000000000001 109.782 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 1.5800000000000001 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 1.1200000000000001 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.9299999999999999 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.9199999999999999 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.95999999999999996 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 2.0600000000000001 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.5700000000000001 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 2.1800000000000002 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 1.5700000000000001 110.077 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.74 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.968 ' HB2' HE21 ' A' ' 23' ' ' GLN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.9199999999999999 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.69999999999999996 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 1.04 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 1.1399999999999999 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.45000000000000001 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 1.0700000000000001 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.0699999999999998 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.85999999999999999 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.68000000000000005 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.968 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.0 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.71 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG2' HG21 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 1.1499999999999999 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 1.1100000000000001 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.34000000000000002 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77000000000000002 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.84999999999999998 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 1.24 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.8300000000000001 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 2.0899999999999999 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 2.1600000000000001 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.9500000000000002 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.493 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.8799999999999999 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.95 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92000000000000004 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.54000000000000004 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.79 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.734 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 1.1299999999999999 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 1.52 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.422 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.91000000000000003 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 1.1499999999999999 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.594 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.46999999999999997 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.776 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.71 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 1.3600000000000001 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.776 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 2.0 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.0899999999999999 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.8300000000000001 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.8200000000000001 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.542 ' HB3' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.8500000000000001 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.72 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD13 HG21 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.78 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.3100000000000001 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.49 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.8600000000000001 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.95 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 1.4099999999999999 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' OD1' ' A' ' 37' ' ' ASP . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.41999999999999998 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.66000000000000003 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 1.7 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 1.03 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0800000000000001 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.38 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 3.3199999999999998 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.81999999999999995 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 2.3599999999999999 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.46000000000000002 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.497 HG21 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.71 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.734 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.66000000000000003 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.2 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 1.24 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.1299999999999999 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 1.1399999999999999 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD3' ' CE2' ' A' ' 22' ' ' PHE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.89000000000000001 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.23 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.68000000000000005 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.55000000000000004 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 2.1600000000000001 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 1.1399999999999999 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.831 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 1.2 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.79 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.831 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.9399999999999999 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 1.1499999999999999 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 1.28 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.8100000000000001 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 1.3200000000000001 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 1.1000000000000001 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 1.3100000000000001 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.9199999999999999 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 1.1299999999999999 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.74 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.497 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 1.0900000000000001 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.9300000000000002 110.833 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.59999999999999998 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.5900000000000001 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.5 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.34999999999999998 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 1.1299999999999999 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.3700000000000001 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 1.0700000000000001 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.31 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.91000000000000003 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 1.2 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.8500000000000001 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 174.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.409 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.94999999999999996 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 1.1599999999999999 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 1.4299999999999999 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.2400000000000002 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.8600000000000001 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 1.3999999999999999 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.3999999999999999 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.8399999999999999 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.1899999999999999 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.3700000000000001 111.877 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.2 111.794 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.5299999999999998 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 2.6099999999999999 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.667 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.79000000000000004 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.621 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.57999999999999996 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.97 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 2.5 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 1.4299999999999999 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.6299999999999999 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.552 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 3.5299999999999998 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.95999999999999996 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 1.21 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.6000000000000001 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 1.1200000000000001 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.8500000000000001 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 2.5 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.81999999999999995 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.7999999999999998 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.76 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 1.2 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.46 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.53000000000000003 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 4.04 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.6 ' O ' ' HE3' ' A' ' 1' ' ' MET . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 1.3200000000000001 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.8 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.514 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.3199999999999998 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.4900000000000002 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.8900000000000001 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.84 0.352 . . . . 3.2599999999999998 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -63.05 118.52 7.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 2.0800000000000001 111.054 -173.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 1.5800000000000001 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 1.1200000000000001 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.9299999999999999 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.9199999999999999 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.95999999999999996 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 2.0600000000000001 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.5700000000000001 108.668 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.8 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 2.1800000000000002 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 1.5700000000000001 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.683 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.74 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 12' ' ' LEU . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.9199999999999999 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.69999999999999996 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 1.04 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 1.1399999999999999 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.45000000000000001 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 1.0700000000000001 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.0699999999999998 108.672 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.85999999999999999 113.377 -174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.68000000000000005 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.683 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.7 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.71 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.8 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 1.1499999999999999 110.931 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 1.1100000000000001 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.652 ' HG ' HG11 ' A' ' 65' ' ' VAL . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.84999999999999998 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 1.24 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.8300000000000001 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.1800000000000002 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 2.0899999999999999 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 2.1600000000000001 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.9500000000000002 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.8799999999999999 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.95 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HA ' HD11 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92000000000000004 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.54000000000000004 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.79 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 1.1299999999999999 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.654 HG12 HG21 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 1.52 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.91000000000000003 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 1.1499999999999999 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.582 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.46999999999999997 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.71 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.593 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 1.3600000000000001 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 2.0 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.0899999999999999 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.8300000000000001 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.582 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.8500000000000001 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.72 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.49 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.8600000000000001 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.95 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 1.4099999999999999 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.41999999999999998 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.66000000000000003 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.652 HG11 ' HG ' ' A' ' 30' ' ' CYS . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 1.7 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 1.03 113.441 -171.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 1.0800000000000001 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.38 111.936 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 3.3199999999999998 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.81999999999999995 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 2.3599999999999999 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.46000000000000002 110.046 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.71 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.66000000000000003 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.0 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.77 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 1.24 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.1299999999999999 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 1.1399999999999999 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.89000000000000001 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.23 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.68000000000000005 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.55000000000000004 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 2.1600000000000001 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.517 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 1.1399999999999999 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 1.2 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.79 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.9399999999999999 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 1.1499999999999999 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 1.28 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.8100000000000001 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.638 HG21 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 1.3200000000000001 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 1.1000000000000001 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 1.3100000000000001 108.983 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.9199999999999999 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.553 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 1.1299999999999999 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.74 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.74 110.251 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 1.1599999999999999 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 1.0900000000000001 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.9300000000000002 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.59999999999999998 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.3100000000000001 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.5900000000000001 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.34999999999999998 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 1.1299999999999999 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.3700000000000001 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 1.0700000000000001 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.31 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.91000000000000003 110.823 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 1.2 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.8500000000000001 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.73 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 1.1599999999999999 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 1.4299999999999999 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.2400000000000002 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.8600000000000001 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 1.3999999999999999 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.3999999999999999 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.8399999999999999 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.1899999999999999 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.3700000000000001 111.262 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.2 111.689 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.5299999999999998 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 2.6099999999999999 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.79000000000000004 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.716 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.57999999999999996 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.97 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 2.5 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 1.4299999999999999 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.558 ' HB2' HG21 ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.6299999999999999 108.452 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 3.5299999999999998 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.95999999999999996 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 1.21 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 1.6000000000000001 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 1.1200000000000001 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.8500000000000001 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 2.5 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.7999999999999998 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 1.2 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.46 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.53000000000000003 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 4.04 110.045 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 1.3200000000000001 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.8 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.438 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.3199999999999998 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.4900000000000002 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.8900000000000001 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.576 0.227 . . . . 3.2599999999999998 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.2 128.78 45.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.666 0.269 . . . . 2.0800000000000001 110.788 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 1.1200000000000001 109.415 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.612 ' HB2' HD12 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.9299999999999999 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.9199999999999999 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.95999999999999996 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 9.5 t30 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 2.0600000000000001 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 HG11 ' HH ' ' A' ' 111' ' ' TYR . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.5700000000000001 109.302 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 2.1800000000000002 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.612 HG13 ' HB3' ' A' ' 141' ' ' ALA . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 1.5700000000000001 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.54 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.74 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.756 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' OD1' HG11 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.9199999999999999 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.69999999999999996 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.565 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 1.04 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 1.1399999999999999 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.45000000000000001 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 1.0700000000000001 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.565 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.0699999999999998 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.85999999999999999 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.676 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.68000000000000005 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.756 HE21 ' HB2' ' A' ' 13' ' ' ASP . 8.3 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.71 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.568 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 1.1499999999999999 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 1.1100000000000001 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.34000000000000002 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77000000000000002 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.84999999999999998 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 1.24 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.8300000000000001 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.1800000000000002 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.87 HD13 HG21 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 2.0899999999999999 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 2.1600000000000001 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.9500000000000002 109.582 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.8799999999999999 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.95 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92000000000000004 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.54000000000000004 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.79 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 1.1299999999999999 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG12 HG23 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 1.52 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.91000000000000003 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.55 HG23 ' HB ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 1.1499999999999999 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.71 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 1.3600000000000001 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.616 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 2.0 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.0899999999999999 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.8300000000000001 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.8200000000000001 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.603 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.8500000000000001 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.441 HG23 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.72 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.78 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.49 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.8600000000000001 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.95 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 1.4099999999999999 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.41999999999999998 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.66000000000000003 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.87 HG21 HD13 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 1.7 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 1.03 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 1.0800000000000001 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.38 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 3.3199999999999998 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.81999999999999995 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 2.3599999999999999 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.46000000000000002 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.71 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.66000000000000003 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.77 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 1.24 110.18 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.1299999999999999 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 1.1399999999999999 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.89000000000000001 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.23 111.991 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.68000000000000005 112.207 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.55000000000000004 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 2.1600000000000001 110.741 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 1.1399999999999999 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 1.2 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.79 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.661 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.9399999999999999 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 1.1499999999999999 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 1.28 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.8100000000000001 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 1.3200000000000001 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' HB ' HG23 ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 1.1000000000000001 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.3100000000000001 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.9199999999999999 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 1.1299999999999999 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.74 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.74 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 1.1599999999999999 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.808 ' HH ' ' HB2' ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 1.0900000000000001 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.9300000000000002 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.59999999999999998 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.3100000000000001 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.34999999999999998 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 1.1299999999999999 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.3700000000000001 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 1.0700000000000001 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.509 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.31 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.425 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.91000000000000003 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 1.2 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.442 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.73 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' HD23 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.94999999999999996 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.592 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 1.1599999999999999 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 1.4299999999999999 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.2400000000000002 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.8600000000000001 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 1.3999999999999999 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.3999999999999999 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.8399999999999999 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.1899999999999999 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.521 ' HB3' HG12 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.3700000000000001 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.2 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.5299999999999998 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 2.6099999999999999 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.592 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.79000000000000004 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.57999999999999996 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.97 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 2.5 109.802 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 1.4299999999999999 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.6299999999999999 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.442 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 3.5299999999999998 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.95999999999999996 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.517 HD12 ' ND2' ' A' ' 14' ' ' ASN . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 1.21 109.919 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 1.6000000000000001 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.612 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.1200000000000001 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.8500000000000001 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 2.5 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.81999999999999995 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.7999999999999998 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.76 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 1.2 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.46 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.53000000000000003 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 4.04 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 1.3200000000000001 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.8 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.3199999999999998 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.4900000000000002 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.8900000000000001 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 111.491 0.182 . . . . 3.2599999999999998 111.491 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 -70.89 0.55 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 2.0800000000000001 112.155 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 1.5800000000000001 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 1.1200000000000001 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.9299999999999999 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.9199999999999999 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.95999999999999996 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 2.0600000000000001 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.5700000000000001 109.782 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 2.1800000000000002 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 1.5700000000000001 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.74 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.9199999999999999 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.69999999999999996 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 1.04 110.499 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 1.1399999999999999 114.275 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.45000000000000001 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.532 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 1.0700000000000001 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.0699999999999998 108.945 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.85999999999999999 112.702 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.68000000000000005 109.126 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.3 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.71 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 1.1499999999999999 111.451 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 1.1100000000000001 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.34000000000000002 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77000000000000002 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.84999999999999998 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 1.24 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.8300000000000001 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.1800000000000002 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD21 ' CG1' ' A' ' 65' ' ' VAL . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 2.0899999999999999 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 2.1600000000000001 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.9500000000000002 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.8799999999999999 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.95 109.904 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' A' ' 41' ' ' LYS . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92000000000000004 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.54000000000000004 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.79 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 1.1299999999999999 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 1.52 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.91000000000000003 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.558 ' HB ' HG21 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 1.1499999999999999 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.46999999999999997 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.982 ' HG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.71 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 1.3600000000000001 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 2.0 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.0899999999999999 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.8300000000000001 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.588 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.8200000000000001 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.588 ' HB3' HD12 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.72 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.78 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.49 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.8600000000000001 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.95 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 1.4099999999999999 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.41999999999999998 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.66000000000000003 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' CG1' HD21 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 1.7 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 1.03 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 1.0800000000000001 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.38 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 3.3199999999999998 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.81999999999999995 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 2.3599999999999999 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.46000000000000002 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.71 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.66000000000000003 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.77 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 1.24 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.1299999999999999 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 1.1399999999999999 110.548 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.89000000000000001 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.23 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.68000000000000005 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.55000000000000004 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 2.1600000000000001 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 1.1399999999999999 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 1.12 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 1.2 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.79 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 1.12 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.9399999999999999 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 1.1499999999999999 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 1.28 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.8100000000000001 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.558 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 1.3200000000000001 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 1.1000000000000001 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 1.3100000000000001 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.9199999999999999 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.614 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 1.1299999999999999 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.74 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.74 109.639 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 1.1599999999999999 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 1.0900000000000001 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.557 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.9300000000000002 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.59999999999999998 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.467 HE22 ' ND2' ' A' ' 152' ' ' ASN . 21.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.3100000000000001 110.033 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.5900000000000001 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.34999999999999998 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 1.1299999999999999 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.4 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.3700000000000001 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 1.0700000000000001 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.31 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.91000000000000003 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 1.2 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.8500000000000001 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.73 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.94999999999999996 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.651 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 1.1599999999999999 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 1.4299999999999999 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.2400000000000002 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.673 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.8600000000000001 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 1.3999999999999999 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.3999999999999999 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.8399999999999999 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.1899999999999999 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.621 ' HB3' HG12 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.3700000000000001 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.2 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.5299999999999998 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 2.6099999999999999 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.651 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.79000000000000004 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' H ' ' HH ' ' A' ' 117' ' ' TYR . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.579 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.57999999999999996 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.532 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.97 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 2.5 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 1.4299999999999999 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.435 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 3.5299999999999998 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.95999999999999996 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 1.21 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 1.6000000000000001 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 1.1200000000000001 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.8500000000000001 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 2.5 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.81999999999999995 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.7999999999999998 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.76 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.4 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 1.2 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.46 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.53000000000000003 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 4.04 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 1.3200000000000001 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.467 ' ND2' HE22 ' A' ' 104' ' ' GLN . 7.7 p30 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.8 109.657 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.473 ' HZ3' HD23 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.3199999999999998 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.4900000000000002 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.8900000000000001 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HE2' ' CD2' ' A' ' 150' ' ' HIS . 19.0 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.832 0.349 . . . . 3.2599999999999998 111.017 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -84.4 104.16 14.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.876 -0.416 . . . . 2.0800000000000001 109.876 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.759 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 1.5800000000000001 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 1.1200000000000001 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.9299999999999999 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.9199999999999999 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 2.0600000000000001 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.5700000000000001 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 1.5700000000000001 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.74 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.736 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 15' ' ' PRO . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.9199999999999999 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.69999999999999996 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.736 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 1.04 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 1.1399999999999999 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.45000000000000001 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 1.0700000000000001 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.0699999999999998 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.85999999999999999 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.68000000000000005 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.739 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.71 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 1.1499999999999999 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 1.1100000000000001 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.34000000000000002 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.84999999999999998 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 1.24 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.759 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.8300000000000001 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.1800000000000002 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD22 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 2.0899999999999999 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.9500000000000002 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.8799999999999999 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.492 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.95 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92000000000000004 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.45 ' CZ3' HG23 ' A' ' 26' ' ' ILE . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.54000000000000004 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.79 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.566 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 1.1299999999999999 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.626 HG13 HG21 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 1.52 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.91000000000000003 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HB ' HG21 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 1.1499999999999999 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.46999999999999997 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.66 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.71 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 1.3600000000000001 108.704 168.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 2.0 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.0899999999999999 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.8300000000000001 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.558 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.8200000000000001 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.8500000000000001 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.626 HG21 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.72 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.78 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.49 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.95 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 1.4099999999999999 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.41999999999999998 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.66000000000000003 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.06 ' HB ' HD22 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 1.7 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 1.03 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 1.0800000000000001 111.42 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.38 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 3.3199999999999998 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.81999999999999995 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 2.3599999999999999 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.46000000000000002 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.71 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.66000000000000003 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.77 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 1.24 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.1299999999999999 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 1.1399999999999999 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.57 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.89000000000000001 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.23 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.68000000000000005 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.55000000000000004 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 2.1600000000000001 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 1.1399999999999999 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.66 ' HG2' ' HG ' ' A' ' 47' ' ' SER . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 1.2 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.79 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.599 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.9399999999999999 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 1.1499999999999999 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 1.28 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.8100000000000001 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 1.3200000000000001 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 1.1000000000000001 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 1.3100000000000001 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.9199999999999999 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.566 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 1.1299999999999999 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.74 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.74 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 1.1599999999999999 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.534 ' HH ' ' HB2' ' A' ' 34' ' ' LEU . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 1.0900000000000001 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.9300000000000002 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.59999999999999998 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.421 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 26.8 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.3100000000000001 109.85 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.5900000000000001 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.34999999999999998 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 1.1299999999999999 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.3700000000000001 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 1.0700000000000001 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.31 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.91000000000000003 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 1.2 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.73 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.491 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.94999999999999996 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.727 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 1.1599999999999999 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 1.4299999999999999 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.2400000000000002 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.8600000000000001 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 1.3999999999999999 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.3999999999999999 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.8399999999999999 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.1899999999999999 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.3700000000000001 110.937 169.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.2 111.19 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.5299999999999998 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 2.6099999999999999 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.727 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.79000000000000004 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.686 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.57999999999999996 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.447 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 2.5 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 1.4299999999999999 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.6299999999999999 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 3.5299999999999998 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.95999999999999996 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.452 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.21 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 1.6000000000000001 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 1.1200000000000001 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 2.5 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.81999999999999995 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.7999999999999998 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.76 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 1.2 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.46 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.53000000000000003 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.52 ' CD2' ' HE2' ' A' ' 1' ' ' MET . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 4.04 109.418 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.448 ' O ' ' HE1' ' A' ' 1' ' ' MET . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 1.3200000000000001 110.58 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.8 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.418 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.638 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.3199999999999998 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.4900000000000002 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.8900000000000001 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.606 0.241 . . . . 3.2599999999999998 111.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.67 125.4 29.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.057 0.456 . . . . 2.0800000000000001 112.113 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.902 ' HZ3' ' HG3' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 1.5800000000000001 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 1.1200000000000001 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.9299999999999999 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.9199999999999999 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.95999999999999996 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.542 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 2.0600000000000001 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.5700000000000001 109.909 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 2.1800000000000002 110.412 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 1.5700000000000001 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.74 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.794 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.9199999999999999 111.381 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.69999999999999996 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 1.04 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 1.1399999999999999 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.45000000000000001 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 1.0700000000000001 111.634 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.0699999999999998 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.85999999999999999 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.68000000000000005 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.794 HE21 ' HB2' ' A' ' 13' ' ' ASP . 16.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.71 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 1.1499999999999999 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 1.1100000000000001 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.34000000000000002 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77000000000000002 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' H ' ' A' ' 68' ' ' GLY . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.84999999999999998 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 1.24 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.902 ' HG3' ' HZ3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.8300000000000001 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.1800000000000002 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.82 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 2.0899999999999999 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 2.1600000000000001 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.8799999999999999 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.509 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.95 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92000000000000004 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.54000000000000004 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.617 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.79 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 1.1299999999999999 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.603 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 1.52 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.443 ' HE1' HG13 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.91000000000000003 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 1.1499999999999999 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.602 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.46999999999999997 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.912 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.71 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 1.3600000000000001 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 2.0 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.0899999999999999 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.8300000000000001 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.912 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.8200000000000001 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.602 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.8500000000000001 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.72 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.78 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.3100000000000001 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.617 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.49 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.8600000000000001 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.95 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 1.4099999999999999 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.41999999999999998 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.569 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.66000000000000003 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 1.7 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 1.03 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 1.0800000000000001 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.469 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.38 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 3.3199999999999998 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.81999999999999995 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 2.3599999999999999 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.46000000000000002 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.71 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.492 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.66000000000000003 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.77 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 1.24 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.1299999999999999 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 1.1399999999999999 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 57' ' ' LEU . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.89000000000000001 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.672 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.23 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.68000000000000005 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.55000000000000004 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.672 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 2.1600000000000001 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 1.1399999999999999 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG3' ' CB ' ' A' ' 47' ' ' SER . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 1.2 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.79 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.9399999999999999 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 1.1499999999999999 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 1.28 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.8100000000000001 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 1.3200000000000001 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 1.1000000000000001 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 1.3100000000000001 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.687 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.9199999999999999 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 1.1299999999999999 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.74 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.74 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 1.1599999999999999 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 1.0900000000000001 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.9300000000000002 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.59999999999999998 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.471 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.3100000000000001 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.5900000000000001 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.34999999999999998 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 1.1299999999999999 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.496 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.3700000000000001 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 1.0700000000000001 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.91000000000000003 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 1.2 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.443 HG13 ' HE1' ' A' ' 44' ' ' TYR . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.8500000000000001 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.73 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' HB3' HD22 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.774 ' HH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 1.1599999999999999 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 1.4299999999999999 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.2400000000000002 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.8600000000000001 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 1.3999999999999999 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.3999999999999999 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.8399999999999999 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.1899999999999999 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.3700000000000001 111.825 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.2 112.005 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.449 HG12 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.5299999999999998 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 2.6099999999999999 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HA ' ' HH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.79000000000000004 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.57999999999999996 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 2.5 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.441 HD11 ' HA ' ' A' ' 135' ' ' LEU . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 1.4299999999999999 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.5 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.6299999999999999 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 3.5299999999999998 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.95999999999999996 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.542 HG23 HG13 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 1.21 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 1.6000000000000001 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 1.1200000000000001 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.8500000000000001 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 2.5 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.81999999999999995 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.7999999999999998 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.76 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 1.2 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.46 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.53000000000000003 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 4.04 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 1.3200000000000001 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.853 HD22 ' HA ' ' A' ' 155' ' ' ASP . 6.2 t30 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.8 110.427 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.3199999999999998 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.853 ' HA ' HD22 ' A' ' 152' ' ' ASN . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.4900000000000002 111.502 -166.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.8900000000000001 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.575 0.226 . . . . 3.2599999999999998 111.005 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -78.83 139.1 38.42 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 2.0800000000000001 110.373 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 1.5800000000000001 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 1.1200000000000001 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.9299999999999999 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.9199999999999999 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.95999999999999996 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 2.0600000000000001 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.5700000000000001 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 2.1800000000000002 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 1.5700000000000001 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.74 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.9199999999999999 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.69999999999999996 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 1.04 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 1.1399999999999999 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.45000000000000001 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 1.0700000000000001 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.0699999999999998 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.85999999999999999 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.68000000000000005 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.739 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.71 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.868 ' HG2' HG23 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.422 HD13 HD11 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 1.1499999999999999 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.34000000000000002 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77000000000000002 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.84999999999999998 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 1.24 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.8300000000000001 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.1800000000000002 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 2.0899999999999999 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 2.1600000000000001 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.9500000000000002 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.8799999999999999 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.412 HD11 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.95 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92000000000000004 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.412 ' NE1' HD11 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.54000000000000004 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.63 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.79 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.627 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 1.1299999999999999 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 1.52 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.91000000000000003 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 1.1499999999999999 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.46999999999999997 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.71 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 1.3600000000000001 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.522 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 2.0 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.0899999999999999 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.8300000000000001 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.641 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.8200000000000001 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.8500000000000001 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.72 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.78 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.3100000000000001 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.63 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.49 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.8600000000000001 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.95 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 1.4099999999999999 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.41999999999999998 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.66000000000000003 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 1.7 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 1.03 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 1.0800000000000001 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.38 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 3.3199999999999998 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.81999999999999995 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 2.3599999999999999 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.46000000000000002 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.868 HG23 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.71 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.66000000000000003 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.77 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 1.24 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.1299999999999999 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 1.1399999999999999 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.89000000000000001 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.23 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.68000000000000005 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.55000000000000004 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 2.1600000000000001 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 1.1399999999999999 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.711 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 1.2 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.79 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.711 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.9399999999999999 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 1.1499999999999999 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 1.28 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.8100000000000001 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 1.3200000000000001 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 1.1000000000000001 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 1.3100000000000001 108.436 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.7 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.9199999999999999 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 1.1299999999999999 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.74 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.74 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 1.1599999999999999 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 1.0900000000000001 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.9300000000000002 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.59999999999999998 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3100000000000001 109.751 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.5900000000000001 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.34999999999999998 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.419 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 1.1299999999999999 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.3700000000000001 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 1.0700000000000001 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.31 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.91000000000000003 110.121 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 1.2 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.8500000000000001 110.819 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.73 109.079 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.94999999999999996 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 1.1599999999999999 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 1.4299999999999999 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.2400000000000002 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.8600000000000001 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 1.3999999999999999 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.3999999999999999 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.8399999999999999 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.1899999999999999 111.353 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.3700000000000001 111.671 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.2 112.267 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.5299999999999998 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 2.6099999999999999 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.79000000000000004 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.57999999999999996 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 2.5 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 1.4299999999999999 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.519 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.3 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.6299999999999999 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 3.5299999999999998 109.978 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.529 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.95999999999999996 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.544 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 1.21 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 1.6000000000000001 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 1.1200000000000001 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.8500000000000001 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 2.5 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.81999999999999995 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.7999999999999998 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.76 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 1.2 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.46 110.553 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.53000000000000003 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 4.04 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 1.3200000000000001 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.8 109.915 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.3199999999999998 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.47 ' C ' HD21 ' A' ' 156' ' ' ASN . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.4900000000000002 108.968 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.8900000000000001 109.669 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 19.3 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.085 -0.339 . . . . 3.2599999999999998 110.085 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -100.88 -73.89 0.63 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 2.0800000000000001 110.798 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 1.5800000000000001 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 1.1200000000000001 110.331 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.9299999999999999 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.9199999999999999 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.676 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.0 t-20 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 2.0600000000000001 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.5700000000000001 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 2.1800000000000002 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 1.5700000000000001 109.376 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.744 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.74 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.403 ' HB2' HE21 ' A' ' 23' ' ' GLN . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.439 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.9199999999999999 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.69999999999999996 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 1.04 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 1.1399999999999999 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.45000000000000001 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 1.0700000000000001 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.776 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.0699999999999998 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.85999999999999999 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.68000000000000005 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.744 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.0 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.71 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.504 HD12 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 1.1499999999999999 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.676 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 1.1100000000000001 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.34000000000000002 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77000000000000002 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.84999999999999998 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 1.24 108.557 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.688 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD22 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 2.0899999999999999 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 2.1600000000000001 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.9500000000000002 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.8799999999999999 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.95 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92000000000000004 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.54000000000000004 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.79 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 1.1299999999999999 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.826 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 1.52 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.542 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.91000000000000003 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 1.1499999999999999 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.46999999999999997 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.655 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.71 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 1.3600000000000001 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 2.0 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.0899999999999999 111.189 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.8300000000000001 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.8200000000000001 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.8500000000000001 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.826 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.72 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.621 HD23 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.78 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.3100000000000001 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.49 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.95 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 1.4099999999999999 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.41999999999999998 112.17 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.66000000000000003 110.243 -14.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 1.7 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 1.03 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.38 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 3.3199999999999998 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.81999999999999995 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 2.3599999999999999 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.46000000000000002 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.71 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.66000000000000003 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.428 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 25.2 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.77 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 1.24 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.1299999999999999 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 1.1399999999999999 113.794 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.89000000000000001 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.535 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.23 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.68000000000000005 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.55000000000000004 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.535 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 2.1600000000000001 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.476 HG22 ' HB3' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 1.1399999999999999 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.678 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 1.2 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.79 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.9399999999999999 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 1.1499999999999999 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 1.28 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.8100000000000001 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.417 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 1.3200000000000001 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 1.1000000000000001 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 1.3100000000000001 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.9199999999999999 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 1.1299999999999999 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.74 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.476 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.74 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 1.1599999999999999 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.5 ' CE1' HD22 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 1.0900000000000001 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.474 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.9300000000000002 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.59999999999999998 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.3100000000000001 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.5900000000000001 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.494 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.34999999999999998 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 1.1299999999999999 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 96' ' ' LEU . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.3700000000000001 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 1.0700000000000001 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.31 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.91000000000000003 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.749 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 1.2 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.8500000000000001 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.73 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.689 HD21 HD11 ' A' ' 135' ' ' LEU . 10.0 m120 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.94999999999999996 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 1.1599999999999999 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 1.4299999999999999 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.8600000000000001 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 1.3999999999999999 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.3999999999999999 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.8399999999999999 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.3700000000000001 110.68 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.2 111.463 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.5299999999999998 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 2.6099999999999999 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.715 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.79000000000000004 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.716 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.57999999999999996 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.97 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 2.5 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.689 HD11 HD21 ' A' ' 115' ' ' ASN . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 1.4299999999999999 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.586 ' HB2' HG21 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.6299999999999999 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.945 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 3.5299999999999998 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.95999999999999996 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.945 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 1.21 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 1.6000000000000001 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 1.1200000000000001 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.8500000000000001 109.524 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 2.9 t-20 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 2.5 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.81999999999999995 112.105 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.749 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.7999999999999998 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.76 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 1.2 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.46 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.53000000000000003 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 4.04 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.494 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 1.3200000000000001 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.8 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.3199999999999998 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.4900000000000002 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.8900000000000001 110.096 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.906 0.384 . . . . 1.48 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 0.98 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 0.45 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.39 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.32 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.96 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 1.47 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.01 110.112 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 1.54 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.91 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.18 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.88 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.6 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 0.83 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.71 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.41 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 0.65 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.07 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.62 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.58 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.497 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 56.2 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.41 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 0.36 111.377 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 0.46 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.28 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.51 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 0.57 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.83 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.18 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 1.55 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.95 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.88 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.32 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.43 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.23 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 0.46 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 0.69 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HD1' ' HB ' ' A' ' 95' ' ' VAL . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.59 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 0.37 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.661 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.47 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.23 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 0.82 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 1.72 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.09 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.83 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.85 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.08 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.05 111.299 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.31 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.09 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.22 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.34 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 0.72 109.913 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.42 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.55 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 0.95 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 0.7 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 0.41 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.33 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 2.78 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.62 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 1.8 109.985 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.37 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.12 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.44 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 91.6 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.14 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 0.56 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.13 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 0.46 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.53 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.19 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.54 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.51 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 1.6 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 0.52 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 1.037 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 0.81 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.25 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 1.037 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.94 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 0.54 110.578 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 0.56 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.23 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.63 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 0.36 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 0.6 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.21 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 0.33 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.42 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.32 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 0.5 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.73 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.45 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.57 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.31 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.59 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.31 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 0.37 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.14 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 0.38 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.27 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HB2' HG13 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.4 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 0.78 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.536 HG21 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.19 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.63 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.95 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.69 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.84 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.24 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.413 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.41 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 0.9 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.03 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.84 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.19 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.24 111.304 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.19 111.753 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.16 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 1.96 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.567 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.71 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.5 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.46 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 1.87 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.79 110.458 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.934 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.63 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.71 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 2.82 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.638 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.84 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 0.48 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 0.99 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 0.55 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.42 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.66 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.15 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.14 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 0.56 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.0 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.46 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 3.14 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 0.64 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.78 109.848 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.32 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.49 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.57 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 111.209 0.077 . . . . 1.48 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 0.98 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG23 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 0.45 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.39 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.32 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.96 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.769 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.47 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.01 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 1.54 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 0.91 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.18 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.88 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.6 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 0.77 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 0.83 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.683 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.41 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 0.65 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.57 HD22 ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.07 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.62 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.58 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 52.1 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.41 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 0.36 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 0.46 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.28 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.869 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.51 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 0.57 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.83 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.18 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HG23 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 1.52 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 1.55 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.95 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.88 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.32 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.43 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.23 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 97' ' ' ILE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.46 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.674 ' HB ' HD11 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 0.69 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.589 ' HE1' HG11 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.59 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 0.37 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.47 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 50' ' ' SER . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.23 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 0.82 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 1.72 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.09 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.83 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.48 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.85 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.08 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.31 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.09 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.22 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.34 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 0.72 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.42 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.55 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 0.95 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.7 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 0.41 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.33 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.869 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 2.78 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.62 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 1.8 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.37 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.14 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.56 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.13 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 0.46 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.53 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.19 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.54 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.51 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 1.6 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 0.52 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 0.81 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.25 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.833 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.94 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.54 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 0.56 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.23 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 0.36 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 0.6 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.21 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 0.33 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.42 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.32 110.717 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 0.73 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.565 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.45 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.57 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.31 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.59 110.5 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' HG12 ' A' ' 151' ' ' ILE . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.31 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 0.37 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.14 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 0.38 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.27 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.4 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 0.78 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.19 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.63 109.478 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.95 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 0.69 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 0.84 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.24 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.41 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.9 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.03 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.84 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.19 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.24 110.451 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.19 112.539 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.16 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 1.96 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.658 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.71 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 135' ' ' LEU . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.5 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.46 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 1.87 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 0.79 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.679 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.63 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.943 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 2.82 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.84 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.943 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 0.48 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 0.99 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 0.55 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.42 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 1.91 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.66 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.15 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.14 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 0.56 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.46 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 3.14 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 0.64 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.78 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.32 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.49 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.57 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 1.48 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.751 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 0.98 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.503 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 0.45 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.39 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.32 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.96 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 25.9 t-20 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 1.47 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.01 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 1.54 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG1' HD12 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 0.91 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.18 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.88 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.6 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 0.77 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 0.83 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.41 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 0.65 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.07 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.62 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.58 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.41 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 0.36 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.46 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.28 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.51 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.57 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.751 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.83 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.18 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 1.55 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.95 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.88 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.32 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.43 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.23 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 0.46 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.69 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.59 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.47 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.23 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 0.82 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.09 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.83 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.48 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.643 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.85 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.08 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.05 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.31 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.09 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.22 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.34 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 0.72 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.42 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.55 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 0.95 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 0.7 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 0.41 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.33 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 2.78 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.62 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.37 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.12 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.44 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.14 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 0.56 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.13 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 0.46 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.53 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' CB ' HD13 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.19 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.54 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.51 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 1.6 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 89' ' ' ALA . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.52 110.418 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 0.81 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.25 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.94 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 0.54 111.481 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 0.56 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.23 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 0.63 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 0.36 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 0.6 107.973 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.21 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 0.33 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.42 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.32 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 0.5 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.604 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 0.73 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.453 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.45 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.57 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.31 109.51 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.59 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.31 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 0.37 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.14 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 0.38 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.27 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.4 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' HD13 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 0.78 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.19 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.554 ' ND2' HD11 ' A' ' 140' ' ' LEU . 49.2 m-20 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.63 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.95 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.69 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.754 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 0.84 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.24 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.41 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 0.9 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.03 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.84 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.19 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.24 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.19 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.16 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 1.96 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.71 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.5 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 1.87 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.79 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.754 ' HB2' HG23 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.63 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.695 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 2.82 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.84 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.621 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 0.48 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.554 HD11 ' ND2' ' A' ' 114' ' ' ASN . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 0.99 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 0.55 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.42 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 1.91 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.66 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.15 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.14 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 0.56 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.0 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.46 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 3.14 109.3 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.64 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.78 110.075 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.639 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.32 109.744 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.453 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.49 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.57 109.416 177.781 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.491 0.186 . . . . 1.48 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.561 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 0.98 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.681 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 0.45 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.39 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.32 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.96 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.9 t30 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 1.47 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.01 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 1.54 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 0.91 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.986 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.18 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.88 110.05 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.6 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.77 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 0.83 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.41 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 0.65 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.07 109.694 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.62 111.971 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.58 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' HD13 ' A' ' 12' ' ' LEU . 43.8 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.41 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 0.36 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 0.46 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.28 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.51 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 0.57 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.561 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.83 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.18 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD11 HG23 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.55 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.95 109.432 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.88 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.32 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.651 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.43 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.666 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.23 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.46 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 0.69 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.59 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 0.37 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.47 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.23 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 0.82 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 1.72 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.09 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.83 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 83' ' ' LEU . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.48 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.85 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.08 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.05 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.31 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.09 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.22 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.34 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 0.72 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.42 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.55 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 0.95 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 0.7 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.41 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.33 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.78 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 1.8 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.442 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.12 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.44 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.1 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.14 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.56 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.13 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.53 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.19 110.952 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.54 112.134 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.51 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 53' ' ' TYR . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 1.6 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.52 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 0.81 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.25 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.94 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.54 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 0.56 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.23 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 0.63 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 0.36 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 0.6 108.297 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.759 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.21 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 0.33 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.42 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 0.5 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.73 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.45 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.57 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.31 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.59 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.31 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 0.37 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.401 HH21 ' CB ' ' A' ' 147' ' ' THR . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.14 109.402 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 0.38 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.27 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' HG13 ' A' ' 95' ' ' VAL . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.4 110.18 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 0.78 110.027 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.19 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.63 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.95 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 0.69 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 0.84 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.24 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.41 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.03 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.84 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.19 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.24 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.19 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.16 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 1.96 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.71 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.5 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.46 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 1.87 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 0.79 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB2' HG22 ' A' ' 118' ' ' THR . 31.0 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.63 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 2.82 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.84 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 0.48 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 0.99 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.55 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.42 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 1.91 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.66 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.15 109.587 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.14 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.401 ' CB ' HH21 ' A' ' 108' ' ' ARG . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 0.56 108.937 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.0 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.46 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 3.14 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 0.64 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.78 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.539 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.32 108.576 -171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.49 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.57 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.69 -0.485 . . . . 1.48 109.69 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 1.0 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 0.98 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.712 HG23 HD21 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.45 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HG3' HD11 ' A' ' 31' ' ' ILE . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.39 110.249 174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.32 109.76 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.96 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.784 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.4 t30 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 1.47 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.01 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 1.54 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 0.91 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.18 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.677 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.88 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.6 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.77 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 0.83 112.39 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.41 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 0.65 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' ND2' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.07 108.162 174.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.62 113.225 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.58 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.677 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 64.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.41 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 0.36 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 0.46 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.28 109.461 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.51 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 0.57 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.0 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.83 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.18 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.712 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 1.52 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 1.55 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.95 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.88 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.853 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.32 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.43 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.23 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 0.46 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.805 ' HB ' HD11 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 0.69 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.59 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 0.37 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.672 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.47 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.23 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 0.82 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 1.72 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.09 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.83 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.48 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.672 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.85 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.08 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.05 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.31 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.64 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.09 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.22 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.34 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 0.72 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.42 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.55 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 0.95 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 0.7 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 0.41 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.33 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 2.78 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.62 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 1.8 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.37 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.12 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.44 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 78.4 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 0.56 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.13 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 0.46 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.53 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.19 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.54 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.51 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 1.6 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 0.52 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 0.81 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.25 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.94 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.54 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 0.56 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.23 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 0.63 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.612 ' HB ' HG21 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 0.36 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 0.6 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.21 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 0.33 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.615 HG23 HD13 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.42 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.32 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 0.5 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.697 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 0.73 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.45 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.57 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.31 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.59 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.31 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 0.37 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.14 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 0.38 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.27 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.4 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 0.78 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.19 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.63 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.95 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.535 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 0.69 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 0.84 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.24 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.41 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.9 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.03 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.84 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.19 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.828 ' HB3' HG11 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.24 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.19 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.667 HG13 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.16 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.667 ' HD2' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.71 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.5 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.46 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 1.87 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.79 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.63 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.646 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 2.82 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.84 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 0.48 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 0.99 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 0.55 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.42 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.91 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.66 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.15 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.14 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 0.56 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.0 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.46 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 3.14 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 0.64 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.78 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.414 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.32 107.958 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.49 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.57 109.737 -179.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.654 0.264 . . . . 1.48 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 0.98 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 0.45 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.39 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.32 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.96 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 63.3 t30 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 1.47 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.01 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 1.54 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 0.91 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.705 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.18 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.88 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.6 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.578 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 0.77 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 0.83 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.553 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.41 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 0.65 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.07 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.62 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.58 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.705 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.41 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 0.36 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 0.46 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.28 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.51 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 0.57 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.83 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.18 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 1.52 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 1.55 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.95 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.88 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.32 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.43 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.23 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 0.46 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 0.69 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HE1' HG11 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.59 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.647 ' HB ' HG22 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.37 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.47 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.23 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.82 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.628 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 1.72 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.09 112.08 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.83 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.48 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.85 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.08 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.05 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.31 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.09 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.22 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.34 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 0.72 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.42 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.55 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 0.95 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 0.7 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 0.41 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.33 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 2.78 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.62 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.439 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 1.8 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.37 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.12 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.44 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.14 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 0.56 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.13 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 0.46 110.625 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.53 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.19 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.54 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.51 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 1.6 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 0.52 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 0.81 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.25 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.94 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.54 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 0.56 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.23 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 0.63 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 0.36 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 0.6 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.21 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 0.33 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.417 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.42 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.32 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 0.5 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 0.73 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.45 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.57 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.31 110.011 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.417 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.59 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.31 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 0.37 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.14 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.44 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.27 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.4 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 0.78 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.62 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.19 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.63 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.95 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 0.69 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 0.84 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.24 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.41 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.9 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.03 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.84 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.19 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.24 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.19 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.16 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 1.96 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.71 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.5 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.46 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 1.87 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 0.79 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.975 ' HB2' HG23 ' A' ' 118' ' ' THR . 38.4 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.63 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.58 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 2.82 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.84 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.58 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.48 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.99 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.55 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.42 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 1.91 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.66 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.15 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.14 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.411 ' CB ' HH21 ' A' ' 108' ' ' ARG . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 0.56 109.432 174.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.0 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.46 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 3.14 109.677 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 0.64 110.33 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.78 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.32 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.57 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.337 -0.246 . . . . 1.48 110.337 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 0.98 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.728 HG23 HD21 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 0.45 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.505 ' NE2' HH11 ' A' ' 148' ' ' ARG . 8.2 tp60 -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.39 109.89 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.32 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.96 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 1.47 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.01 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 1.54 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.427 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 0.91 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.18 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.88 109.714 167.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.6 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 0.77 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 0.83 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.706 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.41 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.65 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.07 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.62 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.58 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 4.6 tp60 -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.41 110.809 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 74' ' ' PHE . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 0.36 111.424 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 0.46 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.28 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.51 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 0.57 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.83 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.18 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.728 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 1.52 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 1.55 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.95 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.527 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.88 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.32 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.43 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.23 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 0.46 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 0.69 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.59 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.667 ' HB ' HG22 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 0.37 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.666 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.47 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.496 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.23 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 0.82 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 1.72 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.09 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.83 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.48 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.666 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG3' HD12 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.85 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.08 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.05 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.31 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.09 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.22 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.72 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.42 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.55 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 0.95 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 0.7 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 0.41 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.33 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 2.78 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.62 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 1.8 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.37 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.12 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.44 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.14 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 0.56 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.13 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 0.46 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.53 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.19 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.54 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.43 HD12 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 1.6 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.45 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 0.52 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 0.81 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.25 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.94 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 0.54 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 0.56 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.23 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 0.63 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 0.36 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 0.6 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.717 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.21 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 0.33 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.42 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.32 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.5 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 0.73 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.45 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.57 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.31 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.59 110.569 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.31 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 0.37 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.14 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 0.38 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.27 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.4 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 0.78 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.19 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.63 110.019 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.95 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 0.69 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 0.84 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.24 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.41 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 0.9 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.03 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.84 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.19 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.24 111.73 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.19 113.008 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.16 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 1.96 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.71 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.706 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.5 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.46 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 1.87 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 0.79 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.5 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.63 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 2.82 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.84 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 0.48 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 0.99 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 0.55 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.42 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 1.91 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.66 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.15 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.14 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 0.56 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.505 HH11 ' NE2' ' A' ' 5' ' ' GLN . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.0 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.46 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 3.14 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 0.64 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.78 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.32 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.49 109.762 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.57 109.611 177.496 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.141 0.496 . . . . 1.48 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 0.98 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 0.45 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.39 110.193 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.32 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.96 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 59.4 t30 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 1.47 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.01 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 1.54 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 0.91 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.942 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.18 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.88 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.6 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 0.77 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 0.83 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.41 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HE2' ' HG ' ' A' ' 133' ' ' SER . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 0.65 111.358 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.07 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.62 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.58 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.942 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 30.4 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.41 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 0.36 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 0.46 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.28 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.51 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 0.57 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.83 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.18 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 1.52 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 1.55 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.95 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.88 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.32 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.43 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.23 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 0.46 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 0.69 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.59 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.37 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.69 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.47 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.571 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.23 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 88' ' ' ASP . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 0.82 109.131 170.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 1.72 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.09 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.83 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.48 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.69 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.85 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.08 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.675 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.05 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.31 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.608 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.09 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.22 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.34 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 0.72 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.42 112.085 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.55 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 0.95 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 0.7 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.41 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.33 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 2.78 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.62 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 1.8 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.37 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.12 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.44 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 12.7 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.14 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 0.56 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.13 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 0.46 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 84' ' ' ILE . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.53 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.19 110.911 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.54 112.324 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.51 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 1.6 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 0.52 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 0.81 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.25 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.94 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.54 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 0.56 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.23 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 0.63 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.36 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 0.6 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.21 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 0.33 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.42 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.32 109.988 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 0.5 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.73 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.45 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.57 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.31 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.59 110.33 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.31 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 0.37 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.492 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.14 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.4 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 0.78 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.19 110.978 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 93.6 m-20 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.63 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.95 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 0.69 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.84 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.24 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.41 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.56 HD22 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 0.9 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.03 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.84 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.19 110.921 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.462 ' HG3' HG11 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.24 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' HD22 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.19 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.16 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 1.96 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.71 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.518 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.5 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.401 ' HG ' ' HE2' ' A' ' 19' ' ' TYR . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.46 110.684 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 1.87 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 0.79 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.63 108.683 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 2.82 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.84 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 0.48 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 0.99 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.55 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.42 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 1.91 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.66 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.15 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.14 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.56 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.46 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 3.14 109.183 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.64 109.916 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.78 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.32 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.49 109.334 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.57 109.733 -177.733 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.867 0.321 . . . . 1.48 111.867 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 0.98 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 0.45 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.39 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.32 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.96 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 1.47 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.01 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 1.54 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 14' ' ' ASN . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.531 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.18 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 1.007 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 18.3 m-20 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.88 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.6 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 0.77 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 0.83 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.41 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 0.65 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.07 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.62 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.58 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.41 110.243 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.65 ' HB2' HD21 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 0.36 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 0.46 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.28 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.823 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.51 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 0.57 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.83 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.18 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 1.52 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 1.55 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.95 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.88 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.64 HD12 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.32 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' NE1' HD12 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.43 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.23 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 0.46 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.885 HG12 HG22 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 0.69 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.59 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 0.37 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.47 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.23 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 0.82 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 1.72 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.09 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.83 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.48 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.85 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.08 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.05 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.31 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.09 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.22 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.34 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 0.72 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.42 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.55 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 0.95 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 0.7 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.41 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.33 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.823 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 2.78 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.62 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 1.8 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.37 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.12 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.44 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.2 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.14 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.56 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.13 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 0.46 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.53 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.19 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.54 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.51 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.6 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 0.52 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 0.81 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.25 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.94 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.54 111.672 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.56 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.23 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 0.63 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 0.36 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 0.6 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.21 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 0.33 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.42 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.32 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 0.5 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.73 109.238 172.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.45 111.166 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.57 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.31 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.59 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.31 111.56 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 0.37 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.14 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 0.38 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.27 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.4 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 0.78 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.19 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.63 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.95 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 0.69 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 0.84 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.24 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.41 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 0.9 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.03 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.84 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.19 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.24 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.19 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.16 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.71 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.5 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.46 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 1.87 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 0.79 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.63 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.644 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 2.82 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.84 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.007 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 0.48 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 0.99 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 0.55 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.42 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 1.91 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.66 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.15 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.14 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 0.56 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.0 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.46 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 3.14 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.64 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.78 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.32 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.49 110.668 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.57 108.984 176.513 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.906 0.384 . . . . 1.48 110.858 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 0.98 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.45 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.39 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.32 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.96 109.921 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 1.47 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.01 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 1.54 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 0.91 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.18 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.88 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.6 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 0.77 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 0.83 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.41 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 0.65 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.07 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.62 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.58 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 57.6 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.41 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 0.36 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 0.46 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.28 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.51 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 0.57 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.83 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.18 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 1.52 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 1.55 110.646 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.95 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.88 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.32 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.497 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.43 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.66 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.23 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 0.46 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.629 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 0.69 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.59 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.47 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.23 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 0.82 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 1.72 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.09 111.202 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.83 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.48 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.581 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.85 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.08 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.652 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.05 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.31 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.09 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.22 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.34 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 0.72 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.42 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.55 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 0.95 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 0.7 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 0.41 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.33 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.877 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 2.78 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.62 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 1.8 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.37 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.12 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.44 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.14 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 0.56 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.13 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 0.46 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.53 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.19 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.54 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.51 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 1.6 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 0.52 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.811 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 0.81 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.25 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.94 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 0.54 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 0.56 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.23 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 0.63 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 0.36 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 0.6 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.21 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 0.33 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.42 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.491 ' HB3' HD11 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.32 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 153' ' ' TRP . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 0.73 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.474 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.45 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.57 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.31 109.599 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.59 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.31 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 0.37 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.14 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 0.38 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.27 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.4 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 0.78 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.19 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 80.5 m-20 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.63 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.95 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.697 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 0.69 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.84 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.24 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.41 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 0.9 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.03 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.84 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.19 110.509 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.24 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.19 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.16 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 1.96 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.697 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.71 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.46 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.5 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.46 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 1.87 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 0.79 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.693 ' HB2' HG23 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.63 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 2.82 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 28.3 t-20 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.84 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 0.48 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 0.99 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 0.55 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.42 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 1.91 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.66 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.15 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.14 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 0.56 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.0 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.46 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 3.14 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 0.64 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.78 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.459 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.32 109.069 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.446 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.49 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.57 110.487 -178.434 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.721 0.296 . . . . 1.48 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.98 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 0.45 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.39 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.32 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.96 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 1.47 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.01 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 1.54 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.91 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.18 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.88 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.6 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.749 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 0.77 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 0.83 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.755 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.41 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 0.65 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.07 108.762 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.62 112.996 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.58 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 12' ' ' LEU . 33.6 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.41 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.008 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 0.36 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.46 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.28 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.51 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 0.57 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.83 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.18 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 1.52 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 1.55 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.95 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.88 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.32 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 38' ' ' LEU . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.43 109.475 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.23 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 0.46 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.59 HG12 HG22 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 0.69 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.59 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 0.37 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.47 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 50' ' ' SER . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.23 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 0.82 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 1.72 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.09 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.83 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.48 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.85 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.08 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.09 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.22 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.34 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 0.72 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.42 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.55 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.623 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 0.95 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 0.7 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.41 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.33 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 2.78 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.62 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 1.8 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.37 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.12 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.14 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 0.56 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.13 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.46 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.53 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.19 110.772 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.54 111.948 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.51 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 1.6 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 0.52 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 0.81 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.25 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.836 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.94 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 0.54 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 0.56 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.23 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.588 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 0.63 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 0.36 110.542 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 0.6 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.21 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 0.33 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HD12 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.42 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.32 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 0.5 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.721 ' CE1' HD21 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.73 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.45 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.57 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.31 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.59 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.31 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 0.37 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.14 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 0.38 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.27 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.4 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 0.78 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.19 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.63 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.95 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.69 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 0.84 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.24 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.41 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 0.9 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.03 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.84 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.19 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.24 111.809 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.19 112.07 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.16 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 1.96 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.636 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.71 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.755 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.5 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 1.87 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 0.79 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.649 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.63 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 2.82 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.84 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.511 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 0.48 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 0.99 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.55 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.42 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 1.91 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.66 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.15 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.14 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 0.56 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.0 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.46 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 3.14 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 0.64 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.78 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.32 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.49 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.57 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.895 0.379 . . . . 1.48 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 0.98 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 0.45 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.39 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.96 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 47.5 t30 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 1.47 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.01 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 1.54 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.18 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 1.0 OUTLIER -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.88 110.443 176.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.6 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 0.77 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 0.83 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.661 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.41 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 0.65 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.07 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.62 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.58 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.609 ' HB3' HD23 ' A' ' 12' ' ' LEU . 46.0 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.41 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.003 ' HG3' HD21 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.36 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 0.46 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.28 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.819 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.51 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 0.57 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.83 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.18 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 1.52 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 1.55 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.95 111.026 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.88 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 65' ' ' VAL . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.32 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.887 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.43 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.23 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 0.46 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.921 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 0.69 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.59 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 0.37 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.47 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.888 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.23 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 0.82 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 1.72 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.09 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.83 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.48 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.85 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.921 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.08 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.31 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.09 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.22 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.887 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.34 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 0.72 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.42 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.55 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.777 HG21 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 0.95 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 0.7 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 0.41 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.33 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 2.78 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.62 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 1.8 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.37 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.12 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.44 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 45.3 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.14 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 0.56 110.149 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.13 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 0.46 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.53 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.19 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.54 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.51 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 1.6 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.888 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 0.81 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.94 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.54 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.56 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.23 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 0.63 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 0.36 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 0.6 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.21 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 0.33 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.42 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.32 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 0.5 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 0.73 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.777 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.45 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.57 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.31 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.59 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.31 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 0.37 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.14 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.27 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.4 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.78 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.19 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.63 109.312 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.95 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 0.69 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 0.84 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.24 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.559 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.41 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 0.9 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.03 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.84 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.19 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.24 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.19 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' H ' HG23 ' A' ' 128' ' ' VAL . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.16 110.338 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.751 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.71 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.661 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.5 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.46 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 1.87 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 0.79 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.63 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 2.82 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.84 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.48 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 0.99 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.42 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 1.91 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.66 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.15 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.14 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 0.56 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.0 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.46 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 3.14 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 0.64 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.78 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.32 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.49 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.57 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 1.48 109.782 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.666 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 0.98 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 0.45 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.39 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.32 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.96 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 50.3 t30 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.01 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 0.91 110.077 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.18 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.88 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.6 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 0.77 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 0.83 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.41 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 0.65 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.07 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.62 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.58 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 53.3 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.41 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HG2' HG22 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 0.36 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 0.46 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.28 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.51 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 0.57 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.83 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.18 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 1.52 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 1.55 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.95 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.88 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.32 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.43 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.23 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 0.46 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 0.69 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.59 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.37 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.664 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.47 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.785 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.23 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.82 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 1.72 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.09 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.83 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.48 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.85 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.08 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.31 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.599 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.09 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.22 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.34 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.72 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.42 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.55 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 0.95 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 0.7 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 0.41 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.33 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 2.78 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.62 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 1.8 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.37 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.12 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.44 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.4 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.14 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 0.56 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.13 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 0.46 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 84' ' ' ILE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.53 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.19 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.54 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.51 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 1.6 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 79' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 0.52 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 0.81 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.25 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.838 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.94 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.54 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 0.56 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.23 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.63 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 0.6 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.21 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 0.33 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.42 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.32 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 0.5 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 0.73 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.45 110.833 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.57 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.31 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.59 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.31 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 0.37 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.14 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 0.38 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.27 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' HG13 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.4 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 0.78 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.19 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.63 109.175 174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.95 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 0.69 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 0.84 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.24 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.41 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 0.9 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.03 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.84 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.19 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.516 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.24 111.877 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.19 111.794 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.16 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 1.96 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.643 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.71 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.5 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.46 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 1.87 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 0.79 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.63 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.556 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 2.82 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.84 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 0.48 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 0.99 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 0.55 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.42 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 1.91 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.66 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.15 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.14 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 0.56 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.0 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.46 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 3.14 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 0.64 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.78 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.32 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.49 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.57 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 1.48 111.054 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 0.98 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 0.45 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.39 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.32 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.96 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 1.47 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.01 108.668 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 1.54 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 0.91 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.676 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.18 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.88 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.6 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 0.77 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 0.83 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.731 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.41 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 0.65 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.07 108.672 175.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.62 113.377 -174.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.58 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 56.1 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.41 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.82 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 0.36 110.931 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 0.46 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.28 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.51 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 0.57 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.83 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 1.52 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 1.55 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.88 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 HG11 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.32 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HA ' HD13 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.43 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.23 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 0.46 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 0.69 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.59 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG22 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 0.37 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.626 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.47 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.597 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.23 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 0.82 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.598 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 1.72 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.09 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.83 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.48 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.85 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.08 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.05 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.31 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.09 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.22 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.34 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 0.72 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.42 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.55 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.615 HG11 HD22 ' A' ' 38' ' ' LEU . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 0.95 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 0.7 113.441 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 0.41 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.33 111.936 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 2.78 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.62 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 1.8 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.12 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.44 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 95.9 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.14 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 0.56 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.13 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 0.46 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.53 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.19 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.54 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.51 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 1.6 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 0.52 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 0.81 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.25 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.605 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.94 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 0.54 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 0.56 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.23 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 0.63 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' HB ' HG21 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 0.36 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 111' ' ' TYR . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 0.6 108.983 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.21 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.42 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.32 110.251 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 0.5 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.461 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 0.73 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.45 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.57 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.31 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.59 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.31 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 0.37 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.14 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 0.38 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.27 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.4 110.823 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 0.78 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.19 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.63 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.95 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 0.69 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 0.84 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.24 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.41 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 0.9 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.03 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.84 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.19 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.24 111.262 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.19 111.689 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.16 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 1.96 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.71 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.731 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.5 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.46 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 0.79 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.565 ' HB2' HG22 ' A' ' 118' ' ' THR . 7.4 tt0 -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.63 108.452 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 2.82 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.84 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 0.48 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 0.99 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 0.55 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.42 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 1.91 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.66 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.15 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.14 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.56 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.0 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.46 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 3.14 110.045 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 0.64 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.78 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.32 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.49 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.57 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.666 0.269 . . . . 1.48 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 0.98 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 0.45 109.415 176.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.39 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.96 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 26.7 t-20 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.01 109.302 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 1.54 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.746 HG13 ' ND2' ' A' ' 14' ' ' ASN . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 0.91 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.18 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.746 ' ND2' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.88 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.6 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.581 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 0.77 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 0.83 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.41 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 0.65 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.07 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.62 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.58 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 49.8 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.41 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 0.36 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 0.46 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.28 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 0.57 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.83 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.18 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.886 HD11 HG23 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 1.52 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 1.55 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.95 109.582 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.88 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.32 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.43 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.23 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 0.46 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 0.69 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.59 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' ' H ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 0.37 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.646 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.47 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.23 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 0.82 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 1.72 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.09 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.83 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.48 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.85 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.08 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.05 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.31 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.09 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.22 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.34 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 0.72 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.42 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.55 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.886 HG23 HD11 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 0.95 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 0.7 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.724 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.41 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.33 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 2.78 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.62 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 1.8 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.37 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.12 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.44 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.14 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 0.56 110.18 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.13 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 0.46 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.53 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.19 111.991 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.54 112.207 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.51 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 83' ' ' LEU . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 1.6 110.741 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 0.52 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.662 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 0.81 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.25 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.662 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.94 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 0.54 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 0.56 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.23 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 0.63 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' H ' ' HB ' ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 0.36 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 0.6 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.21 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 0.33 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.42 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 0.5 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 0.73 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.45 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.57 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.31 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.59 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.31 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 0.37 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.14 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 0.38 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.522 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.27 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.4 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 0.78 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.19 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.63 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB3' HD21 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.95 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 0.69 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 0.84 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.24 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.636 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.41 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 0.9 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.03 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.84 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.19 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' HG11 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.24 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.19 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.16 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 1.96 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.583 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.71 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.401 ' H ' ' HE2' ' A' ' 117' ' ' TYR . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.5 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.46 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 1.87 109.802 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 0.79 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.506 ' HB2' HG22 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.63 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 2.82 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.84 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 0.48 109.919 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.99 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 0.55 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.42 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 1.91 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.66 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.15 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.14 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 0.56 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.0 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.46 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 3.14 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.64 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.78 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.32 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.49 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.57 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 1.48 112.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 0.98 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.45 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.39 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.32 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.96 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.47 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 26' ' ' ILE . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.01 109.782 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.54 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 0.91 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.18 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.88 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.6 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 0.77 110.499 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 0.83 114.275 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.41 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.07 108.945 173.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.62 112.702 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.58 109.126 169.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 48.8 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.41 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 9' ' ' VAL . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 0.36 111.451 -174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.28 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.51 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 0.57 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.83 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.18 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.524 HD21 ' HZ3' ' A' ' 153' ' ' TRP . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 1.52 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 1.55 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.95 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.88 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.32 109.904 -174.345 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.43 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.23 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.46 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 0.69 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.59 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' HG22 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 0.37 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.47 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.628 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.23 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 0.82 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 1.72 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.09 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.83 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.48 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.85 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.08 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.31 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.09 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.22 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.34 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 0.72 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.42 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.55 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 0.95 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 0.7 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 0.41 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.33 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 2.78 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.62 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 1.8 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.37 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.12 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.44 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.14 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 0.56 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.13 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 0.46 110.548 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.53 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.19 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.54 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.51 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 1.6 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 0.52 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 1.114 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 0.81 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.25 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 1.114 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.94 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.54 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.56 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.23 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.63 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 0.36 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 0.6 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.21 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 0.33 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.42 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HB3' HD11 ' A' ' 38' ' ' LEU . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.32 109.639 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 0.5 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.73 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.45 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.57 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.31 110.033 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.59 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.31 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.14 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.27 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.4 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 0.78 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.19 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.63 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.95 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.639 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 0.69 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 0.84 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.24 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.41 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 0.9 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.03 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.84 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.19 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HB3' HG11 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.24 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.19 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.16 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 1.96 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.639 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.71 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.5 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.46 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 1.87 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 0.79 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.63 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 2.82 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.84 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 0.48 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 0.99 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 0.55 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.42 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 1.91 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.66 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.15 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.416 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.56 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.0 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.46 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 3.14 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 0.64 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.78 109.657 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.524 ' HZ3' HD21 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.32 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.49 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.4 m120 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.57 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 109.876 -0.416 . . . . 1.48 109.876 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.786 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 0.98 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.45 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.39 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.32 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.96 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 1.47 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.01 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 1.54 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 0.91 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.18 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.752 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.88 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.6 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.752 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 0.77 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 0.83 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.695 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.41 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 0.65 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.07 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.62 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.58 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.41 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 0.36 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 0.46 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.28 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.51 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 0.57 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.83 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.18 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.085 HD21 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 1.52 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 1.55 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.95 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.88 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.32 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' SER . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.43 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.23 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 0.46 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 0.69 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.59 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.47 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.23 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 0.82 108.704 168.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 1.72 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.09 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.83 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.48 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.85 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.628 HG22 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.08 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.05 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.31 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.09 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.22 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.34 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 0.72 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.42 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.55 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.085 ' HB ' HD21 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 0.95 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 0.7 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 0.41 111.42 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.33 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 2.78 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.62 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 1.8 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.37 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.12 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.44 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.14 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 0.56 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.13 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.46 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.53 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.19 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.54 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.51 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 1.6 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 0.52 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 0.81 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.25 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.605 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.94 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.54 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 0.56 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.531 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.23 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 0.63 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 0.36 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 0.6 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 0.33 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.42 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.32 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 0.5 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 0.73 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.45 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.57 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.31 109.85 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.59 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.31 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 0.37 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.14 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 0.38 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.575 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.27 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.4 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 0.78 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.19 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.531 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.63 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.95 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 0.69 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 0.84 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.24 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.41 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 0.9 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.03 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.84 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.19 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.24 110.937 169.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.19 111.19 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.16 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 1.96 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.71 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.5 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.471 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.46 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 1.87 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 0.79 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.63 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 2.82 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.84 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.459 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 0.48 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 0.99 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 0.55 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.42 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 1.91 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.66 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.15 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.14 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 0.56 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.46 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 3.14 109.418 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.64 110.58 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.78 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.431 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.653 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.32 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.49 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.57 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.057 0.456 . . . . 1.48 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 0.98 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 0.45 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.39 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.32 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.96 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 1.47 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.01 109.909 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 25' ' ' GLU . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 1.54 110.412 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 0.91 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.18 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.88 111.381 177.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.6 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 0.77 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 0.83 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.41 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 0.65 111.634 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.07 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.62 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.58 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 11.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.41 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 0.36 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.28 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.51 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 0.57 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.83 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.18 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.847 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 1.52 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 1.55 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.95 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.88 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.32 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.43 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.23 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 0.46 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.627 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 0.69 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' HE1' HG11 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.59 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.37 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.47 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.849 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.23 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 0.82 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 1.72 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.09 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.83 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.849 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.48 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.85 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.08 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.05 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.31 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.669 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.09 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.22 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.34 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 0.72 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.42 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.55 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 0.95 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 0.7 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 0.41 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.33 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 2.78 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.62 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 1.8 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.37 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.12 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.44 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.14 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 0.56 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.13 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 0.46 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.53 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.19 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.54 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.51 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.683 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 1.6 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 0.52 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 0.81 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.25 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.94 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 0.54 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.56 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.23 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 0.63 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 0.36 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 0.6 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.21 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 0.33 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.42 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.32 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.73 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.45 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.57 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.31 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.59 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.31 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 0.37 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 0.38 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.27 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.4 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 0.78 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 137' ' ' ARG . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.19 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.63 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.522 ' HB3' HD21 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.95 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 0.69 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 0.84 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.24 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.41 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 0.9 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.03 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.84 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.19 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.24 111.825 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.19 112.005 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.16 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.536 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.71 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.46 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 1.87 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 115' ' ' ASN . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 0.79 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.543 ' HB2' HG22 ' A' ' 118' ' ' THR . 31.1 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.63 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 113' ' ' VAL . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 2.82 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.84 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.549 HG21 HG11 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 0.48 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 0.99 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 0.55 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.42 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 1.91 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.66 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.15 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.14 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.0 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.515 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.46 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 3.14 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 0.64 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.78 110.427 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.32 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.49 111.502 -166.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.57 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 1.48 110.373 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.98 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 0.45 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.39 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.32 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.96 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 1.47 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.01 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 1.54 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 0.91 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.708 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.18 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.88 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.6 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 0.77 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 0.83 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.41 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 0.65 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.07 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.62 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.58 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.41 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.36 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 0.46 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.28 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.51 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.57 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.83 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.18 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 1.52 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 1.55 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.95 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.88 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.32 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.422 ' NE1' HD12 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.43 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.632 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.23 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.46 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.69 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.59 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 0.37 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.47 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.23 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 0.82 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 1.72 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.09 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.83 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.85 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.08 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.05 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.31 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.09 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.22 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.34 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 0.72 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.42 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.55 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 0.95 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 0.7 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 0.41 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.33 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 2.78 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.62 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.37 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.886 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.12 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.14 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 0.56 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.13 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 0.46 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.53 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.19 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.54 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.51 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 1.6 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 0.52 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 0.81 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.25 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.94 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.54 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 0.56 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.23 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 0.63 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 0.36 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 0.6 108.436 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.21 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 0.33 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.42 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.32 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.5 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 0.73 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.45 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.57 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.31 109.751 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.59 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.31 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 0.37 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.14 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 0.38 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.27 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.4 110.121 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 0.78 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.19 110.819 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.63 109.079 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.95 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.69 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 0.84 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.24 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.583 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.41 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 0.9 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.03 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.84 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.19 111.353 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.24 111.671 175.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.19 112.267 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.16 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 1.96 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.71 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.87 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 0.79 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 39.8 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.63 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 137' ' ' ARG . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 2.82 109.978 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.84 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.546 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 0.48 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 0.99 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 0.55 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.42 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 1.91 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.66 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.15 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.14 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 0.56 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.0 110.553 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.46 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 3.14 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 0.64 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.78 109.915 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.32 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.49 108.968 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.57 109.669 -177.515 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.48 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 0.98 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 0.45 110.331 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.39 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.32 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.96 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 54.3 t30 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 1.47 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.01 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 1.54 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 139' ' ' ILE . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 0.91 109.376 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.743 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.18 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.88 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HB2' HE21 ' A' ' 136' ' ' GLN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.6 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.77 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.83 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.723 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.41 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 0.65 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.79 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.07 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.62 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.58 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.743 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 48.5 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.41 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 0.36 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 0.46 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.28 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.51 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 31' ' ' ILE . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 0.57 108.557 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.705 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.83 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.18 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 1.52 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.55 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.95 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.88 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.731 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.32 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.43 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.23 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 0.46 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 0.69 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.59 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 0.37 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.677 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.47 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.23 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 0.82 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 1.72 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.09 111.189 -175.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.458 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.48 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.85 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.05 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.31 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.09 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 0.72 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.42 112.17 174.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.55 110.243 -14.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 0.95 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 0.7 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.41 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.33 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 2.78 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 1.8 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.37 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.12 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.44 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 77.5 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.14 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 0.56 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.13 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 0.46 113.794 -172.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.53 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.544 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.19 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.54 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.51 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 1.6 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.52 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.682 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 0.81 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.25 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.682 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.94 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 0.54 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 0.56 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.23 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 0.63 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 0.36 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 0.6 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.21 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.33 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.42 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.32 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 0.5 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.73 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.45 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.57 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.31 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.59 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.31 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 0.37 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 107' ' ' ILE . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.14 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.38 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.27 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.4 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.754 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 0.78 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.19 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.63 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.408 ' HB3' HD11 ' A' ' 135' ' ' LEU . 15.5 m-80 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.95 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 0.69 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 0.84 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.24 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.41 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.9 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.03 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.84 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.19 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.24 110.68 169.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.19 111.463 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.16 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.711 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.71 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.5 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.46 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 1.87 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 0.79 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.63 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.969 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 2.82 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.84 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.969 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 0.48 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.99 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.55 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.42 109.524 174.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 41.9 t30 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 1.91 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 142' ' ' SER . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.66 112.105 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.754 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.15 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.14 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 0.56 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.0 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.46 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 3.14 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.64 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.78 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.32 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.49 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.57 110.096 179.777 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.656 ' HE1' ' HA ' ' A' ' 152' ' ' ASN . 26.9 ptm . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.514 0.197 . . . . 2.96 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -74.29 135.82 42.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 1.48 111.013 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 0.98 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 0.45 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.39 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.32 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.96 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 1.47 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.01 110.112 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 1.54 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.91 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.18 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.88 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.6 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 0.83 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.71 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.41 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 0.65 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.07 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.62 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.58 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.497 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 56.2 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.41 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 0.36 111.377 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 0.46 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.28 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.51 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 0.57 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.83 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.18 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 1.55 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.95 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.88 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.32 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.43 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.23 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 0.46 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 0.69 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HD1' ' HB ' ' A' ' 95' ' ' VAL . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.59 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 0.37 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.661 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.47 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.23 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 0.82 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 1.72 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.09 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.83 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.85 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.08 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.05 111.299 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.31 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.09 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.22 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.34 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 0.72 109.913 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.42 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.55 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 0.95 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 0.7 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 0.41 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.33 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 2.78 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.62 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 1.8 109.985 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.37 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.12 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.44 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 91.6 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.14 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 0.56 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.13 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 0.46 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.53 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.19 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.54 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.51 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 1.6 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 0.52 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 1.037 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 0.81 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.25 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 1.037 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.94 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 0.54 110.578 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 0.56 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.23 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.63 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 0.36 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 0.6 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.21 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 0.33 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.42 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.32 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 0.5 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.73 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.45 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.57 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.31 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.59 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.31 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 0.37 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.14 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 0.38 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.27 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HB2' HG13 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.4 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 0.78 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.536 HG21 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.19 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.63 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.95 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.69 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.84 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.24 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.413 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.41 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 0.9 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.03 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.84 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.19 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.24 111.304 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.19 111.753 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.16 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 1.96 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.567 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.71 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.5 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.46 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 1.87 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.79 110.458 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.934 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.63 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.71 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 2.82 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.638 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.84 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 0.48 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 0.99 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 0.55 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.42 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.66 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.15 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.14 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 0.56 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.0 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.46 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 3.14 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 0.64 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.656 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.78 109.848 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.32 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.49 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.57 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.765 0.283 . . . . 2.96 111.765 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.88 -84.63 0.41 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.416 -0.514 . . . . 1.48 111.209 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 0.98 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG23 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 0.45 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.39 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.32 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.96 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.769 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.47 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.01 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 1.54 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 0.91 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.18 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.88 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.6 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 0.77 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 0.83 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.683 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.41 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 0.65 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.57 HD22 ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.07 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.62 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.58 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 52.1 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.41 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 0.36 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 0.46 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.28 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.869 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.51 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 0.57 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.83 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.18 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HG23 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 1.52 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 1.55 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.95 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.88 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.32 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.43 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.23 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 97' ' ' ILE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.46 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.674 ' HB ' HD11 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 0.69 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.589 ' HE1' HG11 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.59 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 0.37 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.47 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 50' ' ' SER . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.23 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 0.82 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 1.72 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.09 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.83 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.48 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.85 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.08 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.31 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.09 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.22 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.34 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 0.72 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.42 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.55 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 0.95 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.7 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 0.41 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.33 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.869 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 2.78 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.62 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 1.8 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.37 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.12 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.14 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.56 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.13 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 0.46 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.53 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.19 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.54 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.51 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 1.6 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 0.52 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 0.81 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.25 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.833 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.94 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.54 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 0.56 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.23 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 0.36 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 0.6 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.21 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 0.33 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.42 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.32 110.717 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 0.73 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.565 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.45 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.57 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.31 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.59 110.5 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' HG12 ' A' ' 151' ' ' ILE . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.31 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 0.37 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.14 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 0.38 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.27 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.4 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 0.78 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.19 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.63 109.478 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.95 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 0.69 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 0.84 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.24 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.41 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.9 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.03 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.84 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.19 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.24 110.451 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.19 112.539 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.16 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 1.96 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.658 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.71 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 135' ' ' LEU . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.5 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.46 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 1.87 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 0.79 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.679 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.63 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.943 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 2.82 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.84 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.943 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 0.48 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 0.99 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 0.55 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.42 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 1.91 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.66 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HA ' ' HE ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.15 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.14 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 0.56 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.46 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 3.14 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 0.64 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.78 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.32 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.49 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.57 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 8.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.365 0.126 . . . . 2.96 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -64.2 107.99 1.45 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 1.48 110.788 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.751 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 0.98 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.503 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 0.45 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.39 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.32 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.96 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 25.9 t-20 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 1.47 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.01 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 1.54 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG1' HD12 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 0.91 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.18 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.88 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.6 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 0.77 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 0.83 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.41 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 0.65 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.07 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.62 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.58 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 11.3 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.41 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 0.36 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.46 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.28 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.51 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.57 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.751 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.83 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.18 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 1.55 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.95 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.88 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.32 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.43 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.23 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 0.46 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.69 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.59 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.47 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.23 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 0.82 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.09 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.83 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.48 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.85 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.08 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.05 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.31 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.09 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.22 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.34 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 0.72 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.42 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.55 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 0.95 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 0.7 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 0.41 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.33 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 2.78 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.62 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.37 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.12 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.44 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.14 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 0.56 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.13 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 0.46 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.53 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' CB ' HD13 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.19 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.54 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.51 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 1.6 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 89' ' ' ALA . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.52 110.418 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 0.81 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.25 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.94 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 0.54 111.481 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 0.56 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.23 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 0.63 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 0.36 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 0.6 107.973 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.21 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 0.33 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.42 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.32 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 0.5 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.604 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 0.73 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.453 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.45 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.57 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.31 109.51 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.59 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.31 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 0.37 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.14 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 0.38 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.27 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.4 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' HD13 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 0.78 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.19 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.554 ' ND2' HD11 ' A' ' 140' ' ' LEU . 49.2 m-20 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.63 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.95 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.69 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.754 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 0.84 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.24 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.41 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 0.9 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.03 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.84 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.19 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.24 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.19 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.16 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 1.96 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.71 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.5 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 1.87 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.79 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.754 ' HB2' HG23 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.63 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.695 ' O ' ' HD2' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 2.82 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.84 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.621 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 0.48 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.554 HD11 ' ND2' ' A' ' 114' ' ' ASN . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 0.99 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 0.55 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.42 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 1.91 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.66 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.15 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.14 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 0.56 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.0 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.46 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.427 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 2.1 t60 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 3.14 109.3 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.64 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.78 110.075 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.639 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.32 109.744 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.453 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.49 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.57 109.416 177.781 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.807 0.337 . . . . 2.96 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 139.89 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.323 -0.398 . . . . 1.48 110.508 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.561 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 0.98 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.681 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 0.45 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.39 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.32 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.96 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.9 t30 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 1.47 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.01 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 1.54 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 0.91 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.986 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.18 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.88 110.05 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.6 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.77 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 0.83 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.41 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 0.65 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.07 109.694 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.62 111.971 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.58 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' HD13 ' A' ' 12' ' ' LEU . 43.8 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.41 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 0.36 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 0.46 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.28 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.51 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 0.57 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.83 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.18 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD11 HG23 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.55 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.95 109.432 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.88 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.32 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.651 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.43 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.666 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.23 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.46 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 0.69 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.59 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 0.37 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.47 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.23 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 0.82 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 1.72 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.09 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.83 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 83' ' ' LEU . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.48 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.85 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.08 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.05 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.31 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.09 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.22 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.34 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 0.72 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.42 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.55 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 0.95 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 0.7 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.41 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.33 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.78 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 1.8 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.442 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.12 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.44 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.1 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.14 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.56 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.13 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.46 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.53 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.19 110.952 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.54 112.134 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.51 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 53' ' ' TYR . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 1.6 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.52 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 0.81 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.25 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.94 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.54 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 0.56 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.23 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 0.63 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 0.36 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 0.6 108.297 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.759 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.21 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 0.33 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.42 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 0.5 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.73 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.45 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.57 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.31 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.59 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.31 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 0.37 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.401 HH21 ' CB ' ' A' ' 147' ' ' THR . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.14 109.402 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 0.38 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.27 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' HG13 ' A' ' 95' ' ' VAL . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.4 110.18 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 0.78 110.027 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.19 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.63 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.95 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 0.69 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 0.84 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.24 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.41 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.03 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.84 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.19 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.24 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.19 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.16 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 1.96 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.71 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.5 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.46 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 1.87 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 0.79 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB2' HG22 ' A' ' 118' ' ' THR . 31.0 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.63 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 2.82 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.84 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 0.48 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 0.99 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.55 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.42 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 1.91 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.66 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.15 109.587 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.14 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.401 ' CB ' HH21 ' A' ' 108' ' ' ARG . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 0.56 108.937 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.0 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.46 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 3.14 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 0.64 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.78 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.539 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.32 108.576 -171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.49 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.57 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG2' ' HE3' ' A' ' 3' ' ' LYS . 26.7 ttp . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.499 0.666 . . . . 2.96 110.234 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -79.53 127.82 32.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.69 -0.485 . . . . 1.48 109.69 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 1.0 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 0.98 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.712 HG23 HD21 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.45 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HG3' HD11 ' A' ' 31' ' ' ILE . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.39 110.249 174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.32 109.76 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.96 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.784 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.4 t30 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 1.47 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.01 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 1.54 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 0.91 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.18 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.677 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.88 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.6 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.77 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 0.83 112.39 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.41 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 0.65 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' ND2' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.07 108.162 174.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.62 113.225 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.58 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.677 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 64.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.41 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 0.36 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 0.46 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.28 109.461 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.51 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 0.57 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.0 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.83 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.18 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.712 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 1.52 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 1.55 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.95 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.88 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.853 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.32 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.43 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.23 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 0.46 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.805 ' HB ' HD11 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 0.69 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.59 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 0.37 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.672 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.47 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.23 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 0.82 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 1.72 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.09 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.83 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.48 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.672 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.85 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.08 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.05 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.31 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.64 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.09 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.22 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.34 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 0.72 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.42 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.55 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 0.95 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 0.7 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 0.41 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.33 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 2.78 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.62 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 1.8 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.37 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.12 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.44 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 78.4 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 0.56 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.13 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 0.46 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.53 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.19 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.54 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.51 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 1.6 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 0.52 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 0.81 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.25 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.94 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.54 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 0.56 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.23 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 0.63 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.612 ' HB ' HG21 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 0.36 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 0.6 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.21 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 0.33 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.615 HG23 HD13 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.42 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.32 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 0.5 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.697 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 0.73 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.45 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.57 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.31 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.59 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.31 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 0.37 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.14 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 0.38 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.27 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.4 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 0.78 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.19 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.63 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.95 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.535 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 0.69 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 0.84 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.24 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.41 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.9 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.03 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.84 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.19 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.828 ' HB3' HG11 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.24 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.19 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.667 HG13 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.16 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.667 ' HD2' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.71 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.5 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.46 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 1.87 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.79 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.63 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.646 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 2.82 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.84 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 0.48 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 0.99 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 0.55 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.42 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.91 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.66 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.15 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.14 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 0.56 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.0 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.46 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 3.14 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 0.64 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.78 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.414 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.32 107.958 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.49 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.57 109.737 -179.484 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.689 0.281 . . . . 2.96 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.16 131.9 35.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 1.48 110.518 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 0.98 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 0.45 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.39 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.32 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.96 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 63.3 t30 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 1.47 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.01 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 1.54 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 0.91 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.705 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.18 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.88 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.6 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.578 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 0.77 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 0.83 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.553 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.41 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 0.65 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.07 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.62 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.58 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.705 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.41 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 0.36 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 0.46 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.28 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.51 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 0.57 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.83 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.18 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 1.52 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 1.55 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.95 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.88 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.32 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.43 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.23 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 0.46 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 0.69 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HE1' HG11 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.59 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.647 ' HB ' HG22 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.37 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.47 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.23 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.82 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.628 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 1.72 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.09 112.08 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.83 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.48 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.85 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.08 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.05 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.31 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.09 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.22 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.34 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 0.72 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.42 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.55 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 0.95 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 0.7 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 0.41 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.33 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 2.78 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.62 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.439 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 1.8 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.37 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.12 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.44 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.14 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 0.56 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.13 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 0.46 110.625 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.53 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.19 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.54 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.51 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 1.6 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 0.52 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 0.81 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.25 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.94 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.54 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 0.56 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.23 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 0.63 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 0.36 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 0.6 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.21 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 0.33 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.417 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.42 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.32 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 0.5 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 0.73 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.45 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.57 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.31 110.011 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.417 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.59 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.31 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 0.37 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.14 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.44 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.27 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.4 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 0.78 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.62 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.19 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.63 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.95 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 0.69 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 0.84 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.24 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.41 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.9 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.03 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.84 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.19 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.24 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.19 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.16 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 1.96 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.71 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.5 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.46 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 1.87 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 0.79 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.975 ' HB2' HG23 ' A' ' 118' ' ' THR . 38.4 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.63 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.58 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 2.82 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.84 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.58 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.48 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.99 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.55 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.42 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 1.91 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.66 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.15 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.14 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.411 ' CB ' HH21 ' A' ' 108' ' ' ARG . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 0.56 109.432 174.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.0 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.46 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 3.14 109.677 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 0.64 110.33 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.78 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.32 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.49 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.57 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.95 0.405 . . . . 2.96 110.1 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -104.36 135.01 46.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.552 -0.294 . . . . 1.48 110.337 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 0.98 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.728 HG23 HD21 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 0.45 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.505 ' NE2' HH11 ' A' ' 148' ' ' ARG . 8.2 tp60 -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.39 109.89 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.32 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.96 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 1.47 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.01 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 1.54 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.427 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 0.91 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.18 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.88 109.714 167.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.6 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 0.77 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 0.83 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.706 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.41 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.65 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.07 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.62 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.58 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 4.6 tp60 -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.41 110.809 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 74' ' ' PHE . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 0.36 111.424 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 0.46 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.28 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.51 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 0.57 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.83 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.18 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.728 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 1.52 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 1.55 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.95 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.88 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.32 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.43 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.23 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 0.46 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 0.69 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.59 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.667 ' HB ' HG22 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 0.37 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.666 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.47 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.496 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.23 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 0.82 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 1.72 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.09 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.83 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.48 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.666 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG3' HD12 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.85 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.08 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.05 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.31 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.09 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.22 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.72 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.42 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.55 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 0.95 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 0.7 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 0.41 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.33 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 2.78 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.62 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 1.8 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.37 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.12 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.44 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.14 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 0.56 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.13 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 0.46 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.53 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.19 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.54 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.43 HD12 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 1.6 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.45 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 0.52 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 0.81 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.25 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.94 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 0.54 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 0.56 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.23 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 0.63 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 0.36 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 0.6 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.717 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.21 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 0.33 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.42 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.32 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.5 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 0.73 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.45 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.57 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.31 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.59 110.569 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.31 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 0.37 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.14 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 0.38 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.27 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.4 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 0.78 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.19 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.63 110.019 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.95 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 0.69 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 0.84 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.24 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.41 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 0.9 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.03 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.84 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.19 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.24 111.73 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.19 113.008 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.16 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 1.96 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.71 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.706 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.5 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.46 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 1.87 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 0.79 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.5 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.63 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 2.82 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.84 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 0.48 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 0.99 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 0.55 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.42 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 1.91 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.66 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.15 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.14 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 0.56 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.505 HH11 ' NE2' ' A' ' 5' ' ' GLN . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.0 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.46 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 3.14 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 0.64 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.78 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.32 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.49 109.762 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.57 109.611 177.496 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' ' H ' ' A' ' 151' ' ' ILE . 14.2 ptt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.484 0.183 . . . . 2.96 111.325 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.03 21.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.141 0.496 . . . . 1.48 111.994 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 0.98 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 0.45 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.39 110.193 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.32 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.96 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 59.4 t30 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 1.47 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.01 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 1.54 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 0.91 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.942 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.18 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.88 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.6 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 0.77 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 0.83 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.41 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HE2' ' HG ' ' A' ' 133' ' ' SER . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 0.65 111.358 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.07 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.62 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.58 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.942 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 30.4 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.41 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 0.36 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 0.46 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.28 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.51 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 0.57 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.83 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.18 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 1.52 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 1.55 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.95 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.88 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.32 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.43 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.23 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 0.46 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 0.69 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.59 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.37 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.69 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.47 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.571 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.23 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 88' ' ' ASP . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 0.82 109.131 170.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 1.72 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.09 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.83 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.48 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.69 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.85 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.08 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.675 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.05 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.31 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.608 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.09 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.22 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.34 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 0.72 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.42 112.085 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.55 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 0.95 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 0.7 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.41 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.33 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 2.78 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.62 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 1.8 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.37 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.12 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.44 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 12.7 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.14 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 0.56 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.13 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 0.46 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 84' ' ' ILE . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.53 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.19 110.911 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.54 112.324 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.51 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 1.6 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 0.52 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 0.81 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.25 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.94 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.54 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 0.56 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.23 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 0.63 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.36 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 0.6 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.21 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 0.33 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.42 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.32 109.988 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 0.5 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.73 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.45 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.57 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.31 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.59 110.33 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.31 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 0.37 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.492 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.14 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.4 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 0.78 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.19 110.978 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 93.6 m-20 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.63 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.95 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 0.69 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.84 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.24 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.41 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.56 HD22 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 0.9 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.03 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.84 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.19 110.921 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.462 ' HG3' HG11 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.24 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' HD22 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.19 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.16 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 1.96 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.71 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.518 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.5 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.401 ' HG ' ' HE2' ' A' ' 19' ' ' TYR . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.46 110.684 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 1.87 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 0.79 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.63 108.683 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 2.82 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.84 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 0.48 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 0.99 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.55 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.42 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 1.91 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.66 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.15 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.14 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.56 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.46 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 3.14 109.183 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.441 ' H ' ' HE3' ' A' ' 1' ' ' MET . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.64 109.916 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.78 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.32 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.49 109.334 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.57 109.733 -177.733 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' HB2' ' A' ' 106' ' ' PHE . 43.3 ttp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.383 -0.229 . . . . 2.96 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.53 -84.47 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.8 -0.36 . . . . 1.48 111.867 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 0.98 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 0.45 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.39 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.32 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.96 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 1.47 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.01 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 1.54 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 14' ' ' ASN . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 0.91 110.531 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.18 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 1.007 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 18.3 m-20 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.88 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.6 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 0.77 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 0.83 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.41 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 0.65 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.07 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.62 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.58 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.41 110.243 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.65 ' HB2' HD21 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 0.36 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 0.46 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.28 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.823 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.51 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 0.57 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.83 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.18 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 1.52 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 1.55 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.95 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.88 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.64 HD12 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.32 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' NE1' HD12 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.43 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.23 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 0.46 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.885 HG12 HG22 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 0.69 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.59 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 0.37 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.47 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.23 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 0.82 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 1.72 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.09 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.83 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.48 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.85 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.08 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.05 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.31 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.09 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.22 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.34 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 0.72 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.42 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.55 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 0.95 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 0.7 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.41 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.33 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.823 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 2.78 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.62 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 1.8 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.37 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.12 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.44 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.2 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.14 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.56 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.13 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 0.46 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.53 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.19 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.54 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.51 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.6 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 0.52 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 0.81 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.25 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.94 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.54 111.672 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.56 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.23 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 0.63 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 0.36 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 0.6 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.21 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 0.33 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.42 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.32 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 0.5 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.73 109.238 172.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.45 111.166 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.57 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.31 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.59 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.31 111.56 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 0.37 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.14 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 0.38 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.27 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.4 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 0.78 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.19 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.63 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.95 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 0.69 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 0.84 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.24 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.41 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 0.9 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.03 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.84 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.19 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.24 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.19 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.16 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.71 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.5 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.46 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 1.87 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 0.79 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.63 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.644 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 2.82 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.84 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.007 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 0.48 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 0.99 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 0.55 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.42 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 1.91 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.66 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.15 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.14 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 0.56 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.0 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.46 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 3.14 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.64 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.78 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.32 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.49 110.668 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.57 108.984 176.513 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.472 0.177 . . . . 2.96 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -78.75 122.78 26.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 1.48 110.858 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 0.98 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.45 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.39 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.32 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.96 109.921 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 1.47 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.01 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 1.54 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 0.91 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.18 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.88 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.6 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 0.77 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 0.83 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.41 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 0.65 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.07 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.62 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.58 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 57.6 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.41 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 0.36 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 0.46 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.28 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.51 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 0.57 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.83 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.18 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 1.52 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 1.55 110.646 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.95 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.88 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.32 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.497 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.43 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.66 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.23 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 0.46 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.629 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 0.69 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.59 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.47 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.23 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 0.82 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 1.72 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.09 111.202 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.83 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.48 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.581 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.85 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.08 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.652 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.05 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.31 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.09 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.22 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.34 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 0.72 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.42 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.55 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 0.95 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 0.7 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 0.41 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.33 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.877 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 2.78 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.62 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 1.8 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.37 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.12 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.44 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.14 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 0.56 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.13 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 0.46 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.53 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.19 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.54 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.51 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 1.6 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 0.52 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.811 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 0.81 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.25 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.94 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 0.54 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 0.56 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.23 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 0.63 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 0.36 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 0.6 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.21 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 0.33 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.42 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.491 ' HB3' HD11 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.32 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 153' ' ' TRP . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 0.73 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.474 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.45 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.57 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.31 109.599 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.59 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.31 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 0.37 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.14 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 0.38 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.27 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.4 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 0.78 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.19 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 80.5 m-20 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.63 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.95 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.697 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 0.69 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.84 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.24 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.41 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 0.9 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.03 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.84 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.19 110.509 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.24 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.19 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.16 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 1.96 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.697 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.71 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.5 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.46 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 1.87 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 0.79 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.693 ' HB2' HG23 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.63 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 2.82 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 28.3 t-20 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.84 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 0.48 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 0.99 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 0.55 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.42 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 1.91 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.66 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.15 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.14 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 0.56 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.0 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.46 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 3.14 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 0.64 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.78 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.459 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.32 109.069 -175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.446 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.49 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.57 110.487 -178.434 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 tmm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.431 -0.211 . . . . 2.96 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . -51.12 115.98 1.8 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.152 -0.476 . . . . 1.48 110.936 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.98 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 0.45 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.39 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.32 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.96 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 1.47 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.01 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 1.54 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.91 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.18 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.88 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.6 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.749 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 0.77 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 0.83 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.755 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.41 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 0.65 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.07 108.762 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.62 112.996 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.58 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 12' ' ' LEU . 33.6 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.41 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.008 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 0.36 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.46 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.28 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.51 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 0.57 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.83 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.18 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 1.52 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 1.55 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.95 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.88 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.32 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 38' ' ' LEU . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.43 109.475 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.23 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 0.46 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.59 HG12 HG22 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 0.69 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.59 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 0.37 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.47 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 50' ' ' SER . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.23 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 0.82 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 1.72 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.09 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.83 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.48 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.85 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.08 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.31 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.09 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.22 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.34 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 0.72 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.42 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.55 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.623 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 0.95 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 0.7 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.41 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.33 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 2.78 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.62 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 1.8 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.37 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.12 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.14 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 0.56 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.13 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.46 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.53 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.19 110.772 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.54 111.948 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.51 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 1.6 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 0.52 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 0.81 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.25 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.836 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.94 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 0.54 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 0.56 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.23 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.588 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 0.63 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 0.36 110.542 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 0.6 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.21 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 0.33 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HD12 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.42 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.32 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 0.5 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.721 ' CE1' HD21 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.73 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.45 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.57 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.31 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.59 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.31 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 0.37 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.14 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 0.38 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.27 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.4 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 0.78 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.19 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.63 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.95 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.69 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 0.84 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.24 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.41 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 0.9 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.03 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.84 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.19 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.24 111.809 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.19 112.07 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.16 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 1.96 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.636 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.71 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.755 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.5 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 1.87 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 0.79 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.649 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.63 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 2.82 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.84 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.511 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 0.48 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 0.99 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.55 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.42 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 1.91 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.66 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.15 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.14 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 0.56 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.0 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.46 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 3.14 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 0.64 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.78 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.32 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.49 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.57 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.905 0.383 . . . . 2.96 110.887 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.64 133.41 39.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 1.48 110.849 -175.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 0.98 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 0.45 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.39 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.96 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 47.5 t30 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 1.47 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.01 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 1.54 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.18 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 1.0 OUTLIER -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.88 110.443 176.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.6 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 0.77 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 0.83 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.661 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.41 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 0.65 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.07 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.62 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.58 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.609 ' HB3' HD23 ' A' ' 12' ' ' LEU . 46.0 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.41 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.003 ' HG3' HD21 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.36 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 0.46 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.28 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.819 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.51 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 0.57 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.83 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.18 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 1.52 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 1.55 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.95 111.026 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.88 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' HG ' HG21 ' A' ' 65' ' ' VAL . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.32 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.887 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.43 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.23 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 0.46 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.921 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 0.69 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.59 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 0.37 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.47 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.888 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.23 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 0.82 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 1.72 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.09 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.83 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.48 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.85 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.921 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.08 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.31 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.09 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.22 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.887 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.34 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 0.72 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.42 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.55 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.777 HG21 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 0.95 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 0.7 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 0.41 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.33 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 2.78 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.62 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 1.8 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.37 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.12 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.44 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 45.3 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.14 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 0.56 110.149 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.13 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 0.46 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.53 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.19 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.54 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.51 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 1.6 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.888 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 0.81 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.94 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.54 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.56 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.23 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 0.63 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 0.36 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 0.6 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.21 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 0.33 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.42 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.32 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 0.5 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 0.73 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.777 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.45 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.57 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.31 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.59 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.31 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 0.37 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.14 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.27 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.4 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.78 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.19 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.63 109.312 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.95 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 0.69 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 0.84 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.24 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.559 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.41 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 0.9 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.03 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.84 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.19 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.24 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.19 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' H ' HG23 ' A' ' 128' ' ' VAL . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.16 110.338 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.751 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.71 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.661 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.5 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.46 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 1.87 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 0.79 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.63 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 2.82 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.84 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.48 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 0.99 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.42 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 1.91 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.66 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.15 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.14 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 0.56 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.0 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.46 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 3.14 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 0.64 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.78 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.32 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.49 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.57 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.31 0.1 . . . . 2.96 110.966 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.34 103.49 6.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 1.48 109.782 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.666 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 0.98 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 0.45 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.39 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.32 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.96 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 50.3 t30 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.01 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 0.91 110.077 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.18 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.542 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.88 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.6 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 0.77 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 0.83 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.41 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 0.65 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.07 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.62 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.58 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 53.3 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.41 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HG2' HG22 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 0.36 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 0.46 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.28 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.51 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 0.57 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.83 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.18 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 1.52 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 1.55 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.95 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.88 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.32 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.43 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.23 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 0.46 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 0.69 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.59 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.37 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.664 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.47 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.785 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.23 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.82 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 1.72 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.09 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.83 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.48 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.85 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.08 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.31 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.599 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.09 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.22 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.34 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.72 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.42 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.55 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 0.95 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 0.7 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 0.41 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.33 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 2.78 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.62 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 1.8 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.37 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.12 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.44 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.4 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.14 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 0.56 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.13 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 0.46 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 84' ' ' ILE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.53 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.19 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.54 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.51 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 1.6 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 79' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 0.52 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 0.81 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.25 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.838 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.94 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.54 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 0.56 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.23 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.63 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 0.6 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.21 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 0.33 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.42 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.32 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 0.5 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 0.73 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.45 110.833 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.57 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.31 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.59 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.31 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 0.37 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.14 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 0.38 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.27 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' HG13 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.4 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 0.78 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.19 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.63 109.175 174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.95 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 0.69 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 0.84 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.24 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.41 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 0.9 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.03 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.84 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.19 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.516 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.24 111.877 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.19 111.794 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.16 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 1.96 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.643 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.71 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.5 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.46 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 1.87 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 0.79 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.63 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.556 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 2.82 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.84 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 0.48 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 0.99 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 0.55 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.42 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 1.91 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.66 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.15 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.14 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 0.56 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.0 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.46 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 3.14 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 0.64 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.78 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.32 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.49 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.57 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.84 0.352 . . . . 2.96 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -63.05 118.52 7.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 1.48 111.054 -173.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 0.98 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 0.45 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.39 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.32 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.96 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 1.47 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.01 108.668 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 1.54 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 0.91 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.676 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.18 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.88 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.6 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 0.77 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 0.83 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.731 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.41 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 0.65 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.07 108.672 175.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.62 113.377 -174.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.58 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 56.1 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.41 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.82 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 0.36 110.931 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 0.46 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.28 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.51 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 0.57 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.83 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 1.52 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 1.55 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.88 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 HG11 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.32 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HA ' HD13 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.43 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.23 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 0.46 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 0.69 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.59 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG22 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 0.37 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.626 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.47 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.597 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.23 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 0.82 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.598 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 1.72 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.09 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.83 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.48 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.85 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.08 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.05 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.31 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.09 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.22 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.34 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 0.72 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.42 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.55 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.615 HG11 HD22 ' A' ' 38' ' ' LEU . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 0.95 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 0.7 113.441 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 0.41 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.33 111.936 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 2.78 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.62 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 1.8 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.12 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.44 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 95.9 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.14 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 0.56 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.13 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 0.46 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.53 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.19 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.54 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.51 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 1.6 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 0.52 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 0.81 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.25 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.605 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.94 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 0.54 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 0.56 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.23 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 0.63 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' HB ' HG21 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 0.36 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 111' ' ' TYR . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 0.6 108.983 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.21 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.42 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.32 110.251 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 0.5 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.461 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 0.73 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.45 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.57 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.31 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.59 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.31 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 0.37 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.14 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 0.38 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.27 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.4 110.823 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 0.78 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.19 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.63 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.95 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 0.69 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 0.84 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.24 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.41 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 0.9 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.03 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.84 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.19 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.24 111.262 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.19 111.689 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.16 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 1.96 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.71 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.731 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.5 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.46 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 1.87 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 0.79 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.565 ' HB2' HG22 ' A' ' 118' ' ' THR . 7.4 tt0 -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.63 108.452 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 2.82 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.84 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 0.48 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 0.99 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 0.55 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.42 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 1.91 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.66 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.15 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.14 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.56 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.0 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.46 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 3.14 110.045 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 0.64 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.78 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.32 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.49 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.57 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.576 0.227 . . . . 2.96 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.2 128.78 45.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.48 110.788 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 0.98 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 0.45 109.415 176.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.39 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.96 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 26.7 t-20 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.01 109.302 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 1.54 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.746 HG13 ' ND2' ' A' ' 14' ' ' ASN . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 0.91 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.18 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.746 ' ND2' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.88 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.6 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.581 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 0.77 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 0.83 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.41 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 0.65 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.07 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.62 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.58 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 49.8 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.41 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 0.36 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 0.46 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.28 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.51 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 0.57 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.83 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.18 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.886 HD11 HG23 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 1.52 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 1.55 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.95 109.582 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.88 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.32 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.43 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.23 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 0.46 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 0.69 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.59 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' ' H ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 0.37 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.646 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.47 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.23 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 0.82 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 1.72 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.09 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.83 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.48 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.85 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.08 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.05 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.31 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.09 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.22 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.34 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 0.72 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.42 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.55 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.886 HG23 HD11 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 0.95 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 0.7 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.724 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.41 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.33 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 2.78 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.62 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 1.8 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.37 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.12 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.44 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.14 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 0.56 110.18 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.13 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 0.46 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.53 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.19 111.991 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.54 112.207 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.51 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 83' ' ' LEU . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 1.6 110.741 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 0.52 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.662 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 0.81 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.25 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.662 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.94 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 0.54 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 0.56 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.23 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 0.63 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' H ' ' HB ' ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 0.36 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 0.6 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.21 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 0.33 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.42 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 0.5 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 0.73 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.45 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.57 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.31 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.59 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.31 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 0.37 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.14 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 0.38 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.522 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.27 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.4 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 0.78 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.19 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.63 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB3' HD21 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.95 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 0.69 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 0.84 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.24 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.636 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.41 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 0.9 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.03 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.84 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.19 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' HG11 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.24 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.19 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.16 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 1.96 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.583 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.71 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.401 ' H ' ' HE2' ' A' ' 117' ' ' TYR . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.5 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.46 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 1.87 109.802 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 0.79 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.506 ' HB2' HG22 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.63 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 2.82 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.84 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 0.48 109.919 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.99 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 0.55 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.42 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 1.91 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.66 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.15 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.14 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 0.56 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.0 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.46 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 3.14 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.64 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.78 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.32 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.49 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.57 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 111.491 0.182 . . . . 2.96 111.491 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 -70.89 0.55 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 1.48 112.155 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 0.98 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.45 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.39 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.32 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.96 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.47 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 26' ' ' ILE . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.01 109.782 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.54 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 0.91 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.18 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.88 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.6 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 0.77 110.499 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 0.83 114.275 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.41 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.07 108.945 173.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.62 112.702 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.58 109.126 169.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 48.8 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.41 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 9' ' ' VAL . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 0.36 111.451 -174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.28 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.51 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 0.57 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.83 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.18 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD21 ' HZ3' ' A' ' 153' ' ' TRP . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 1.52 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 1.55 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.95 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.88 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.32 109.904 -174.345 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.43 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.23 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.46 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 0.69 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.59 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' HG22 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 0.37 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.47 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.628 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.23 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 0.82 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 1.72 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.09 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.83 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.48 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.85 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.08 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.31 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.09 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.22 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.34 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 0.72 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.42 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.55 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 0.95 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 0.7 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 0.41 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.33 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 2.78 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.62 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 1.8 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.37 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.12 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.44 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.14 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 0.56 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.13 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 0.46 110.548 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.53 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.19 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.54 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.51 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 1.6 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 0.52 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 1.114 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 0.81 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.25 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 1.114 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.94 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.54 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.56 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.23 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.63 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 0.36 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 0.6 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.21 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 0.33 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.42 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HB3' HD11 ' A' ' 38' ' ' LEU . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.32 109.639 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 0.5 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.73 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.45 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.57 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.31 110.033 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.59 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.31 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.14 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.27 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.4 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 0.78 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.19 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.63 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.95 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 0.69 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 0.84 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.24 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.41 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 0.9 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.03 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.84 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.19 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HB3' HG11 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.24 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.19 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.16 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 1.96 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.639 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.71 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.5 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.46 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 1.87 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 0.79 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.63 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 2.82 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.84 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 0.48 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 0.99 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 0.55 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.42 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 1.91 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.66 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.15 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.416 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.56 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.0 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.46 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 3.14 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 0.64 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.78 109.657 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.524 ' HZ3' HD21 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.32 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.49 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 24.4 m120 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.57 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.832 0.349 . . . . 2.96 111.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -84.4 104.16 14.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.876 -0.416 . . . . 1.48 109.876 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.786 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 0.98 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.45 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.39 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.32 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.96 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 1.47 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.01 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 1.54 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 0.91 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.18 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.752 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.88 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.6 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.752 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 0.77 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 0.83 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.695 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.41 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 0.65 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.07 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.62 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.58 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.41 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 0.36 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 0.46 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.28 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.51 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 0.57 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.83 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.18 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.085 HD21 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 1.52 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 1.55 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.95 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.88 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.32 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' SER . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.43 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.23 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 0.46 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 0.69 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.59 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.47 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.23 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 0.82 108.704 168.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 1.72 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.09 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.83 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.48 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.85 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.628 HG22 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.08 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.05 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.31 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.09 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.22 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.34 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 0.72 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.42 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.55 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.085 ' HB ' HD21 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 0.95 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 0.7 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 0.41 111.42 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.33 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 2.78 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.62 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 1.8 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.37 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.12 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.44 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.14 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 0.56 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.13 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.46 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.53 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.19 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.54 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.51 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 1.6 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 0.52 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 0.81 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.25 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.605 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.94 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.54 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 0.56 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.531 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.23 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 0.63 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 0.36 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 0.6 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 0.33 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.42 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.32 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 0.5 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 0.73 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.45 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.57 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.31 109.85 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.59 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.31 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 0.37 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.14 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 0.38 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.575 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.27 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.4 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 0.78 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.19 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.531 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.63 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.95 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 0.69 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 0.84 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.24 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.41 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 0.9 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.03 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.84 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.19 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.24 110.937 169.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.19 111.19 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.16 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 1.96 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.71 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.5 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.471 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.46 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 1.87 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 0.79 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.63 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 2.82 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.84 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.459 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 0.48 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 0.99 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 0.55 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.42 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 1.91 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.66 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.15 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.14 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 0.56 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.46 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 3.14 109.418 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.64 110.58 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.78 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.431 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.653 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.32 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.49 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.57 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.606 0.241 . . . . 2.96 111.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.67 125.4 29.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.057 0.456 . . . . 1.48 112.113 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 0.98 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 0.45 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.39 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.32 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.96 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 1.47 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.01 109.909 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 25' ' ' GLU . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 1.54 110.412 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 0.91 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.18 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.88 111.381 177.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.6 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 0.77 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 0.83 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.41 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 0.65 111.634 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.07 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.62 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.58 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 11.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.41 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 0.36 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.28 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.51 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 0.57 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.83 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.18 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.847 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 1.52 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 1.55 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.95 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.88 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.32 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.43 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.23 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 0.46 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.627 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 0.69 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' HE1' HG11 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.59 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.37 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.47 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.849 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.23 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 0.82 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 1.72 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.09 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.83 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.849 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.48 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.85 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.08 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.05 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.31 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.669 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.09 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.22 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.34 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 0.72 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.42 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.55 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 0.95 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 0.7 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 0.41 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.33 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 2.78 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.62 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 1.8 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.37 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.12 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.44 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.14 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 0.56 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.13 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 0.46 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.53 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.19 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.54 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.51 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.683 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 1.6 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 0.52 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 0.81 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.25 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.94 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 0.54 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.56 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.23 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 0.63 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 0.36 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 0.6 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.21 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 0.33 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.42 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.32 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.73 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.45 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.57 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.31 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.59 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.31 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 0.37 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 0.38 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.27 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.4 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 0.78 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 137' ' ' ARG . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.19 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.63 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.522 ' HB3' HD21 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.95 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 0.69 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 0.84 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.24 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.41 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 0.9 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.03 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.84 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.19 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.24 111.825 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.19 112.005 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.16 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.536 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.71 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.46 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 1.87 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 115' ' ' ASN . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 0.79 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.543 ' HB2' HG22 ' A' ' 118' ' ' THR . 31.1 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.63 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 113' ' ' VAL . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 2.82 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.84 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.549 HG21 HG11 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 0.48 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 0.99 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 0.55 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.42 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 1.91 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.66 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.15 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.14 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.0 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.515 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.46 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 3.14 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 0.64 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.78 110.427 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.32 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.49 111.502 -166.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.57 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.575 0.226 . . . . 2.96 111.005 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -78.83 139.1 38.42 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 1.48 110.373 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.98 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 0.45 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.39 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.32 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.96 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 1.47 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.01 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 1.54 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 0.91 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.708 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.18 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.88 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.6 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 0.77 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 0.83 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.41 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 0.65 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.07 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.62 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.58 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.41 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.36 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 0.46 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.28 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.51 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.57 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.83 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.18 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 1.52 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 1.55 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.95 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.88 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.32 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.422 ' NE1' HD12 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.43 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.632 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.23 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.46 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.69 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.59 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 0.37 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.47 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.23 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 0.82 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 1.72 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.09 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.83 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.85 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.08 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.05 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.31 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.09 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.22 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.34 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 0.72 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.42 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.55 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 0.95 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 0.7 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 0.41 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.33 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 2.78 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.62 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.37 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.886 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.12 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.14 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 0.56 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.13 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 0.46 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.53 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.19 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.54 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.51 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 1.6 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 0.52 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 0.81 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.25 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.94 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.54 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 0.56 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.23 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 0.63 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 0.36 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 0.6 108.436 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.21 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 0.33 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.42 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.32 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.5 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 0.73 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.45 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.57 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.31 109.751 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.59 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.31 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 0.37 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.14 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 0.38 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.27 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.4 110.121 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 0.78 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.19 110.819 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.63 109.079 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.95 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.69 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 0.84 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.24 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.583 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.41 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 0.9 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.03 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.84 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.19 111.353 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.24 111.671 175.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.19 112.267 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.16 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 1.96 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.71 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.87 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 0.79 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 39.8 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.63 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 137' ' ' ARG . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 2.82 109.978 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.84 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.546 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 0.48 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 0.99 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 0.55 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.42 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 1.91 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.66 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.15 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.14 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 0.56 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.0 110.553 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.46 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 3.14 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 0.64 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.78 109.915 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.32 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.49 108.968 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.57 109.669 -177.515 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.085 -0.339 . . . . 2.96 110.085 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.88 -73.89 0.63 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.48 110.798 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 0.98 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 0.45 110.331 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.39 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.32 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.96 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 54.3 t30 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 1.47 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.01 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 1.54 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 139' ' ' ILE . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 0.91 109.376 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.743 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.18 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.88 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HB2' HE21 ' A' ' 136' ' ' GLN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.6 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.77 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.83 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.723 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.41 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 0.65 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.79 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.07 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.62 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.58 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.743 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 48.5 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.41 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 0.36 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 0.46 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.28 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.51 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 31' ' ' ILE . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 0.57 108.557 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.705 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.83 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.18 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 1.52 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.55 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.95 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.88 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.731 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.32 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.43 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.23 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 0.46 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 0.69 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.59 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 0.37 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.677 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.47 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.23 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 0.82 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 1.72 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.09 111.189 -175.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.83 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.458 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.48 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.85 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.05 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.31 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.09 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 0.72 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.42 112.17 174.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.55 110.243 -14.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 0.95 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 0.7 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.41 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.33 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 2.78 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 1.8 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.37 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.12 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.44 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 77.5 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.14 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 0.56 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.13 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 0.46 113.794 -172.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.53 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.544 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.19 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.54 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.51 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 1.6 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.52 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.682 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 0.81 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.25 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.682 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.94 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 0.54 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 0.56 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.23 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 0.63 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 0.36 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 0.6 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.21 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.33 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.42 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.32 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 0.5 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.73 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.45 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.57 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.31 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.59 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.31 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 0.37 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 107' ' ' ILE . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.14 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.38 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.27 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.4 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.754 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 0.78 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.19 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.63 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.408 ' HB3' HD11 ' A' ' 135' ' ' LEU . 15.5 m-80 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.95 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 0.69 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 0.84 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.24 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.41 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.9 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.03 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.84 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.19 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.24 110.68 169.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.19 111.463 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.16 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.711 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.71 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.5 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.46 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 1.87 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 0.79 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.63 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.969 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 2.82 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.84 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.969 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 0.48 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.99 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.55 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.42 109.524 174.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 41.9 t30 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 1.91 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 142' ' ' SER . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.66 112.105 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.754 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.15 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.14 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 0.56 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.0 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.46 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 3.14 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 151' ' ' ILE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.64 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.78 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.32 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.49 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.57 110.096 179.777 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.906 0.384 . . . . 1.48 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 0.97999999999999998 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 0.45000000000000001 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.3899999999999999 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.3200000000000001 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.95999999999999996 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 1.47 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.01 110.112 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 1.54 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.91000000000000003 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.837 ' HB2' HE21 ' A' ' 23' ' ' GLN . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.8799999999999999 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.59999999999999998 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 0.77000000000000002 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 0.82999999999999996 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.71 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.40999999999999998 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 0.65000000000000002 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.62 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.57999999999999996 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.837 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.6 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.4099999999999999 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 0.35999999999999999 111.377 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 0.46000000000000002 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.28000000000000003 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77000000000000002 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.51000000000000001 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 0.56999999999999995 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.8300000000000001 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 1.55 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.9500000000000002 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.8799999999999999 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92000000000000004 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.42999999999999999 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.23 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 0.46000000000000002 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 0.68999999999999995 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HD1' ' HB ' ' A' ' 95' ' ' VAL . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.58999999999999997 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 0.37 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.661 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.23 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 0.81999999999999995 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 1.72 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.0899999999999999 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.8300000000000001 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.8500000000000001 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.0800000000000001 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.05 111.299 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.3100000000000001 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.0900000000000001 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.22 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.3400000000000001 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 0.71999999999999997 109.913 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.41999999999999998 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.55000000000000004 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 0.94999999999999996 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 0.69999999999999996 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 0.40999999999999998 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.33000000000000002 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 2.7799999999999998 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.62 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 1.8 109.985 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.37 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.1200000000000001 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.44 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 20.8 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.1399999999999999 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 0.56000000000000005 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.1299999999999999 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 0.46000000000000002 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.53000000000000003 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.1899999999999999 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.54000000000000004 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.51000000000000001 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 1.6000000000000001 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 0.52000000000000002 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 1.037 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 0.81000000000000005 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.25 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 1.037 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.9399999999999999 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 0.54000000000000004 110.578 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 0.56000000000000005 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.23 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.63 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 0.35999999999999999 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 0.59999999999999998 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.21 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 0.33000000000000002 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.4199999999999999 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.3200000000000001 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 0.5 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.72999999999999998 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.4500000000000002 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.56999999999999995 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.3100000000000001 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.5900000000000001 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.31 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 0.37 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.1399999999999999 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 0.38 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.27000000000000002 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HB2' HG13 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.40000000000000002 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 0.78000000000000003 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.536 HG21 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.1899999999999999 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.6299999999999999 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.94999999999999996 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.68999999999999995 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.83999999999999997 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.2400000000000002 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.413 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.4099999999999999 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 0.90000000000000002 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.0299999999999998 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.8399999999999999 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.1899999999999999 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.24 111.304 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.1899999999999999 111.753 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.1600000000000001 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 1.96 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.567 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.70999999999999996 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.5 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.46 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 1.8700000000000001 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 110.458 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.934 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.71 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 2.8199999999999998 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.638 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.83999999999999997 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 0.47999999999999998 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 0.98999999999999999 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 0.55000000000000004 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.4199999999999999 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 1.9099999999999999 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.66000000000000003 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.1499999999999999 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.1399999999999999 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 0.56000000000000005 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.0 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.46000000000000002 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 3.1400000000000001 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 0.64000000000000001 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.78 109.848 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.3199999999999998 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.4900000000000002 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.5699999999999998 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 111.209 0.077 . . . . 1.48 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 0.97999999999999998 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG23 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 0.45000000000000001 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.3899999999999999 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.3200000000000001 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.95999999999999996 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.769 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.47 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.01 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 1.54 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 0.91000000000000003 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.1799999999999999 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.8799999999999999 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.59999999999999998 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 0.77000000000000002 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 0.82999999999999996 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.683 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 0.65000000000000002 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.675 ' ND2' HH21 ' A' ' 137' ' ' ARG . 0.0 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.0699999999999998 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.62 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.57999999999999996 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 7.5 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.4099999999999999 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 0.35999999999999999 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 0.46000000000000002 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.28000000000000003 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.869 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77000000000000002 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.51000000000000001 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 0.56999999999999995 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.8300000000000001 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.1800000000000002 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HG23 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 1.52 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 1.55 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.9500000000000002 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.8799999999999999 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.3200000000000001 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92000000000000004 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.42999999999999999 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.23 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 97' ' ' ILE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.46000000000000002 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.674 ' HB ' HD11 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 0.68999999999999995 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.589 ' HE1' HG11 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.58999999999999997 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 0.37 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.46999999999999997 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 50' ' ' SER . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.23 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 0.81999999999999995 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 1.72 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.0899999999999999 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.8300000000000001 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.48 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.8500000000000001 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.0800000000000001 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.3100000000000001 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.0900000000000001 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.22 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.3400000000000001 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 0.71999999999999997 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.41999999999999998 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.55000000000000004 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 0.94999999999999996 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.69999999999999996 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 0.40999999999999998 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.33000000000000002 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.869 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 2.7799999999999998 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.62 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 1.8 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.37 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.1200000000000001 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.1399999999999999 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.56000000000000005 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.1299999999999999 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 0.46000000000000002 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.53000000000000003 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.1899999999999999 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.54000000000000004 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.51000000000000001 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 1.6000000000000001 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 0.52000000000000002 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 0.81000000000000005 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.25 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.833 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.9399999999999999 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.54000000000000004 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 0.56000000000000005 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.23 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 0.35999999999999999 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 0.59999999999999998 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.21 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 0.33000000000000002 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.4199999999999999 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.3200000000000001 110.717 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 0.72999999999999998 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.565 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.4500000000000002 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.56999999999999995 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.3100000000000001 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.5900000000000001 110.5 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' HG12 ' A' ' 151' ' ' ILE . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.31 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 0.37 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 0.38 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.27000000000000002 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.40000000000000002 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 0.78000000000000003 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.1899999999999999 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.6299999999999999 109.478 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.94999999999999996 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 0.68999999999999995 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 0.83999999999999997 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.2400000000000002 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.4099999999999999 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.90000000000000002 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.0299999999999998 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.8399999999999999 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.1899999999999999 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.24 110.451 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.1899999999999999 112.539 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.1600000000000001 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 1.96 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.658 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.70999999999999996 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 135' ' ' LEU . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.5 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.46 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 1.8700000000000001 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 0.79000000000000004 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.679 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.6299999999999999 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.943 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 2.8199999999999998 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.83999999999999997 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.943 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 0.47999999999999998 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 0.98999999999999999 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 0.55000000000000004 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.4199999999999999 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 1.9099999999999999 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.66000000000000003 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HE ' ' HA ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.1499999999999999 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 0.56000000000000005 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.46000000000000002 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 3.1400000000000001 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 0.64000000000000001 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.78 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.3199999999999998 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.4900000000000002 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.5699999999999998 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 1.48 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.751 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 0.97999999999999998 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.503 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 0.45000000000000001 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.3899999999999999 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.3200000000000001 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.95999999999999996 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.3 t30 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 1.47 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.01 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 1.54 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG1' HD12 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 0.91000000000000003 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.1799999999999999 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.8799999999999999 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.59999999999999998 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 0.77000000000000002 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 0.82999999999999996 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.40999999999999998 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 0.65000000000000002 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.0699999999999998 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.62 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.57999999999999996 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.756 HE21 ' HB2' ' A' ' 12' ' ' LEU . 2.8 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.4099999999999999 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 0.35999999999999999 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.46000000000000002 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.28000000000000003 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77000000000000002 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.51000000000000001 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.56999999999999995 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.751 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.8300000000000001 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 1.55 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.9500000000000002 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.3200000000000001 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92000000000000004 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.42999999999999999 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.23 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 0.46000000000000002 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.68999999999999995 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.58999999999999997 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.46999999999999997 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.23 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 0.81999999999999995 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.0899999999999999 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.8300000000000001 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.48 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.643 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.8500000000000001 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.0800000000000001 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.05 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.3100000000000001 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.22 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.3400000000000001 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 0.71999999999999997 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.41999999999999998 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.55000000000000004 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 0.94999999999999996 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 0.69999999999999996 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 0.40999999999999998 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.33000000000000002 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 2.7799999999999998 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.62 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.37 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.1200000000000001 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.44 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.1399999999999999 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 0.56000000000000005 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.1299999999999999 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 0.46000000000000002 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.53000000000000003 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' CB ' HD13 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.1899999999999999 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.54000000000000004 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.51000000000000001 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 1.6000000000000001 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 89' ' ' ALA . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.52000000000000002 110.418 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 0.81000000000000005 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.25 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 0.54000000000000004 111.481 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 0.56000000000000005 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.23 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 0.63 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 0.35999999999999999 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 0.59999999999999998 107.973 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.21 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 0.33000000000000002 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.3200000000000001 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 0.5 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.604 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 0.72999999999999998 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.453 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.4500000000000002 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.56999999999999995 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 152' ' ' ASN . 25.6 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.3100000000000001 109.51 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.5900000000000001 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.31 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 0.37 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.1399999999999999 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 0.38 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.27000000000000002 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.40000000000000002 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' HD13 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 0.78000000000000003 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.1899999999999999 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HD11 ' A' ' 140' ' ' LEU . 2.3 m120 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.6299999999999999 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.94999999999999996 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.68999999999999995 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.754 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 0.83999999999999997 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.2400000000000002 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.4099999999999999 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 0.90000000000000002 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.0299999999999998 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.8399999999999999 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.1899999999999999 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.24 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.1899999999999999 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.1600000000000001 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 1.96 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.70999999999999996 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.5 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 1.8700000000000001 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.79000000000000004 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.754 ' HB2' HG23 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.6299999999999999 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.695 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 2.8199999999999998 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.83999999999999997 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.621 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 0.47999999999999998 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 140' ' ' LEU . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 0.98999999999999999 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 0.55000000000000004 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.4199999999999999 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 1.9099999999999999 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.66000000000000003 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.1499999999999999 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.1399999999999999 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 0.56000000000000005 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.0 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.46000000000000002 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 3.1400000000000001 109.3 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.64000000000000001 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.424 ' H ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.78 110.075 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.639 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.3199999999999998 109.744 -170.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.453 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.4900000000000002 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 7.3 p30 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.5699999999999998 109.416 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.491 0.186 . . . . 1.48 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.561 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 0.97999999999999998 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.681 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 0.45000000000000001 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.3899999999999999 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.3200000000000001 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.95999999999999996 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 1.47 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.01 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 1.54 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 0.91000000000000003 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.986 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.1799999999999999 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.8799999999999999 110.05 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.59999999999999998 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.77000000000000002 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 0.82999999999999996 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.40999999999999998 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 0.65000000000000002 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.0699999999999998 109.694 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.62 111.971 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.57999999999999996 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.4 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.4099999999999999 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 0.35999999999999999 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 0.46000000000000002 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.28000000000000003 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77000000000000002 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.51000000000000001 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 0.56999999999999995 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.561 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.8300000000000001 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.1800000000000002 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD11 HG23 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.55 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.9500000000000002 109.432 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.8799999999999999 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.3200000000000001 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.651 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92000000000000004 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.42999999999999999 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.666 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.23 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.46000000000000002 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 0.68999999999999995 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.58999999999999997 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 0.37 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.46999999999999997 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.23 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 0.81999999999999995 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 1.72 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.0899999999999999 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.8300000000000001 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 83' ' ' LEU . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.48 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.8500000000000001 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.0800000000000001 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.05 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.3100000000000001 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.0900000000000001 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.22 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 0.71999999999999997 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.41999999999999998 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.55000000000000004 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 0.94999999999999996 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 0.69999999999999996 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.33000000000000002 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.7799999999999998 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 1.8 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.442 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.1200000000000001 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.44 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 23.5 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.1399999999999999 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.56000000000000005 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.1299999999999999 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.46000000000000002 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.53000000000000003 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.1899999999999999 110.952 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.54000000000000004 112.134 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.51000000000000001 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 53' ' ' TYR . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 1.6000000000000001 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.52000000000000002 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 0.81000000000000005 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.25 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.9399999999999999 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.54000000000000004 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 0.56000000000000005 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.23 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 0.63 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 0.35999999999999999 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 0.59999999999999998 108.297 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.759 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.21 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 0.33000000000000002 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.4199999999999999 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.3200000000000001 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 0.5 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.72999999999999998 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.4500000000000002 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.56999999999999995 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.3100000000000001 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.5900000000000001 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.31 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 0.37 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.401 HH21 ' CB ' ' A' ' 147' ' ' THR . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 109.402 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 0.38 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.27000000000000002 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' HG13 ' A' ' 95' ' ' VAL . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.18 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 0.78000000000000003 110.027 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.1899999999999999 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.6299999999999999 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.94999999999999996 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 0.68999999999999995 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 0.83999999999999997 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.2400000000000002 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.4099999999999999 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.0299999999999998 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.8399999999999999 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.1899999999999999 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.24 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.1899999999999999 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.1600000000000001 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 1.96 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.70999999999999996 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.5 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.46 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 1.8700000000000001 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 0.79000000000000004 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.8 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.6299999999999999 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 2.8199999999999998 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.83999999999999997 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 0.47999999999999998 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 0.98999999999999999 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.55000000000000004 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.4199999999999999 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 1.9099999999999999 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.66000000000000003 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.1499999999999999 109.587 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.1399999999999999 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.401 ' CB ' HH21 ' A' ' 108' ' ' ARG . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 0.56000000000000005 108.937 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.0 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.46000000000000002 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 3.1400000000000001 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 0.64000000000000001 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.78 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.539 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.3199999999999998 108.576 -171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.4900000000000002 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.5699999999999998 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.69 -0.485 . . . . 1.48 109.69 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 1.0 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 0.97999999999999998 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.712 HG23 HD21 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.45000000000000001 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HG3' HD11 ' A' ' 31' ' ' ILE . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.3899999999999999 110.249 174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.3200000000000001 109.76 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.95999999999999996 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.784 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 1.47 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.01 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 1.54 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 0.91000000000000003 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.1799999999999999 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.677 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.8799999999999999 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.59999999999999998 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.77000000000000002 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 0.82999999999999996 112.39 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.40999999999999998 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 0.65000000000000002 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' ND2' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.0699999999999998 108.162 174.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.62 113.225 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.57999999999999996 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.677 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 10.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.4099999999999999 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 0.46000000000000002 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.28000000000000003 109.461 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77000000000000002 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.51000000000000001 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 0.56999999999999995 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.0 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.8300000000000001 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.1800000000000002 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.712 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 1.52 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 1.55 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.9500000000000002 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.853 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.3200000000000001 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92000000000000004 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.42999999999999999 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.23 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 0.46000000000000002 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.805 ' HB ' HD11 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 0.68999999999999995 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.58999999999999997 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 0.37 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.672 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.46999999999999997 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.23 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 0.81999999999999995 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 1.72 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.0899999999999999 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.8300000000000001 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.48 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.672 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.8500000000000001 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.0800000000000001 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.05 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.64 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.0900000000000001 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.22 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.3400000000000001 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 0.71999999999999997 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.41999999999999998 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.55000000000000004 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 0.94999999999999996 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 0.69999999999999996 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 2.7799999999999998 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.62 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 1.8 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.37 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.1200000000000001 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.44 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.9 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.1399999999999999 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 0.56000000000000005 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 0.46000000000000002 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.53000000000000003 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.1899999999999999 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.54000000000000004 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.51000000000000001 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 1.6000000000000001 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 0.81000000000000005 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.25 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.54000000000000004 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 0.56000000000000005 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.23 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 0.63 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.612 ' HB ' HG21 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 0.35999999999999999 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 0.59999999999999998 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.21 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 0.33000000000000002 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.615 HG23 HD13 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.4199999999999999 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.3200000000000001 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 0.5 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.697 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 0.72999999999999998 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.4500000000000002 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.56999999999999995 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.3100000000000001 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.5900000000000001 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.31 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 0.37 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.1399999999999999 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 0.38 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.27000000000000002 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.40000000000000002 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 0.78000000000000003 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.1899999999999999 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.6299999999999999 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.94999999999999996 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.535 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 0.68999999999999995 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.2400000000000002 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.4099999999999999 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.0299999999999998 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.8399999999999999 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.1899999999999999 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.828 ' HB3' HG11 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.24 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.1899999999999999 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.667 HG13 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.1600000000000001 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.667 ' HD2' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.70999999999999996 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.5 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.46 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 1.8700000000000001 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.79000000000000004 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.6299999999999999 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.646 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 2.8199999999999998 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.83999999999999997 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 0.47999999999999998 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 0.98999999999999999 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.4199999999999999 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.9099999999999999 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.66000000000000003 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.1499999999999999 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.1399999999999999 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 0.56000000000000005 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.0 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.46000000000000002 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 3.1400000000000001 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 0.64000000000000001 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.78 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.414 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.3199999999999998 107.958 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.4900000000000002 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.557 HD21 ' HB3' ' A' ' 154' ' ' GLU . 1.9 p30 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.5699999999999998 109.737 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.654 0.264 . . . . 1.48 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 0.97999999999999998 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 0.45000000000000001 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.3899999999999999 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.3200000000000001 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.95999999999999996 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 1.47 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.01 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 1.54 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 0.91000000000000003 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.705 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.1799999999999999 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.8799999999999999 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.59999999999999998 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.578 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 0.77000000000000002 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 0.82999999999999996 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.553 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.40999999999999998 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 0.65000000000000002 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.0699999999999998 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.62 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.57999999999999996 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.705 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.4099999999999999 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 0.35999999999999999 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 0.46000000000000002 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.28000000000000003 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.51000000000000001 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 0.56999999999999995 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.1800000000000002 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 1.52 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 1.55 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.9500000000000002 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.8799999999999999 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.3200000000000001 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92000000000000004 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.42999999999999999 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.23 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 0.68999999999999995 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HE1' HG11 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.58999999999999997 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.647 ' HB ' HG22 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.37 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.46999999999999997 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.23 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.81999999999999995 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.628 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 1.72 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.0899999999999999 112.08 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.8300000000000001 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.48 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.0800000000000001 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.05 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.3100000000000001 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.0900000000000001 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.22 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.3400000000000001 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 0.71999999999999997 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.41999999999999998 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.55000000000000004 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 0.94999999999999996 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 0.69999999999999996 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.33000000000000002 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 2.7799999999999998 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.62 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.439 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 1.8 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.37 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.1200000000000001 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.44 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.1399999999999999 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 0.56000000000000005 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.1299999999999999 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 0.46000000000000002 110.625 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.53000000000000003 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.1899999999999999 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.54000000000000004 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.51000000000000001 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 1.6000000000000001 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 0.52000000000000002 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 0.81000000000000005 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.25 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.54000000000000004 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 0.56000000000000005 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.23 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 0.63 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 0.59999999999999998 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.21 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 0.33000000000000002 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.417 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.4199999999999999 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 0.5 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 0.72999999999999998 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.4500000000000002 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.56999999999999995 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.406 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 23.1 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.3100000000000001 110.011 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.417 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.5900000000000001 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.31 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 0.37 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.1399999999999999 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.44 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.27000000000000002 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.40000000000000002 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 0.78000000000000003 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.62 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.1899999999999999 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.6299999999999999 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.94999999999999996 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 0.68999999999999995 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 0.83999999999999997 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.2400000000000002 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.4099999999999999 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.90000000000000002 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.0299999999999998 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.8399999999999999 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.1899999999999999 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.24 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.1899999999999999 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.1600000000000001 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 1.96 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.70999999999999996 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.5 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.46 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 1.8700000000000001 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 0.79000000000000004 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.975 ' HB2' HG23 ' A' ' 118' ' ' THR . 5.0 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.6299999999999999 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.58 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 2.8199999999999998 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.83999999999999997 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.58 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.47999999999999998 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.98999999999999999 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.55000000000000004 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.4199999999999999 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 1.9099999999999999 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.1499999999999999 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.1399999999999999 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.411 ' CB ' HH21 ' A' ' 108' ' ' ARG . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 0.56000000000000005 109.432 174.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.0 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.46000000000000002 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 3.1400000000000001 109.677 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.406 ' HB ' ' NE2' ' A' ' 104' ' ' GLN . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 0.64000000000000001 110.33 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.78 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.3199999999999998 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.4900000000000002 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.5699999999999998 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.337 -0.246 . . . . 1.48 110.337 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 0.97999999999999998 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.728 HG23 HD21 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 0.45000000000000001 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.882 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 109.89 177.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.3200000000000001 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.95999999999999996 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 1.47 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.01 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 1.54 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.427 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 0.91000000000000003 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.1799999999999999 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.8799999999999999 109.714 167.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.59999999999999998 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 0.77000000000000002 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 0.82999999999999996 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.706 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.40999999999999998 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.65000000000000002 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.0699999999999998 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.62 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.57999999999999996 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.4099999999999999 110.809 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 74' ' ' PHE . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 0.35999999999999999 111.424 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 0.46000000000000002 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.28000000000000003 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77000000000000002 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.51000000000000001 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 0.56999999999999995 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.8300000000000001 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.1800000000000002 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.728 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 1.52 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 1.55 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.9500000000000002 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.527 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.8799999999999999 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92000000000000004 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.42999999999999999 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.23 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 0.46000000000000002 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 0.68999999999999995 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.58999999999999997 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.667 ' HB ' HG22 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 0.37 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.666 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.46999999999999997 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.496 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.23 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 0.81999999999999995 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 1.72 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.0899999999999999 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.8300000000000001 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.48 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.666 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG3' HD12 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.8500000000000001 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.0800000000000001 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.05 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.3100000000000001 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.0900000000000001 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.22 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.3400000000000001 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.71999999999999997 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.41999999999999998 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.55000000000000004 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 0.94999999999999996 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 0.69999999999999996 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 0.40999999999999998 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.33000000000000002 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 2.7799999999999998 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.62 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 1.8 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.37 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.1200000000000001 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.44 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.1399999999999999 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 0.56000000000000005 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.1299999999999999 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 0.46000000000000002 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.53000000000000003 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.1899999999999999 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.54000000000000004 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.51000000000000001 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.43 HD12 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 1.6000000000000001 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.45 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 0.52000000000000002 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 0.81000000000000005 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.25 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.9399999999999999 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 0.54000000000000004 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 0.56000000000000005 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.23 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 0.63 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 0.35999999999999999 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 0.59999999999999998 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.717 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.21 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 0.33000000000000002 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.4199999999999999 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.5 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 0.72999999999999998 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.4500000000000002 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.56999999999999995 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.3100000000000001 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.5900000000000001 110.569 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.31 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 0.37 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.1399999999999999 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 0.38 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.27000000000000002 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.40000000000000002 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 0.78000000000000003 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.1899999999999999 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.6299999999999999 110.019 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.94999999999999996 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 0.68999999999999995 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 0.83999999999999997 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.2400000000000002 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.4099999999999999 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 0.90000000000000002 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.0299999999999998 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.8399999999999999 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.1899999999999999 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.24 111.73 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.1899999999999999 113.008 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.1600000000000001 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 1.96 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.70999999999999996 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.706 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.5 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.46 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 1.8700000000000001 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 0.79000000000000004 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.9 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.6299999999999999 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 2.8199999999999998 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.83999999999999997 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 0.47999999999999998 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 0.98999999999999999 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.4199999999999999 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 1.9099999999999999 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.66000000000000003 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.1499999999999999 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.1399999999999999 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.0 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.46000000000000002 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 3.1400000000000001 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 0.64000000000000001 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.78 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.3199999999999998 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.412 ' C ' HD22 ' A' ' 156' ' ' ASN . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.4900000000000002 109.762 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.5699999999999998 109.611 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.141 0.496 . . . . 1.48 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 0.97999999999999998 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 0.45000000000000001 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.3899999999999999 110.193 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.3200000000000001 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.95999999999999996 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 1.47 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.01 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 1.54 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 0.91000000000000003 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.942 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.1799999999999999 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.8799999999999999 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.59999999999999998 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 0.77000000000000002 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 0.82999999999999996 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.40999999999999998 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HE2' ' HG ' ' A' ' 133' ' ' SER . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 0.65000000000000002 111.358 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.62 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.57999999999999996 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.942 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 25.3 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.4099999999999999 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 0.35999999999999999 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 0.46000000000000002 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.28000000000000003 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77000000000000002 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.51000000000000001 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 0.56999999999999995 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 1.52 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 1.55 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.9500000000000002 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.8799999999999999 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92000000000000004 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.42999999999999999 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.23 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 0.46000000000000002 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 0.68999999999999995 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.58999999999999997 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.37 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.69 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.46999999999999997 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.571 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.23 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 88' ' ' ASP . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 0.81999999999999995 109.131 170.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 1.72 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.0899999999999999 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.8300000000000001 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.48 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.69 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.8500000000000001 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.0800000000000001 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.675 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.05 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.3100000000000001 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.608 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.0900000000000001 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.22 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.3400000000000001 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.41999999999999998 112.085 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.55000000000000004 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 0.94999999999999996 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 0.69999999999999996 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.40999999999999998 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.33000000000000002 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 2.7799999999999998 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.62 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 1.8 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.37 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.1200000000000001 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.44 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.1 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.1399999999999999 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 0.56000000000000005 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.1299999999999999 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 0.46000000000000002 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 84' ' ' ILE . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.53000000000000003 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.1899999999999999 110.911 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.54000000000000004 112.324 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.51000000000000001 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 1.6000000000000001 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 0.52000000000000002 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 0.81000000000000005 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.25 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.9399999999999999 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.54000000000000004 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 0.56000000000000005 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.23 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 0.63 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.35999999999999999 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 0.59999999999999998 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.21 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 0.33000000000000002 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.4199999999999999 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.3200000000000001 109.988 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 0.5 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.72999999999999998 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.4500000000000002 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.56999999999999995 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.3100000000000001 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.5900000000000001 110.33 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.31 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 0.37 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.492 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.27000000000000002 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.40000000000000002 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.1899999999999999 110.978 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 14.8 m120 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.6299999999999999 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.94999999999999996 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 0.68999999999999995 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.83999999999999997 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.2400000000000002 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.4099999999999999 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.56 HD22 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 0.90000000000000002 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.0299999999999998 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.8399999999999999 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.58 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.1899999999999999 110.921 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.462 ' HG3' HG11 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.24 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' HD22 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.1899999999999999 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.1600000000000001 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 1.96 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.70999999999999996 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.518 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.5 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.401 ' HG ' ' HE2' ' A' ' 19' ' ' TYR . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.46 110.684 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 1.8700000000000001 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 0.79000000000000004 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.479 HE21 ' HB3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.6299999999999999 108.683 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.83999999999999997 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 0.47999999999999998 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 0.98999999999999999 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.55000000000000004 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.4199999999999999 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 1.9099999999999999 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.66000000000000003 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.1499999999999999 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.1399999999999999 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.56000000000000005 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.46000000000000002 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 3.1400000000000001 109.183 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 109.916 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.78 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.3199999999999998 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' C ' HD22 ' A' ' 156' ' ' ASN . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.4900000000000002 109.334 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.5699999999999998 109.733 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.867 0.321 . . . . 1.48 111.867 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 0.97999999999999998 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 0.45000000000000001 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.3200000000000001 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.95999999999999996 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 1.47 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.01 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 1.54 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 0.91000000000000003 110.531 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.91 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.1799999999999999 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.859 ' OD1' ' HB ' ' A' ' 139' ' ' ILE . 1.6 m120 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.8799999999999999 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.59999999999999998 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 0.77000000000000002 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 0.82999999999999996 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.40999999999999998 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 0.65000000000000002 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.62 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.57999999999999996 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.91 HE21 ' HB2' ' A' ' 12' ' ' LEU . 4.8 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.4099999999999999 110.243 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.65 ' HB2' HD21 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 0.35999999999999999 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 0.46000000000000002 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.28000000000000003 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.823 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77000000000000002 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.51000000000000001 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 0.56999999999999995 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.8300000000000001 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.1800000000000002 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 1.52 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 1.55 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.9500000000000002 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.8799999999999999 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.64 HD12 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.3200000000000001 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92000000000000004 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' NE1' HD12 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.42999999999999999 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.23 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 0.46000000000000002 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.885 HG12 HG22 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 0.68999999999999995 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.58999999999999997 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 0.37 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.46999999999999997 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.23 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 0.81999999999999995 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 1.72 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.0899999999999999 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.8300000000000001 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.48 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.8500000000000001 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.05 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.0900000000000001 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.22 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.3400000000000001 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 0.71999999999999997 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.41999999999999998 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.55000000000000004 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 0.94999999999999996 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 0.69999999999999996 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.33000000000000002 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.823 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 2.7799999999999998 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.62 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 1.8 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.37 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.1200000000000001 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.44 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.6 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.1399999999999999 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.56000000000000005 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.1299999999999999 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 0.46000000000000002 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.53000000000000003 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.1899999999999999 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.54000000000000004 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.51000000000000001 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.6000000000000001 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 0.52000000000000002 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.25 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.9399999999999999 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.54000000000000004 111.672 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.56000000000000005 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.23 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 0.63 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 0.35999999999999999 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 0.59999999999999998 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.21 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 0.33000000000000002 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.4199999999999999 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.3200000000000001 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 0.5 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.72999999999999998 109.238 172.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.4500000000000002 111.166 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.56999999999999995 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.3100000000000001 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.5900000000000001 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.31 111.56 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 0.37 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 0.38 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.27000000000000002 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.40000000000000002 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 0.78000000000000003 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.1899999999999999 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.6299999999999999 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.94999999999999996 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 0.68999999999999995 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 0.83999999999999997 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.2400000000000002 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.4099999999999999 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 0.90000000000000002 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.0299999999999998 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.8399999999999999 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.1899999999999999 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.24 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.1899999999999999 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.1600000000000001 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.70999999999999996 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.5 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.46 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 1.8700000000000001 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 0.79000000000000004 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.6299999999999999 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.644 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 2.8199999999999998 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.83999999999999997 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.859 ' HB ' ' OD1' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 0.98999999999999999 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 0.55000000000000004 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.4199999999999999 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 1.9099999999999999 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.66000000000000003 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.1499999999999999 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.1399999999999999 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 0.56000000000000005 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.0 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 3.1400000000000001 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.64000000000000001 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.78 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.3199999999999998 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.474 ' C ' HD22 ' A' ' 156' ' ' ASN . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.4900000000000002 110.668 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.474 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.5699999999999998 108.984 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.906 0.384 . . . . 1.48 110.858 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 0.97999999999999998 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.45000000000000001 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.3899999999999999 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.3200000000000001 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.95999999999999996 109.921 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 1.47 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.01 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 1.54 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 0.91000000000000003 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.1799999999999999 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.8799999999999999 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.59999999999999998 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 0.77000000000000002 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 0.82999999999999996 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.40999999999999998 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 0.65000000000000002 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.0699999999999998 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.62 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.57999999999999996 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.5 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.4099999999999999 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 0.35999999999999999 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 0.46000000000000002 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.28000000000000003 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77000000000000002 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.51000000000000001 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 0.56999999999999995 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.8300000000000001 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.1800000000000002 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 1.52 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 1.55 110.646 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.9500000000000002 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.8799999999999999 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.3200000000000001 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.497 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.42999999999999999 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.66 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.23 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 0.46000000000000002 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.629 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 0.68999999999999995 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.58999999999999997 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.46999999999999997 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.23 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 0.81999999999999995 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 1.72 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.0899999999999999 111.202 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.8300000000000001 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.48 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.581 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.8500000000000001 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.0800000000000001 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.652 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.05 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.22 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.3400000000000001 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 0.71999999999999997 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.41999999999999998 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.55000000000000004 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 0.94999999999999996 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 0.69999999999999996 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 0.40999999999999998 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.33000000000000002 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.877 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 2.7799999999999998 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.62 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 1.8 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.37 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.44 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.1399999999999999 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 0.56000000000000005 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.1299999999999999 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 0.46000000000000002 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.53000000000000003 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.1899999999999999 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.54000000000000004 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.51000000000000001 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 1.6000000000000001 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 0.52000000000000002 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.811 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 0.81000000000000005 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.25 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.9399999999999999 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 0.54000000000000004 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 0.56000000000000005 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.23 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 0.63 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 0.35999999999999999 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 0.59999999999999998 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.21 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 0.33000000000000002 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.4199999999999999 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.491 ' HB3' HD11 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.3200000000000001 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 153' ' ' TRP . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 0.72999999999999998 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.474 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.4500000000000002 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.56999999999999995 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.426 HE21 ' HB ' ' A' ' 151' ' ' ILE . 17.6 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.3100000000000001 109.599 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.5900000000000001 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.31 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 0.37 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.1399999999999999 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 0.38 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.27000000000000002 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.40000000000000002 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 0.78000000000000003 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.1899999999999999 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 12.9 m120 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.6299999999999999 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.94999999999999996 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.697 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 0.68999999999999995 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.83999999999999997 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.2400000000000002 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.4099999999999999 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.0299999999999998 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.8399999999999999 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.1899999999999999 110.509 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.24 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.1899999999999999 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.1600000000000001 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 1.96 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.697 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.70999999999999996 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.46 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.5 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.46 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 1.8700000000000001 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 0.79000000000000004 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.693 ' HB2' HG23 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.6299999999999999 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 2.8199999999999998 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 7.5 t30 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.83999999999999997 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 0.47999999999999998 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 0.55000000000000004 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.4199999999999999 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 1.9099999999999999 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.66000000000000003 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.1499999999999999 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.1399999999999999 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 0.56000000000000005 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.0 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.46000000000000002 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 3.1400000000000001 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 0.64000000000000001 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.78 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.459 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB2' HD22 ' A' ' 156' ' ' ASN . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.3199999999999998 109.069 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.446 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.4900000000000002 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 154' ' ' GLU . 47.2 m-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.5699999999999998 110.487 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.721 0.296 . . . . 1.48 110.936 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.97999999999999998 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 0.45000000000000001 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.3899999999999999 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.3200000000000001 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.95999999999999996 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 1.47 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.01 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 1.54 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.91000000000000003 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.1799999999999999 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.8799999999999999 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.59999999999999998 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.749 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 0.77000000000000002 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 0.82999999999999996 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.755 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.40999999999999998 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 0.65000000000000002 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.0699999999999998 108.762 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.62 112.996 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.57999999999999996 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.896 HE21 ' HB2' ' A' ' 12' ' ' LEU . 9.1 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.4099999999999999 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.008 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 0.35999999999999999 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.46000000000000002 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.28000000000000003 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77000000000000002 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 0.56999999999999995 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.1800000000000002 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 1.52 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 1.55 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.9500000000000002 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.8799999999999999 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.3200000000000001 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92000000000000004 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 38' ' ' LEU . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.42999999999999999 109.475 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.23 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 0.46000000000000002 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.59 HG12 HG22 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 0.68999999999999995 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.58999999999999997 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 0.37 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.46999999999999997 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 50' ' ' SER . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.23 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 0.81999999999999995 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 1.72 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.0899999999999999 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.8300000000000001 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.48 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.8500000000000001 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.0800000000000001 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.0900000000000001 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.22 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.3400000000000001 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 0.71999999999999997 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.41999999999999998 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.55000000000000004 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.623 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 0.94999999999999996 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 0.69999999999999996 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.40999999999999998 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.33000000000000002 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 2.7799999999999998 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.62 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 1.8 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.37 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 0.56000000000000005 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.1299999999999999 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.46000000000000002 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.53000000000000003 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.1899999999999999 110.772 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.54000000000000004 111.948 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.51000000000000001 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 1.6000000000000001 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 0.52000000000000002 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 0.81000000000000005 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.25 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.836 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.9399999999999999 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 0.54000000000000004 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 0.56000000000000005 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.23 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.588 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 0.63 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 0.35999999999999999 110.542 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 0.59999999999999998 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.21 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 0.33000000000000002 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HD12 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.4199999999999999 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.3200000000000001 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 0.5 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.721 ' CE1' HD21 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.72999999999999998 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.4500000000000002 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.56999999999999995 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.3100000000000001 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.5900000000000001 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.31 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 0.37 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.1399999999999999 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 0.38 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.27000000000000002 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.40000000000000002 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 0.78000000000000003 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.1899999999999999 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.6299999999999999 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.94999999999999996 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.68999999999999995 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 0.83999999999999997 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.2400000000000002 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.4099999999999999 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 0.90000000000000002 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.0299999999999998 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.8399999999999999 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.1899999999999999 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.24 111.809 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.1899999999999999 112.07 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.1600000000000001 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 1.96 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.636 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.70999999999999996 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.755 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.5 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 1.8700000000000001 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 0.79000000000000004 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.649 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.6299999999999999 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 2.8199999999999998 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.83999999999999997 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.511 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 0.47999999999999998 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 0.98999999999999999 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.55000000000000004 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.4199999999999999 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.66000000000000003 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.1499999999999999 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.1399999999999999 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 0.56000000000000005 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.0 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.46000000000000002 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 3.1400000000000001 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 0.64000000000000001 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.78 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.3199999999999998 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.4900000000000002 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.5699999999999998 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.895 0.379 . . . . 1.48 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 0.97999999999999998 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 0.45000000000000001 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.95999999999999996 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.2 t-20 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 1.47 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.01 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 1.54 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.91000000000000003 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.1799999999999999 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 4.6 p30 -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.443 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.59999999999999998 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 0.77000000000000002 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 0.82999999999999996 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.661 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.40999999999999998 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 0.65000000000000002 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.0699999999999998 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.62 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.57999999999999996 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.609 ' HB3' HD23 ' A' ' 12' ' ' LEU . 47.4 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.4099999999999999 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.003 ' HG3' HD21 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.35999999999999999 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 0.46000000000000002 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.28000000000000003 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.819 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77000000000000002 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.51000000000000001 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 0.56999999999999995 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.1800000000000002 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 1.52 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 1.55 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.9500000000000002 111.026 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.8799999999999999 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.3200000000000001 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.887 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92000000000000004 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.42999999999999999 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.23 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.921 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 0.68999999999999995 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.58999999999999997 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 0.37 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.46999999999999997 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.888 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.23 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 0.81999999999999995 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 1.72 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.0899999999999999 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.8300000000000001 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.48 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.8500000000000001 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.921 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.0800000000000001 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.3100000000000001 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.0900000000000001 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.22 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.887 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 0.71999999999999997 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.41999999999999998 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.55000000000000004 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.777 HG21 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 0.94999999999999996 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 0.69999999999999996 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 0.40999999999999998 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.33000000000000002 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 2.7799999999999998 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.62 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 1.8 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.37 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.1200000000000001 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.44 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 48.6 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.1399999999999999 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 0.56000000000000005 110.149 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.1299999999999999 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 0.46000000000000002 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.53000000000000003 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.1899999999999999 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.54000000000000004 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.51000000000000001 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 1.6000000000000001 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.52000000000000002 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.888 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 0.81000000000000005 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.9399999999999999 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.54000000000000004 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.56000000000000005 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.23 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 0.63 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 0.35999999999999999 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 0.59999999999999998 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.21 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 0.33000000000000002 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.4199999999999999 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.3200000000000001 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 0.5 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 0.72999999999999998 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.777 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.4500000000000002 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.56999999999999995 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.3100000000000001 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.31 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 0.37 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.1399999999999999 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.27000000000000002 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.40000000000000002 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.78000000000000003 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.6299999999999999 109.312 175.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.94999999999999996 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 0.68999999999999995 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 0.83999999999999997 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.2400000000000002 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.559 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.4099999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 0.90000000000000002 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.0299999999999998 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.8399999999999999 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.1899999999999999 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.24 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.1899999999999999 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' H ' HG23 ' A' ' 128' ' ' VAL . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.1600000000000001 110.338 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.751 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.70999999999999996 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.661 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.5 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.46 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 1.8700000000000001 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 0.79000000000000004 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.6299999999999999 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 2.8199999999999998 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.83999999999999997 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.47999999999999998 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 0.98999999999999999 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.55000000000000004 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.4199999999999999 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 1.9099999999999999 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.66000000000000003 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.1499999999999999 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.1399999999999999 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.0 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.46000000000000002 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 3.1400000000000001 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.78 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.3199999999999998 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.4900000000000002 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.5699999999999998 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 1.48 109.782 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.666 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 0.97999999999999998 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 0.45000000000000001 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.3899999999999999 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.3200000000000001 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.95999999999999996 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.01 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 0.91000000000000003 110.077 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.1799999999999999 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 1.011 ' HB2' HE21 ' A' ' 23' ' ' GLN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.8799999999999999 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.59999999999999998 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 0.77000000000000002 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 0.82999999999999996 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.40999999999999998 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 0.65000000000000002 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.0699999999999998 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.62 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.57999999999999996 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.011 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.0 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.4099999999999999 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HG2' HG22 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 0.35999999999999999 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 0.46000000000000002 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.28000000000000003 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77000000000000002 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.51000000000000001 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 0.56999999999999995 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.8300000000000001 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 1.52 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 1.55 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.9500000000000002 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.8799999999999999 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.3200000000000001 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92000000000000004 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.42999999999999999 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.23 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 0.46000000000000002 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 0.68999999999999995 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.58999999999999997 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.37 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.664 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.46999999999999997 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.785 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.23 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.81999999999999995 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 1.72 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.0899999999999999 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.8300000000000001 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.48 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.8500000000000001 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.0800000000000001 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.3100000000000001 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.599 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.0900000000000001 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.22 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.3400000000000001 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.71999999999999997 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.41999999999999998 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.55000000000000004 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 0.94999999999999996 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 0.69999999999999996 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 0.40999999999999998 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.33000000000000002 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 2.7799999999999998 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.62 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 1.8 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.37 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.1200000000000001 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.44 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.2 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.1399999999999999 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 0.56000000000000005 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.1299999999999999 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 0.46000000000000002 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 84' ' ' ILE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.53000000000000003 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.1899999999999999 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.54000000000000004 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.51000000000000001 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 1.6000000000000001 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 79' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 0.52000000000000002 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 0.81000000000000005 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.25 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.838 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.9399999999999999 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.54000000000000004 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 0.56000000000000005 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.23 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.63 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 0.35999999999999999 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 0.59999999999999998 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.21 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 0.33000000000000002 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.4199999999999999 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.3200000000000001 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 0.5 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.4500000000000002 110.833 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.56999999999999995 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.5900000000000001 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.31 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 0.37 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.1399999999999999 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 0.38 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.27000000000000002 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' HG13 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.40000000000000002 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 0.78000000000000003 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.6299999999999999 109.175 174.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.94999999999999996 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 0.68999999999999995 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 0.83999999999999997 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.2400000000000002 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.4099999999999999 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 0.90000000000000002 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.0299999999999998 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.8399999999999999 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.1899999999999999 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.516 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.24 111.877 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.1899999999999999 111.794 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.1600000000000001 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 1.96 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.643 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.70999999999999996 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.5 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.46 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 1.8700000000000001 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 0.79000000000000004 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.6299999999999999 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.556 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 2.8199999999999998 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.83999999999999997 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 0.47999999999999998 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 0.98999999999999999 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 0.55000000000000004 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.4199999999999999 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 1.9099999999999999 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.66000000000000003 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.1499999999999999 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.1399999999999999 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.0 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.46000000000000002 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 3.1400000000000001 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 0.64000000000000001 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.78 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.3199999999999998 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.4900000000000002 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.5699999999999998 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 1.48 111.054 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 0.97999999999999998 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 0.45000000000000001 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.3899999999999999 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.3200000000000001 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.95999999999999996 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 1.47 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.01 108.668 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 1.54 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 0.91000000000000003 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.676 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.1799999999999999 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.8799999999999999 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.59999999999999998 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 0.77000000000000002 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 0.82999999999999996 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.731 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.40999999999999998 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 0.65000000000000002 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.0699999999999998 108.672 175.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.62 113.377 -174.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.57999999999999996 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.7 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.4099999999999999 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.82 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 0.35999999999999999 110.931 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 0.46000000000000002 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.51000000000000001 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 0.56999999999999995 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.8300000000000001 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.1800000000000002 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 1.52 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 1.55 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.9500000000000002 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.8799999999999999 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 HG11 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.3200000000000001 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HA ' HD13 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92000000000000004 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.42999999999999999 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.23 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 0.46000000000000002 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 0.68999999999999995 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.58999999999999997 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG22 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 0.37 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.626 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.46999999999999997 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.597 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.23 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 0.81999999999999995 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.598 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 1.72 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.0899999999999999 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.8300000000000001 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.48 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.8500000000000001 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.0800000000000001 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.05 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.0900000000000001 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.22 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.3400000000000001 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 0.71999999999999997 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.41999999999999998 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.55000000000000004 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.615 HG11 HD22 ' A' ' 38' ' ' LEU . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 0.94999999999999996 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 0.69999999999999996 113.441 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 0.40999999999999998 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.33000000000000002 111.936 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 2.7799999999999998 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.62 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 1.8 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.1200000000000001 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.44 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.0 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.1399999999999999 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 0.56000000000000005 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.1299999999999999 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 0.46000000000000002 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.53000000000000003 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.1899999999999999 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.54000000000000004 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.51000000000000001 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 1.6000000000000001 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 0.52000000000000002 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 0.81000000000000005 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.25 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.605 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.9399999999999999 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 0.54000000000000004 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 0.56000000000000005 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.23 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 0.63 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' HB ' HG21 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 0.35999999999999999 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 111' ' ' TYR . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 0.59999999999999998 108.983 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.21 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 0.33000000000000002 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.4199999999999999 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.3200000000000001 110.251 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 0.5 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.461 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 0.72999999999999998 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.4500000000000002 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.56999999999999995 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.3100000000000001 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.5900000000000001 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.31 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 0.37 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.1399999999999999 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 0.38 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.27000000000000002 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.40000000000000002 110.823 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 0.78000000000000003 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.1899999999999999 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.6299999999999999 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 0.68999999999999995 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 0.83999999999999997 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.2400000000000002 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.4099999999999999 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 0.90000000000000002 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.0299999999999998 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.8399999999999999 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.1899999999999999 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.24 111.262 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.1899999999999999 111.689 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.1600000000000001 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 1.96 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.70999999999999996 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.731 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.5 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.46 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 1.8700000000000001 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 0.79000000000000004 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.565 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.6299999999999999 108.452 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 2.8199999999999998 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.83999999999999997 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 0.47999999999999998 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 0.98999999999999999 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 0.55000000000000004 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.4199999999999999 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 1.9099999999999999 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.66000000000000003 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.1499999999999999 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.1399999999999999 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.56000000000000005 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.0 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.46000000000000002 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 3.1400000000000001 110.045 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 0.64000000000000001 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.78 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.3199999999999998 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.4900000000000002 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.5699999999999998 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.666 0.269 . . . . 1.48 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 0.97999999999999998 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 0.45000000000000001 109.415 176.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.3899999999999999 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.95999999999999996 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 9.5 t30 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.01 109.302 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 1.54 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.633 HG12 ' HB2' ' A' ' 141' ' ' ALA . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 0.91000000000000003 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.1799999999999999 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.809 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.593 ' OD1' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.8799999999999999 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.59999999999999998 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.581 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 0.77000000000000002 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 0.82999999999999996 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.40999999999999998 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 0.65000000000000002 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.0699999999999998 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.62 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.57999999999999996 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.809 HE21 ' HB2' ' A' ' 13' ' ' ASP . 8.3 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.4099999999999999 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 0.35999999999999999 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.28000000000000003 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77000000000000002 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 0.56999999999999995 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.8300000000000001 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.1800000000000002 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.886 HD11 HG23 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 1.52 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 1.55 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.9500000000000002 109.582 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.8799999999999999 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.3200000000000001 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92000000000000004 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.42999999999999999 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.23 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 0.46000000000000002 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 0.68999999999999995 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.58999999999999997 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' ' H ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 0.37 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.646 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.23 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 0.81999999999999995 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 1.72 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.0899999999999999 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.8300000000000001 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.48 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.8500000000000001 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.0800000000000001 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.05 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.0900000000000001 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.22 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.3400000000000001 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 0.71999999999999997 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.41999999999999998 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.55000000000000004 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.886 HG23 HD11 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 0.94999999999999996 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 0.69999999999999996 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.724 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.33000000000000002 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 2.7799999999999998 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.62 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 1.8 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.37 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.1200000000000001 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.44 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.1399999999999999 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 0.56000000000000005 110.18 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.1299999999999999 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 0.46000000000000002 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.53000000000000003 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.1899999999999999 111.991 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.54000000000000004 112.207 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.51000000000000001 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 83' ' ' LEU . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 1.6000000000000001 110.741 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 0.52000000000000002 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.662 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 0.81000000000000005 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.25 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.662 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.9399999999999999 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 0.54000000000000004 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 0.56000000000000005 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.23 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 0.63 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' H ' ' HB ' ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 0.35999999999999999 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 0.59999999999999998 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.21 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 0.33000000000000002 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.4199999999999999 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.3200000000000001 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 0.5 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 0.72999999999999998 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.4500000000000002 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.56999999999999995 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.3100000000000001 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.31 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 0.37 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.1399999999999999 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 0.38 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.522 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.27000000000000002 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.40000000000000002 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 0.78000000000000003 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.1899999999999999 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.6299999999999999 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB3' HD21 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.94999999999999996 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 0.68999999999999995 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 0.83999999999999997 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.2400000000000002 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.636 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.4099999999999999 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 0.90000000000000002 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.0299999999999998 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.8399999999999999 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.1899999999999999 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' HG11 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.24 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.1899999999999999 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.1600000000000001 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 1.96 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.583 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.70999999999999996 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.401 ' H ' ' HE2' ' A' ' 117' ' ' TYR . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.5 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.46 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 1.8700000000000001 109.802 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 0.79000000000000004 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.506 ' HB2' HG22 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.6299999999999999 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 2.8199999999999998 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.83999999999999997 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.518 HD12 ' ND2' ' A' ' 14' ' ' ASN . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 0.47999999999999998 109.919 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.98999999999999999 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 0.55000000000000004 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.4199999999999999 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 1.9099999999999999 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.66000000000000003 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.1499999999999999 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.1399999999999999 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 0.56000000000000005 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.0 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 3.1400000000000001 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.64000000000000001 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.78 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.3199999999999998 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.4900000000000002 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.5699999999999998 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 1.48 112.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 0.97999999999999998 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.45000000000000001 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.3899999999999999 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.3200000000000001 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.95999999999999996 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.47 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 26' ' ' ILE . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.01 109.782 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.54 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 0.91000000000000003 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.1799999999999999 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.8799999999999999 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.59999999999999998 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 0.77000000000000002 110.499 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 0.82999999999999996 114.275 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.40999999999999998 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 0.65000000000000002 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.0699999999999998 108.945 173.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.62 112.702 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.57999999999999996 109.126 169.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.3 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.4099999999999999 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 9' ' ' VAL . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 0.35999999999999999 111.451 -174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 0.46000000000000002 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.28000000000000003 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77000000000000002 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.51000000000000001 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 0.56999999999999995 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.8300000000000001 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.1800000000000002 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.524 HD21 ' HZ3' ' A' ' 153' ' ' TRP . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 1.52 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 1.55 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.9500000000000002 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.8799999999999999 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.3200000000000001 109.904 -174.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92000000000000004 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.42999999999999999 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.23 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.46000000000000002 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 0.68999999999999995 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.58999999999999997 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' HG22 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 0.37 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.46999999999999997 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.628 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.23 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 0.81999999999999995 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 1.72 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.0899999999999999 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.8300000000000001 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.48 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.0800000000000001 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.0900000000000001 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.22 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.3400000000000001 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 0.71999999999999997 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.41999999999999998 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.55000000000000004 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 0.94999999999999996 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 0.69999999999999996 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 0.40999999999999998 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.33000000000000002 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 2.7799999999999998 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.62 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 1.8 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.37 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.1200000000000001 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.44 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.1399999999999999 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 0.56000000000000005 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.1299999999999999 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 0.46000000000000002 110.548 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.53000000000000003 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.1899999999999999 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.54000000000000004 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.51000000000000001 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 1.6000000000000001 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 0.52000000000000002 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 1.114 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 0.81000000000000005 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.25 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 1.114 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.9399999999999999 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.54000000000000004 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.56000000000000005 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.23 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.63 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 0.35999999999999999 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 0.59999999999999998 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.21 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 0.33000000000000002 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HB3' HD11 ' A' ' 38' ' ' LEU . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.3200000000000001 109.639 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 0.5 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.72999999999999998 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.4500000000000002 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.56999999999999995 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.472 HE22 ' ND2' ' A' ' 152' ' ' ASN . 21.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.3100000000000001 110.033 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.5900000000000001 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.31 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.1399999999999999 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.27000000000000002 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.40000000000000002 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 0.78000000000000003 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.1899999999999999 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.6299999999999999 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.94999999999999996 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.639 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 0.68999999999999995 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 0.83999999999999997 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.2400000000000002 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.4099999999999999 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 0.90000000000000002 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.0299999999999998 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.8399999999999999 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.1899999999999999 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HB3' HG11 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.24 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.1899999999999999 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.1600000000000001 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 1.96 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.639 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.70999999999999996 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.5 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.46 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 1.8700000000000001 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 0.79000000000000004 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 2.8199999999999998 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.83999999999999997 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 0.98999999999999999 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 0.55000000000000004 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.4199999999999999 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 1.9099999999999999 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.66000000000000003 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.1499999999999999 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.416 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.56000000000000005 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.0 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.46000000000000002 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 3.1400000000000001 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 0.64000000000000001 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.472 ' ND2' HE22 ' A' ' 104' ' ' GLN . 7.7 p30 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.78 109.657 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.524 ' HZ3' HD21 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.3199999999999998 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.4900000000000002 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.5699999999999998 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 109.876 -0.416 . . . . 1.48 109.876 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.786 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 0.97999999999999998 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.45000000000000001 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.3899999999999999 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.3200000000000001 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 1.47 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.01 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 1.54 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 0.91000000000000003 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.1799999999999999 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.752 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.8799999999999999 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.59999999999999998 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.752 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 0.77000000000000002 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 0.82999999999999996 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.695 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.40999999999999998 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 0.65000000000000002 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.615 ' ND2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.0699999999999998 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.62 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.57999999999999996 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.4099999999999999 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 0.35999999999999999 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 0.46000000000000002 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.28000000000000003 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.51000000000000001 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 0.56999999999999995 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.8300000000000001 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.1800000000000002 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.085 HD21 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 1.52 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 1.55 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.9500000000000002 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.8799999999999999 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.3200000000000001 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92000000000000004 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' SER . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.42999999999999999 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.23 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 0.46000000000000002 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 0.68999999999999995 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.58999999999999997 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.46999999999999997 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.23 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 0.81999999999999995 108.704 168.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 1.72 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.0899999999999999 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.8300000000000001 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.48 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.8500000000000001 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.628 HG22 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.0800000000000001 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.05 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.0900000000000001 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.22 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 0.71999999999999997 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.41999999999999998 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.55000000000000004 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.085 ' HB ' HD21 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 0.94999999999999996 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 0.69999999999999996 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 0.40999999999999998 111.42 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.33000000000000002 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 2.7799999999999998 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.62 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 1.8 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.37 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.1200000000000001 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.44 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.1399999999999999 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 0.56000000000000005 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.1299999999999999 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.46000000000000002 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.53000000000000003 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.1899999999999999 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.54000000000000004 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.51000000000000001 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 1.6000000000000001 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 0.52000000000000002 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 0.81000000000000005 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.25 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.605 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.9399999999999999 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.54000000000000004 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 0.56000000000000005 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.531 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.23 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 0.63 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 0.35999999999999999 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 0.59999999999999998 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 0.33000000000000002 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.4199999999999999 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.3200000000000001 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 0.5 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 0.72999999999999998 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.4500000000000002 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.56999999999999995 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.428 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 26.8 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.3100000000000001 109.85 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.5900000000000001 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.31 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 0.37 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.1399999999999999 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 0.38 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.575 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.27000000000000002 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 0.78000000000000003 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.1899999999999999 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.531 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.6299999999999999 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.94999999999999996 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 0.68999999999999995 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 0.83999999999999997 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.2400000000000002 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.4099999999999999 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 0.90000000000000002 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.0299999999999998 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.8399999999999999 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.1899999999999999 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.24 110.937 169.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.1899999999999999 111.19 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.1600000000000001 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 1.96 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.70999999999999996 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.5 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.471 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.46 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 1.8700000000000001 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 0.79000000000000004 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.6299999999999999 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 2.8199999999999998 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.83999999999999997 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.459 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 0.47999999999999998 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 0.98999999999999999 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 0.55000000000000004 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.4199999999999999 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 1.9099999999999999 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.66000000000000003 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.1499999999999999 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.1399999999999999 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 0.56000000000000005 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.46000000000000002 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 3.1400000000000001 109.418 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.428 ' HB ' ' NE2' ' A' ' 104' ' ' GLN . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.64000000000000001 110.58 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.78 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.431 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.653 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.3199999999999998 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.4900000000000002 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.5699999999999998 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.057 0.456 . . . . 1.48 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 0.97999999999999998 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 0.45000000000000001 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.3899999999999999 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.3200000000000001 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.95999999999999996 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 1.47 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.01 109.909 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 25' ' ' GLU . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 1.54 110.412 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 0.91000000000000003 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.1799999999999999 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.837 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.8799999999999999 111.381 177.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.59999999999999998 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 0.77000000000000002 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 0.82999999999999996 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.40999999999999998 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 0.65000000000000002 111.634 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.0699999999999998 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.62 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.57999999999999996 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.837 HE21 ' HB2' ' A' ' 13' ' ' ASP . 16.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.4099999999999999 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 0.35999999999999999 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 0.46000000000000002 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.28000000000000003 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77000000000000002 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.51000000000000001 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 0.56999999999999995 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.8300000000000001 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.1800000000000002 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.847 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 1.52 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 1.55 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.8799999999999999 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.3200000000000001 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92000000000000004 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.42999999999999999 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.23 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.627 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 0.68999999999999995 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' HE1' HG11 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.58999999999999997 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.37 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.46999999999999997 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.849 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.23 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 0.81999999999999995 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 1.72 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.0899999999999999 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.8300000000000001 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.849 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.48 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.8500000000000001 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.0800000000000001 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.05 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.3100000000000001 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.669 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.0900000000000001 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.22 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.3400000000000001 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 0.71999999999999997 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.41999999999999998 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.55000000000000004 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 0.94999999999999996 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 0.69999999999999996 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 0.40999999999999998 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.33000000000000002 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 2.7799999999999998 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.62 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 1.8 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.37 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.1200000000000001 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.44 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 0.56000000000000005 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.1299999999999999 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 0.46000000000000002 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.53000000000000003 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.1899999999999999 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.54000000000000004 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.51000000000000001 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.683 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 1.6000000000000001 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 0.52000000000000002 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.25 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.9399999999999999 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 0.54000000000000004 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.56000000000000005 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.23 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 0.63 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 0.35999999999999999 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 0.59999999999999998 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.21 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 0.33000000000000002 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.4199999999999999 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.3200000000000001 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.72999999999999998 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.4500000000000002 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.56999999999999995 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.3100000000000001 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.5900000000000001 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.31 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 0.37 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 0.38 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.27000000000000002 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.40000000000000002 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 0.78000000000000003 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 137' ' ' ARG . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.6299999999999999 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.522 ' HB3' HD21 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 0.68999999999999995 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 0.83999999999999997 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.2400000000000002 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.4099999999999999 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 0.90000000000000002 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.0299999999999998 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.8399999999999999 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.1899999999999999 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.24 111.825 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.1899999999999999 112.005 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.1600000000000001 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.536 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.70999999999999996 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.46 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 1.8700000000000001 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 115' ' ' ASN . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 0.79000000000000004 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.543 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.5 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.6299999999999999 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 113' ' ' VAL . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 2.8199999999999998 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.83999999999999997 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.549 HG21 HG11 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 0.47999999999999998 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 0.98999999999999999 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 0.55000000000000004 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.4199999999999999 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 1.9099999999999999 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.66000000000000003 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.1499999999999999 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 0.56000000000000005 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.0 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.515 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.46000000000000002 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 3.1400000000000001 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 0.64000000000000001 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.893 HD21 ' HA ' ' A' ' 155' ' ' ASP . 6.2 t30 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.78 110.427 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.3199999999999998 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.893 ' HA ' HD21 ' A' ' 152' ' ' ASN . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.4900000000000002 111.502 -166.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.5699999999999998 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 1.48 110.373 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.97999999999999998 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.3899999999999999 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.3200000000000001 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.95999999999999996 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 1.47 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.01 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 1.54 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 0.91000000000000003 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.708 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.1799999999999999 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.8799999999999999 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.59999999999999998 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 0.77000000000000002 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 0.82999999999999996 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.40999999999999998 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 0.65000000000000002 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.0699999999999998 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.62 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.57999999999999996 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.4099999999999999 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.35999999999999999 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 0.46000000000000002 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77000000000000002 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.51000000000000001 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.56999999999999995 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.8300000000000001 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.1800000000000002 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 1.52 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 1.55 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.9500000000000002 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.8799999999999999 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.3200000000000001 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92000000000000004 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.422 ' NE1' HD12 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.42999999999999999 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.632 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.23 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.46000000000000002 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.68999999999999995 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.58999999999999997 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 0.37 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.46999999999999997 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.23 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 1.72 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.0899999999999999 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.8300000000000001 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.8500000000000001 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.0800000000000001 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.05 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.3100000000000001 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.0900000000000001 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.22 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.3400000000000001 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 0.71999999999999997 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.41999999999999998 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.55000000000000004 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 0.94999999999999996 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 0.69999999999999996 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 0.40999999999999998 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.33000000000000002 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 2.7799999999999998 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.62 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.37 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.886 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.1200000000000001 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.1399999999999999 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 0.56000000000000005 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.1299999999999999 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 0.46000000000000002 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.53000000000000003 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.1899999999999999 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.54000000000000004 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.51000000000000001 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 1.6000000000000001 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 0.52000000000000002 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 0.81000000000000005 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.25 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.9399999999999999 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.54000000000000004 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 0.56000000000000005 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.23 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 0.63 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 0.35999999999999999 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 0.59999999999999998 108.436 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.21 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 0.33000000000000002 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.4199999999999999 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.3200000000000001 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.5 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 0.72999999999999998 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.4500000000000002 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.56999999999999995 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 152' ' ' ASN . 27.0 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3100000000000001 109.751 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.5900000000000001 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.31 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 0.37 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.1399999999999999 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 0.38 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.27000000000000002 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.40000000000000002 110.121 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 0.78000000000000003 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.1899999999999999 110.819 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.6299999999999999 109.079 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.94999999999999996 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.68999999999999995 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 0.83999999999999997 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.2400000000000002 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.583 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.4099999999999999 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 0.90000000000000002 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.0299999999999998 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.8399999999999999 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.1899999999999999 111.353 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.24 111.671 175.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.1899999999999999 112.267 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.1600000000000001 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 1.96 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.70999999999999996 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.8700000000000001 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 0.79000000000000004 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.3 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.6299999999999999 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 137' ' ' ARG . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 2.8199999999999998 109.978 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.83999999999999997 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.546 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 0.47999999999999998 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 0.98999999999999999 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 0.55000000000000004 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.4199999999999999 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 1.9099999999999999 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.66000000000000003 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.1499999999999999 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.1399999999999999 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 0.56000000000000005 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.0 110.553 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 3.1400000000000001 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 0.64000000000000001 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' NE2' ' A' ' 104' ' ' GLN . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.78 109.915 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.3199999999999998 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' C ' HD22 ' A' ' 156' ' ' ASN . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.4900000000000002 108.968 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.502 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 109.669 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.48 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 0.97999999999999998 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 0.45000000000000001 110.331 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.3899999999999999 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.3200000000000001 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.0 t-20 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 1.47 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.01 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 1.54 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 139' ' ' ILE . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 0.91000000000000003 109.376 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.743 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.1799999999999999 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB2' HE21 ' A' ' 23' ' ' GLN . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.8799999999999999 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HB2' HE21 ' A' ' 136' ' ' GLN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.59999999999999998 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.77000000000000002 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.82999999999999996 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.723 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.40999999999999998 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 0.65000000000000002 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.79 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.0699999999999998 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.62 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.57999999999999996 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.743 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.0 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.4099999999999999 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 0.35999999999999999 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 0.46000000000000002 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.28000000000000003 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77000000000000002 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.51000000000000001 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 31' ' ' ILE . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 0.56999999999999995 108.557 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.705 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 1.52 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.55 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.9500000000000002 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.8799999999999999 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.731 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.3200000000000001 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92000000000000004 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.42999999999999999 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.23 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 0.46000000000000002 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 0.68999999999999995 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.58999999999999997 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 0.37 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.677 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.46999999999999997 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.23 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 0.81999999999999995 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 1.72 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.0899999999999999 111.189 -175.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.8300000000000001 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.458 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.48 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.8500000000000001 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.05 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.3100000000000001 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.0900000000000001 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.3400000000000001 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 0.71999999999999997 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.41999999999999998 112.17 174.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.55000000000000004 110.243 -14.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 0.94999999999999996 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 0.69999999999999996 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.33000000000000002 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 2.7799999999999998 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 1.8 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.37 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.1200000000000001 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.44 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 25.2 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.1399999999999999 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 0.56000000000000005 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.1299999999999999 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 0.46000000000000002 113.794 -172.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.53000000000000003 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.544 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.1899999999999999 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.54000000000000004 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.51000000000000001 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 1.6000000000000001 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.52000000000000002 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.682 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 0.81000000000000005 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.25 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.682 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.9399999999999999 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 0.54000000000000004 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 0.56000000000000005 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.23 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 0.63 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 0.35999999999999999 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 0.59999999999999998 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.21 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.33000000000000002 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.4199999999999999 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.3200000000000001 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 0.5 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.72999999999999998 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.4500000000000002 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.56999999999999995 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.3100000000000001 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.5900000000000001 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.31 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 0.37 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 107' ' ' ILE . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.1399999999999999 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.38 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.27000000000000002 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.40000000000000002 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.754 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 0.78000000000000003 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.1899999999999999 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.6299999999999999 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.718 HD22 HD11 ' A' ' 135' ' ' LEU . 10.0 m120 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.94999999999999996 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 0.68999999999999995 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 0.83999999999999997 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.4099999999999999 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.90000000000000002 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.0299999999999998 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.8399999999999999 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.24 110.68 169.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.1899999999999999 111.463 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.1600000000000001 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.711 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.70999999999999996 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.5 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.46 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 1.8700000000000001 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 115' ' ' ASN . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 0.79000000000000004 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.6299999999999999 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.969 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 2.8199999999999998 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.83999999999999997 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.969 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 0.47999999999999998 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.98999999999999999 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.4199999999999999 109.524 174.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 2.9 t-20 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 1.9099999999999999 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 142' ' ' SER . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.66000000000000003 112.105 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.754 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.1499999999999999 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.1399999999999999 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 0.56000000000000005 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.0 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.46000000000000002 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 3.1400000000000001 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.64000000000000001 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.78 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.3199999999999998 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.4900000000000002 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.5699999999999998 110.096 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.656 ' HE1' ' HA ' ' A' ' 152' ' ' ASN . 26.9 ptm . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.514 0.197 . . . . 2.96 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -74.29 135.82 42.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 1.48 111.013 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 153' ' ' TRP . 6.3 mmpt? -86.59 -32.67 20.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.632 -0.507 . . . . 0.97999999999999998 109.632 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -135.9 132.57 50.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.571 -0.74 . . . . 0.45000000000000001 110.305 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.43 112.5 13.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.64 -0.504 . . . . 1.3899999999999999 109.64 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.5 t -72.15 120.66 20.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.942 0.401 . . . . 1.3200000000000001 110.104 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -105.54 -60.88 1.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.831 -0.622 . . . . 0.95999999999999996 110.592 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.9 t30 -101.51 125.34 48.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 1.47 110.119 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.97 120.46 5.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.263 0.554 . . . . 1.01 110.112 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.68 152.39 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.706 -0.679 . . . . 1.54 110.86 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.61 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -104.84 132.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.91000000000000003 109.845 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.0 mp -115.57 179.33 4.0 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.327 -0.397 . . . . 1.1799999999999999 110.088 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.837 ' HB2' HE21 ' A' ' 23' ' ' GLN . 13.1 t70 72.75 -25.81 0.19 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.033 0.933 . . . . 2.73 112.245 177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.7 p30 -85.22 149.26 52.13 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.751 0.31 . . . . 1.8799999999999999 110.256 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 7.4 Cg_endo -89.97 142.57 15.48 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.755 -1.352 . . . . 0.59999999999999998 112.502 -2.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.6 m -150.46 167.41 13.03 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.996 -0.742 . . . . 0.77000000000000002 108.996 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 72.8 Cg_exo -48.2 143.68 14.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.476 2.118 . . . . 0.82999999999999996 111.949 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.71 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 9.7 t80 -48.28 -25.56 1.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.632 0.975 . . . . 0.40999999999999998 113.632 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.85 16.39 1.46 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.994 0.426 . . . . 0.65000000000000002 111.536 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' OD1' ' HD3' ' A' ' 137' ' ' ARG . 23.4 p-10 -87.17 158.71 52.18 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 109.983 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.73 149.14 11.14 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.712 2.275 . . . . 0.62 112.883 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE2' ' HD3' ' A' ' 79' ' ' PRO . 97.6 m-85 -69.41 93.71 0.68 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.064 -0.717 . . . . 0.57999999999999996 109.064 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.837 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.6 tt0 -98.84 109.24 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.097 0.475 . . . . 1.4099999999999999 110.876 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 93.7 m-85 -116.98 138.94 51.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.623 -0.717 . . . . 0.5 110.624 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.5 99.85 9.32 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.805 -0.813 . . . . 1.98 108.805 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 66.6 mt -100.51 115.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.168 -0.924 . . . . 0.35999999999999999 111.377 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.9 m -109.69 106.17 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 0.46000000000000002 109.889 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.3 p90 -120.43 136.52 54.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.189 -0.46 . . . . 0.28000000000000003 109.792 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.9 tt0 -104.2 114.54 28.85 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.758 -0.46 . . . . 0.77000000000000002 109.758 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 34.7 m -75.45 115.14 14.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.51000000000000001 109.312 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 2' ' ' ALA . 13.7 mt -76.2 -29.79 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.474 -0.784 . . . . 0.56999999999999995 109.307 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.5 mt-10 -139.06 165.68 26.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 1.8300000000000001 110.154 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.17 129.72 38.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 111.484 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 4.1 mm? -89.4 131.76 35.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.335 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -102.3 -26.99 13.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.47 . . . . 1.55 109.86 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 36.9 tt0 -94.55 163.87 13.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.039 -0.726 . . . . 2.9500000000000002 109.039 172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.3 p-10 -87.97 137.87 31.95 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.019 0.437 . . . . 1.8799999999999999 110.638 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.71 119.74 28.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 109.597 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 33.1 tt0 -96.72 101.03 12.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.872 0.368 . . . . 0.92000000000000004 110.938 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.7 m95 -87.77 138.67 31.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.928 -0.767 . . . . 0.42999999999999999 108.928 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 1.3 mtmt -138.72 145.99 40.95 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.543 0.572 . . . . 1.23 112.543 -174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 HG13 ' CE1' ' A' ' 74' ' ' PHE . 35.9 mt -105.41 96.92 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.549 -0.75 . . . . 0.46000000000000002 109.63 169.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 64.5 mt -96.64 105.67 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.579 -0.897 . . . . 0.68999999999999995 108.579 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HD1' ' HB ' ' A' ' 95' ' ' VAL . 66.6 t80 -93.95 145.35 24.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.969 -0.56 . . . . 0.58999999999999997 110.487 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.06 116.04 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.048 -0.353 . . . . 0.37 110.048 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.661 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.1 -54.89 11.75 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.538 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.709 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 13.2 m -138.33 134.84 34.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.434 -0.21 . . . . 1.23 110.434 177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.01 60.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.627 0.727 . . . . 0.81999999999999995 109.212 167.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.06 -42.3 80.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.781 -1.099 . . . . 1.99 109.643 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.1 m -143.27 103.11 4.09 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.419 -0.956 . . . . 1.72 108.419 172.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 35.7 mt-10 -68.57 -11.23 59.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.13 -0.487 . . . . 2.0899999999999999 111.702 -170.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.1 -8.42 45.09 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.148 0.499 . . . . 2.8300000000000001 110.669 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 38.8 m-85 -83.8 7.96 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.754 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.7 p-10 -64.1 146.07 54.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.009 0.433 . . . . 1.22 110.507 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.25 132.82 27.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.378 0.608 . . . . 1.8500000000000001 111.316 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 p -81.44 134.95 26.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.574 -0.739 . . . . 1.0800000000000001 109.43 170.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . 6.9 mp -99.81 -63.19 1.15 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 1.05 111.299 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -132.17 155.26 48.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.716 -0.675 . . . . 1.3100000000000001 110.044 -173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 1.5 p -140.29 121.84 15.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.181 0.515 . . . . 1.0900000000000001 110.101 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.1 t -102.77 117.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.751 -0.659 . . . . 1.22 109.326 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.1 mp -114.89 131.02 57.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.507 -0.315 . . . . 1.3400000000000001 110.263 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.91 102.69 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.419 -0.512 . . . . 0.71999999999999997 109.913 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.82 113.14 4.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.932 -0.927 . . . . 0.41999999999999998 112.553 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.9 Cg_endo -98.44 167.24 11.14 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.978 2.389 . . . . 0.55000000000000004 110.993 -10.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -99.45 111.32 61.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 120.672 0.272 . . . . 0.94999999999999996 110.595 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.3 149.4 31.51 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.402 2.068 . . . . 0.69999999999999996 112.623 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.72 123.07 17.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.879 -0.6 . . . . 0.40999999999999998 111.033 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 154.5 163.19 11.74 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.876 -0.89 . . . . 0.33000000000000002 110.876 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.2 ttp180 -86.24 105.86 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.02 0.438 . . . . 2.7799999999999998 110.395 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -101.81 137.57 39.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.62 110.233 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.3 ttp -121.26 99.01 6.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.241 -0.436 . . . . 1.8 109.985 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -112.56 160.42 17.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.852 0.358 . . . . 0.37 110.312 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.17 123.83 61.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.992 -0.549 . . . . 1.1200000000000001 109.867 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -97.56 124.27 41.76 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.44 108.475 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 20.8 mt-30 -133.82 122.75 23.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.1399999999999999 111.258 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.81 158.61 38.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.028 -0.731 . . . . 0.56000000000000005 109.028 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.26 -170.08 2.36 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.337 -0.616 . . . . 2.1299999999999999 109.337 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.12 94.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 110.121 -0.326 . . . . 0.46000000000000002 110.121 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 84' ' ' ILE . 36.5 Cg_endo -65.96 164.22 28.15 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.418 2.078 . . . . 0.53000000000000003 110.965 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -58.68 112.67 5.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.052 -0.351 . . . . 2.1899999999999999 110.052 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.36 35.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.181 2.588 . . . . 0.54000000000000004 112.424 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.27 -11.01 73.24 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.619 -0.801 . . . . 0.51000000000000001 111.274 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.47 -20.24 18.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.217 . . . . 1.6000000000000001 111.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 79' ' ' PRO . 46.2 mt -80.83 123.15 82.52 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.91 -0.404 . . . . 0.52000000000000002 109.91 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 1.037 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 85.2 Cg_endo -78.03 155.74 30.02 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.282 2.655 . . . . 0.81000000000000005 112.986 -172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 13.9 m-20 -53.92 -55.85 23.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.79 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.39 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.724 -0.671 . . . . 1.25 112.677 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 1.037 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 27.3 t70 -109.33 -18.38 13.59 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.296 -0.562 . . . . 1.9399999999999999 111.659 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.79 -36.58 83.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 0.54000000000000004 110.578 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -86.23 40.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.447 0.641 . . . . 0.56000000000000005 109.421 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.67 -157.98 8.37 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.728 -0.749 . . . . 0.62 112.802 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.86 116.44 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.453 0.644 . . . . 1.23 111.561 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.73 166.5 10.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.63 109.599 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.29 141.71 26.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.651 -0.419 . . . . 0.35999999999999999 110.274 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.8 p -113.91 116.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.948 -0.76 . . . . 0.59999999999999998 108.948 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 28.9 mt -100.82 134.75 43.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.304 0.573 . . . . 1.21 110.964 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 56.8 mt -108.35 101.35 12.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.099 -0.955 . . . . 0.33000000000000002 109.054 171.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.2 p -101.28 143.75 30.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 1.4199999999999999 109.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 34.0 m -118.98 110.27 16.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.177 -0.465 . . . . 1.3200000000000001 110.504 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.5 m -88.33 122.24 31.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.769 -0.651 . . . . 0.5 111.085 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -131.88 124.59 29.83 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.72999999999999998 109.71 172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 62.46 22.02 12.98 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.638 0.375 . . . . 2.4500000000000002 111.148 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.11 4.78 81.24 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.899 -0.667 . . . . 0.56999999999999995 111.806 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -124.77 125.29 43.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.3100000000000001 109.808 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 53.0 mt-10 -90.89 126.34 36.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.819 0.342 . . . . 1.5900000000000001 110.102 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' HG12 ' A' ' 151' ' ' ILE . 24.6 p90 -101.83 -8.65 21.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 0.31 112.819 -169.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.8 tt -154.11 145.9 14.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.041 0.448 . . . . 0.37 110.08 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -138.47 107.61 6.06 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.472 -0.785 . . . . 1.1399999999999999 109.526 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.6 t -84.76 113.63 23.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.253 -0.431 . . . . 0.38 110.617 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -95.29 98.25 2.24 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 116.099 -0.5 . . . . 0.27000000000000002 112.212 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HB2' HG13 ' A' ' 95' ' ' VAL . 11.0 m-85 -97.53 124.38 41.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.788 0.328 . . . . 0.40000000000000002 110.501 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -89.84 114.3 26.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.002 0.43 . . . . 0.78000000000000003 110.454 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.536 HG21 ' CZ ' ' A' ' 137' ' ' ARG . 2.5 p -100.74 121.8 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.545 0.688 . . . . 1.1899999999999999 110.024 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.54 120.15 35.29 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.282 -0.872 . . . . 1.6299999999999999 109.576 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 21.4 m-80 -108.87 114.13 27.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.269 0.557 . . . . 0.94999999999999996 110.537 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -137.24 142.29 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.199 -0.909 . . . . 1.97 109.077 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.567 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.1 m-85 -56.8 148.25 21.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.68999999999999995 111.048 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -86.66 -29.97 22.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.83999999999999997 108.832 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 13.7 mm-40 -70.53 111.61 6.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.906 -1.043 . . . . 2.2400000000000002 108.326 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.413 ' HA ' ' CD ' ' A' ' 123' ' ' ARG . 5.0 m -53.19 -37.53 62.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.17 0.509 . . . . 1.4099999999999999 110.671 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -63.63 -34.37 77.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.674 -0.694 . . . . 2.21 111.613 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.37 -19.57 49.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 120.194 -0.602 . . . . 0.90000000000000002 110.095 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 55.3 mtt180 -71.74 -31.34 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.509 -0.923 . . . . 2.0299999999999998 108.509 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.67 -49.75 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.834 -1.075 . . . . 2.8399999999999999 111.013 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -128.98 84.42 63.13 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 121.217 0.532 . . . . 2.1899999999999999 111.583 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 50.9 Cg_exo -56.13 118.32 5.1 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.505 2.136 . . . . 1.24 111.304 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -67.39 163.19 35.59 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.898 2.399 . . . . 1.1899999999999999 111.753 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -57.49 -32.58 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.137 0.494 . . . . 2.1600000000000001 110.825 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 68.2 mmtt -114.71 114.72 44.37 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.772 -0.649 . . . . 1.96 109.341 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.567 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 16.8 Cg_endo -56.61 150.13 54.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.803 2.335 . . . . 0.70999999999999996 112.428 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 6.9 t0 -109.97 96.7 6.41 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.838 -0.619 . . . . 1.28 109.554 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.499 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 47.1 m-85 -65.5 -23.84 66.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.377 -0.829 . . . . 0.5 111.915 -171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.3 p -79.95 -8.81 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.839 0.352 . . . . 1.46 111.782 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -110.41 -10.01 14.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.768 -0.827 . . . . 1.8700000000000001 108.768 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.5 tp -79.51 131.99 36.2 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 110.458 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.934 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.2 tm0? -101.71 130.66 48.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.677 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.71 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 61.1 mtp85 -96.42 104.75 16.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.115 -0.493 . . . . 2.8199999999999998 110.602 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.638 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 1.7 t-20 -100.56 90.17 4.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.149 -0.686 . . . . 0.83999999999999997 109.149 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.61 HG21 HG11 ' A' ' 11' ' ' VAL . 36.7 mt -77.13 101.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.223 -0.899 . . . . 0.47999999999999998 109.479 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.6 mt -73.42 82.92 1.45 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.375 -0.829 . . . . 0.98999999999999999 110.404 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.18 -15.97 63.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.474 -0.784 . . . . 0.55000000000000004 110.628 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.52 -10.75 60.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 1.4199999999999999 110.314 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.53 80.11 22.32 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.343 -0.39 . . . . 1.9099999999999999 110.361 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -93.26 106.46 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.192 2.595 . . . . 0.66000000000000003 112.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.86 92.12 7.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.303 -0.629 . . . . 3.1499999999999999 109.303 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.59 104.59 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 1.1399999999999999 111.104 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 m -105.03 109.04 20.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.746 -0.464 . . . . 0.56000000000000005 109.746 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -103.62 144.07 31.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.425 0.631 . . . . 3.0 110.441 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -113.9 130.38 56.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.861 -1.063 . . . . 0.46000000000000002 109.456 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -79.47 109.98 14.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.21 -0.663 . . . . 3.1400000000000001 109.21 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.7 pt -121.88 179.02 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.256 -0.646 . . . . 0.64000000000000001 109.256 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.656 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 5.2 p-10 -102.83 110.59 22.57 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.653 0.739 . . . . 1.78 109.848 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB3' ' HG2' ' A' ' 3' ' ' LYS . 15.9 m95 -77.94 -28.17 49.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.286 -0.87 . . . . 0.87 108.687 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 130.53 35.26 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.219 -1.4 . . . . 2.3199999999999998 107.219 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.77 83.15 4.93 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.55 0.69 . . . . 2.4900000000000002 110.021 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-N 114.915 -1.039 . . . . 2.5699999999999998 109.567 -178.381 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 111.765 0.283 . . . . 2.96 111.765 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.88 -84.63 0.41 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.416 -0.514 . . . . 1.48 111.209 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.6 -19.22 19.94 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.756 -0.378 . . . . 0.97999999999999998 111.352 -177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG23 HD21 ' A' ' 34' ' ' LEU . 2.4 t -135.9 136.12 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.647 -0.501 . . . . 0.45000000000000001 109.647 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -145.71 112.29 5.88 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.056 -0.52 . . . . 1.3899999999999999 109.879 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.3 m -67.71 153.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 1.3200000000000001 110.372 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -133.94 -56.06 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.32 -0.4 . . . . 0.95999999999999996 110.654 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.769 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.5 t30 -101.97 114.67 28.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 1.47 110.273 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -131.75 107.69 13.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.18 -0.674 . . . . 1.01 109.18 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.46 151.68 32.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.125 0.488 . . . . 1.54 111.553 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.78 143.36 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.391 -0.966 . . . . 0.91000000000000003 108.391 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 25' ' ' GLU . 3.6 mp -116.82 -35.23 4.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 1.1799999999999999 111.949 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 8.1 p-10 -82.14 -3.55 55.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.944 -0.571 . . . . 2.73 111.802 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.3 p-10 -86.4 136.31 35.51 Favored Pre-proline 0 C--N 1.32 -0.716 0 O-C-N 121.782 -0.574 . . . . 1.8799999999999999 110.701 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 4.5 Cg_endo -92.99 144.9 10.45 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 124.446 -1.064 . . . . 0.59999999999999998 112.606 -9.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 71.0 m -153.96 165.89 16.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.105 -0.702 . . . . 0.77000000000000002 109.105 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 80.8 Cg_exo -49.92 154.41 5.17 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.883 2.389 . . . . 0.82999999999999996 113.477 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.683 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 24.3 t80 -58.16 -38.43 76.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 112.444 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.579 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 42.3 m-85 -73.06 -7.04 49.51 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.84 0.352 . . . . 0.65000000000000002 111.862 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.675 ' ND2' HH21 ' A' ' 137' ' ' ARG . 0.0 OUTLIER -76.71 137.24 66.73 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.114 -0.699 . . . . 2.0699999999999998 109.114 173.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 11.7 Cg_exo -69.97 133.47 25.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.706 2.27 . . . . 0.62 113.422 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 90.2 m-85 -54.78 113.22 1.24 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.15 -0.932 . . . . 0.57999999999999996 109.721 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 13' ' ' ASP . 7.5 tt0 -112.56 101.87 9.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.273 0.558 . . . . 1.4099999999999999 111.001 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 98.4 m-85 -112.46 140.39 47.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.735 -0.666 . . . . 0.5 111.149 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.3 tt0 -105.73 98.99 8.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.751 -0.833 . . . . 1.98 108.751 174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 97' ' ' ILE . 68.9 mt -97.44 116.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.693 -0.685 . . . . 0.35999999999999999 111.2 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 12.0 m -115.18 107.09 14.85 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.702 -0.681 . . . . 0.46000000000000002 110.197 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -117.91 139.28 51.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.761 -0.654 . . . . 0.28000000000000003 109.848 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.869 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.5 tt0 -102.87 116.67 33.01 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.105 0.479 . . . . 0.77000000000000002 110.334 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.4 m -79.0 110.02 13.85 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.639 -0.709 . . . . 0.51000000000000001 109.463 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.8 mt -77.24 -21.36 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.548 0.69 . . . . 0.56999999999999995 109.297 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 43.6 mt-10 -141.81 175.69 9.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.812 -1.085 . . . . 1.8300000000000001 109.189 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -90.48 122.33 33.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.009 0.433 . . . . 2.1800000000000002 110.063 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HG23 ' A' ' 4' ' ' VAL . 4.0 mm? -72.49 131.77 42.98 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.833 -0.621 . . . . 1.52 110.644 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -99.78 14.7 29.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.342 0.591 . . . . 1.55 110.619 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 30.8 tt0 -150.46 165.01 34.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.906 -0.776 . . . . 2.9500000000000002 108.906 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.25 125.03 26.31 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.012 -0.366 . . . . 1.8799999999999999 110.012 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -82.51 118.5 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.485 -0.932 . . . . 1.3200000000000001 108.485 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.8 tt0 -94.65 104.35 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.147 0.498 . . . . 0.92000000000000004 111.003 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' SER . 87.1 m95 -88.7 110.14 20.73 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.535 -0.913 . . . . 0.42999999999999999 108.535 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 28.3 ttmt -122.05 131.53 54.03 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.815 -0.354 . . . . 1.23 110.76 -171.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 97' ' ' ILE . 10.0 mt -104.0 107.96 23.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.46000000000000002 110.032 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.674 ' HB ' HD11 ' A' ' 96' ' ' LEU . 69.2 mt -100.43 111.81 31.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.266 -0.879 . . . . 0.68999999999999995 109.201 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.589 ' HE1' HG11 ' A' ' 113' ' ' VAL . 77.3 t80 -92.65 126.82 37.91 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.014 -0.736 . . . . 0.58999999999999997 109.014 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 94' ' ' VAL . 96.4 t -56.52 114.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.392 . . . . 0.37 110.116 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.09 -53.98 30.3 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.481 -0.866 . . . . 0.46999999999999997 111.499 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 50' ' ' SER . 40.0 t -142.58 149.36 38.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.01 0.434 . . . . 1.23 111.71 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.35 21.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.506 -0.924 . . . . 0.81999999999999995 108.506 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 37.4 tt0 -70.23 -46.86 63.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.336 -1.302 . . . . 1.99 109.706 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 47' ' ' SER . 48.7 m -139.49 98.68 3.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.331 -0.618 . . . . 1.72 109.331 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.9 pt-20 -69.68 -7.36 38.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.095 -0.502 . . . . 2.0899999999999999 111.828 -171.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.63 0.0 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.113 0.482 . . . . 2.8300000000000001 110.63 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 22.0 m-30 -89.56 9.1 27.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.594 . . . . 1.48 110.14 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -57.01 129.07 40.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.036 -0.529 . . . . 1.22 110.273 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.18 146.47 46.74 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.725 -0.671 . . . . 1.8500000000000001 111.652 -171.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.3 t -95.57 111.55 26.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.302 -0.863 . . . . 1.0800000000000001 109.566 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.2 mt -69.07 -60.1 2.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.012 -0.54 . . . . 1.05 110.439 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -158.6 160.44 36.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.436 -0.802 . . . . 1.3100000000000001 109.444 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.5 p -138.28 121.57 17.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.242 0.544 . . . . 1.0900000000000001 110.128 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.75 115.07 44.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 1.22 110.179 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.2 mm? -98.4 134.52 41.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.808 -0.633 . . . . 1.3400000000000001 110.141 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.19 102.13 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.063 -0.655 . . . . 0.71999999999999997 109.807 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.77 118.34 5.75 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.796 -1.002 . . . . 0.41999999999999998 112.173 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 42.9 Cg_endo -99.82 167.97 9.29 Favored 'Cis proline' 0 N--CA 1.452 -0.965 0 CA-C-N 120.915 2.357 . . . . 0.55000000000000004 110.597 -11.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -104.13 104.69 45.24 Favored Pre-proline 0 C--N 1.314 -0.952 0 C-N-CA 120.462 -0.495 . . . . 0.94999999999999996 110.493 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -81.33 154.52 18.77 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.9 2.4 . . . . 0.69999999999999996 113.242 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.14 131.96 37.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.213 -0.903 . . . . 0.40999999999999998 111.737 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.81 154.84 6.68 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.3 -0.864 . . . . 0.33000000000000002 110.973 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.869 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.8 ttp180 -85.72 109.14 18.41 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.223 0.535 . . . . 2.7799999999999998 110.65 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -97.72 147.39 24.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.435 -0.802 . . . . 0.62 110.043 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.4 ttm -125.41 111.57 15.28 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.852 -0.425 . . . . 1.8 109.852 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -127.53 149.34 50.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.906 0.384 . . . . 0.37 110.175 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.13 122.74 50.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.045 -0.525 . . . . 1.1200000000000001 109.967 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -100.15 128.69 46.19 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 26.3 mt-30 -137.42 126.34 24.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.164 0.507 . . . . 1.1399999999999999 111.179 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.02 124.82 19.69 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.56000000000000005 109.66 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 7.6 p-10 -78.04 -170.56 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.057 0.391 . . . . 2.1299999999999999 112.057 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -47.45 125.21 9.61 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 113.219 0.822 . . . . 0.46000000000000002 113.219 -171.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 28.7 Cg_exo -62.93 175.69 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.139 2.559 . . . . 0.53000000000000003 112.125 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.3 t-20 -70.63 114.37 25.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.742 -0.663 . . . . 2.1899999999999999 110.026 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 13.4 Cg_exo -72.29 -6.7 19.59 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.537 2.825 . . . . 0.54000000000000004 112.729 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.52 -17.87 50.87 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.365 -0.694 . . . . 0.51000000000000001 111.365 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 mt -89.15 -30.35 18.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.456 0.17 . . . . 1.6000000000000001 110.548 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 37.0 mt -81.16 112.59 34.17 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 109.815 -0.439 . . . . 0.52000000000000002 109.815 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 18.7 Cg_exo -70.28 161.99 43.99 Favored 'Trans proline' 0 CA--C 1.517 -0.343 0 C-N-CA 123.652 2.902 . . . . 0.81000000000000005 112.446 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 23.6 m-20 -57.6 -40.36 78.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.652 -0.704 . . . . 2.29 111.348 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.66 -37.76 62.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 1.25 111.492 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.833 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 75.1 m-20 -81.64 -24.73 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.9399999999999999 111.702 -174.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -65.21 -46.49 80.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.119 0.485 . . . . 0.54000000000000004 110.315 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 13.0 t -95.14 40.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.635 0.731 . . . . 0.56000000000000005 109.121 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.02 -139.45 2.95 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.656 -0.783 . . . . 0.62 112.963 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.06 132.07 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.972 0.415 . . . . 1.23 111.087 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.42 168.23 20.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 45' ' ' VAL . 42.1 t -117.99 140.9 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.113 -0.329 . . . . 0.35999999999999999 110.113 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.66 112.97 40.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.703 -0.851 . . . . 0.59999999999999998 108.703 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.9 pp -117.31 138.58 51.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.815 0.817 . . . . 1.21 112.644 -171.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.547 HG12 HG12 ' A' ' 42' ' ' ILE . 56.7 mt -104.59 107.72 23.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.318 -1.31 . . . . 0.33000000000000002 108.937 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -107.12 145.43 32.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.587 -0.733 . . . . 1.4199999999999999 109.721 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 57.8 m -113.36 117.32 31.46 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.976 -0.556 . . . . 1.3200000000000001 110.717 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 25.2 m -101.03 124.72 47.18 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.649 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 65.2 t80 -141.57 128.74 20.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.102 -0.703 . . . . 0.72999999999999998 109.102 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.565 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 34.0 mmt180 66.75 14.7 9.9 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.815 0.446 . . . . 2.4500000000000002 110.734 -175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.63 79.52 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.077 -0.809 . . . . 0.56999999999999995 111.077 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -129.72 134.77 47.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.118 -0.697 . . . . 1.3100000000000001 109.118 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 31.0 mt-10 -97.41 131.99 43.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.657 -0.247 . . . . 1.5900000000000001 110.5 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' HG12 ' A' ' 151' ' ' ILE . 31.1 p90 -111.85 -10.88 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.811 0.671 . . . . 0.31 112.811 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.1 tt -154.58 151.33 10.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 121.991 -0.443 . . . . 0.37 110.665 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' ILE . 40.3 ttp180 -144.16 115.66 8.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.964 -0.562 . . . . 1.1399999999999999 110.258 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 54.8 t -92.89 104.14 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 0.38 110.359 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.98 102.85 2.3 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 0.27000000000000002 112.813 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -94.27 134.91 36.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.478 . . . . 0.40000000000000002 109.708 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.4 112.24 20.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.376 0.608 . . . . 0.78000000000000003 110.293 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.6 p -97.57 128.75 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 1.1899999999999999 110.61 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.03 124.55 50.34 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.739 -0.664 . . . . 1.6299999999999999 109.478 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -116.51 123.87 48.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.925 0.393 . . . . 0.94999999999999996 110.528 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.39 158.52 43.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 1.97 109.465 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.63 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 93.7 m-85 -63.86 153.67 36.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.946 0.403 . . . . 0.68999999999999995 111.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.679 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.1 p -89.65 -41.23 12.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.766 -0.652 . . . . 0.83999999999999997 111.102 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.0 mt-10 -80.39 136.08 36.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.427 -0.806 . . . . 2.2400000000000002 110.537 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 17.9 m -52.52 -46.04 66.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.307 -0.86 . . . . 1.4099999999999999 112.031 -172.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 41.3 tt0 -61.66 -38.92 89.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 2.21 111.013 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.8 -30.03 65.08 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.90000000000000002 110.457 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 50.6 mtp180 -69.44 -32.42 71.36 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.362 -0.607 . . . . 2.0299999999999998 109.362 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 120' ' ' THR . 50.8 mt-10 -69.36 -46.49 66.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.406 -0.816 . . . . 2.8399999999999999 110.763 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.76 103.09 12.18 Favored Pre-proline 0 N--CA 1.453 -0.293 0 C-N-CA 120.897 -0.321 . . . . 2.1899999999999999 111.632 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -59.05 116.34 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.037 1.824 . . . . 1.24 110.451 165.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.0 Cg_exo -55.66 166.4 2.78 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.331 2.688 . . . . 1.1899999999999999 112.539 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.7 p -39.61 -34.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.417 0.687 . . . . 2.1600000000000001 112.362 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -135.78 130.45 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.764 -0.828 . . . . 1.96 108.764 167.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.658 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 10.6 Cg_endo -50.71 146.42 20.55 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.385 2.723 . . . . 0.70999999999999996 112.956 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 135' ' ' LEU . 12.9 t70 -114.82 115.93 27.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.547 -0.751 . . . . 1.28 110.494 -170.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 25.9 m-85 -78.6 -18.33 54.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.816 -0.629 . . . . 0.5 111.391 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -77.16 -30.94 55.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 1.46 111.032 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -93.55 3.5 55.43 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.617 0.722 . . . . 1.8700000000000001 109.473 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 131' ' ' ASP . 1.4 tp -86.61 131.77 34.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.522 -1.217 . . . . 0.79000000000000004 111.708 -171.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.679 ' HB2' HG23 ' A' ' 118' ' ' THR . 1.6 tm0? -97.65 119.93 37.12 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.276 -1.329 . . . . 1.6299999999999999 108.317 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.943 HH11 HG13 ' A' ' 139' ' ' ILE . 10.6 ttp85 -92.45 112.95 25.08 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.185 -0.461 . . . . 2.8199999999999998 109.877 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -108.97 100.68 9.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.704 -0.48 . . . . 0.83999999999999997 109.704 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.943 HG13 HH11 ' A' ' 137' ' ' ARG . 60.1 mt -79.25 111.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.693 -0.685 . . . . 0.47999999999999998 109.378 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.44 87.08 2.59 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.783 -0.644 . . . . 0.98999999999999999 110.543 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -7.28 50.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.516 -0.766 . . . . 0.55000000000000004 110.492 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t -79.62 -14.34 58.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.719 . . . . 1.4199999999999999 110.022 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -125.57 85.53 58.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.717 -0.475 . . . . 1.9099999999999999 109.717 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -92.2 108.26 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.362 2.708 . . . . 0.66000000000000003 112.2 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HE ' ' HA ' ' A' ' 145' ' ' ARG . 4.2 tpm_? -81.66 87.68 6.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 3.1499999999999999 109.363 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.4 t -91.91 103.86 14.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 109.925 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 m -114.06 108.56 17.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.875 -0.602 . . . . 0.56000000000000005 110.003 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 22.8 ptt180 -100.59 141.92 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.216 0.531 . . . . 3.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.21 158.91 19.11 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.343 -0.844 . . . . 0.46000000000000002 109.915 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -99.61 116.33 31.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.912 -0.403 . . . . 3.1400000000000001 109.912 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.7 pt -127.24 -175.67 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.227 -0.442 . . . . 0.64000000000000001 110.28 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -114.85 114.27 25.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.616 0.722 . . . . 1.78 109.8 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -79.94 -22.26 42.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.413 -0.812 . . . . 0.87 109.386 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.55 160.05 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.588 -1.187 . . . . 2.3199999999999998 108.133 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.45 75.97 9.1 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.272 0.558 . . . . 2.4900000000000002 110.357 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.205 -0.902 . . . . 2.5699999999999998 109.898 178.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' SD ' ' HD2' ' A' ' 150' ' ' HIS . 8.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.365 0.126 . . . . 2.96 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -64.2 107.99 1.45 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.139 0.495 . . . . 1.48 110.788 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.751 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 9.9 mttm -98.12 -8.89 26.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.614 -0.721 . . . . 0.97999999999999998 110.039 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.503 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -142.98 117.81 4.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.316 -0.856 . . . . 0.45000000000000001 109.05 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -128.12 112.79 14.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.528 -0.545 . . . . 1.3899999999999999 109.528 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.5 m -68.47 144.87 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.637 -0.505 . . . . 1.3200000000000001 109.637 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -127.45 -60.39 1.19 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.278 0.561 . . . . 0.95999999999999996 110.024 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.791 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.3 t30 -101.26 112.27 24.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.476 -0.784 . . . . 1.47 109.953 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.18 109.43 21.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.521 0.677 . . . . 1.01 109.701 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 99.4 t -100.47 116.53 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.507 -0.769 . . . . 1.54 110.524 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' CG1' HD12 ' A' ' 139' ' ' ILE . 44.9 t -87.57 116.95 30.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.219 -0.66 . . . . 0.91000000000000003 109.219 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 mp -103.08 146.91 27.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.313 0.578 . . . . 1.1799999999999999 110.984 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.16 34.32 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.461 -1.245 . . . . 2.73 111.243 171.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.7 p-10 -108.72 126.15 30.1 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.035 -0.53 . . . . 1.8799999999999999 109.846 168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -90.88 147.14 17.06 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.157 -1.184 . . . . 0.59999999999999998 113.127 -3.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.643 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -153.17 164.06 21.59 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.229 -1.026 . . . . 0.77000000000000002 108.229 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.3 Cg_endo -50.72 141.02 36.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.727 2.285 . . . . 0.82999999999999996 112.994 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 7.8 t80 -46.71 -34.13 4.89 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.031 -0.986 . . . . 0.40999999999999998 112.974 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 30.4 m-85 -80.31 1.91 26.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.9 0.381 . . . . 0.65000000000000002 111.642 -177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.2 127.74 41.36 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.099 -0.704 . . . . 2.0699999999999998 109.099 173.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -58.53 145.54 94.42 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.265 2.643 . . . . 0.62 113.428 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -68.99 109.47 3.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.859 -0.609 . . . . 0.57999999999999996 109.505 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.756 HE21 ' HB2' ' A' ' 12' ' ' LEU . 2.8 mt-30 -97.64 110.9 23.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.055 -0.52 . . . . 1.4099999999999999 109.938 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -115.72 122.35 45.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.169 -0.468 . . . . 0.5 110.662 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -95.79 98.24 10.29 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.624 -1.25 . . . . 1.98 107.624 174.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.09 106.59 19.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.491 -0.777 . . . . 0.35999999999999999 111.995 -171.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 38.8 m -102.82 106.32 16.89 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.46000000000000002 109.53 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.9 p90 -118.23 139.36 51.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.086 0.47 . . . . 0.28000000000000003 110.233 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.3 tt0 -103.61 114.95 29.61 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.726 -0.67 . . . . 0.77000000000000002 110.225 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.7 m -76.05 110.02 10.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.661 -0.7 . . . . 0.51000000000000001 109.372 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mt -75.97 -25.21 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.56999999999999995 109.421 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.751 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 64.2 mt-10 -138.32 177.56 7.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.9 -1.045 . . . . 1.8300000000000001 109.157 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.36 134.51 34.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.833 0.349 . . . . 2.1800000000000002 110.403 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 4' ' ' VAL . 9.7 mp -89.82 131.74 35.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.733 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 m -85.53 -32.44 22.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.139 0.495 . . . . 1.55 110.437 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 37' ' ' ASP . 35.3 tt0 -101.44 171.21 7.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.804 -0.635 . . . . 2.9500000000000002 109.719 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 5.9 p-10 -82.53 146.29 29.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.846 0.355 . . . . 1.8799999999999999 110.581 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -98.39 119.83 37.77 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.844 -0.428 . . . . 1.3200000000000001 109.844 -178.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.3 tt0 -96.35 114.78 26.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.887 0.375 . . . . 0.92000000000000004 110.947 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' SER . 71.2 m95 -95.33 111.98 23.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.73 -0.668 . . . . 0.42999999999999999 109.341 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 12.7 mttp -113.0 136.72 52.38 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.9 0.381 . . . . 1.23 111.326 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 97' ' ' ILE . 8.6 mt -104.69 102.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.075 -0.713 . . . . 0.46000000000000002 109.075 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.7 mt -91.82 128.03 43.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.68999999999999995 109.544 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -105.42 130.95 53.4 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.771 -0.65 . . . . 0.58999999999999997 109.878 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' HB ' ' A' ' 94' ' ' VAL . 94.4 t -62.21 112.64 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.31 -50.59 58.9 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.079 -1.057 . . . . 0.46999999999999997 111.349 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 30.2 t -144.77 137.24 26.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 110.454 -0.202 . . . . 1.23 110.454 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.59 -17.87 46.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.744 . . . . 0.81999999999999995 108.99 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 33.8 tt0 -70.92 -40.42 72.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 1.99 109.248 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 47.4 t -148.32 109.21 4.25 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 170.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.44 1.47 11.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.0899999999999999 111.373 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.5 -13.16 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.373 0.606 . . . . 2.8300000000000001 110.005 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.61 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 14.7 m-30 -90.69 13.35 16.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.222 -0.899 . . . . 1.48 110.288 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 11.2 p-10 -58.7 145.18 41.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.578 -0.737 . . . . 1.22 110.791 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -136.22 162.44 32.95 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.925 -0.579 . . . . 1.8500000000000001 110.506 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -109.12 115.22 48.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.35 -0.611 . . . . 1.0800000000000001 109.35 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 44.9 mt -70.51 -53.0 17.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.141 -0.481 . . . . 1.05 111.545 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -163.35 157.65 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.304 -0.407 . . . . 1.3100000000000001 110.052 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.541 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 54.1 p -135.38 118.56 16.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 110.397 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -110.43 116.98 53.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.035 -0.529 . . . . 1.22 110.047 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 6.1 mp -111.28 131.57 55.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 1.3400000000000001 111.064 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.14 103.84 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.246 0.546 . . . . 0.71999999999999997 109.768 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.67 117.41 5.49 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.946 -0.919 . . . . 0.41999999999999998 112.939 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 71.6 Cg_endo -102.1 166.49 6.88 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 CA-C-N 120.632 2.216 . . . . 0.55000000000000004 110.457 -14.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -105.69 111.38 64.71 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 120.294 -0.563 . . . . 0.94999999999999996 110.529 -178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -79.54 157.52 25.24 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.147 2.565 . . . . 0.69999999999999996 112.861 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.28 133.89 44.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.221 -0.9 . . . . 0.40999999999999998 111.457 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 137.43 162.94 9.5 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.492 -0.776 . . . . 0.33000000000000002 111.389 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 26.8 ttp180 -84.14 118.56 24.2 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.892 0.377 . . . . 2.7799999999999998 110.492 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -111.59 143.38 42.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.62 109.693 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 ttt -123.54 106.54 10.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.242 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -137.18 150.52 47.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.924 0.392 . . . . 0.37 110.618 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.96 131.79 45.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.482 0.658 . . . . 1.1200000000000001 111.241 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -109.47 129.28 55.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.057 -1.09 . . . . 0.44 108.057 176.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 44.6 mt-30 -129.87 128.4 42.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.992 0.425 . . . . 1.1399999999999999 110.355 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -122.81 130.71 53.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.534 -0.757 . . . . 0.56000000000000005 110.0 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.21 -173.69 1.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.456 -0.338 . . . . 2.1299999999999999 110.832 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -70.52 127.4 92.06 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 116.596 -0.275 . . . . 0.46000000000000002 110.967 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.2 Cg_exo -55.57 162.94 5.71 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.198 2.599 . . . . 0.53000000000000003 112.387 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' CB ' HD13 ' A' ' 83' ' ' LEU . 45.8 m-80 -64.76 116.9 33.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.019 -0.537 . . . . 2.1899999999999999 110.445 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.05 -15.7 39.95 Favored 'Trans proline' 0 N--CA 1.466 -0.115 0 C-N-CA 122.81 2.34 . . . . 0.54000000000000004 112.353 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.32 -7.13 73.31 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.321 -0.712 . . . . 0.51000000000000001 111.321 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.8 mp -98.44 -24.56 15.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.641 -0.279 . . . . 1.6000000000000001 110.517 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 89' ' ' ALA . 45.2 mt -81.99 127.98 69.98 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.823 0.344 . . . . 0.52000000000000002 110.418 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 9.2 Cg_endo -53.89 146.06 48.24 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.201 3.268 . . . . 0.81000000000000005 113.825 -175.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.99 -38.01 89.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.159 -0.928 . . . . 2.29 111.061 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.56 -24.87 15.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.071 0.397 . . . . 1.25 112.071 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.779 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.7 t70 -99.22 -11.17 21.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.981 0.363 . . . . 1.9399999999999999 111.981 -172.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -61.47 -22.2 64.86 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.939 0.399 . . . . 0.54000000000000004 111.481 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.12 40.11 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.106 0.479 . . . . 0.56000000000000005 109.8 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.39 -127.29 2.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.56 -0.829 . . . . 0.62 113.156 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.67 128.56 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.398 0.618 . . . . 1.23 110.742 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.5 m -130.26 131.51 45.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.923 -0.58 . . . . 0.63 109.665 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 45' ' ' VAL . 39.4 t -86.6 137.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.15 0.5 . . . . 0.35999999999999999 111.469 -177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 117.01 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.973 -1.121 . . . . 0.59999999999999998 107.973 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -122.73 129.0 51.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.346 0.593 . . . . 1.21 112.028 -169.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.6 HG12 HG12 ' A' ' 42' ' ' ILE . 72.3 mt -95.1 110.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.093 -0.958 . . . . 0.33000000000000002 109.453 174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -111.85 136.17 51.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.013 -0.54 . . . . 1.4199999999999999 109.816 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 38' ' ' LEU . 60.8 m -106.66 124.29 49.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.121 -0.491 . . . . 1.3200000000000001 110.091 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.4 m -107.37 123.51 48.47 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.463 -0.789 . . . . 0.5 110.388 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.604 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 24.0 t80 -137.16 129.91 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.182 -0.673 . . . . 0.72999999999999998 109.182 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.453 HH12 ' HB2' ' A' ' 155' ' ' ASP . 21.2 mmm-85 63.73 14.68 8.41 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.336 0.654 . . . . 2.4500000000000002 111.484 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.98 11.03 70.84 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.683 -0.77 . . . . 0.56999999999999995 111.697 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 152' ' ' ASN . 25.6 mt-30 -129.56 144.84 51.45 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.51 -0.552 . . . . 1.3100000000000001 109.51 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -100.26 130.67 46.41 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.819 0.343 . . . . 1.5900000000000001 111.066 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 36.3 p90 -109.77 -8.73 14.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.31 112.344 -172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.7 tt -154.81 147.58 13.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 122.184 -0.323 . . . . 0.37 110.368 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -144.22 112.0 6.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.803 -0.635 . . . . 1.1399999999999999 110.084 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 50.2 t -91.54 103.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.97 -0.559 . . . . 0.38 110.095 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -97.19 101.97 2.66 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.003 -0.618 . . . . 0.27000000000000002 112.352 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.59 136.77 35.56 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.826 -0.435 . . . . 0.40000000000000002 109.826 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' HD13 ' A' ' 140' ' ' LEU . 78.9 m-85 -94.75 118.58 31.98 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.564 -0.532 . . . . 0.78000000000000003 109.564 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 138' ' ' ASN . 75.6 t -97.25 125.01 50.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.886 -0.597 . . . . 1.1899999999999999 110.671 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HD11 ' A' ' 140' ' ' LEU . 2.3 m120 -95.75 107.36 19.58 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.55 -0.537 . . . . 1.6299999999999999 109.55 174.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -93.58 108.78 20.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.94999999999999996 110.371 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.484 -0.78 . . . . 1.97 109.786 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 65.3 m-85 -63.34 154.25 32.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.461 . . . . 0.68999999999999995 111.423 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.754 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.0 OUTLIER -89.59 -22.23 22.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.755 0.788 . . . . 0.83999999999999997 109.349 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.48 124.36 27.8 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.479 -1.237 . . . . 2.2400000000000002 109.665 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.9 m -55.56 -38.57 69.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 1.4099999999999999 109.961 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.51 -44.87 96.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 2.21 110.794 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 79.3 mt -76.56 -20.86 56.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.614 -0.434 . . . . 0.90000000000000002 110.482 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.43 -33.92 71.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.176 0.512 . . . . 2.0299999999999998 109.72 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 120' ' ' THR . 20.3 mm-40 -75.24 -32.72 61.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.365 -0.834 . . . . 2.8399999999999999 110.806 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -149.57 95.96 3.68 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 2.1899999999999999 111.812 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.5 Cg_exo -57.82 122.94 12.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.089 1.86 . . . . 1.24 110.507 168.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 30.5 Cg_exo -65.08 163.71 27.78 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 122.932 2.422 . . . . 1.1899999999999999 111.441 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.1 p -52.77 -33.22 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.068 0.461 . . . . 2.1600000000000001 111.001 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -117.66 129.95 25.01 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.846 -0.798 . . . . 1.96 108.846 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.1 Cg_endo -60.68 148.42 91.67 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.372 2.048 . . . . 0.70999999999999996 111.937 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.6 t70 -109.73 100.12 9.18 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.718 -0.674 . . . . 1.28 109.656 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.422 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 94.8 m-85 -72.99 -16.1 61.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.5 111.039 -175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.1 m -79.28 -22.83 44.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.247 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -113.03 -1.46 14.45 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.709 0.766 . . . . 1.8700000000000001 109.15 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 17.0 tp -78.27 123.87 27.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.79000000000000004 109.801 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.754 ' HB2' HG23 ' A' ' 118' ' ' THR . 6.7 tt0 -95.01 137.37 34.15 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.21 0.528 . . . . 1.6299999999999999 109.947 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.695 ' HD2' ' O ' ' A' ' 137' ' ' ARG . 2.3 tmm_? -98.75 106.58 18.86 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.002 -0.999 . . . . 2.8199999999999998 109.016 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 48.8 t30 -100.03 138.4 37.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.211 -0.663 . . . . 0.83999999999999997 109.211 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.621 ' CG1' ' HD3' ' A' ' 137' ' ' ARG . 5.9 mt -114.36 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 C-N-CA 120.648 -0.421 . . . . 0.47999999999999998 110.029 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 140' ' ' LEU . 6.6 mp -67.04 88.29 0.16 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.742 -0.663 . . . . 0.98999999999999999 110.541 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.32 -11.33 59.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.731 -0.668 . . . . 0.55000000000000004 109.313 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.6 m -70.92 -32.2 69.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.938 -1.028 . . . . 1.4199999999999999 110.301 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -125.41 85.21 58.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 1.9099999999999999 110.194 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -93.05 130.3 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.319 2.679 . . . . 0.66000000000000003 112.843 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -84.46 89.56 7.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 3.1499999999999999 109.828 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.33 112.64 28.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.698 -0.482 . . . . 1.1399999999999999 109.698 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.7 m -135.44 114.01 11.72 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.195 -0.457 . . . . 0.56000000000000005 110.368 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 34.9 ptt180 -105.25 141.1 37.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.241 -0.584 . . . . 3.0 109.581 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -106.98 146.64 30.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.391 -0.822 . . . . 0.46000000000000002 110.568 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.522 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 22.0 t-160 -83.82 115.47 22.26 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.3 -0.63 . . . . 3.1400000000000001 109.3 174.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.2 pt -137.7 -173.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.64000000000000001 110.441 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.424 ' H ' ' NE2' ' A' ' 104' ' ' GLN . 15.5 t30 -106.8 107.76 18.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.966 -1.015 . . . . 1.78 110.075 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.639 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 16.1 m95 -84.64 -20.86 30.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.625 0.726 . . . . 0.87 109.335 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 9.6 mm-40 -88.7 -172.08 3.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.75 -1.113 . . . . 2.3199999999999998 109.744 -170.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.453 ' HB2' HH12 ' A' ' 102' ' ' ARG . 22.4 t70 -116.02 79.04 1.25 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 2.4900000000000002 110.43 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 7.3 p30 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.375 -0.829 . . . . 2.5699999999999998 109.416 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ppp? . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.807 0.337 . . . . 2.96 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 139.89 30.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.323 -0.398 . . . . 1.48 110.508 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.561 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU . 9.2 mmpt? -79.53 -16.25 56.3 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.27 -0.641 . . . . 0.97999999999999998 109.27 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.681 HG23 HD11 ' A' ' 34' ' ' LEU . 2.4 t -137.39 127.69 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.681 -0.69 . . . . 0.45000000000000001 109.731 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -126.6 107.49 10.25 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.913 -0.585 . . . . 1.3899999999999999 109.694 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 11.3 m -69.68 149.6 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.515 -0.55 . . . . 1.3200000000000001 109.515 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -132.57 -61.62 0.85 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.126 0.488 . . . . 0.95999999999999996 110.453 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.67 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.15 130.86 48.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.622 -0.717 . . . . 1.47 109.672 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 p -140.09 103.97 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.862 0.839 . . . . 1.01 109.842 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 48.8 t -96.6 123.13 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.323 -0.853 . . . . 1.54 111.548 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.55 122.0 46.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.048 -0.723 . . . . 0.91000000000000003 109.048 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.986 HD11 ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp -112.67 161.58 16.68 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.402 -0.519 . . . . 1.1799999999999999 111.657 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 75.2 0.98 3.62 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 114.272 -1.331 . . . . 2.73 111.893 169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 20.1 p-10 -87.82 135.26 33.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 110.05 -0.352 . . . . 1.8799999999999999 110.05 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 34.3 Cg_endo -95.24 144.77 7.62 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.216 -1.16 . . . . 0.59999999999999998 112.998 -3.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 75.5 m -153.83 164.28 21.15 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.77000000000000002 109.831 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 80.2 Cg_exo -45.82 135.9 13.43 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.805 2.336 . . . . 0.82999999999999996 112.391 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 7.1 t80 -50.7 -21.7 1.73 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.974 1.101 . . . . 0.40999999999999998 113.974 -172.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.9 m-85 -80.43 7.07 10.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.168 -0.333 . . . . 0.65000000000000002 111.707 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -81.01 149.51 66.83 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.694 -0.484 . . . . 2.0699999999999998 109.694 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.89 139.72 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.408 2.072 . . . . 0.62 111.971 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 48.7 m-85 -65.9 104.52 1.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.915 -0.772 . . . . 0.57999999999999996 108.915 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.53 ' HB3' HD13 ' A' ' 12' ' ' LEU . 8.4 mt-30 -95.34 110.25 22.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.937 -0.574 . . . . 1.4099999999999999 110.183 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 86.6 m-85 -121.31 116.13 24.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.886 0.374 . . . . 0.5 110.684 176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.986 ' HG3' HD11 ' A' ' 12' ' ' LEU . 63.9 mt-10 -94.47 93.71 7.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.653 -0.869 . . . . 1.98 108.653 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.4 mt -94.24 115.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.064 -0.971 . . . . 0.35999999999999999 111.217 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 25.1 m -109.55 106.83 16.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.432 -0.803 . . . . 0.46000000000000002 109.646 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -122.18 136.75 54.95 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.28000000000000003 110.101 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -106.98 113.96 27.75 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.718 -0.674 . . . . 0.77000000000000002 110.886 -174.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 40.4 m -75.48 112.47 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.522 -0.763 . . . . 0.51000000000000001 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.22 -29.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.715 -0.846 . . . . 0.56999999999999995 108.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' CD ' ' HZ3' ' A' ' 3' ' ' LYS . 39.7 mt-10 -137.16 161.23 36.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.171 -1.377 . . . . 1.8300000000000001 108.228 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -83.51 137.39 33.89 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.509 -0.477 . . . . 2.1800000000000002 109.842 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD11 HG23 ' A' ' 4' ' ' VAL . 7.3 mp -87.13 140.59 29.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 1.52 110.182 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 m -101.19 -14.71 17.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.55 110.637 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -112.9 168.63 9.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.432 -0.581 . . . . 2.9500000000000002 109.432 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -77.28 147.17 36.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.883 0.373 . . . . 1.8799999999999999 110.065 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 15.9 tp -105.87 119.01 38.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.185 -0.461 . . . . 1.3200000000000001 110.399 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.651 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 43.8 tt0 -93.58 113.09 25.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 0.92000000000000004 111.25 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 59' ' ' SER . 81.4 m95 -102.12 114.14 28.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.578 -0.737 . . . . 0.42999999999999999 109.137 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.666 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 29.7 ttmt -124.66 134.65 52.81 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.685 -0.406 . . . . 1.23 110.932 -175.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 97' ' ' ILE . 6.0 mt -104.84 111.48 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.46000000000000002 109.853 175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 63.0 mt -108.31 116.82 52.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.769 . . . . 0.68999999999999995 109.522 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -95.12 131.76 40.78 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.987 -0.746 . . . . 0.58999999999999997 108.987 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' HG22 ' A' ' 93' ' ' THR . 93.2 t -59.42 123.09 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.044 -0.354 . . . . 0.37 110.044 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' N ' ' HA ' ' A' ' 54' ' ' ASP . . . -70.85 -49.65 27.86 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.221 -0.99 . . . . 0.46999999999999997 111.891 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 12.9 t -138.3 130.89 29.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 122.938 -0.154 . . . . 1.23 111.004 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.34 -15.62 60.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.245 0.545 . . . . 0.81999999999999995 110.338 170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 26.4 tt0 -84.88 -49.56 8.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.99 110.9 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.1 t -104.53 -39.15 6.5 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.975 0.361 . . . . 1.72 111.975 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 68.11 -34.68 0.26 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.476 1.11 . . . . 2.0899999999999999 112.699 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 50' ' ' SER . 20.6 tt0 -68.18 -7.83 33.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 2.8300000000000001 110.371 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 83' ' ' LEU . 19.0 m-30 -80.69 9.71 5.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 1.48 110.621 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.601 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 3.5 p30 -57.79 142.52 45.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 1.22 112.069 -174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -107.79 116.65 32.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.571 -0.74 . . . . 1.8500000000000001 110.51 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.56 106.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.281 -0.637 . . . . 1.0800000000000001 109.281 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 79' ' ' PRO . 71.0 mt -67.48 -64.83 0.78 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 1.05 111.233 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.27 172.49 16.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.917 -0.583 . . . . 1.3100000000000001 109.454 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 21.1 t -158.07 114.49 2.82 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.862 -0.422 . . . . 1.0900000000000001 109.862 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.39 131.09 59.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.07 -0.514 . . . . 1.22 110.202 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 5.4 mp -118.59 110.55 17.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 110.406 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.92 103.62 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 0.71999999999999997 109.943 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.78 117.51 5.5 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.008 -0.885 . . . . 0.41999999999999998 112.743 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 67.5 Cg_endo -99.93 167.21 9.18 Favored 'Cis proline' 0 N--CA 1.452 -0.948 0 CA-C-N 120.569 2.185 . . . . 0.55000000000000004 110.489 -14.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -101.5 113.25 65.86 Favored Pre-proline 0 C--N 1.317 -0.817 0 C-N-CA 120.35 -0.54 . . . . 0.94999999999999996 110.579 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 6.0 Cg_exo -77.75 159.83 31.32 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 123.154 2.57 . . . . 0.69999999999999996 112.677 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -61.71 133.72 55.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.59 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.74 165.16 10.32 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.687 -0.688 . . . . 0.33000000000000002 111.593 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttm180 -86.53 112.19 21.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.029 0.442 . . . . 2.7799999999999998 110.192 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' THR . 86.8 m-70 -104.4 142.53 34.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.329 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -125.68 106.25 9.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.129 -0.323 . . . . 1.8 110.129 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -124.25 144.95 49.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.442 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.9 t -101.62 115.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.111 0.481 . . . . 1.1200000000000001 110.285 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -93.51 125.83 38.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.437 -0.949 . . . . 0.44 108.437 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 23.5 mt-30 -135.84 126.48 27.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.935 0.397 . . . . 1.1399999999999999 110.973 -175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.31 34.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.56000000000000005 110.242 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.72 -171.25 1.23 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.779 0.324 . . . . 2.1299999999999999 111.757 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -63.59 130.22 94.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.46000000000000002 111.929 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB3' HD21 ' A' ' 57' ' ' LEU . 37.2 Cg_endo -66.12 164.18 28.74 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.019 2.479 . . . . 0.53000000000000003 112.151 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 41.7 t-20 -54.54 110.57 2.22 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 115.995 -0.548 . . . . 2.1899999999999999 110.952 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.7 Cg_exo -69.54 -10.92 29.96 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.211 2.607 . . . . 0.54000000000000004 112.134 -177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.04 -18.31 72.49 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.798 -0.921 . . . . 0.51000000000000001 110.798 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 53' ' ' TYR . 3.8 mm? -87.89 -24.7 23.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.408 . . . . 1.6000000000000001 110.729 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.7 mt -79.15 114.58 45.81 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.52000000000000002 110.096 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 88.8 Cg_endo -77.75 163.15 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.877 3.051 . . . . 0.81000000000000005 112.889 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -48.26 -50.81 28.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.969 -1.014 . . . . 2.29 112.497 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.37 -20.71 59.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.34 0.496 . . . . 1.25 112.34 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 13.8 t70 -84.43 -45.93 12.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.874 0.368 . . . . 1.9399999999999999 111.416 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -61.98 -27.18 68.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.54000000000000004 111.875 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.27 22.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.456 0.646 . . . . 0.56000000000000005 110.018 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.5 -125.53 2.4 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.117 -1.04 . . . . 0.62 113.746 -171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.4 122.78 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 1.23 111.037 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.674 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.3 m -119.89 167.4 12.16 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.034 -0.728 . . . . 0.63 109.034 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 32.4 t -119.17 139.44 46.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.936 -0.477 . . . . 0.35999999999999999 110.378 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.2 p -116.69 116.13 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.297 -1.001 . . . . 0.59999999999999998 108.297 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.759 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 4.0 pp -120.98 131.85 54.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.524 0.678 . . . . 1.21 111.871 -170.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 42' ' ' ILE . 64.8 mt -101.54 106.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.35 -0.841 . . . . 0.33000000000000002 109.636 174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 t -99.0 138.26 36.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.336 -0.616 . . . . 1.4199999999999999 109.336 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 27.7 m -117.36 121.61 41.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.15 -0.477 . . . . 1.3200000000000001 110.371 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -105.18 125.84 51.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 0.5 111.242 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 33.0 t80 -140.8 131.16 25.13 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.72999999999999998 109.605 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.6 mmt180 68.02 14.61 9.37 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.905 0.482 . . . . 2.4500000000000002 110.658 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 -4.47 77.15 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.56999999999999995 111.643 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -114.69 138.46 50.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.405 -0.591 . . . . 1.3100000000000001 109.405 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.5 mp0 -88.76 128.92 35.64 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.2 -0.667 . . . . 1.5900000000000001 109.2 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 26.2 p90 -104.83 -11.72 16.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.343 -0.39 . . . . 0.31 112.05 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.9 tt -155.85 147.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.977 0.418 . . . . 0.37 110.221 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.401 HH21 ' CB ' ' A' ' 147' ' ' THR . 43.5 ttp180 -138.04 104.62 5.29 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.587 -0.733 . . . . 1.1399999999999999 109.402 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.5 t -81.72 102.4 7.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.106 -0.497 . . . . 0.38 110.206 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.61 104.21 2.81 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.937 -0.649 . . . . 0.27000000000000002 112.391 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HB2' HG13 ' A' ' 95' ' ' VAL . 19.2 m-85 -97.65 122.7 41.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.18 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -86.64 115.71 24.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 0.78000000000000003 110.027 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.675 HG21 ' HG2' ' A' ' 137' ' ' ARG . 3.2 p -104.24 134.36 45.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.533 0.682 . . . . 1.1899999999999999 111.17 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -94.83 121.64 36.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.385 -0.825 . . . . 1.6299999999999999 109.506 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -107.9 115.63 30.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.268 0.556 . . . . 0.94999999999999996 110.026 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.68 148.8 29.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.494 -0.775 . . . . 1.97 109.449 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 64.8 m-85 -55.07 157.96 3.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.257 0.551 . . . . 0.68999999999999995 112.153 -176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.557 HG22 ' HB2' ' A' ' 136' ' ' GLN . 43.9 p -86.09 -35.77 20.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.648 -0.705 . . . . 0.83999999999999997 110.33 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 36.6 mt-10 -88.77 131.06 35.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.482 -0.781 . . . . 2.2400000000000002 109.679 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 123' ' ' ARG . 2.2 m -55.01 -39.31 68.93 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.641 0.588 . . . . 1.4099999999999999 111.773 -174.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.78 -41.76 78.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.127 0.489 . . . . 2.21 110.588 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.71 -26.96 37.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.792 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 77.7 mtp180 -66.5 -38.56 87.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.404 0.621 . . . . 2.0299999999999998 109.438 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.13 -27.49 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.934 -1.03 . . . . 2.8399999999999999 111.012 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -134.16 89.39 28.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.974 -0.29 . . . . 2.1899999999999999 110.976 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.56 116.49 3.37 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.407 2.071 . . . . 1.24 111.378 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.07 166.89 13.38 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.302 2.668 . . . . 1.1899999999999999 111.67 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 t -23.64 -64.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 124.609 1.193 . . . . 2.1600000000000001 111.857 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 69.4 mmtt -124.99 136.26 27.86 Favored Pre-proline 0 N--CA 1.436 -1.141 0 CA-C-N 115.554 -0.748 . . . . 1.96 109.712 173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.662 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.5 Cg_endo -44.88 147.13 2.04 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.903 3.069 . . . . 0.70999999999999996 113.28 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.4 t70 -113.52 114.59 26.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.206 -0.906 . . . . 1.28 109.865 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.78 -18.0 54.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.699 -0.682 . . . . 0.5 110.873 -173.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -83.03 -14.11 54.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 1.46 110.141 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 25.1 mmtp -121.6 10.98 10.49 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.476 0.655 . . . . 1.8700000000000001 109.75 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 11.7 tp -93.94 131.36 39.45 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.942 -1.027 . . . . 0.79000000000000004 109.331 -177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.8 tt0 -99.26 124.72 44.57 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.306 -0.627 . . . . 1.6299999999999999 109.306 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 113' ' ' VAL . 33.9 ttp180 -89.74 104.87 17.39 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.805 -0.813 . . . . 2.8199999999999998 108.805 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.5 t30 -105.17 87.72 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.604 . . . . 0.83999999999999997 110.12 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 46.2 mt -74.62 120.23 23.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.679 -0.691 . . . . 0.47999999999999998 110.491 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.14 82.48 3.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.183 -0.462 . . . . 0.98999999999999999 109.993 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.19 -16.67 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.55000000000000004 110.437 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.4 m -73.57 -10.48 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.688 . . . . 1.4199999999999999 110.178 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -124.84 77.22 65.63 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.009 -0.541 . . . . 1.9099999999999999 110.847 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.53 106.55 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.765 2.31 . . . . 0.66000000000000003 110.969 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -86.2 99.71 11.73 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.587 -0.523 . . . . 3.1499999999999999 109.587 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.14 103.76 15.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 116.063 -0.517 . . . . 1.1399999999999999 110.306 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.401 ' CB ' HH21 ' A' ' 108' ' ' ARG . 7.4 m -104.28 107.86 18.97 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.937 -0.764 . . . . 0.56000000000000005 108.937 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 14.5 ptm180 -105.29 137.7 42.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.505 0.669 . . . . 3.0 110.139 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -105.31 138.68 41.13 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.952 -1.022 . . . . 0.46000000000000002 110.223 -172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -78.2 111.12 13.82 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.02 -0.733 . . . . 3.1400000000000001 109.02 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 27.2 pt -130.36 -179.32 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 109.566 -0.531 . . . . 0.64000000000000001 109.566 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.79 103.84 14.59 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.59 -0.732 . . . . 1.78 111.091 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.539 ' CE3' ' HG2' ' A' ' 3' ' ' LYS . 40.8 m95 -82.2 -12.39 58.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.394 -0.965 . . . . 0.87 108.394 172.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.43 132.67 52.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.289 -1.323 . . . . 2.3199999999999998 108.576 -171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -82.4 71.76 9.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.9 0.857 . . . . 2.4900000000000002 110.904 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-N 115.264 -0.88 . . . . 2.5699999999999998 110.385 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG2' ' HE3' ' A' ' 3' ' ' LYS . 26.7 ttp . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.499 0.666 . . . . 2.96 110.234 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.566 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -79.53 127.82 32.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.69 -0.485 . . . . 1.48 109.69 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 1.0 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -89.02 -16.12 32.42 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.556 -0.458 . . . . 0.97999999999999998 110.21 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.712 HG23 HD21 ' A' ' 34' ' ' LEU . 4.8 t -137.97 129.07 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.45000000000000001 110.502 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HG3' HD11 ' A' ' 31' ' ' ILE . 23.2 mm-40 -129.91 115.1 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 1.3899999999999999 110.249 174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 84.1 t -76.41 103.86 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.086 0.47 . . . . 1.3200000000000001 109.76 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -89.16 -59.62 2.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.789 -0.642 . . . . 0.95999999999999996 110.382 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.784 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.3 t-20 -102.43 126.36 49.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.976 -0.556 . . . . 1.47 110.271 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.74 107.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.692 0.758 . . . . 1.01 110.501 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 25' ' ' GLU . 20.0 m -113.74 152.22 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 1.54 111.587 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.4 t -118.26 110.77 31.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.497 -0.774 . . . . 0.91000000000000003 109.688 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 6.9 mp -88.58 -22.01 23.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.599 0.714 . . . . 1.1799999999999999 110.559 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.677 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 10.3 t70 -71.81 -19.13 62.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.866 -1.061 . . . . 2.73 111.952 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 52.5 t30 -89.06 123.57 67.05 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.311 -0.404 . . . . 1.8799999999999999 111.751 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 44.1 Cg_endo -103.09 144.87 1.76 Allowed 'Cis proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.451 -1.062 . . . . 0.59999999999999998 112.216 -11.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.0 m -149.57 161.5 31.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.77000000000000002 110.99 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 51.3 Cg_exo -55.29 145.81 64.52 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.685 2.257 . . . . 0.82999999999999996 112.39 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 10.9 t80 -55.4 -37.1 67.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.40999999999999998 112.612 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -73.02 1.13 9.51 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.622 0.601 . . . . 0.65000000000000002 112.622 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' ND2' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -96.42 150.01 36.56 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.162 -1.051 . . . . 2.0699999999999998 108.162 174.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -68.35 148.76 74.49 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.424 2.083 . . . . 0.62 113.225 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 26.7 m-85 -61.72 112.54 2.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.26 -0.645 . . . . 0.57999999999999996 109.26 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.677 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 10.1 tt0 -108.84 98.59 8.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.434 -0.803 . . . . 1.4099999999999999 111.107 -172.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.44 153.47 27.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.571 . . . . 0.5 110.621 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.6 tt0 -129.69 105.33 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.83 -0.804 . . . . 1.98 108.83 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -99.69 127.26 52.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 111.728 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 28.6 m -114.05 105.78 13.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 0.46000000000000002 109.759 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.8 p90 -121.18 136.78 54.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.461 -0.57 . . . . 0.28000000000000003 109.461 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 40.4 tt0 -104.22 118.91 37.77 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.202 -0.454 . . . . 0.77000000000000002 110.61 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 61.2 m -79.07 100.43 7.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.588 -0.733 . . . . 0.51000000000000001 109.427 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 2' ' ' ALA . 13.0 mt -64.07 -31.37 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.809 0.814 . . . . 0.56999999999999995 109.348 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.0 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -141.48 154.5 45.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.45 -1.25 . . . . 1.8300000000000001 107.753 -174.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 10.8 t70 -74.66 128.56 35.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.742 0.306 . . . . 2.1800000000000002 110.484 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.712 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -76.3 130.4 38.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.083 0.468 . . . . 1.52 110.29 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 m -87.29 -23.2 24.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.922 -0.581 . . . . 1.55 110.184 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 29.5 mm-40 -115.59 179.99 3.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 2.9500000000000002 110.261 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.46 143.61 29.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 1.8799999999999999 110.733 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.853 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -97.25 120.61 37.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.301 -0.629 . . . . 1.3200000000000001 109.301 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.4 tt0 -90.08 104.51 17.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.97 0.414 . . . . 0.92000000000000004 110.844 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -95.48 110.09 22.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.917 -0.583 . . . . 0.42999999999999999 109.751 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 80.7 mttt -121.73 139.28 53.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.679 0.276 . . . . 1.23 111.071 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 97' ' ' ILE . 10.4 mt -105.18 96.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.334 -0.617 . . . . 0.46000000000000002 109.334 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.805 ' HB ' HD11 ' A' ' 96' ' ' LEU . 46.5 mt -91.37 109.04 20.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.944 -0.761 . . . . 0.68999999999999995 108.944 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -88.21 130.73 34.99 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.384 -0.598 . . . . 0.58999999999999997 109.384 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG22 ' A' ' 93' ' ' THR . 60.7 t -62.65 120.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.744 -0.835 . . . . 0.37 108.744 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.672 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.36 -44.17 75.46 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 119.952 -1.118 . . . . 0.46999999999999997 111.208 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 50' ' ' SER . 41.5 t -144.15 134.84 24.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.928 0.394 . . . . 1.23 110.947 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -72.75 -28.81 62.85 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.054 -0.721 . . . . 0.81999999999999995 109.054 169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.99 -49.45 57.74 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.29 -0.868 . . . . 1.99 109.805 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 47' ' ' SER . 13.6 m -136.01 104.43 5.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.141 -0.688 . . . . 1.72 109.141 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.41 2.39 7.77 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.661 -0.416 . . . . 2.0899999999999999 111.417 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.6 -14.83 62.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.361 0.6 . . . . 2.8300000000000001 110.333 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HD2' ' O ' ' A' ' 50' ' ' SER . 83.5 m-85 -77.44 2.28 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.704 -0.68 . . . . 1.48 110.682 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.672 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p-10 -59.83 138.86 57.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.287 0.565 . . . . 1.22 111.48 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pm0 -138.19 125.47 21.71 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.671 -0.695 . . . . 1.8500000000000001 110.796 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.5 p -76.52 128.42 37.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.857 -0.61 . . . . 1.0800000000000001 109.754 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 93.5 mt -76.38 -63.24 1.38 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.556 -0.747 . . . . 1.05 111.047 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.44 161.34 40.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.598 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.64 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -133.26 116.14 15.81 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.325 0.584 . . . . 1.0900000000000001 110.198 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.31 106.81 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.397 -0.82 . . . . 1.22 110.022 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.4 mm? -98.68 117.05 32.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.781 -0.645 . . . . 1.3400000000000001 110.522 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.88 100.98 11.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.507 -0.877 . . . . 0.71999999999999997 109.937 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.69 119.73 6.2 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.728 -1.04 . . . . 0.41999999999999998 111.992 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.0 Cg_endo -95.11 167.43 17.31 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.995 2.398 . . . . 0.55000000000000004 110.226 -12.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -97.5 106.7 34.55 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.47 -0.492 . . . . 0.94999999999999996 110.179 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 6.7 Cg_exo -73.81 145.16 36.02 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.831 2.354 . . . . 0.69999999999999996 112.975 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -54.38 131.38 42.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 111.223 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 143.04 157.47 7.16 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 111.247 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 ttm180 -80.82 104.65 11.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.316 0.579 . . . . 2.7799999999999998 110.709 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -91.36 152.01 20.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.486 -0.779 . . . . 0.62 110.442 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.8 ttt -138.11 96.69 3.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.302 -0.629 . . . . 1.8 109.302 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 2.4 p90 -125.22 148.61 48.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.391 -0.368 . . . . 0.37 110.397 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 m -91.83 134.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.158 0.504 . . . . 1.1200000000000001 110.803 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.51 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -110.89 118.85 37.23 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.331 -0.989 . . . . 0.44 108.331 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.9 mt-30 -132.69 127.46 34.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.159 -0.473 . . . . 1.1399999999999999 110.692 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -137.11 141.5 42.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.559 -0.746 . . . . 0.56000000000000005 109.133 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -66.98 175.15 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.762 0.315 . . . . 2.1299999999999999 111.703 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -55.92 134.8 73.33 Favored Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 115.862 -0.608 . . . . 0.46000000000000002 111.126 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 78' ' ' ALA . 23.7 Cg_exo -64.3 157.86 51.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.909 2.406 . . . . 0.53000000000000003 111.755 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -49.19 112.63 2.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.672 0.608 . . . . 2.1899999999999999 110.911 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.88 -12.27 34.8 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.85 2.367 . . . . 0.54000000000000004 111.752 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.5 -13.81 69.66 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.983 -0.627 . . . . 0.51000000000000001 111.911 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 55' ' ' GLN . 36.4 mt -97.17 -24.9 15.51 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.853 -0.204 . . . . 1.6000000000000001 111.11 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 60.1 mt -81.75 110.11 18.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.368 -0.604 . . . . 0.52000000000000002 109.368 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 19.1 Cg_exo -69.47 161.51 45.6 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.283 2.655 . . . . 0.81000000000000005 112.423 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 5.9 p-10 -58.87 -46.99 86.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.629 -0.714 . . . . 2.29 111.361 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.65 -32.4 73.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.811 0.338 . . . . 1.25 111.252 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.92 -39.92 63.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.757 -178.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.45 -31.6 69.45 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.54000000000000004 111.299 -177.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.828 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.2 t -100.79 39.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.167 0.508 . . . . 0.56000000000000005 110.087 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.97 -150.33 5.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.215 -0.993 . . . . 0.62 112.721 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.25 128.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.332 0.587 . . . . 1.23 111.39 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.1 m -132.88 166.82 21.42 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.01 -1.478 . . . . 0.63 107.01 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.612 ' HB ' HG21 ' A' ' 45' ' ' VAL . 59.9 t -112.39 143.68 21.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 119.465 1.03 . . . . 0.35999999999999999 111.467 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.46 124.9 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.926 -1.138 . . . . 0.59999999999999998 107.926 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 43' ' ' ILE . 3.9 pp -126.86 137.98 53.26 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.76 -0.776 . . . . 1.21 112.326 -172.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 42' ' ' ILE . 64.1 mt -102.15 107.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.755 -1.111 . . . . 0.33000000000000002 109.457 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.615 HG23 HD13 ' A' ' 96' ' ' LEU . 23.2 p -96.87 126.8 42.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.0 -0.546 . . . . 1.4199999999999999 110.17 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 38' ' ' LEU . 26.1 m -105.32 105.16 15.08 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.3200000000000001 109.636 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.2 m -97.93 127.39 43.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.451 -0.795 . . . . 0.5 110.582 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.697 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 50.3 t80 -128.15 116.97 20.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.244 -0.65 . . . . 0.72999999999999998 109.244 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' GLU . 19.6 mmm180 67.98 23.87 8.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.615 0.366 . . . . 2.4500000000000002 111.614 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.48 16.66 80.09 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 110.748 -0.941 . . . . 0.56999999999999995 110.748 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -126.53 115.48 19.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.67 -0.765 . . . . 1.3100000000000001 109.495 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -80.62 127.9 33.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.986 -0.376 . . . . 1.5900000000000001 109.986 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -109.38 -14.28 14.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 0.31 111.336 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.0 tt -154.81 145.46 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.946 0.403 . . . . 0.37 110.058 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -138.6 119.68 14.5 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.773 -0.649 . . . . 1.1399999999999999 109.79 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 70.0 t -96.1 108.47 21.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.219 -0.446 . . . . 0.38 110.95 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.02 102.26 2.55 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.255 -0.497 . . . . 0.27000000000000002 112.359 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -99.83 126.81 45.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.989 0.423 . . . . 0.40000000000000002 110.518 177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -83.13 111.31 18.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 0.78000000000000003 111.055 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 137' ' ' ARG . 84.8 t -88.08 114.99 27.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.391 -0.822 . . . . 1.1899999999999999 109.939 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -102.39 114.36 28.48 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.108 -0.701 . . . . 1.6299999999999999 109.108 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 135' ' ' LEU . 25.2 m-80 -99.44 118.99 37.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.241 0.543 . . . . 0.94999999999999996 109.992 -176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -139.57 142.51 37.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.402 -0.817 . . . . 1.97 108.985 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.535 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 84.7 m-85 -60.66 160.41 9.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.066 0.46 . . . . 0.68999999999999995 110.803 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.4 p -86.21 -38.64 17.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 110.351 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.21 138.03 39.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.551 -0.749 . . . . 2.2400000000000002 111.048 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.3 m -56.05 -43.24 77.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 1.4099999999999999 111.119 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -56.41 -47.14 79.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.851 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.93 -24.54 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.909 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -75.91 -41.57 51.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.046 -0.525 . . . . 2.0299999999999998 110.832 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -67.69 -32.08 72.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.798 -0.637 . . . . 2.8399999999999999 111.137 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -142.1 82.58 13.22 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.991 0.424 . . . . 2.1899999999999999 111.267 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.828 ' HB3' HG11 ' A' ' 90' ' ' VAL . 73.5 Cg_exo -50.52 116.07 2.32 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.899 2.399 . . . . 1.24 111.781 173.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.73 146.87 95.26 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.695 2.264 . . . . 1.1899999999999999 111.33 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.667 HG13 ' HD2' ' A' ' 129' ' ' LYS . 5.6 p -59.67 -32.64 49.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.155 0.502 . . . . 2.1600000000000001 110.604 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.667 ' HD2' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -110.99 101.57 50.34 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 171.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.2 Cg_endo -55.71 168.48 1.65 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.904 3.069 . . . . 0.70999999999999996 113.944 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.29 115.52 19.14 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.113 -0.949 . . . . 1.28 109.278 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 48.6 m-85 -76.96 -17.92 58.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.951 -0.568 . . . . 0.5 111.316 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.0 t -91.32 -5.87 53.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.417 . . . . 1.46 110.73 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -111.24 3.72 18.62 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 1.8700000000000001 109.274 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 89' ' ' ALA . 10.0 tp -95.76 127.59 41.92 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.79000000000000004 111.469 -169.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -100.55 112.16 24.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.285 -0.87 . . . . 1.6299999999999999 109.218 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.646 ' HG3' HG13 ' A' ' 113' ' ' VAL . 37.3 ttp180 -80.64 106.87 12.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.799 -0.637 . . . . 2.8199999999999998 110.4 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.48 96.73 7.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.83999999999999997 110.049 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.6 mt -78.69 104.3 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.09 0.472 . . . . 0.47999999999999998 110.139 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.2 mt -67.07 88.78 0.17 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.269 -0.878 . . . . 0.98999999999999999 110.949 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.58 -15.86 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 109.366 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.7 m -71.43 -15.47 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.159 -0.928 . . . . 1.4199999999999999 110.425 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -122.92 75.42 48.57 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.469 . . . . 1.9099999999999999 110.278 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -93.58 106.95 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.015 2.477 . . . . 0.66000000000000003 112.081 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -77.7 96.37 4.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 3.1499999999999999 109.962 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.13 102.52 13.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 109.133 -0.692 . . . . 1.1399999999999999 109.133 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.7 m -111.48 108.49 18.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 0.56000000000000005 109.54 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.7 ptp180 -109.57 142.02 41.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.587 0.708 . . . . 3.0 110.387 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -111.63 166.29 11.29 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.939 -1.028 . . . . 0.46000000000000002 110.823 -171.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -104.41 121.58 43.71 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.441 -0.577 . . . . 3.1400000000000001 109.441 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.7 pt -137.8 172.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.137 -0.32 . . . . 0.64000000000000001 110.137 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.48 105.38 17.45 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.877 0.846 . . . . 1.78 110.45 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.414 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 40.4 m95 -75.72 -7.39 54.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.304 -0.862 . . . . 0.87 110.068 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.557 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.8 mm-40 -107.93 144.78 34.71 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.958 -1.127 . . . . 2.3199999999999998 107.958 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.59 73.25 9.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.368 0.604 . . . . 2.4900000000000002 109.375 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.557 HD21 ' HB3' ' A' ' 154' ' ' GLU . 1.9 p30 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.001 -0.999 . . . . 2.5699999999999998 109.737 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' HD2' ' A' ' 150' ' ' HIS . 22.6 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.689 0.281 . . . . 2.96 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.16 131.9 35.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.654 0.264 . . . . 1.48 110.518 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -98.44 -12.87 20.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.903 0.383 . . . . 0.97999999999999998 110.475 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.04 123.14 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.839 -0.619 . . . . 0.45000000000000001 109.471 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -122.3 105.54 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.987 0.422 . . . . 1.3899999999999999 110.169 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 44.8 t -68.87 130.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.595 -0.52 . . . . 1.3200000000000001 109.595 176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -118.71 -67.99 0.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.95999999999999996 110.813 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -101.44 101.37 11.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.724 -0.671 . . . . 1.47 110.153 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.86 111.81 37.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.479 0.657 . . . . 1.01 109.97 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.45 139.58 27.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.676 -0.693 . . . . 1.54 110.217 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 45.5 t -99.6 127.28 52.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.747 -0.464 . . . . 0.91000000000000003 109.747 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.705 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -118.42 162.0 19.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 1.1799999999999999 111.593 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.9 t70 72.67 5.74 5.28 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.353 -1.294 . . . . 2.73 109.88 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -99.19 140.68 21.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.175 -0.92 . . . . 1.8799999999999999 110.839 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 5.3 Cg_endo -92.65 145.35 11.49 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.766 -0.931 . . . . 0.59999999999999998 112.613 -5.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.578 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 64.8 m -155.51 166.92 15.22 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.939 -0.573 . . . . 0.77000000000000002 109.894 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.5 Cg_exo -49.36 131.51 27.39 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.703 2.269 . . . . 0.82999999999999996 112.62 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.553 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 5.2 t80 -39.28 -29.86 0.05 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.177 1.547 . . . . 0.40999999999999998 115.177 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -74.35 4.1 6.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.942 -0.474 . . . . 0.65000000000000002 111.756 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 31.7 p-10 -84.14 146.19 47.78 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 2.0699999999999998 110.413 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 10.2 Cg_exo -69.16 132.81 25.13 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.636 2.224 . . . . 0.62 112.013 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -65.42 104.41 0.97 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.158 0.504 . . . . 0.57999999999999996 109.847 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.705 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 6.5 tt0 -107.12 117.92 35.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.102 -0.954 . . . . 1.4099999999999999 110.792 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -124.17 146.7 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.618 -0.719 . . . . 0.5 110.334 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' OE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -115.19 103.8 11.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.707 -1.22 . . . . 1.98 107.707 172.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 39.3 mt -105.36 107.32 22.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.452 -0.795 . . . . 0.35999999999999999 111.484 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.5 m -96.94 106.08 18.34 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.288 0.566 . . . . 0.46000000000000002 109.779 170.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 33.0 p90 -116.22 137.43 52.14 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.687 -0.688 . . . . 0.28000000000000003 109.216 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -105.87 115.38 30.13 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 109.995 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 68.7 m -74.88 114.39 13.28 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.75 -0.659 . . . . 0.51000000000000001 109.321 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.67 -32.19 28.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.924 -0.769 . . . . 0.56999999999999995 108.924 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 12.9 mm-40 -126.85 167.72 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 108.92 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.44 122.15 29.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.726 -0.472 . . . . 2.1800000000000002 109.726 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 7.2 mp -89.88 133.5 34.72 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.278 -0.638 . . . . 1.52 109.278 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 p -96.61 0.26 49.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.89 0.376 . . . . 1.55 110.994 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 40.0 mt-10 -133.27 173.27 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.217 -0.447 . . . . 2.9500000000000002 111.251 -174.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.57 137.8 36.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 1.8799999999999999 112.283 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -100.4 120.38 39.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.278 -0.874 . . . . 1.3200000000000001 109.072 174.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 42.6 tt0 -97.26 106.11 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.903 0.382 . . . . 0.92000000000000004 110.945 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' SER . 58.9 m95 -94.06 110.55 22.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.42999999999999999 109.816 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 83.3 mttt -111.11 143.85 41.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.684 0.278 . . . . 1.23 110.733 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 10.8 mt -105.52 100.01 9.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.212 -0.662 . . . . 0.46000000000000002 109.212 168.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 56' ' ' VAL . 62.0 mt -96.72 106.74 18.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.34 -0.845 . . . . 0.68999999999999995 109.461 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.62 ' HE1' HG11 ' A' ' 113' ' ' VAL . 73.4 t80 -85.88 139.95 30.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.346 -0.612 . . . . 0.58999999999999997 109.346 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.647 ' HB ' HG22 ' A' ' 93' ' ' THR . 78.9 t -61.31 114.9 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.37 110.448 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -68.8 -50.96 32.28 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.753 -0.736 . . . . 0.46999999999999997 112.402 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 50' ' ' SER . 23.6 m -142.96 134.82 26.82 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 120.65 0.262 . . . . 1.23 111.402 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.47 -20.31 60.06 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.81999999999999995 109.181 165.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.88 -49.34 68.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.081 -0.963 . . . . 1.99 109.054 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.628 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 28.9 t -143.28 113.64 7.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.473 -0.936 . . . . 1.72 108.473 168.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.16 21.59 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.08 0.4 . . . . 2.0899999999999999 112.08 -170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -95.14 -6.79 41.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 2.8300000000000001 110.653 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.628 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 57.2 m-85 -88.68 20.66 3.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.959 -0.564 . . . . 1.48 111.375 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 53.5 m-20 -55.88 146.56 21.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.062 -0.517 . . . . 1.22 112.109 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' HG3' HD12 ' A' ' 83' ' ' LEU . 13.0 mp0 -109.6 108.73 19.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.855 -0.611 . . . . 1.8500000000000001 110.35 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 43' ' ' ILE . 59.1 t -68.49 104.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.048 -0.723 . . . . 1.0800000000000001 109.048 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 88.7 mt -71.05 -61.49 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.785 -0.643 . . . . 1.05 111.302 -174.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.28 162.09 40.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.551 -0.536 . . . . 1.3100000000000001 109.551 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 33.4 p -137.73 116.47 12.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.157 0.503 . . . . 1.0900000000000001 110.579 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.39 109.11 26.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.22 109.768 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.7 mp -106.82 112.44 25.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.033 -0.53 . . . . 1.3400000000000001 110.203 -178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.45 103.74 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.3 -0.56 . . . . 0.71999999999999997 110.467 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -104.8 123.69 7.74 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.779 -1.012 . . . . 0.41999999999999998 111.199 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 25.9 Cg_endo -100.74 168.54 8.27 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 CA-C-N 120.583 2.191 . . . . 0.55000000000000004 111.487 -7.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -107.83 94.93 13.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 120.933 -0.307 . . . . 0.94999999999999996 110.577 178.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.3 158.3 44.94 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.508 2.139 . . . . 0.69999999999999996 112.842 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -57.09 131.59 50.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 110.845 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.83 163.57 10.34 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.54 -0.755 . . . . 0.33000000000000002 111.284 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -88.73 110.24 20.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.221 0.534 . . . . 2.7799999999999998 109.882 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' THR . 98.4 m-70 -101.74 126.26 48.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.531 -0.759 . . . . 0.62 110.925 -174.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.439 ' HG3' ' OE1' ' A' ' 25' ' ' GLU . 35.4 ttm -107.34 110.87 22.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.969 -0.56 . . . . 1.8 109.556 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.4 p90 -137.11 148.66 46.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.031 0.443 . . . . 0.37 110.54 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.72 133.73 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.283 0.563 . . . . 1.1200000000000001 110.922 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -107.25 130.77 54.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.549 -0.908 . . . . 0.44 108.549 178.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -130.14 132.75 46.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 1.1399999999999999 110.256 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -134.71 161.48 35.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.838 -0.619 . . . . 0.56000000000000005 110.136 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -83.59 -177.93 6.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.1299999999999999 110.704 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -75.98 131.62 75.66 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 116.236 -0.438 . . . . 0.46000000000000002 110.625 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.2 Cg_exo -54.55 145.17 59.8 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 123.115 2.543 . . . . 0.53000000000000003 112.397 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -51.12 113.39 3.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 2.1899999999999999 111.121 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.16 -27.2 64.82 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.268 2.645 . . . . 0.54000000000000004 112.242 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.37 -3.55 71.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.91 -0.662 . . . . 0.51000000000000001 112.579 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.431 HD12 ' HG3' ' A' ' 55' ' ' GLN . 56.4 mt -103.86 -29.42 11.0 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.871 -0.194 . . . . 1.6000000000000001 111.294 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 50.4 mt -72.62 125.84 91.07 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 120.775 0.321 . . . . 0.52000000000000002 110.741 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 22.3 Cg_exo -66.44 161.17 42.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.582 2.855 . . . . 0.81000000000000005 113.125 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 3.0 m-20 -60.25 -58.3 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 2.29 111.079 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.06 -35.44 64.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.312 -0.404 . . . . 1.25 111.239 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 40.7 t0 -65.68 -34.18 77.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 111.187 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.98 -28.39 70.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.54000000000000004 111.152 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 130' ' ' PRO . 3.2 t -100.57 39.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.123 0.487 . . . . 0.56000000000000005 110.015 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.06 -132.78 1.38 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.808 -1.187 . . . . 0.62 113.539 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.67 117.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.013 0.435 . . . . 1.23 111.509 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.647 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.4 m -118.4 168.74 10.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.826 -1.176 . . . . 0.63 107.826 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 13.0 t -119.17 144.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 110.656 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.19 121.44 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.944 -0.761 . . . . 0.59999999999999998 108.944 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 15.7 mt -111.42 137.61 48.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.21 0.528 . . . . 1.21 111.224 -172.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -108.75 99.69 9.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.215 -1.032 . . . . 0.33000000000000002 108.215 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.417 ' HB ' ' OE2' ' A' ' 105' ' ' GLU . 12.7 p -93.54 125.65 38.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.248 -0.887 . . . . 1.4199999999999999 110.323 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.1 m -105.98 104.74 14.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.378 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 40.9 m -96.38 123.58 40.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.499 -0.773 . . . . 0.5 110.559 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 25.0 t80 -126.21 118.92 26.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.033 -0.729 . . . . 0.72999999999999998 109.033 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 15.5 mmm180 68.95 23.74 6.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.398 0.436 . . . . 2.4500000000000002 110.871 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.66 -5.1 83.85 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.806 -0.711 . . . . 0.56999999999999995 111.973 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.406 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 23.1 mt-30 -116.66 130.03 56.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.011 -0.366 . . . . 1.3100000000000001 110.011 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.417 ' OE2' ' HB ' ' A' ' 98' ' ' THR . 19.8 mt-10 -88.76 130.4 35.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 1.5900000000000001 109.606 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -106.04 -15.47 14.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.246 -0.434 . . . . 0.31 111.671 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 108' ' ' ARG . 6.3 tt -155.49 153.65 7.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.77 -0.456 . . . . 0.37 109.77 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 107' ' ' ILE . 46.3 ttp180 -144.14 112.12 6.26 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.026 -0.534 . . . . 1.1399999999999999 109.85 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.5 t -93.83 108.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.051 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.44 ' CA ' HD23 ' A' ' 96' ' ' LEU . . . -111.99 123.89 6.55 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 119.825 -1.178 . . . . 0.27000000000000002 112.861 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -111.64 129.99 55.91 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.488 -0.56 . . . . 0.40000000000000002 109.488 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.71 109.99 13.45 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.14 0.495 . . . . 0.78000000000000003 109.744 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.62 HG11 ' HE1' ' A' ' 44' ' ' TYR . 2.0 p -87.88 124.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.441 0.639 . . . . 1.1899999999999999 109.877 176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.39 116.0 28.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.419 -0.81 . . . . 1.6299999999999999 109.244 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -98.66 121.78 41.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.538 0.685 . . . . 0.94999999999999996 110.987 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.27 144.45 36.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.745 -1.116 . . . . 1.97 109.269 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -66.47 148.73 51.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.18 0.514 . . . . 0.68999999999999995 111.016 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 136' ' ' GLN . 1.4 p -91.06 -32.95 15.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.853 0.835 . . . . 0.83999999999999997 108.944 177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 40.2 tt0 -69.95 113.25 7.0 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.177 -1.374 . . . . 2.2400000000000002 109.676 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 m -56.49 -30.16 62.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.4099999999999999 110.282 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' A' ' 119' ' ' GLU . 11.9 tp10 -53.57 -45.04 69.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 2.21 111.011 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -84.41 -17.63 38.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.90000000000000002 110.86 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -69.39 -37.92 77.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.454 0.645 . . . . 2.0299999999999998 109.364 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.08 -39.14 50.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.978 -1.01 . . . . 2.8399999999999999 110.553 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -132.31 87.65 42.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.567 -0.288 . . . . 2.1899999999999999 110.685 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.9 Cg_endo -72.75 114.41 4.02 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.813 1.675 . . . . 1.24 110.633 173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.7 Cg_exo -68.34 163.54 36.01 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.929 2.419 . . . . 1.1899999999999999 111.504 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.0 t -52.73 -50.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 121.384 0.612 . . . . 2.1600000000000001 110.097 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -101.57 116.03 64.13 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.114 -0.948 . . . . 1.96 109.988 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 9.2 Cg_endo -52.18 158.51 5.12 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.563 2.842 . . . . 0.70999999999999996 113.45 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.1 t0 -121.95 114.81 21.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 1.28 109.358 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 71.2 m-85 -77.1 -20.27 55.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.066 -0.516 . . . . 0.5 111.323 -174.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.6 m -80.28 -18.61 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 1.46 110.775 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 32.3 mmtp -105.75 -8.25 17.91 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.969 0.89 . . . . 1.8700000000000001 108.875 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.8 tp -83.37 127.87 34.03 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.935 -1.484 . . . . 0.79000000000000004 110.187 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.975 ' HB2' HG23 ' A' ' 118' ' ' THR . 5.0 tt0 -99.92 124.93 45.78 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.591 -0.522 . . . . 1.6299999999999999 109.591 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.58 ' HD3' HG13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -78.88 110.35 14.01 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.76 -0.83 . . . . 2.8199999999999998 108.76 173.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.3 t30 -111.85 86.52 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.811 0.815 . . . . 0.83999999999999997 109.882 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.58 HG13 ' HD3' ' A' ' 137' ' ' ARG . 88.4 mt -63.17 121.0 11.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.47999999999999998 110.618 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 72.0 mt -87.31 88.25 7.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.98999999999999999 109.811 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.99 -6.98 46.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.61 -0.723 . . . . 0.55000000000000004 110.024 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -26.31 66.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.065 -0.971 . . . . 1.4199999999999999 110.724 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.73 96.54 42.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.357 -0.383 . . . . 1.9099999999999999 110.779 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -93.03 106.14 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 112.185 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -85.97 97.39 10.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 3.1499999999999999 109.355 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -109.54 103.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.116 0.484 . . . . 1.1399999999999999 110.816 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.411 ' CB ' HH21 ' A' ' 108' ' ' ARG . 3.4 m -97.08 111.29 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.774 -0.648 . . . . 0.56000000000000005 109.432 174.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 16.7 ptp180 -107.58 137.44 45.6 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.018 -0.673 . . . . 3.0 110.328 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -109.69 159.0 17.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.164 -0.925 . . . . 0.46000000000000002 110.695 -171.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.457 ' HD2' ' SD ' ' A' ' 1' ' ' MET . 62.7 m80 -103.94 111.01 23.37 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.677 -0.49 . . . . 3.1400000000000001 109.677 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.406 ' HB ' ' NE2' ' A' ' 104' ' ' GLN . 30.2 pt -134.72 164.45 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.492 -0.322 . . . . 0.64000000000000001 110.33 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.97 118.65 29.69 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.61 0.719 . . . . 1.78 109.49 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 14.8 m95 -84.98 -10.03 57.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.188 -0.914 . . . . 0.87 109.992 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.7 163.7 21.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.385 -0.825 . . . . 2.3199999999999998 109.918 -171.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.79 71.13 8.71 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.476 -0.565 . . . . 2.4900000000000002 109.476 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.315 -0.85 . . . . 2.5699999999999998 110.584 177.118 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.95 0.405 . . . . 2.96 110.1 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -104.36 135.01 46.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.552 -0.294 . . . . 1.48 110.337 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.802 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -96.06 -27.74 14.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.577 -0.527 . . . . 0.97999999999999998 109.577 176.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.728 HG23 HD21 ' A' ' 34' ' ' LEU . 2.6 t -135.59 123.52 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.212 -0.904 . . . . 0.45000000000000001 108.947 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.882 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.76 115.2 15.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.3899999999999999 109.89 177.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 14.1 m -67.97 143.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.609 -0.515 . . . . 1.3200000000000001 109.609 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -124.16 -56.21 1.65 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.149 0.5 . . . . 0.95999999999999996 110.273 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.3 t30 -101.89 104.66 15.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.71 -0.677 . . . . 1.47 109.442 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -120.07 98.29 6.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.011 0.91 . . . . 1.01 109.761 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.94 130.14 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 115.271 -0.877 . . . . 1.54 110.53 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.427 HG11 HG21 ' A' ' 139' ' ' ILE . 38.6 t -88.42 130.29 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.434 -0.58 . . . . 0.91000000000000003 109.434 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.1 mp -115.58 168.46 9.99 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.206 -0.664 . . . . 1.1799999999999999 109.206 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 59.81 28.57 18.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.824 0.821 . . . . 2.73 110.764 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 24.0 p-10 -120.7 131.27 24.51 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 114.836 -1.075 . . . . 1.8799999999999999 109.714 167.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 9.8 Cg_endo -88.31 135.99 14.2 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.937 -1.276 . . . . 0.59999999999999998 112.543 -0.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -153.22 158.81 32.75 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.204 -0.453 . . . . 0.77000000000000002 110.158 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 87.1 Cg_exo -48.59 152.65 3.98 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.579 2.853 . . . . 0.82999999999999996 114.542 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.706 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.7 t80 -62.61 -34.14 76.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.954 -1.021 . . . . 0.40999999999999998 112.153 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.51 1.74 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.938 0.399 . . . . 0.65000000000000002 111.634 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -92.81 134.99 26.7 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 108.681 -0.859 . . . . 2.0699999999999998 108.681 174.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.5 Cg_exo -58.78 145.77 95.07 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.353 2.035 . . . . 0.62 113.002 -175.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 47.6 m-85 -66.02 116.01 6.68 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.579 -0.526 . . . . 0.57999999999999996 109.579 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -104.3 109.77 21.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.438 -0.801 . . . . 1.4099999999999999 110.809 -173.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.32 121.68 37.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.46 . . . . 0.5 111.548 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.717 ' HB2' HD11 ' A' ' 12' ' ' LEU . 43.3 tt0 -91.17 95.97 10.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.58 -0.896 . . . . 1.98 108.58 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 74' ' ' PHE . 84.4 mt -99.61 106.84 19.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.6 -0.727 . . . . 0.35999999999999999 111.424 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 10.5 m -105.3 106.17 16.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 0.46000000000000002 109.527 173.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 34.4 p90 -116.9 137.05 52.48 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.926 -0.579 . . . . 0.28000000000000003 109.673 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 38.0 tt0 -105.79 117.92 35.26 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.127 -0.488 . . . . 0.77000000000000002 110.319 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.1 m -77.53 111.05 12.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.586 -0.734 . . . . 0.51000000000000001 109.037 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 2' ' ' ALA . 8.7 mt -76.65 -24.89 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.75 0.786 . . . . 0.56999999999999995 109.353 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.802 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.1 mt-10 -138.51 -177.63 4.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.523 -1.217 . . . . 1.8300000000000001 108.558 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 66' ' ' PRO . 36.8 t70 -92.1 136.47 33.15 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.299 -0.26 . . . . 2.1800000000000002 110.299 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.728 HD21 HG23 ' A' ' 4' ' ' VAL . 4.1 mm? -85.02 131.6 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.87 0.367 . . . . 1.52 110.055 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 m -83.06 -24.28 32.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.175 0.512 . . . . 1.55 110.382 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 4.7 tp10 -128.26 -178.99 4.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.673 -0.694 . . . . 2.9500000000000002 109.543 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.0 p-10 -81.15 146.65 30.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.962 0.41 . . . . 1.8799999999999999 110.738 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.866 ' HB2' HG21 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -95.14 125.97 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 109.717 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' A' ' 61' ' ' LEU . 35.6 tt0 -97.1 119.63 35.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.92000000000000004 111.325 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.3 m95 -109.07 110.23 21.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.07 -0.513 . . . . 0.42999999999999999 109.95 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.5 mttp -110.96 138.08 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.653 0.263 . . . . 1.23 110.888 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 5.9 mt -105.7 105.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.147 -0.686 . . . . 0.46000000000000002 109.147 168.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 56' ' ' VAL . 68.8 mt -101.85 115.6 43.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.889 -0.596 . . . . 0.68999999999999995 109.648 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -96.9 136.52 37.33 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.429 -0.582 . . . . 0.58999999999999997 109.429 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.667 ' HB ' HG22 ' A' ' 93' ' ' THR . 73.8 t -63.03 114.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.014 -0.365 . . . . 0.37 110.014 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.666 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.29 -68.85 1.52 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.375 -0.917 . . . . 0.46999999999999997 111.11 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.496 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 34.1 m -119.1 138.61 52.77 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.566 0.222 . . . . 1.23 110.862 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.82 -26.76 60.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.195 -0.669 . . . . 0.81999999999999995 109.195 170.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.63 -49.09 79.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.815 -1.084 . . . . 1.99 109.436 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.4 m -147.83 109.81 4.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.21 -1.033 . . . . 1.72 108.21 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.17 -1.06 16.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.765 -0.374 . . . . 2.0899999999999999 111.223 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.22 -13.5 58.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.405 0.622 . . . . 2.8300000000000001 109.953 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 45.6 m-85 -89.49 17.39 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.775 -0.648 . . . . 1.48 110.565 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.666 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p30 -58.84 156.03 12.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.165 0.507 . . . . 1.22 111.555 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HG3' HD12 ' A' ' 83' ' ' LEU . 11.0 mp0 -120.14 108.95 14.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.586 . . . . 1.8500000000000001 110.136 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 43' ' ' ILE . 96.0 t -68.83 101.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.919 -0.771 . . . . 1.0800000000000001 108.919 170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 79' ' ' PRO . 94.4 mt -66.36 -49.03 68.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.492 -0.776 . . . . 1.05 111.917 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.02 167.77 25.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.352 -0.385 . . . . 1.3100000000000001 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.5 p -144.64 110.73 5.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.742 -0.663 . . . . 1.0900000000000001 109.626 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.84 122.04 54.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.961 -0.563 . . . . 1.22 110.186 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.8 mm? -107.58 123.89 49.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.087 -0.506 . . . . 1.3400000000000001 110.378 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.06 101.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.71999999999999997 109.792 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 119.27 5.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 118.77 -1.017 . . . . 0.41999999999999998 112.712 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 57.7 Cg_endo -98.1 168.42 11.57 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 CA-C-N 120.922 2.361 . . . . 0.55000000000000004 110.063 -13.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -100.96 108.79 55.97 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.458 -0.497 . . . . 0.94999999999999996 110.828 -177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 69.6 Cg_endo -78.9 150.21 23.47 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.745 2.296 . . . . 0.69999999999999996 113.058 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.5 124.73 21.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.548 -0.751 . . . . 0.40999999999999998 111.373 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 153.62 162.33 10.98 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.041 -0.824 . . . . 0.33000000000000002 111.041 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 15.2 ttm180 -84.19 109.87 18.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.209 0.528 . . . . 2.7799999999999998 109.965 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.8 149.38 27.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.698 -0.683 . . . . 0.62 110.215 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -134.91 109.34 8.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.654 0.264 . . . . 1.8 110.468 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -123.88 145.11 49.34 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.577 -0.527 . . . . 0.37 109.577 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.87 105.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 1.1200000000000001 109.969 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -78.04 122.65 25.86 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.45 -0.944 . . . . 0.44 108.45 177.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -122.3 116.04 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.723 -0.843 . . . . 1.1399999999999999 108.723 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -109.12 151.1 26.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.262 -0.426 . . . . 0.56000000000000005 110.899 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.46 -179.17 2.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.924 -0.58 . . . . 2.1299999999999999 110.907 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.79 126.15 71.45 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 116.183 -0.462 . . . . 0.46000000000000002 109.896 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 57' ' ' LEU . 50.7 Cg_exo -54.7 150.97 33.79 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.173 2.582 . . . . 0.53000000000000003 112.811 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -51.95 113.45 4.2 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.086 -0.506 . . . . 2.1899999999999999 110.645 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.11 -24.41 73.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.887 2.391 . . . . 0.54000000000000004 111.977 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.52 -7.89 85.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.895 -0.669 . . . . 0.51000000000000001 112.787 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.43 HD12 ' HG3' ' A' ' 55' ' ' GLN . 80.4 mt -104.06 -15.5 15.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.905 0.352 . . . . 1.6000000000000001 111.659 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.45 HG22 ' HB2' ' A' ' 89' ' ' ALA . 48.8 mt -83.4 116.65 65.56 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 120.927 0.394 . . . . 0.52000000000000002 110.673 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.496 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -79.51 157.65 25.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.561 2.841 . . . . 0.81000000000000005 113.152 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.09 -39.81 69.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.882 -0.599 . . . . 2.29 110.934 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.01 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.32 -0.855 . . . . 1.25 113.053 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -115.21 -8.12 12.37 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.295 -0.562 . . . . 1.9399999999999999 112.472 -170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -62.11 -39.84 93.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.771 0.319 . . . . 0.54000000000000004 111.554 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.68 39.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.456 -0.572 . . . . 0.56000000000000005 109.456 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.95 -127.6 2.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.183 -1.008 . . . . 0.62 113.19 -170.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 3.7 p -130.28 106.61 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.656 0.741 . . . . 1.23 111.47 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 45' ' ' VAL . 4.3 m -100.54 166.96 10.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.185 -0.916 . . . . 0.63 109.134 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 42.0 t -111.51 136.48 47.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.901 -0.499 . . . . 0.35999999999999999 110.41 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.14 111.52 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.197 -1.038 . . . . 0.59999999999999998 108.197 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.717 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -119.34 129.14 54.7 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.506 0.669 . . . . 1.21 112.138 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG12 HG12 ' A' ' 42' ' ' ILE . 64.7 mt -95.09 112.67 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.131 -0.94 . . . . 0.33000000000000002 109.923 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.8 p -102.42 130.58 49.24 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.942 -0.572 . . . . 1.4199999999999999 110.199 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 59.2 m -109.15 111.82 23.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.721 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -98.55 121.5 40.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.417 -0.81 . . . . 0.5 110.672 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -128.32 122.25 31.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.544 -0.539 . . . . 0.72999999999999998 109.544 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 66.24 19.07 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.445 0.466 . . . . 2.4500000000000002 111.041 -176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.93 1.85 86.64 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.177 -0.769 . . . . 0.56999999999999995 111.177 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -114.93 124.0 50.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.316 -0.442 . . . . 1.3100000000000001 109.913 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 39.5 mt-10 -83.64 128.83 34.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.783 0.325 . . . . 1.5900000000000001 110.569 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 39.8 p90 -109.4 -11.68 14.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.31 111.968 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.2 tt -155.1 148.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.95 0.405 . . . . 0.37 110.484 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -139.67 115.79 10.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.528 -0.76 . . . . 1.1399999999999999 109.598 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.3 t -95.97 105.81 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.195 -0.457 . . . . 0.38 110.931 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.41 106.84 3.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.851 -0.69 . . . . 0.27000000000000002 112.589 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.99 129.64 49.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.901 0.382 . . . . 0.40000000000000002 110.451 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -90.38 116.41 28.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.061 -0.518 . . . . 0.78000000000000003 109.882 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.4 p -101.28 127.11 54.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.158 0.504 . . . . 1.1899999999999999 111.119 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.9 109.49 21.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 1.6299999999999999 110.019 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -94.14 121.41 35.61 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.814 -0.63 . . . . 0.94999999999999996 110.438 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -135.5 144.99 46.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.337 -0.847 . . . . 1.97 109.34 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 51.6 m-85 -60.81 141.57 56.9 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.092 0.473 . . . . 0.68999999999999995 110.529 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 24.1 p -74.58 -39.87 61.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.314 -0.995 . . . . 0.83999999999999997 108.314 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -77.27 119.18 20.56 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.171 -1.377 . . . . 2.2400000000000002 109.527 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 15.6 m -56.41 -33.22 65.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.367 -0.605 . . . . 1.4099999999999999 109.367 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.86 -42.82 80.45 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.283 -0.871 . . . . 2.21 110.597 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.8 mt -79.6 -18.65 51.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.494 -0.482 . . . . 0.90000000000000002 110.85 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -78.72 -28.26 44.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.286 -0.635 . . . . 2.0299999999999998 109.286 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.3 mm-40 -63.0 -46.88 85.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.431 -0.804 . . . . 2.8399999999999999 109.974 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -140.18 95.42 8.38 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.282 0.563 . . . . 2.1899999999999999 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 43.2 Cg_exo -58.87 118.3 5.16 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.8 2.333 . . . . 1.24 111.73 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.8 Cg_exo -60.68 164.63 13.17 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.47 2.78 . . . . 1.1899999999999999 113.008 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.19 -24.79 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.838 -0.619 . . . . 2.1600000000000001 110.789 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 25.0 mmtm -130.95 121.5 18.9 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.002 -0.545 . . . . 1.96 110.294 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.7 Cg_endo -54.33 152.82 24.38 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.882 2.388 . . . . 0.70999999999999996 111.581 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.2 t70 -120.73 120.91 37.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.073 0.463 . . . . 1.28 110.221 -173.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.706 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 68.7 m-85 -79.29 -17.92 53.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.389 -0.823 . . . . 0.5 111.782 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.5 t -88.25 -16.42 33.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.133 0.492 . . . . 1.46 110.034 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 64.4 mmtt -111.33 13.95 21.61 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.588 -0.893 . . . . 1.8700000000000001 108.588 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.9 tp -104.33 122.71 46.02 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.01 -0.996 . . . . 0.79000000000000004 109.997 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.48 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.9 tt0 -104.47 124.39 49.16 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.069 -0.715 . . . . 1.6299999999999999 109.069 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 20.4 mtm180 -87.78 105.49 17.43 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.781 -0.368 . . . . 2.8199999999999998 110.245 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.1 t30 -94.5 85.29 4.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.823 -0.806 . . . . 0.83999999999999997 108.823 174.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 69.5 mt -68.06 117.29 9.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.566 -0.743 . . . . 0.47999999999999998 110.471 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -77.31 86.82 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.991 -0.549 . . . . 0.98999999999999999 110.276 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.17 -1.38 22.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.451 0.643 . . . . 0.55000000000000004 109.771 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -73.63 -16.81 61.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.231 -0.895 . . . . 1.4199999999999999 110.481 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -135.19 85.2 34.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 1.9099999999999999 110.393 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.18 106.33 0.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.117 2.545 . . . . 0.66000000000000003 111.41 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -82.74 84.94 7.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.038 0.447 . . . . 3.1499999999999999 109.969 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.77 104.45 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.622 0.725 . . . . 1.1399999999999999 110.439 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.4 m -106.93 109.81 21.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.753 -0.658 . . . . 0.56000000000000005 109.4 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 17.4 ptt180 -108.01 135.81 48.75 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.69 0.757 . . . . 3.0 111.182 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -108.38 151.16 26.4 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.613 -1.176 . . . . 0.46000000000000002 110.056 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -91.72 124.73 36.08 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.25 -0.648 . . . . 3.1400000000000001 109.25 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.5 pt -137.32 172.93 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.153 0.501 . . . . 0.64000000000000001 110.366 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.88 118.97 34.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.189 -0.914 . . . . 1.78 109.381 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -85.17 0.43 51.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.735 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -120.81 163.79 17.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.951 -1.129 . . . . 2.3199999999999998 107.951 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.412 ' C ' HD22 ' A' ' 156' ' ' ASN . 36.9 t70 -79.21 70.45 5.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.277 1.037 . . . . 2.4900000000000002 109.762 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 114.3 -1.318 . . . . 2.5699999999999998 109.611 177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' ' H ' ' A' ' 151' ' ' ILE . 14.2 ptt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.484 0.183 . . . . 2.96 111.325 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 122.03 21.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.141 0.496 . . . . 1.48 111.994 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -94.44 -9.44 35.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.55 . . . . 0.97999999999999998 110.044 172.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.94 130.91 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.516 -0.765 . . . . 0.45000000000000001 109.393 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -135.67 115.73 13.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 1.3899999999999999 110.193 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.7 t -73.91 121.82 25.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.334 -0.394 . . . . 1.3200000000000001 110.029 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.58 -59.66 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.049 -0.523 . . . . 0.95999999999999996 111.218 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -101.95 91.72 4.48 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.952 0.406 . . . . 1.47 109.929 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.0 107.74 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.623 0.725 . . . . 1.01 110.025 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.792 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.7 t -104.43 134.1 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.747 -0.66 . . . . 1.54 110.479 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 139' ' ' ILE . 40.6 t -109.46 122.55 64.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.721 . . . . 0.91000000000000003 109.055 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.942 ' HG ' ' HG2' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -126.6 169.78 12.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.18 -0.464 . . . . 1.1799999999999999 110.339 -176.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.26 25.82 14.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.347 -0.842 . . . . 2.73 110.163 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -118.72 135.97 23.96 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.117 -0.947 . . . . 1.8799999999999999 109.529 167.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.4 Cg_endo -86.66 142.45 26.92 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.966 -1.264 . . . . 0.59999999999999998 111.948 -5.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.717 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.4 m -151.83 168.45 11.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 0.77000000000000002 110.065 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 14.7 Cg_endo -57.43 147.32 78.67 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.581 2.188 . . . . 0.82999999999999996 112.422 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.1 t80 -64.68 -26.32 68.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.263 -0.881 . . . . 0.40999999999999998 112.291 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HE2' ' HG ' ' A' ' 133' ' ' SER . 27.1 m-85 -83.07 5.98 20.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 0.65000000000000002 111.358 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.4 142.07 24.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.61 149.09 84.56 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.761 2.307 . . . . 0.62 113.477 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 33.2 m-85 -67.42 107.43 2.44 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.759 -0.83 . . . . 0.57999999999999996 108.759 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.942 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 25.3 tt0 -102.18 106.39 17.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.319 0.58 . . . . 1.4099999999999999 111.373 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.47 137.75 51.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.724 -0.671 . . . . 0.5 110.708 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 35.8 tt0 -108.83 96.23 6.19 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.395 -0.965 . . . . 1.98 108.395 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 54.3 mt -97.89 111.56 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.782 -0.645 . . . . 0.35999999999999999 111.284 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 44.4 m -103.79 106.38 16.87 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.042 -0.526 . . . . 0.46000000000000002 110.099 174.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.4 p90 -119.37 137.81 53.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.49 -0.559 . . . . 0.28000000000000003 109.49 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.2 tt0 -104.59 118.04 35.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.079 0.466 . . . . 0.77000000000000002 110.317 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 56.3 m -75.8 112.71 12.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.51000000000000001 109.299 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.7 mt -78.91 -16.85 13.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.604 0.716 . . . . 0.56999999999999995 109.302 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -140.68 164.41 30.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.138 -0.937 . . . . 1.8300000000000001 109.005 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.1 127.94 34.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.803 -0.443 . . . . 2.1800000000000002 109.803 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 3' ' ' LYS . 13.7 mt -94.24 132.01 39.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.03 -0.532 . . . . 1.52 110.91 -172.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 p -91.73 -17.6 25.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.451 0.643 . . . . 1.55 109.717 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -96.24 166.64 11.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.359 -0.837 . . . . 2.9500000000000002 110.467 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.36 134.73 36.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.008 0.432 . . . . 1.8799999999999999 110.142 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 16.6 tp -101.61 118.92 37.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.92 -0.582 . . . . 1.3200000000000001 109.55 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.4 tt0 -100.99 116.17 32.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.14 -0.482 . . . . 0.92000000000000004 110.847 -172.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -106.58 113.57 27.16 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.403 -0.591 . . . . 0.42999999999999999 109.403 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 28.7 ttmt -121.45 134.79 55.08 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.482 -0.326 . . . . 1.23 111.06 -172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 97' ' ' ILE . 5.8 mt -105.36 109.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.004 0.431 . . . . 0.46000000000000002 110.245 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HB ' ' HG ' ' A' ' 96' ' ' LEU . 52.7 mt -97.55 124.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.499 -0.773 . . . . 0.68999999999999995 109.335 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -111.35 132.59 54.29 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.069 -0.345 . . . . 0.58999999999999997 110.069 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.602 ' HB ' HG22 ' A' ' 93' ' ' THR . 76.0 t -60.03 113.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.37 110.001 177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.69 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.11 -57.34 8.68 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.775 -0.726 . . . . 0.46999999999999997 111.749 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.571 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 35.3 t -129.27 132.14 47.13 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 110.306 -0.257 . . . . 1.23 110.306 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 88' ' ' ASP . . . -79.92 -17.91 51.86 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.131 -0.692 . . . . 0.81999999999999995 109.131 170.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 42.5 tt0 -69.47 -40.6 77.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.78 -1.1 . . . . 1.99 108.602 176.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.4 m -150.12 110.14 4.12 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.29 -0.868 . . . . 1.72 109.303 169.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.9 -6.17 20.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 2.0899999999999999 111.474 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.83 -13.81 27.56 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.824 -0.626 . . . . 2.8300000000000001 110.867 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.17 11.51 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.48 112.165 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.69 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -61.07 134.54 57.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.039 0.447 . . . . 1.22 111.053 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 pm0 -129.26 150.21 50.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.458 0.647 . . . . 1.8500000000000001 110.85 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.23 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.257 -0.883 . . . . 1.0800000000000001 110.103 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.675 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 72.2 mt -79.71 -61.21 2.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.104 -0.498 . . . . 1.05 110.581 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -153.01 156.87 39.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.014 -0.539 . . . . 1.3100000000000001 109.609 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.608 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 39.5 t -144.98 114.1 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.633 -0.506 . . . . 1.0900000000000001 109.633 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.16 132.26 60.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.255 0.55 . . . . 1.22 110.85 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.3 mp -116.21 122.8 46.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.037 -0.529 . . . . 1.3400000000000001 110.287 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.25 103.16 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.112 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.64 120.6 6.49 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.822 -0.988 . . . . 0.41999999999999998 112.085 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 54.9 Cg_endo -102.02 167.26 7.01 Favored 'Cis proline' 0 N--CA 1.454 -0.832 0 CA-C-N 120.767 2.283 . . . . 0.55000000000000004 110.788 -12.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.65 103.54 51.71 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.421 -0.512 . . . . 0.94999999999999996 110.957 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.11 157.79 60.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.092 2.528 . . . . 0.69999999999999996 112.588 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.3 129.55 40.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.40999999999999998 110.732 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 150.14 170.11 17.06 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.33000000000000002 112.044 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 13.3 ttm180 -85.62 106.03 16.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 2.7799999999999998 110.397 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' THR . 41.9 m-70 -97.68 140.64 31.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.62 110.704 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 ttm -125.08 111.07 14.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.016 -0.538 . . . . 1.8 109.907 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.6 p90 -129.17 151.82 49.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.941 -0.392 . . . . 0.37 109.941 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.51 114.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.145 -0.48 . . . . 1.1200000000000001 110.151 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -93.78 128.84 40.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.728 -0.841 . . . . 0.44 108.728 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 80.1 mt-30 -133.72 116.68 16.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.053 0.454 . . . . 1.1399999999999999 109.8 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -110.25 144.09 39.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.659 -0.7 . . . . 0.56000000000000005 110.584 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.79 173.29 5.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.1299999999999999 111.45 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.84 124.12 90.42 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 115.874 -0.603 . . . . 0.46000000000000002 109.983 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HB2' HD11 ' A' ' 84' ' ' ILE . 53.8 Cg_exo -52.5 144.58 40.68 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.088 2.525 . . . . 0.53000000000000003 112.565 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 49.8 t-20 -50.69 116.96 7.64 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 2.1899999999999999 110.911 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 21.6 Cg_exo -66.6 -12.49 36.06 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.274 2.649 . . . . 0.54000000000000004 112.324 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.91 -13.84 73.95 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.852 -0.689 . . . . 0.51000000000000001 111.503 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.99 -31.18 11.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.19 . . . . 1.6000000000000001 110.876 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.3 mt -77.02 117.08 62.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.006 0.432 . . . . 0.52000000000000002 110.253 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 89.5 Cg_endo -78.26 162.12 28.57 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.409 2.74 . . . . 0.81000000000000005 113.583 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 t70 -50.57 -40.36 52.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.847 -1.069 . . . . 2.29 110.208 170.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.8 -7.54 54.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.312 -0.858 . . . . 1.25 112.884 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 31.1 t70 -115.0 -35.1 4.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 1.9399999999999999 111.771 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.27 -30.4 68.28 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.132 0.419 . . . . 0.54000000000000004 112.132 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 126' ' ' PRO . 2.8 t -102.86 29.25 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.009 0.433 . . . . 0.56000000000000005 111.04 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.14 -154.07 6.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.041 -1.076 . . . . 0.62 113.416 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.81 117.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.325 0.583 . . . . 1.23 111.015 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -106.75 165.87 10.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.505 -0.771 . . . . 0.63 109.259 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 44.8 t -113.97 133.71 59.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.35999999999999999 110.388 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.47 115.51 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.179 -1.045 . . . . 0.59999999999999998 108.179 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -121.36 125.18 46.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.405 0.622 . . . . 1.21 111.608 -170.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 42' ' ' ILE . 67.7 mt -95.74 108.82 21.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.104 -0.953 . . . . 0.33000000000000002 109.726 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' HG3' ' A' ' 108' ' ' ARG . 71.9 p -104.41 135.39 45.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.12 -0.491 . . . . 1.4199999999999999 109.716 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 35.6 t -109.29 118.51 36.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.371 0.605 . . . . 1.3200000000000001 109.988 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.4 m -97.51 119.5 36.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.965 -1.016 . . . . 0.5 110.537 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 69.8 t80 -117.35 117.43 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.72999999999999998 109.319 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 11.8 mmm180 69.26 15.6 8.53 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.361 0.413 . . . . 2.4500000000000002 110.952 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.01 2.59 66.35 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.56999999999999995 111.849 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -120.44 123.34 42.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.558 -0.534 . . . . 1.3100000000000001 109.558 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -83.41 128.34 34.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.753 0.311 . . . . 1.5900000000000001 110.33 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -105.45 -9.46 17.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.31 111.637 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.0 tt -153.75 147.63 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.082 0.468 . . . . 0.37 110.691 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.492 ' HG3' HG22 ' A' ' 98' ' ' THR . 41.6 ttp180 -140.51 112.35 7.57 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.652 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 59.5 t -88.21 109.76 20.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.673 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.76 108.14 3.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.759 -0.734 . . . . 0.27000000000000002 112.549 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.3 m-85 -108.9 134.45 51.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.019 0.437 . . . . 0.40000000000000002 110.491 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -97.97 114.35 26.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.163 -0.471 . . . . 0.78000000000000003 110.256 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.1 p -100.13 126.56 53.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.293 0.568 . . . . 1.1899999999999999 110.978 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 14.8 m120 -90.36 113.89 25.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.756 -0.656 . . . . 1.6299999999999999 109.737 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -97.97 108.56 21.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.486 0.66 . . . . 0.94999999999999996 109.839 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.6 175.18 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.714 -0.847 . . . . 1.97 108.714 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 90.4 m-85 -86.26 162.16 18.41 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.897 0.38 . . . . 0.68999999999999995 110.778 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.8 p -91.19 -40.2 11.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.61 . . . . 0.83999999999999997 111.052 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 46.4 mt-10 -77.89 136.25 38.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 2.2400000000000002 110.548 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.514 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.5 m -46.62 -51.96 14.65 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.915 0.76 . . . . 1.4099999999999999 112.354 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.73 -44.35 81.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 2.21 110.855 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.56 HD22 ' HG3' ' A' ' 127' ' ' PRO . 43.0 mt -72.49 -26.79 61.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.383 -0.372 . . . . 0.90000000000000002 110.734 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 60.8 mtp180 -71.82 -28.34 63.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 2.0299999999999998 109.738 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.9 mm-40 -71.87 -36.24 70.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.662 -0.699 . . . . 2.8399999999999999 110.758 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.58 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.34 122.75 1.82 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.361 -0.381 . . . . 2.1899999999999999 110.921 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.462 ' HG3' HG11 ' A' ' 90' ' ' VAL . 53.5 Cg_exo -56.44 127.74 27.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.637 2.225 . . . . 1.24 111.935 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HG3' HD22 ' A' ' 122' ' ' LEU . 32.3 Cg_exo -60.08 165.93 9.73 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.779 2.319 . . . . 1.1899999999999999 110.829 172.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.4 p -45.09 -34.69 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.393 0.433 . . . . 2.1600000000000001 111.533 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -131.65 131.95 23.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.285 -0.416 . . . . 1.96 110.095 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.62 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.0 Cg_endo -54.49 162.67 4.36 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.154 2.57 . . . . 0.70999999999999996 112.427 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -141.16 124.15 16.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.996 0.427 . . . . 1.28 110.501 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.518 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.7 m-85 -78.37 -20.46 51.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.512 -0.767 . . . . 0.5 111.358 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.401 ' HG ' ' HE2' ' A' ' 19' ' ' TYR . 53.1 m -80.94 -19.28 44.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.049 0.452 . . . . 1.46 110.684 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 33.0 mmtp -104.97 14.84 28.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.404 -0.591 . . . . 1.8700000000000001 109.404 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 89' ' ' ALA . 1.6 tp -99.81 129.56 45.92 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.601 0.715 . . . . 0.79000000000000004 111.536 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.479 HE21 ' HB3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -110.53 116.5 31.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.568 -1.196 . . . . 1.6299999999999999 108.683 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 17.6 mtm180 -85.31 108.13 17.65 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.335 -0.393 . . . . 2.8199999999999998 110.628 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 9.9 t30 -96.55 89.72 5.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.006 -0.543 . . . . 0.83999999999999997 109.707 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 58.8 mt -75.19 120.66 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.985 -0.552 . . . . 0.47999999999999998 110.902 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.471 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 65.6 mt -75.81 83.79 2.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.954 -0.566 . . . . 0.98999999999999999 110.887 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -78.24 -6.91 56.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.55000000000000004 110.162 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -76.76 -17.45 59.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.271 -0.877 . . . . 1.4199999999999999 110.424 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 140' ' ' LEU . 2.8 p-10 -133.47 78.39 62.89 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.409 0.623 . . . . 1.9099999999999999 111.003 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.99 107.22 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.806 2.337 . . . . 0.66000000000000003 111.55 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -78.12 98.79 5.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.687 -0.486 . . . . 3.1499999999999999 109.687 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.15 105.22 16.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.18 0.514 . . . . 1.1399999999999999 110.509 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.1 m -108.05 108.71 19.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.56000000000000005 109.678 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 38.2 ptt180 -106.4 137.83 43.68 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.747 -0.781 . . . . 3.0 110.399 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.75 148.47 25.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.076 -0.966 . . . . 0.46000000000000002 110.125 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -91.94 109.65 20.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.183 -0.673 . . . . 3.1400000000000001 109.183 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.441 ' H ' ' HE3' ' A' ' 1' ' ' MET . 31.3 pt -127.66 -176.52 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 109.916 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.8 112.87 25.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.86 -0.609 . . . . 1.78 109.681 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.5 -23.23 50.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.847 0.832 . . . . 0.87 109.09 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -103.41 153.95 19.94 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.227 -1.351 . . . . 2.3199999999999998 107.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' C ' HD22 ' A' ' 156' ' ' ASN . 13.0 p-10 -89.94 71.19 7.53 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.62 1.2 . . . . 2.4900000000000002 109.334 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-N 114.172 -1.376 . . . . 2.5699999999999998 109.733 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' HB2' ' A' ' 106' ' ' PHE . 43.3 ttp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.383 -0.229 . . . . 2.96 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.53 -84.47 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.8 -0.36 . . . . 1.48 111.867 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -87.09 -31.43 20.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.636 0.255 . . . . 0.97999999999999998 111.338 -177.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.472 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -131.42 144.93 36.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.942 0.401 . . . . 0.45000000000000001 110.135 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -142.64 112.82 7.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.725 -0.67 . . . . 1.3899999999999999 109.998 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 t -68.34 124.41 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.002 0.43 . . . . 1.3200000000000001 109.865 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.13 -75.11 0.57 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.95999999999999996 109.833 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -101.92 132.65 47.6 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.151 -0.931 . . . . 1.47 109.862 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -144.5 99.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.762 0.792 . . . . 1.01 110.318 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.9 151.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.729 -0.668 . . . . 1.54 110.933 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.19 122.99 64.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.793 -0.639 . . . . 0.91000000000000003 110.531 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.91 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.2 OUTLIER -97.67 156.18 16.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.1799999999999999 110.718 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t0 76.96 22.26 1.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.08 -0.963 . . . . 2.73 110.127 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.859 ' OD1' ' HB ' ' A' ' 139' ' ' ILE . 1.6 m120 -93.38 124.39 57.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.03 -0.987 . . . . 1.8799999999999999 111.609 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 10.8 Cg_endo -97.21 154.49 8.93 Favored 'Cis proline' 0 N--CA 1.461 -0.407 0 C-N-CA 124.869 -0.888 . . . . 0.59999999999999998 112.281 -8.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.5 m -152.58 161.18 29.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.568 -0.287 . . . . 0.77000000000000002 110.692 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -50.54 138.21 39.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.059 2.506 . . . . 0.82999999999999996 112.544 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 12.4 t80 -50.41 -23.59 2.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.317 1.229 . . . . 0.40999999999999998 114.317 -171.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.583 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 38.8 m-85 -81.38 10.14 6.14 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.012 -0.43 . . . . 0.65000000000000002 111.525 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -83.91 155.2 64.62 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 2.0699999999999998 110.039 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 7.7 Cg_exo -72.87 139.96 31.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.204 1.936 . . . . 0.62 111.743 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CE1' HG11 ' A' ' 95' ' ' VAL . 32.6 m-85 -66.52 102.31 0.88 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.38 -0.97 . . . . 0.57999999999999996 108.38 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.91 HE21 ' HB2' ' A' ' 12' ' ' LEU . 4.8 mt-30 -94.84 106.73 18.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.832 -0.622 . . . . 1.4099999999999999 110.243 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 84.9 m-85 -114.01 117.2 30.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.065 0.46 . . . . 0.5 110.693 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.65 ' HB2' HD21 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -93.94 91.47 6.92 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.5 mt -100.98 119.51 49.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.342 -0.845 . . . . 0.35999999999999999 111.529 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 m -113.62 106.08 14.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.028 -0.533 . . . . 0.46000000000000002 109.755 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 19.0 p90 -114.57 133.82 55.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.694 -0.484 . . . . 0.28000000000000003 109.694 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.823 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.4 tt0 -102.86 115.12 29.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.196 0.522 . . . . 0.77000000000000002 110.633 -175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 58.8 m -76.06 118.27 18.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.526 -0.761 . . . . 0.51000000000000001 109.419 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.07 -25.36 10.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.098 -0.704 . . . . 0.56999999999999995 109.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.3 169.96 16.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.999 -1.001 . . . . 1.8300000000000001 109.808 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.29 126.5 32.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 2.1800000000000002 109.824 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 65' ' ' VAL . 7.2 mp -88.23 143.44 27.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 1.52 111.566 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -91.55 -28.0 17.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.73 -0.668 . . . . 1.55 112.133 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 37' ' ' ASP . 6.3 tp10 -117.1 174.67 5.98 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.412 -0.218 . . . . 2.9500000000000002 110.412 -174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 4.3 m-20 -64.81 142.81 58.3 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.91 0.385 . . . . 1.8799999999999999 110.018 175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.64 HD12 ' NE1' ' A' ' 40' ' ' TRP . 1.2 tm? -100.64 119.81 39.11 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.234 -0.654 . . . . 1.3200000000000001 109.234 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 61' ' ' LEU . 33.3 tt0 -97.09 115.02 26.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.09 0.472 . . . . 0.92000000000000004 111.941 -173.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' NE1' HD12 ' A' ' 38' ' ' LEU . 80.3 m95 -107.96 116.21 31.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.719 -0.673 . . . . 0.42999999999999999 109.404 171.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 72.3 mttt -117.15 138.44 51.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.702 0.286 . . . . 1.23 111.281 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 9.3 mt -105.56 96.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.232 -0.655 . . . . 0.46000000000000002 109.232 170.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.885 HG12 HG22 ' A' ' 56' ' ' VAL . 53.9 mt -93.53 110.87 23.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.132 -0.692 . . . . 0.68999999999999995 109.132 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' HD1' HG12 ' A' ' 95' ' ' VAL . 49.9 t80 -92.2 142.51 27.4 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.058 -0.519 . . . . 0.58999999999999997 109.928 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.9 t -69.16 111.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.497 -0.557 . . . . 0.37 109.497 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.622 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.75 -55.7 16.13 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.269 -0.967 . . . . 0.46999999999999997 111.46 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.663 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 31.0 t -135.66 134.35 39.11 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.58 -0.156 . . . . 1.23 110.58 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.19 -5.15 59.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 0.81999999999999995 109.627 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.02 -38.6 15.35 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.182 -0.917 . . . . 1.99 108.576 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 47' ' ' SER . 68.3 m -143.23 100.81 3.7 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.452 -0.794 . . . . 1.72 108.915 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' SER . 38.9 mt-10 -71.27 -0.75 10.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 2.0899999999999999 111.366 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.82 -9.31 57.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.508 0.671 . . . . 2.8300000000000001 110.112 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.539 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 57.0 m-85 -90.05 10.75 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.687 -0.688 . . . . 1.48 111.418 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.622 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.0 p-10 -57.56 147.1 28.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.898 0.38 . . . . 1.22 110.669 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -136.83 133.26 35.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.232 0.539 . . . . 1.8500000000000001 111.322 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 43' ' ' ILE . 61.0 t -81.49 114.32 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 109.334 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.4 mt -66.74 -47.69 71.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 1.05 110.965 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.92 172.49 15.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 109.856 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.0 p -148.11 109.02 4.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.421 -0.585 . . . . 1.0900000000000001 109.421 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 40' ' ' TRP . 34.4 m -105.32 125.34 60.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.448 0.642 . . . . 1.22 110.939 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -107.76 107.09 17.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.96 -1.018 . . . . 1.3400000000000001 109.758 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -92.7 100.39 11.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.591 -0.844 . . . . 0.71999999999999997 109.211 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.63 120.35 6.24 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.878 -0.957 . . . . 0.41999999999999998 112.6 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 90.3 Cg_endo -99.33 167.84 9.84 Favored 'Cis proline' 0 N--CA 1.45 -1.043 0 CA-C-N 120.93 2.365 . . . . 0.55000000000000004 110.254 -14.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -102.86 112.72 65.95 Favored Pre-proline 0 C--N 1.315 -0.907 0 C-N-CA 120.384 -0.527 . . . . 0.94999999999999996 110.78 -178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.99 156.51 23.48 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.762 2.308 . . . . 0.69999999999999996 112.715 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -59.43 128.63 38.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.731 -0.668 . . . . 0.40999999999999998 110.79 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.9 158.72 7.94 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.294 -0.722 . . . . 0.33000000000000002 111.294 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.823 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 20.2 ttm180 -83.95 109.88 17.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.777 -0.453 . . . . 2.7799999999999998 109.777 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.39 120.55 40.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.987 -0.551 . . . . 0.62 111.059 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 40.2 ttp -96.84 105.28 17.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.391 -0.822 . . . . 1.8 110.157 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.3 143.92 50.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.37 110.674 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' HG2' ' A' ' 25' ' ' GLU . 9.7 m -98.34 130.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.338 0.589 . . . . 1.1200000000000001 110.98 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -105.66 129.15 53.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.394 -0.965 . . . . 0.44 108.394 176.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.6 mt-30 -133.24 132.67 41.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 1.1399999999999999 111.068 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -144.69 123.58 12.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.56000000000000005 109.983 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 3.7 p30 -71.62 -172.49 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.467 . . . . 2.1299999999999999 111.912 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -53.51 126.63 48.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.419 -0.81 . . . . 0.46000000000000002 112.369 -173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 17.1 Cg_exo -67.27 170.69 12.84 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.041 2.494 . . . . 0.53000000000000003 111.799 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.716 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 43.6 t-20 -53.44 111.18 2.5 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.702 -0.681 . . . . 2.1899999999999999 111.512 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.39 -10.65 28.53 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.317 2.678 . . . . 0.54000000000000004 112.231 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.0 -7.93 59.39 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.555 -0.618 . . . . 0.51000000000000001 111.555 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 10.2 mt -95.44 -26.92 15.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.6000000000000001 110.417 176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.3 mt -81.21 120.68 79.13 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.422 -0.584 . . . . 0.52000000000000002 109.422 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.663 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 71.7 Cg_endo -77.91 161.9 29.74 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.876 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.28 -31.43 72.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 2.29 111.824 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.04 -35.25 37.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.661 0.245 . . . . 1.25 111.661 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 85' ' ' PRO . 23.0 t70 -82.46 -33.94 28.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.518 -0.31 . . . . 1.9399999999999999 111.589 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.43 -27.79 64.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.54000000000000004 111.672 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.56 39.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.291 0.567 . . . . 0.56000000000000005 110.079 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.63 9.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.137 -1.03 . . . . 0.62 112.809 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.95 127.1 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.382 0.61 . . . . 1.23 110.83 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -122.98 167.02 14.13 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.95 -1.129 . . . . 0.63 107.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 136.54 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.069 -0.652 . . . . 0.35999999999999999 111.3 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG11 ' CE1' ' A' ' 22' ' ' PHE . 15.5 m -103.99 131.21 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.215 -0.661 . . . . 0.59999999999999998 109.215 170.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 38.2 mt -119.17 124.29 46.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.436 0.636 . . . . 1.21 111.121 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 49.7 mt -103.4 91.62 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.463 -0.939 . . . . 0.33000000000000002 108.463 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 9.7 t -96.34 134.4 39.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.594 -0.73 . . . . 1.4199999999999999 109.074 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 38' ' ' LEU . 36.8 t -115.75 120.63 39.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.741 -0.663 . . . . 1.3200000000000001 110.266 -174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.4 m -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.079 -0.964 . . . . 0.5 111.086 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 40.0 t80 -140.08 121.01 14.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.72999999999999998 109.238 172.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.3 mmm180 70.44 19.2 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.965 0.506 . . . . 2.4500000000000002 111.166 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.48 2.09 70.75 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.632 -0.794 . . . . 0.56999999999999995 111.762 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -121.6 121.36 37.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.841 -0.429 . . . . 1.3100000000000001 109.841 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 2.9 mp0 -76.18 137.07 39.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.469 -0.567 . . . . 1.5900000000000001 109.469 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 40.2 p90 -114.87 -9.73 12.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.314 . . . . 0.31 111.56 -178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.5 tt -155.85 149.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.889 -0.324 . . . . 0.37 110.303 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 48.7 ttp180 -143.15 111.67 6.31 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 109.999 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 79.3 t -87.03 123.4 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.832 -0.622 . . . . 0.38 110.675 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -112.29 112.68 3.09 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.631 -0.795 . . . . 0.27000000000000002 112.822 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 95' ' ' VAL . 28.7 m-85 -109.9 125.75 53.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.40000000000000002 110.357 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -86.23 114.03 22.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.945 -0.571 . . . . 0.78000000000000003 110.406 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.4 p -103.84 121.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.034 0.445 . . . . 1.1899999999999999 110.661 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 118.6 30.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.463 -0.569 . . . . 1.6299999999999999 109.463 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.504 ' HB3' HD21 ' A' ' 135' ' ' LEU . 44.5 m-80 -96.51 109.42 22.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.571 0.7 . . . . 0.94999999999999996 109.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -132.5 138.44 47.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.097 -0.956 . . . . 1.97 109.459 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 76.5 m-85 -56.31 158.16 4.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.582 0.706 . . . . 0.68999999999999995 112.32 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.9 p -86.86 -28.16 23.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.115 -0.948 . . . . 0.83999999999999997 110.244 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.2 mt-10 -88.52 134.72 33.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.527 -0.76 . . . . 2.2400000000000002 110.818 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 9.4 m -55.31 -43.96 75.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.789 -0.641 . . . . 1.4099999999999999 110.219 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.53 -36.75 72.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.635 -0.711 . . . . 2.21 111.662 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.45 -26.66 28.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.892 -0.323 . . . . 0.90000000000000002 111.218 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.1 mtp180 -74.79 -44.72 47.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.187 0.518 . . . . 2.0299999999999998 110.083 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.4 mm-40 -68.78 -34.99 76.49 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.349 -0.841 . . . . 2.8399999999999999 110.582 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -130.23 76.54 77.69 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 121.012 -0.275 . . . . 2.1899999999999999 110.363 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.73 114.18 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.451 2.101 . . . . 1.24 111.912 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.49 162.66 38.0 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.676 2.251 . . . . 1.1899999999999999 111.132 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.59 -36.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.482 . . . . 2.1600000000000001 110.265 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.0 mmtt -108.72 106.25 58.42 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.624 . . . . 1.96 110.099 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 14.0 Cg_endo -57.1 171.83 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.49 2.793 . . . . 0.70999999999999996 113.204 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.3 t70 -134.98 118.37 16.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.759 -0.655 . . . . 1.28 109.609 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 85.9 m-85 -78.62 -23.72 45.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.178 -0.465 . . . . 0.5 111.268 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -84.94 -5.2 59.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.057 0.456 . . . . 1.46 111.194 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 29.8 mmtp -119.75 10.13 11.57 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.652 0.739 . . . . 1.8700000000000001 109.136 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.2 tp -100.22 131.09 46.36 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.637 -1.165 . . . . 0.79000000000000004 109.314 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -107.73 128.19 54.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.595 -0.52 . . . . 1.6299999999999999 109.595 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.644 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 15.8 mtm180 -86.71 107.04 18.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.643 -0.423 . . . . 2.8199999999999998 109.97 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.665 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 6.1 t30 -98.38 85.59 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.021 -0.733 . . . . 0.83999999999999997 109.021 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.859 ' HB ' ' OD1' ' A' ' 14' ' ' ASN . 67.4 mt -74.38 123.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.333 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.71 91.96 7.1 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.127 -0.488 . . . . 0.98999999999999999 110.388 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.47 -11.7 59.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.214 0.53 . . . . 0.55000000000000004 110.159 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -83.84 1.22 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 1.4199999999999999 110.276 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -134.95 70.71 70.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 1.9099999999999999 110.218 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -87.2 109.42 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.107 2.538 . . . . 0.66000000000000003 111.717 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 81.75 8.59 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.702 -0.481 . . . . 3.1499999999999999 109.702 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.62 104.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.799 -0.637 . . . . 1.1399999999999999 110.29 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.3 m -123.24 107.95 12.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.298 0.57 . . . . 0.56000000000000005 110.169 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -103.72 166.66 10.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.346 -0.843 . . . . 3.0 110.681 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.06 156.03 37.26 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 109.532 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -103.78 115.06 29.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.921 -0.4 . . . . 3.1400000000000001 109.921 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.4 178.42 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.64000000000000001 111.098 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -106.25 122.86 47.07 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.125 -0.943 . . . . 1.78 108.951 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.3 m95 -81.49 -34.73 31.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.682 -0.69 . . . . 0.87 109.352 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.08 125.13 54.04 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.8 -1.185 . . . . 2.3199999999999998 107.8 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.474 ' C ' HD22 ' A' ' 156' ' ' ASN . 1.3 p30 -77.23 69.7 3.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.324 1.059 . . . . 2.4900000000000002 110.668 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.474 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.556 -1.202 . . . . 2.5699999999999998 108.984 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.472 0.177 . . . . 2.96 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -78.75 122.78 26.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 1.48 110.858 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -94.74 -26.94 16.06 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.264 -0.425 . . . . 0.97999999999999998 111.815 -178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.4 t -136.24 126.27 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.169 0.509 . . . . 0.45000000000000001 111.185 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB2' HD11 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -126.36 109.22 12.0 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.582 -0.896 . . . . 1.3899999999999999 108.582 174.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.0 t -70.0 104.62 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.794 -0.447 . . . . 1.3200000000000001 109.794 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.37 -72.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.599 0.714 . . . . 0.95999999999999996 109.921 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -102.44 128.66 48.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.901 -1.045 . . . . 1.47 109.992 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.54 98.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.947 0.879 . . . . 1.01 110.302 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 25' ' ' GLU . 29.4 m -91.88 151.43 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.086 -0.961 . . . . 1.54 110.672 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 141' ' ' ALA . 88.0 t -115.16 110.14 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.72 -0.673 . . . . 0.91000000000000003 110.213 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.656 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.1 mp -95.38 -170.81 2.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.855 -1.535 . . . . 1.1799999999999999 106.855 173.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' CG ' HH21 ' A' ' 137' ' ' ARG . 4.9 t70 70.8 -4.11 1.79 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.854 0.835 . . . . 2.73 110.468 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 26.3 t30 -104.16 121.22 48.37 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 121.526 -0.733 . . . . 1.8799999999999999 111.603 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 8.7 Cg_endo -95.35 141.47 6.33 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.122 -1.199 . . . . 0.59999999999999998 111.259 -13.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 49.1 m -146.5 166.97 15.01 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.612 0.227 . . . . 0.77000000000000002 111.612 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 52.9 Cg_exo -54.31 142.61 68.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.124 2.549 . . . . 0.82999999999999996 112.938 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 18.7 t80 -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.608 -0.724 . . . . 0.40999999999999998 112.229 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -80.41 2.9 23.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.507 0.67 . . . . 0.65000000000000002 111.305 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.29 144.15 27.34 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.292 -1.003 . . . . 2.0699999999999998 108.292 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.74 143.59 96.37 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.659 2.239 . . . . 0.62 114.108 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 18.6 m-85 -60.19 116.42 4.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.901 -0.778 . . . . 0.57999999999999996 108.901 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.656 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.5 tt0 -109.19 99.96 9.17 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.325 0.583 . . . . 1.4099999999999999 111.396 -172.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.13 149.62 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.5 110.248 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 35.3 tt0 -126.71 100.9 6.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.533 0.683 . . . . 1.98 109.441 173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 36.0 mt -96.78 122.94 48.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.061 -0.972 . . . . 0.35999999999999999 111.37 -172.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.9 m -110.73 104.98 13.7 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.551 -0.537 . . . . 0.46000000000000002 109.551 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 26.2 p90 -118.66 135.93 54.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.781 -0.452 . . . . 0.28000000000000003 109.781 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.2 tt0 -102.46 118.64 37.31 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.344 -0.389 . . . . 0.77000000000000002 110.078 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 82.0 m -75.77 107.27 7.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.79 -0.641 . . . . 0.51000000000000001 109.372 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 5' ' ' GLN . 19.2 mt -73.64 -35.8 45.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.757 0.789 . . . . 0.56999999999999995 109.062 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 45.1 mt-10 -133.3 173.74 11.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.518 -1.219 . . . . 1.8300000000000001 109.067 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.05 145.67 24.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.634 0.254 . . . . 2.1800000000000002 110.971 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 65' ' ' VAL . 9.8 mp -99.72 142.16 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 1.52 110.965 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.6 m -92.4 -40.35 10.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.139 -0.482 . . . . 1.55 110.646 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HG3' ' CD ' ' A' ' 102' ' ' ARG . 26.2 mm-40 -103.52 -170.89 1.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.585 . . . . 2.9500000000000002 110.591 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -87.69 148.03 24.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.826 -0.624 . . . . 1.8799999999999999 110.51 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -99.33 127.13 45.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.604 -0.517 . . . . 1.3200000000000001 109.604 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 34.5 tt0 -94.32 105.86 17.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.244 -0.435 . . . . 0.92000000000000004 111.076 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.497 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 79.3 m95 -94.94 110.03 21.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.903 -0.777 . . . . 0.42999999999999999 108.903 171.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.66 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 25.9 ttmt -125.68 137.56 53.86 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.275 -0.57 . . . . 1.23 110.669 -175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 97' ' ' ILE . 7.8 mt -104.24 108.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.161 0.505 . . . . 0.46000000000000002 110.195 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.629 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.7 mp -104.2 110.05 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 0.68999999999999995 109.325 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -95.99 129.75 43.18 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.25 -0.648 . . . . 0.58999999999999997 109.25 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 93' ' ' THR . 44.7 t -57.81 116.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -63.59 -52.29 47.28 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.424 -0.893 . . . . 0.46999999999999997 111.663 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.537 ' HB3' ' HG3' ' A' ' 85' ' ' PRO . 49.5 m -133.42 134.94 44.25 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.358 0.123 . . . . 1.23 111.017 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -20.11 59.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.858 -0.793 . . . . 0.81999999999999995 108.858 166.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.03 -50.32 62.42 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.911 -1.04 . . . . 1.99 109.465 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.1 t -134.94 104.44 5.97 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.49 -0.93 . . . . 1.72 108.49 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -69.08 -7.06 32.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.354 -0.839 . . . . 2.0899999999999999 111.202 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -79.7 -1.92 40.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 2.8300000000000001 110.187 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 22.1 m-85 -89.5 18.85 4.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 1.48 110.072 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.581 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 9.5 p-10 -58.77 140.67 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.9 -0.591 . . . . 1.22 110.278 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.96 165.07 25.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.242 0.544 . . . . 1.8500000000000001 111.774 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' ILE . 97.5 t -114.0 112.35 39.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.331 -0.85 . . . . 1.0800000000000001 110.003 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.652 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 8.3 mp -78.06 -54.74 5.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 1.05 111.026 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -151.46 161.59 42.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.002 -0.545 . . . . 1.3100000000000001 110.04 -177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 11.7 p -148.11 118.69 7.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 110.294 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.63 112.77 37.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 1.22 110.323 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.4 mm? -99.75 112.09 24.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 1.3400000000000001 110.38 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.47 102.07 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 119.773 -0.771 . . . . 0.71999999999999997 109.637 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.06 116.44 4.98 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-O 118.674 -1.07 . . . . 0.41999999999999998 112.294 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 54.9 Cg_endo -101.93 167.01 7.1 Favored 'Cis proline' 0 N--CA 1.448 -1.158 0 CA-C-N 120.967 2.383 . . . . 0.55000000000000004 110.35 -13.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -107.59 98.71 25.34 Favored Pre-proline 0 C--N 1.317 -0.837 0 C-N-CA 120.283 -0.567 . . . . 0.94999999999999996 110.542 -179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 12.0 Cg_exo -70.4 161.28 46.6 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.033 2.488 . . . . 0.69999999999999996 113.178 -175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -50.86 131.87 26.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.145 -0.934 . . . . 0.40999999999999998 111.777 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 141.83 152.14 5.66 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.505 -0.771 . . . . 0.33000000000000002 111.402 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.877 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 22.1 ttp180 -78.92 111.32 14.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.047 0.451 . . . . 2.7799999999999998 109.911 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -104.31 122.65 45.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.057 -0.52 . . . . 0.62 110.067 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ttt -104.83 99.74 9.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.596 -0.729 . . . . 1.8 109.804 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.2 p90 -125.83 159.41 32.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.37 110.329 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.74 140.98 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.013 0.435 . . . . 1.1200000000000001 110.581 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -116.89 120.56 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.307 -0.997 . . . . 0.44 108.307 178.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.7 mt-30 -131.77 118.93 20.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.904 0.383 . . . . 1.1399999999999999 110.675 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -120.35 151.21 39.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 0.56000000000000005 109.571 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 57' ' ' LEU . 3.5 t70 -77.67 -166.85 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.457 -0.497 . . . . 2.1299999999999999 110.644 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.32 133.91 80.43 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.635 0.255 . . . . 0.46000000000000002 110.996 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 50.3 Cg_exo -54.3 148.47 41.31 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.307 . . . . 0.53000000000000003 111.663 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -58.99 115.14 10.87 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.984 -0.553 . . . . 2.1899999999999999 110.42 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.5 -12.89 37.07 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.236 2.624 . . . . 0.54000000000000004 112.469 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.15 -9.22 82.58 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.51000000000000001 111.884 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.67 -18.86 13.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.101 . . . . 1.6000000000000001 111.254 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 79' ' ' PRO . 50.9 mt -82.54 120.46 76.74 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.666 -0.494 . . . . 0.52000000000000002 109.666 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.811 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 61.0 Cg_endo -78.02 161.27 29.85 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.038 2.492 . . . . 0.81000000000000005 113.12 -170.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.78 -56.34 18.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.746 -0.661 . . . . 2.29 111.565 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.21 -31.5 71.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 1.25 112.37 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 36.9 t70 -98.09 -10.63 23.96 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.657 -0.417 . . . . 1.9399999999999999 112.061 -173.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.17 -32.11 73.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.33 0.586 . . . . 0.54000000000000004 110.051 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.27 33.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.913 -0.773 . . . . 0.56000000000000005 108.913 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.87 -145.17 5.49 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.625 -0.797 . . . . 0.62 113.677 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.07 102.77 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 1.23 111.183 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -110.68 166.82 10.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.461 -0.57 . . . . 0.63 109.461 176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.8 t -111.44 140.23 31.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 122.061 -0.4 . . . . 0.35999999999999999 111.044 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.05 127.39 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.868 -0.79 . . . . 0.59999999999999998 108.868 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 35.0 mt -115.56 132.97 56.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.359 0.599 . . . . 1.21 111.167 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.559 HG12 HG12 ' A' ' 42' ' ' ILE . 70.9 mt -111.58 103.92 16.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.034 -0.985 . . . . 0.33000000000000002 109.088 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 t -104.45 143.86 32.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.15 0.5 . . . . 1.4199999999999999 110.266 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.491 ' HB3' HD11 ' A' ' 38' ' ' LEU . 29.8 m -113.38 108.77 17.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.474 -0.785 . . . . 1.3200000000000001 109.708 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -100.35 121.47 41.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.036 -176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 153' ' ' TRP . 1.7 t80 -119.5 123.02 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.104 -0.702 . . . . 0.72999999999999998 109.104 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.474 ' CD ' ' HG3' ' A' ' 36' ' ' GLU . 21.1 mmm-85 65.76 14.79 9.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.241 -0.436 . . . . 2.4500000000000002 111.421 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.42 12.87 64.36 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.485 -0.864 . . . . 0.56999999999999995 111.137 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.426 HE21 ' HB ' ' A' ' 151' ' ' ILE . 17.6 mt-30 -125.4 116.9 22.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 1.3100000000000001 109.599 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.1 mp0 -76.38 130.32 37.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.264 -0.272 . . . . 1.5900000000000001 110.264 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 35.6 p90 -107.16 -13.17 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.726 0.269 . . . . 0.31 111.726 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.7 tt -155.2 145.73 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.872 0.368 . . . . 0.37 110.492 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -138.72 118.64 13.3 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.835 -0.62 . . . . 1.1399999999999999 110.056 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.7 t -94.32 125.59 46.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.035 -0.529 . . . . 0.38 110.849 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.558 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -113.03 115.97 3.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.061 -0.59 . . . . 0.27000000000000002 112.525 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -115.12 128.57 56.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.898 0.38 . . . . 0.40000000000000002 110.278 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -82.28 117.16 22.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.331 -0.395 . . . . 0.78000000000000003 111.006 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.7 116.75 35.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.08 -0.509 . . . . 1.1899999999999999 110.498 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 12.9 m120 -89.44 106.99 18.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.418 -0.586 . . . . 1.6299999999999999 109.418 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.78 108.88 19.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.488 0.661 . . . . 0.94999999999999996 109.81 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 5.8 pt-20 -147.58 138.43 23.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.295 -0.866 . . . . 1.97 109.765 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.697 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 77.4 m-85 -58.6 159.14 6.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.334 0.587 . . . . 0.68999999999999995 112.233 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 136' ' ' GLN . 12.9 p -86.73 -36.42 18.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.83999999999999997 109.366 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 5.3 tt0 -76.79 123.6 26.45 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.569 -1.196 . . . . 2.2400000000000002 110.229 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.0 m -54.23 -42.29 69.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 1.4099999999999999 110.955 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -54.23 -43.51 70.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.95 -0.568 . . . . 2.21 110.925 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.54 -17.29 58.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.636 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 67.4 mtp85 -82.92 -39.98 20.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.058 -0.519 . . . . 2.0299999999999998 110.168 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 16.2 mm-40 -62.74 -39.62 94.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.715 . . . . 2.8399999999999999 110.765 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -149.68 88.15 4.98 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 121.15 0.5 . . . . 2.1899999999999999 110.509 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 88.6 Cg_exo -46.35 124.01 7.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.254 2.636 . . . . 1.24 112.733 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 31.5 Cg_exo -63.86 163.92 23.48 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.002 2.468 . . . . 1.1899999999999999 110.814 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.07 -62.76 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-O 121.246 0.546 . . . . 2.1600000000000001 111.017 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -91.39 127.08 52.29 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 115.556 -0.747 . . . . 1.96 109.383 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.697 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 30.2 Cg_endo -61.64 150.6 84.89 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.883 1.722 . . . . 0.70999999999999996 111.236 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 14.8 t70 -123.18 113.52 19.05 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.116 0.484 . . . . 1.28 110.528 -172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -75.13 -21.92 58.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.548 -0.751 . . . . 0.5 111.235 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -73.27 -24.2 60.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 1.46 110.715 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -109.14 6.72 25.1 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.174 -0.676 . . . . 1.8700000000000001 109.174 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.49 131.95 34.18 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.825 -1.079 . . . . 0.79000000000000004 111.01 -170.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.693 ' HB2' HG23 ' A' ' 118' ' ' THR . 25.1 tt0 -110.83 138.66 46.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 1.6299999999999999 109.334 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.577 HH21 ' CG ' ' A' ' 13' ' ' ASP . 21.1 mtm180 -102.3 113.56 26.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.251 -0.431 . . . . 2.8199999999999998 110.461 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.671 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 7.5 t30 -101.4 94.88 6.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.578 -0.737 . . . . 0.83999999999999997 109.146 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 37.0 mt -83.62 118.74 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.138 0.494 . . . . 0.47999999999999998 110.833 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.6 mt -72.26 87.44 1.12 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 110.55 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . . . -77.44 -17.06 58.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.497 . . . . 0.55000000000000004 110.784 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -84.47 2.75 39.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.4199999999999999 110.188 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -127.1 70.82 75.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.754 -0.657 . . . . 1.9099999999999999 109.999 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.43 106.39 0.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.804 2.336 . . . . 0.66000000000000003 112.215 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 12.5 mmm180 -79.37 81.95 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.929 -0.578 . . . . 3.1499999999999999 110.285 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.11 103.49 13.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.936 -0.575 . . . . 1.1399999999999999 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.8 m -112.47 107.37 16.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.997 -0.547 . . . . 0.56000000000000005 109.799 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.1 ptt180 -102.46 145.25 29.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.517 0.675 . . . . 3.0 110.326 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -110.33 167.59 10.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.835 -1.075 . . . . 0.46000000000000002 110.516 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -102.59 125.66 49.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.559 -0.534 . . . . 3.1400000000000001 109.559 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 35.1 pt -140.22 159.49 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.662 0.268 . . . . 0.64000000000000001 110.687 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -90.32 118.3 29.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.986 -1.487 . . . . 1.78 106.986 164.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.459 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 22.8 m95 -79.01 -11.0 59.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.664 -0.698 . . . . 0.87 112.142 -166.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB2' HD22 ' A' ' 156' ' ' ASN . 47.5 mm-40 -118.68 -149.09 0.43 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.069 -0.715 . . . . 2.3199999999999998 109.069 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.446 ' HB3' ' NH2' ' A' ' 102' ' ' ARG . 4.8 p-10 -120.06 79.46 1.46 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.745 0.783 . . . . 2.4900000000000002 109.47 171.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 154' ' ' GLU . 47.2 m-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.321 -0.847 . . . . 2.5699999999999998 110.487 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 tmm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.431 -0.211 . . . . 2.96 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB3' ' NE2' ' A' ' 5' ' ' GLN . . . -51.12 115.98 1.8 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.152 -0.476 . . . . 1.48 110.936 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -73.26 -8.27 55.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.97999999999999998 112.155 -172.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 28' ' ' PHE . 3.4 t -129.74 117.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.13 0.49 . . . . 0.45000000000000001 110.164 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 77.7 mm-40 -110.84 106.91 16.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.649 -0.705 . . . . 1.3899999999999999 110.445 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 28' ' ' PHE . 68.5 t -73.03 106.07 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 1.3200000000000001 109.1 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -97.78 -58.14 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 0.95999999999999996 111.22 -173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.752 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.8 t-20 -100.26 118.09 35.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.304 -0.407 . . . . 1.47 110.337 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.47 105.12 11.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.834 0.826 . . . . 1.01 110.602 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 25' ' ' GLU . 95.4 t -111.0 135.87 48.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.658 -0.701 . . . . 1.54 110.818 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.1 t -106.67 122.31 60.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.91000000000000003 109.801 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -104.68 157.28 17.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.754 -0.462 . . . . 1.1799999999999999 109.754 -178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.4 OUTLIER 64.9 27.72 12.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.492 1.139 . . . . 2.73 109.6 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 19.5 t30 -111.86 126.11 29.08 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.784 -1.553 . . . . 1.8799999999999999 109.636 168.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 88.5 Cg_endo -92.52 140.37 9.18 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.09 -1.212 . . . . 0.59999999999999998 112.381 -3.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.749 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 73.1 m -154.45 168.08 12.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.375 -0.375 . . . . 0.77000000000000002 111.239 -176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 10.9 Cg_endo -54.07 156.16 13.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.224 2.616 . . . . 0.82999999999999996 113.561 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.755 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 15.2 t80 -63.84 -29.04 70.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.712 -1.131 . . . . 0.40999999999999998 112.884 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.18 5.27 14.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.625 -0.43 . . . . 0.65000000000000002 112.088 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -96.22 147.65 33.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.762 -0.829 . . . . 2.0699999999999998 108.762 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.8 151.89 78.08 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.349 2.033 . . . . 0.62 112.996 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -70.97 100.51 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.25 -0.648 . . . . 0.57999999999999996 109.25 169.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.896 HE21 ' HB2' ' A' ' 12' ' ' LEU . 9.1 mt-30 -94.86 113.19 24.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 1.4099999999999999 110.69 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.54 128.03 51.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.193 -0.458 . . . . 0.5 110.96 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.008 ' HG3' HD11 ' A' ' 12' ' ' LEU . 50.3 mt-10 -96.98 95.29 7.71 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.1 mt -94.51 109.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.656 -0.702 . . . . 0.35999999999999999 111.302 -172.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 19.8 m -105.42 106.31 16.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.538 -0.756 . . . . 0.46000000000000002 110.007 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HE1' ' HD1' ' A' ' 72' ' ' PHE . 26.7 p90 -120.9 140.28 52.03 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.712 -0.677 . . . . 0.28000000000000003 109.423 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 43.7 tt0 -106.44 118.78 37.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.886 0.374 . . . . 0.77000000000000002 110.881 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 56.9 m -83.57 121.76 27.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.614 -0.721 . . . . 0.51000000000000001 109.201 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.09 -27.63 7.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.306 0.574 . . . . 0.56999999999999995 110.1 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.16 163.98 21.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.472 -0.785 . . . . 1.8300000000000001 109.055 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 118.67 21.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.802 -0.814 . . . . 2.1800000000000002 108.802 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.721 HD21 ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -102.21 129.59 48.64 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.893 -1.049 . . . . 1.52 110.195 -166.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m -92.0 -37.79 12.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.34 -0.391 . . . . 1.55 110.881 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -70.39 168.53 15.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 2.9500000000000002 110.394 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -90.89 146.53 23.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.047 0.451 . . . . 1.8799999999999999 110.599 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 HG21 ' A' ' 65' ' ' VAL . 1.1 mm? -94.51 122.63 37.29 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.752 -0.658 . . . . 1.3200000000000001 109.595 173.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.9 tt0 -95.28 91.84 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.483 . . . . 0.92000000000000004 110.383 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 38' ' ' LEU . 55.9 m95 -89.28 110.1 20.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.475 -0.565 . . . . 0.42999999999999999 109.475 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 59.6 mttt -112.41 141.41 46.18 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.844 -0.343 . . . . 1.23 111.238 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.6 mt -105.61 100.64 11.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.893 -0.78 . . . . 0.46000000000000002 108.893 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.59 HG12 HG22 ' A' ' 56' ' ' VAL . 58.7 mt -92.51 125.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.212 -0.662 . . . . 0.68999999999999995 109.212 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -111.44 126.92 55.46 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.837 -0.62 . . . . 0.58999999999999997 110.08 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 93' ' ' THR . 97.2 t -59.35 111.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.848 -0.614 . . . . 0.37 110.065 176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -64.34 -45.87 92.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.331 -0.938 . . . . 0.46999999999999997 111.532 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.562 ' HB3' ' O ' ' A' ' 50' ' ' SER . 42.5 t -147.93 130.29 15.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 120.81 0.338 . . . . 1.23 110.29 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.04 -8.65 57.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.419 0.628 . . . . 0.81999999999999995 109.699 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -96.46 -43.12 7.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.054 -0.976 . . . . 1.99 109.447 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 47' ' ' SER . 33.7 m -132.26 95.01 3.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 1.72 108.975 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.95 6.0 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.097 0.406 . . . . 2.0899999999999999 112.097 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.6 -18.63 62.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.87 0.843 . . . . 2.8300000000000001 109.085 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 25.5 m-85 -84.5 1.73 44.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.895 -1.048 . . . . 1.48 111.189 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 28.8 t70 -54.87 120.02 6.23 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.757 0.423 . . . . 1.22 110.526 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.27 123.99 41.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.31 0.576 . . . . 1.8500000000000001 112.081 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 58.7 t -74.14 111.91 10.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.978 -0.749 . . . . 1.0800000000000001 108.978 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 79' ' ' PRO . 33.3 mt -69.88 -62.35 1.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.302 -176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -147.47 158.11 43.85 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.501 -0.555 . . . . 1.3100000000000001 109.501 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 6.1 p -135.48 117.45 15.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.226 0.536 . . . . 1.0900000000000001 110.376 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.73 107.52 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.721 -0.672 . . . . 1.22 109.512 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' GLU . 22.6 mt -102.04 105.27 15.99 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.334 -0.617 . . . . 1.3400000000000001 109.334 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.89 101.28 11.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.586 0.708 . . . . 0.71999999999999997 111.091 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.26 132.11 10.97 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.845 -0.975 . . . . 0.41999999999999998 111.644 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 38.4 Cg_endo -99.42 168.69 9.71 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 121.028 2.414 . . . . 0.55000000000000004 109.821 -16.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.623 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.78 97.07 46.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 120.242 -0.583 . . . . 0.94999999999999996 111.471 -177.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.2 157.51 49.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.807 2.338 . . . . 0.69999999999999996 112.266 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.73 123.03 16.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.40999999999999998 110.748 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.09 159.94 9.71 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.507 -0.854 . . . . 0.33000000000000002 112.216 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.6 ttm180 -82.36 110.58 17.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.288 0.566 . . . . 2.7799999999999998 109.988 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' THR . 89.9 m-70 -107.56 155.42 20.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.494 -0.775 . . . . 0.62 110.419 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.3 ttm -137.94 113.06 9.2 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.284 -0.416 . . . . 1.8 109.896 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HD1' ' HE1' ' A' ' 28' ' ' PHE . 25.5 p90 -121.31 152.85 38.46 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.776 -0.453 . . . . 0.37 109.776 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.29 110.31 26.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.078 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.46 122.21 32.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 177.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -126.66 117.73 23.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.511 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -108.96 134.86 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.828 -0.624 . . . . 0.56000000000000005 109.6 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.46 172.64 6.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.49 -0.323 . . . . 2.1299999999999999 110.55 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 121.4 64.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 0.46000000000000002 110.994 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' HD11 ' A' ' 84' ' ' ILE . 61.8 Cg_exo -51.36 145.94 26.26 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.067 2.511 . . . . 0.53000000000000003 111.68 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 47.7 t30 -59.63 113.66 7.67 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.637 0.256 . . . . 2.1899999999999999 110.772 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 31.2 Cg_exo -61.29 -20.04 66.46 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.2 2.6 . . . . 0.54000000000000004 111.948 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.45 -22.88 76.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.9 -0.667 . . . . 0.51000000000000001 112.005 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -91.83 -34.55 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.852 -0.204 . . . . 1.6000000000000001 110.938 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 79' ' ' PRO . 27.7 mt -76.75 110.38 11.57 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.818 -0.438 . . . . 0.52000000000000002 109.818 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 5.3 Cg_exo -78.48 161.54 28.27 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.586 2.857 . . . . 0.81000000000000005 112.294 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.9 p-10 -59.08 -29.52 67.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.654 0.74 . . . . 2.29 110.447 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.02 62.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.852 -1.067 . . . . 1.25 111.972 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.836 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 22.7 t70 -106.13 -34.9 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.97 0.359 . . . . 1.9399999999999999 111.97 -173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.01 66.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.417 0.525 . . . . 0.54000000000000004 112.417 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 130' ' ' PRO . 2.7 t -100.58 39.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.215 0.531 . . . . 0.56000000000000005 110.138 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.87 -157.58 7.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.62 113.076 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.54 108.55 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.648 0.737 . . . . 1.23 111.262 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.588 HG22 ' HB ' ' A' ' 45' ' ' VAL . 3.0 m -103.24 166.61 10.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.362 -0.836 . . . . 0.63 108.94 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 21.2 t -116.74 136.62 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.899 -0.501 . . . . 0.35999999999999999 110.542 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 p -121.03 114.88 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.188 -1.041 . . . . 0.59999999999999998 108.188 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -122.31 131.23 53.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.389 0.614 . . . . 1.21 111.79 -170.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 54.5 mt -94.95 98.97 8.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.35 -0.841 . . . . 0.33000000000000002 109.205 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HD12 ' A' ' 96' ' ' LEU . 19.8 p -88.56 104.85 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.783 -0.644 . . . . 1.4199999999999999 110.277 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.8 m -84.74 106.82 16.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.8 -0.637 . . . . 1.3200000000000001 109.589 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.0 m -102.42 131.88 48.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.423 -0.808 . . . . 0.5 110.905 -173.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.721 ' CE1' HD21 ' A' ' 34' ' ' LEU . 78.6 t80 -138.78 129.44 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.356 -0.609 . . . . 0.72999999999999998 109.356 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 32.9 mmt180 67.81 14.22 9.39 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.408 0.283 . . . . 2.4500000000000002 110.618 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.82 84.57 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.885 -0.886 . . . . 0.56999999999999995 110.885 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -112.86 124.55 52.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.933 -0.633 . . . . 1.3100000000000001 109.944 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 19.0 mt-10 -80.77 127.76 32.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.201 -0.454 . . . . 1.5900000000000001 109.889 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 37.9 p90 -107.55 -14.12 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.279 -0.419 . . . . 0.31 111.51 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.8 tt -155.24 141.63 11.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.114 0.483 . . . . 0.37 109.924 174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -130.06 116.69 18.88 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.624 -0.716 . . . . 1.1399999999999999 109.782 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 62.9 t -89.1 102.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.094 -0.503 . . . . 0.38 110.593 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.99 103.97 3.08 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.626 -0.797 . . . . 0.27000000000000002 112.482 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 17.7 m-85 -102.41 122.41 44.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.40000000000000002 110.187 173.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -86.59 110.67 19.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.167 -0.469 . . . . 0.78000000000000003 110.112 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.21 126.02 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.382 0.61 . . . . 1.1899999999999999 110.909 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 138' ' ' ASN . 11.2 m120 -92.07 108.6 20.06 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.969 -0.752 . . . . 1.6299999999999999 108.969 176.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 135' ' ' LEU . 40.2 m-80 -96.67 107.98 20.52 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.949 -0.7 . . . . 0.94999999999999996 109.815 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.5 156.26 43.13 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.204 -0.907 . . . . 1.97 108.594 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.636 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 58.0 m-85 -60.13 153.35 22.1 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.68999999999999995 112.634 -169.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.649 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 17.1 p -79.73 -27.49 40.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.162 -0.926 . . . . 0.83999999999999997 109.133 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 2.1 mm-40 -82.82 122.68 28.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.401 . . . . 2.2400000000000002 109.51 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 7.1 m -53.48 -38.88 64.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.063 0.459 . . . . 1.4099999999999999 109.92 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.94 -43.21 77.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.448 -0.796 . . . . 2.21 111.372 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.34 -22.08 32.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.803 -0.359 . . . . 0.90000000000000002 110.77 -174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 123' ' ' ARG . 43.1 mtp180 -70.78 -40.9 72.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.389 0.614 . . . . 2.0299999999999998 109.627 173.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 120' ' ' THR . 60.8 mm-40 -70.09 -39.51 75.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.918 -1.037 . . . . 2.8399999999999999 110.758 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -128.14 79.69 73.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.612 -0.267 . . . . 2.1899999999999999 110.784 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 52.9 Cg_exo -56.63 117.88 4.62 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.622 2.215 . . . . 1.24 111.809 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.4 Cg_exo -69.47 163.66 37.18 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.957 2.438 . . . . 1.1899999999999999 112.07 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.79 -24.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.202 -0.454 . . . . 2.1600000000000001 111.216 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 36.8 mmtm -131.15 119.72 17.88 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.247 -0.433 . . . . 1.96 110.228 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.636 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.4 Cg_endo -60.03 166.8 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.076 2.517 . . . . 0.70999999999999996 112.807 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 24.3 t70 -141.52 118.92 11.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 1.28 110.38 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.755 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 57.7 m-85 -71.65 -18.62 62.18 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.206 -0.906 . . . . 0.5 110.939 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.34 -18.23 57.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.968 -0.56 . . . . 1.46 111.206 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.3 mmtt -117.76 5.68 12.29 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.22 -0.659 . . . . 1.8700000000000001 109.22 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 115' ' ' ASN . 15.0 tp -92.03 127.5 37.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.813 -1.085 . . . . 0.79000000000000004 110.295 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.649 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 25.3 tt0 -102.75 130.29 49.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.086 -0.506 . . . . 1.6299999999999999 110.013 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 115' ' ' ASN . 29.5 mtm-85 -89.26 106.51 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.55 -0.537 . . . . 2.8199999999999998 109.55 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 114' ' ' ASN . 6.4 t30 -95.07 87.51 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.288 -0.634 . . . . 0.83999999999999997 109.288 174.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.511 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -72.21 117.57 15.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.031 -0.986 . . . . 0.47999999999999998 110.268 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -73.68 79.35 1.53 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.161 0.505 . . . . 0.98999999999999999 110.895 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -74.94 -13.95 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.55000000000000004 109.796 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -71.93 -18.43 62.02 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.286 -0.87 . . . . 1.4199999999999999 110.312 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -132.25 82.19 58.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.024 0.44 . . . . 1.9099999999999999 110.276 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.95 110.22 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.813 2.342 . . . . 0.66000000000000003 110.901 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -82.16 81.98 7.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.271 0.558 . . . . 3.1499999999999999 109.53 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.66 105.94 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.596 -0.729 . . . . 1.1399999999999999 110.48 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 m -110.44 111.14 22.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.811 -0.632 . . . . 0.56000000000000005 109.384 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 37.0 ptt180 -114.8 138.89 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.894 0.854 . . . . 3.0 111.181 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.09 164.76 11.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.941 -1.481 . . . . 0.46000000000000002 110.815 -169.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.14 110.5 22.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 3.1400000000000001 109.539 172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -123.65 -175.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.937 0.399 . . . . 0.64000000000000001 110.393 -177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.49 119.45 39.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.109 -0.7 . . . . 1.78 109.109 172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -84.15 -11.78 56.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.472 -0.785 . . . . 0.87 109.798 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.11 145.28 51.93 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 106.991 -1.485 . . . . 2.3199999999999998 106.991 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -73.24 72.79 1.27 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.54 1.162 . . . . 2.4900000000000002 109.104 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--O 1.244 0.788 0 CA-C-N 113.61 -1.632 . . . . 2.5699999999999998 110.619 -167.771 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.905 0.383 . . . . 2.96 110.887 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.64 133.41 39.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 1.48 110.849 -175.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.899 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -92.51 -14.52 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.131 -0.486 . . . . 0.97999999999999998 110.044 176.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 38' ' ' LEU . 2.5 t -141.33 124.51 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.488 -0.778 . . . . 0.45000000000000001 109.551 177.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -122.51 109.26 14.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.151 -0.477 . . . . 1.3899999999999999 109.94 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 55.1 t -73.93 115.16 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -102.69 -63.92 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.335 -0.393 . . . . 0.95999999999999996 111.056 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.2 t-20 -101.11 127.31 47.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 1.47 110.098 -175.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.99 125.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.875 0.369 . . . . 1.01 110.444 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.15 151.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 1.54 111.198 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 139' ' ' ILE . 19.5 t -110.5 118.19 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.91000000000000003 110.412 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -87.93 -31.2 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.214 0.53 . . . . 1.1799999999999999 112.115 -176.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' SER . 4.7 p-10 -77.16 16.25 0.6 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.972 0.73 . . . . 2.73 112.972 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 139' ' ' ILE . 4.6 p30 -131.61 141.3 41.17 Favored Pre-proline 0 C--N 1.32 -0.676 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.443 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.7 Cg_endo -85.55 125.15 8.83 Favored 'Cis proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.437 -1.484 . . . . 0.59999999999999998 111.727 -4.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.566 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 54.9 m -152.14 160.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.206 -0.452 . . . . 0.77000000000000002 110.029 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 24.6 Cg_endo -60.84 159.05 30.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.926 2.417 . . . . 0.82999999999999996 113.27 -174.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.661 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 28.0 t80 -61.45 -35.84 78.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.462 -0.79 . . . . 0.40999999999999998 112.019 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 50.2 m-85 -82.2 13.24 3.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.086 0.469 . . . . 0.65000000000000002 111.628 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.63 140.83 22.36 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.148 -1.056 . . . . 2.0699999999999998 108.148 170.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.81 139.93 37.65 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.287 1.991 . . . . 0.62 112.725 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 59.5 m-85 -59.62 133.13 55.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.726 -0.472 . . . . 0.57999999999999996 109.726 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.609 ' HB3' HD23 ' A' ' 12' ' ' LEU . 47.4 mt-30 -124.42 109.34 13.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.865 -0.607 . . . . 1.4099999999999999 109.932 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.37 121.83 39.45 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.224 -0.444 . . . . 0.5 110.883 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.003 ' HG3' HD21 ' A' ' 12' ' ' LEU . 40.3 mt-10 -94.94 98.64 10.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.521 -0.918 . . . . 1.98 108.521 173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 76.9 mt -97.91 111.68 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.35999999999999999 111.045 -173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 13.6 m -104.02 105.42 15.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.805 -0.634 . . . . 0.46000000000000002 109.938 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.8 p90 -121.88 134.69 54.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.193 0.52 . . . . 0.28000000000000003 109.689 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.819 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.8 tt0 -104.42 116.88 32.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.114 -0.494 . . . . 0.77000000000000002 110.045 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 60.8 m -75.28 108.21 7.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.232 -0.655 . . . . 0.51000000000000001 109.232 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.82 -23.11 17.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.712 0.768 . . . . 0.56999999999999995 109.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.899 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 49.1 mm-40 -137.22 175.77 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.683 -1.144 . . . . 1.8300000000000001 109.239 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -91.45 135.25 33.97 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 2.1800000000000002 109.078 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HE2' ' A' ' 101' ' ' TYR . 6.1 mp -100.55 141.8 32.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.093 0.473 . . . . 1.52 111.167 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -80.06 -45.17 18.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.57 -0.741 . . . . 1.55 110.308 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.26 174.55 6.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.658 -0.701 . . . . 2.9500000000000002 111.026 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.42 138.39 31.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.561 -0.745 . . . . 1.8799999999999999 110.244 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 9.7 mt -81.92 123.81 29.18 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 116.183 -0.462 . . . . 1.3200000000000001 110.837 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.887 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 39.7 tt0 -90.02 98.82 11.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.042 -0.526 . . . . 0.92000000000000004 109.909 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 61.3 m95 -93.9 111.96 23.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.443 -0.577 . . . . 0.42999999999999999 109.443 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 88.8 mttt -115.06 144.68 43.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.803 0.335 . . . . 1.23 111.434 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 13.1 mt -105.07 97.84 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.107 -0.701 . . . . 0.46000000000000002 109.107 168.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.921 HG12 HG22 ' A' ' 56' ' ' VAL . 55.9 mt -90.73 106.86 17.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.423 -0.584 . . . . 0.68999999999999995 109.423 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -94.86 133.38 38.64 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.46 -0.571 . . . . 0.58999999999999997 109.46 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.638 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.4 t -57.23 118.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.485 -0.325 . . . . 0.37 110.491 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -69.79 -67.94 1.78 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.593 -0.813 . . . . 0.46999999999999997 111.747 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.888 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.4 t -126.97 147.66 50.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.656 0.265 . . . . 1.23 110.527 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 85' ' ' PRO . . . -84.76 -24.79 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.218 -0.66 . . . . 0.81999999999999995 109.218 170.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.56 -41.84 98.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.934 -1.03 . . . . 1.99 108.541 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 43.9 t -143.08 108.13 4.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.936 -1.029 . . . . 1.72 108.815 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.77 4.54 7.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.162 -0.472 . . . . 2.0899999999999999 111.161 -177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.95 -8.46 59.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 2.8300000000000001 109.763 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 24.1 m-85 -86.88 26.12 1.19 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.119 -0.492 . . . . 1.48 110.132 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 2.8 p30 -57.42 143.38 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 1.22 110.18 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -129.52 110.13 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.426 0.631 . . . . 1.8500000000000001 111.477 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.921 HG22 HG12 ' A' ' 43' ' ' ILE . 83.9 t -69.07 119.52 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.233 -0.894 . . . . 1.0800000000000001 109.477 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 79' ' ' PRO . 87.9 mt -71.87 -58.43 3.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.879 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -150.37 160.04 44.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.327 -0.851 . . . . 1.3100000000000001 109.146 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.477 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.5 p -133.11 114.58 14.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.257 0.551 . . . . 1.0900000000000001 110.338 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.0 111.46 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.626 -0.716 . . . . 1.22 109.503 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.887 ' HG ' ' HA ' ' A' ' 39' ' ' GLU . 7.0 mp -111.61 110.32 20.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 110.47 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.95 103.44 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.17 0.51 . . . . 0.71999999999999997 110.763 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.36 131.02 10.46 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.357 -0.838 . . . . 0.41999999999999998 112.271 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 92.2 Cg_endo -97.47 166.21 12.76 Favored 'Cis proline' 0 N--CA 1.453 -0.875 0 CA-C-N 120.158 1.979 . . . . 0.55000000000000004 109.822 -18.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.777 HG21 ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -102.73 109.45 61.07 Favored Pre-proline 0 C--N 1.315 -0.92 0 C-N-CA 120.372 -0.531 . . . . 0.94999999999999996 110.667 -176.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.87 152.72 16.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.39 2.727 . . . . 0.69999999999999996 112.7 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -53.55 130.07 34.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.344 -0.844 . . . . 0.40999999999999998 111.495 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.18 157.38 7.14 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.33000000000000002 110.936 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 ttp180 -83.82 114.65 21.78 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.346 0.573 . . . . 2.7799999999999998 110.485 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.96 141.24 37.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.442 -0.799 . . . . 0.62 109.511 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.7 ttt -128.26 106.45 9.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.973 -0.38 . . . . 1.8 109.973 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -120.31 152.09 38.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.006 0.432 . . . . 0.37 110.7 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.24 105.19 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.741 -0.663 . . . . 1.1200000000000001 109.999 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -84.18 121.0 26.85 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.832 -0.803 . . . . 0.44 108.832 177.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 48.6 mt-30 -130.17 144.07 51.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.069 0.461 . . . . 1.1399999999999999 110.684 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -151.03 138.67 19.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.74 -0.664 . . . . 0.56000000000000005 110.149 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -70.54 172.39 8.59 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.348 0.405 . . . . 2.1299999999999999 111.065 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -56.31 132.81 75.9 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 115.955 -0.566 . . . . 0.46000000000000002 112.427 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 17.1 Cg_endo -59.64 178.99 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.264 2.643 . . . . 0.53000000000000003 112.623 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 42.9 t-20 -78.72 117.07 64.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.123 -0.49 . . . . 2.1899999999999999 110.185 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 16.4 Cg_exo -68.32 -14.25 39.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.08 2.52 . . . . 0.54000000000000004 112.049 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.28 -7.88 86.05 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.962 -0.637 . . . . 0.51000000000000001 111.953 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.86 -30.86 11.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.579 0.228 . . . . 1.6000000000000001 110.674 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 55.8 mt -73.37 121.82 86.08 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.287 -0.415 . . . . 0.52000000000000002 110.738 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.888 ' HD3' ' HA ' ' A' ' 47' ' ' SER . 42.3 Cg_endo -73.97 146.99 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.99 2.46 . . . . 0.81000000000000005 112.461 -175.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.33 -34.47 72.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.36 -0.837 . . . . 2.29 111.023 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -38.09 65.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.879 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 25.2 t70 -89.68 -20.4 23.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.754 -0.378 . . . . 1.9399999999999999 111.485 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' O ' HD21 ' A' ' 135' ' ' LEU . . . -59.44 -30.09 68.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.54000000000000004 110.968 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.28 34.87 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.56000000000000005 109.437 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.28 -130.64 1.97 Allowed Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.712 -0.756 . . . . 0.62 113.212 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.37 109.27 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-O 121.572 0.701 . . . . 1.23 111.739 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.638 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.3 m -100.66 164.95 11.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.358 -0.837 . . . . 0.63 109.282 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 41.4 t -114.58 138.73 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 122.067 -0.396 . . . . 0.35999999999999999 110.391 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.5 p -123.35 112.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.498 -0.927 . . . . 0.59999999999999998 108.498 175.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.0 pp -120.96 128.47 52.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.474 0.654 . . . . 1.21 112.083 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 66.5 mt -95.37 113.36 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.128 -0.942 . . . . 0.33000000000000002 110.016 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -102.34 143.24 32.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.877 -0.602 . . . . 1.4199999999999999 110.371 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.21 112.81 19.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.955 -0.566 . . . . 1.3200000000000001 110.428 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.6 m -95.94 131.53 42.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.852 -0.613 . . . . 0.5 111.9 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t80 -135.84 116.73 14.15 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.73 -0.841 . . . . 0.72999999999999998 108.73 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.777 ' HG2' ' HD1' ' A' ' 101' ' ' TYR . 41.9 mmt180 68.17 23.24 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.015 0.436 . . . . 2.4500000000000002 110.378 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.9 -12.95 51.36 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.189 -0.765 . . . . 0.56999999999999995 111.189 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.77 113.39 24.94 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.024 -0.588 . . . . 1.3100000000000001 109.624 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.35 130.92 41.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.303 -0.408 . . . . 1.5900000000000001 109.935 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 29.5 p90 -106.17 -14.58 15.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.305 0.483 . . . . 0.31 112.305 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.2 tt -155.96 151.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 110.106 -0.331 . . . . 0.37 110.106 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -143.98 119.35 10.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.003 -0.544 . . . . 1.1399999999999999 110.049 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.5 t -97.39 107.9 20.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.92 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.89 113.48 4.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.914 -0.66 . . . . 0.27000000000000002 112.38 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 95' ' ' VAL . 16.4 m-85 -107.3 134.52 50.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.973 0.416 . . . . 0.40000000000000002 110.41 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -99.11 112.98 24.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.78000000000000003 110.305 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 139' ' ' ILE . 2.4 p -102.63 121.82 54.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.044 0.45 . . . . 1.1899999999999999 110.876 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -93.79 118.78 31.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.312 -0.625 . . . . 1.6299999999999999 109.312 175.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 43.6 m-80 -103.82 123.98 48.08 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.256 0.551 . . . . 0.94999999999999996 110.425 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -146.26 154.06 41.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.378 -0.828 . . . . 1.97 109.323 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 70.8 m-85 -59.27 147.6 35.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.146 0.498 . . . . 0.68999999999999995 111.964 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.3 p -79.6 -40.69 28.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.28 -0.873 . . . . 0.83999999999999997 110.598 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 45.5 mt-10 -78.95 137.07 37.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.292 -0.867 . . . . 2.2400000000000002 110.828 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.559 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 54.7 m -55.48 -44.56 76.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.612 -0.722 . . . . 1.4099999999999999 111.142 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.28 -34.64 75.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.483 0.182 . . . . 2.21 111.223 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.22 -21.17 56.72 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.539 -0.464 . . . . 0.90000000000000002 110.087 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 28.3 mtp-105 -82.91 -32.35 27.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.509 -0.552 . . . . 2.0299999999999998 109.509 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.1 mm-40 -58.41 -47.06 85.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.437 -0.801 . . . . 2.8399999999999999 109.989 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.49 96.7 6.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.893 -0.594 . . . . 2.1899999999999999 110.629 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.13 119.79 7.26 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.428 2.085 . . . . 1.24 111.271 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.456 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 31.5 Cg_exo -60.16 163.25 14.8 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.842 2.361 . . . . 1.1899999999999999 112.005 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' H ' HG23 ' A' ' 128' ' ' VAL . 2.7 t -51.9 -53.52 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 O-C-N 123.678 0.611 . . . . 2.1600000000000001 110.338 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 72.6 mmtt -103.71 116.24 62.17 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.751 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 129' ' ' LYS . 9.6 Cg_endo -51.37 150.51 15.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.162 2.575 . . . . 0.70999999999999996 111.701 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 6.7 t70 -114.06 111.77 22.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.926 -0.579 . . . . 1.28 110.405 -169.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.661 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 61.6 m-85 -77.27 -23.71 51.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.5 109.996 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.0 t -73.08 -25.65 60.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.507 -0.769 . . . . 1.46 110.235 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 42.8 mmtm -115.02 18.06 16.53 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.264 0.555 . . . . 1.8700000000000001 109.643 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 89' ' ' ALA . 6.7 tp -97.75 126.91 43.34 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.405 -0.816 . . . . 0.79000000000000004 110.362 -175.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.464 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 13.6 tt0 -103.84 124.63 49.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.693 -0.685 . . . . 1.6299999999999999 109.782 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 31.5 mtm-85 -87.99 111.08 21.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.072 -0.513 . . . . 2.8199999999999998 110.514 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.87 88.41 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.745 -0.835 . . . . 0.83999999999999997 108.745 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 113' ' ' VAL . 45.8 mt -79.62 121.23 32.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.47999999999999998 110.593 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.05 83.18 2.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.672 -0.695 . . . . 0.98999999999999999 110.748 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.09 -18.46 60.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.05 -0.523 . . . . 0.55000000000000004 110.712 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -77.39 -10.13 59.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 1.4199999999999999 110.576 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -137.05 85.3 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 1.9099999999999999 110.027 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -89.64 158.13 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.737 2.291 . . . . 0.66000000000000003 112.336 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -116.4 90.12 3.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.797 -0.638 . . . . 3.1499999999999999 109.617 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.73 104.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.204 0.526 . . . . 1.1399999999999999 110.339 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 m -110.91 108.1 17.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 109.772 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.0 ptt180 -102.46 146.46 28.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.202 -0.599 . . . . 3.0 109.926 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.02 151.74 28.98 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.928 -1.033 . . . . 0.46000000000000002 109.633 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -98.99 109.87 22.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.556 -0.535 . . . . 3.1400000000000001 109.556 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 23.8 pt -129.82 -175.52 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.402 -175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -108.57 110.91 22.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.564 0.697 . . . . 1.78 110.069 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . 26.8 m95 -76.88 2.69 13.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.232 -0.895 . . . . 0.87 111.002 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -131.02 158.75 39.46 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.818 -0.808 . . . . 2.3199999999999998 108.818 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.78 74.49 6.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.355 0.598 . . . . 2.4900000000000002 109.994 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.455 -0.793 . . . . 2.5699999999999998 109.646 175.513 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.31 0.1 . . . . 2.96 110.966 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.34 103.49 6.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.268 0.556 . . . . 1.48 109.782 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.666 ' HG2' ' HB2' ' A' ' 32' ' ' GLU . 37.1 mttm -91.37 -8.41 48.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.236 -0.893 . . . . 0.97999999999999998 111.476 -172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -141.55 122.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.184 -0.673 . . . . 0.45000000000000001 109.184 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -126.59 104.03 7.9 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.905 -0.589 . . . . 1.3899999999999999 110.09 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 m -68.63 147.54 12.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.449 -0.575 . . . . 1.3200000000000001 109.449 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -134.29 -61.37 0.78 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.95999999999999996 110.734 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.598 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -102.35 101.34 11.57 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.728 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.83 120.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.211 0.529 . . . . 1.01 110.241 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 m -126.08 148.7 30.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.821 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 139' ' ' ILE . 42.2 t -105.83 127.47 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.707 -0.679 . . . . 0.91000000000000003 110.077 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.9 mp -116.78 176.25 5.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.102 -0.499 . . . . 1.1799999999999999 109.973 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 1.011 ' HB2' HE21 ' A' ' 23' ' ' GLN . 4.7 t70 70.0 -1.47 2.38 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.877 0.871 . . . . 2.73 111.637 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -107.64 148.62 37.64 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.962 -0.385 . . . . 1.8799999999999999 109.962 177.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 6.5 Cg_endo -88.85 144.6 20.76 Favored 'Cis proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.044 -1.232 . . . . 0.59999999999999998 111.95 -3.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 70.0 m -148.07 167.9 12.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.474 -0.33 . . . . 0.77000000000000002 110.497 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 134.48 64.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.222 1.948 . . . . 0.82999999999999996 111.149 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 1.7 t80 -38.9 -32.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.153 1.538 . . . . 0.40999999999999998 115.153 -169.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.56 -2.9 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.095 0.407 . . . . 0.65000000000000002 112.055 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OD2' ' A' ' 13' ' ' ASP . 3.6 p-10 -77.5 139.97 63.98 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.778 -0.453 . . . . 2.0699999999999998 109.778 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 59.3 Cg_endo -77.02 158.78 34.21 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.642 2.228 . . . . 0.62 113.103 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 75.2 m-85 -74.51 104.12 5.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.526 -0.761 . . . . 0.57999999999999996 109.243 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.011 HE21 ' HB2' ' A' ' 13' ' ' ASP . 9.0 tt0 -104.23 110.97 23.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.75 -0.659 . . . . 1.4099999999999999 110.786 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 92.4 m-85 -120.02 139.84 51.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.5 111.045 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HG2' HG22 ' A' ' 73' ' ' VAL . 26.0 mt-10 -110.16 101.73 10.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.447 -0.945 . . . . 1.98 108.447 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.86 120.34 52.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.569 -0.741 . . . . 0.35999999999999999 111.452 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -107.99 106.59 16.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.531 -0.758 . . . . 0.46000000000000002 110.059 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 21.4 p90 -119.64 135.08 54.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.201 0.524 . . . . 0.28000000000000003 110.07 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -106.08 112.3 25.28 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.697 -0.683 . . . . 0.77000000000000002 109.636 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 61.6 m -75.02 115.77 15.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.012 -0.54 . . . . 0.51000000000000001 109.794 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.2 mt -80.27 -22.66 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.518 0.675 . . . . 0.56999999999999995 109.531 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -138.19 -179.06 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.103 -0.953 . . . . 1.8300000000000001 109.22 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.71 141.87 27.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.411 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 101' ' ' TYR . 8.1 mp -103.08 130.86 50.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.985 -0.552 . . . . 1.52 109.904 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 t -95.95 -5.05 42.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.093 0.473 . . . . 1.55 110.476 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 31.9 tt0 -119.54 169.92 9.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.398 -0.593 . . . . 2.9500000000000002 109.398 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 2.1 m-20 -80.92 124.77 29.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.973 -0.751 . . . . 1.8799999999999999 108.973 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 19.5 tp -82.48 117.49 22.54 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.306 -0.557 . . . . 1.3200000000000001 110.012 -177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.3 tt0 -94.05 108.61 20.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 0.92000000000000004 111.217 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -92.27 110.37 21.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.953 -0.758 . . . . 0.42999999999999999 108.953 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 26.7 ttmt -115.34 138.43 50.98 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.226 -0.443 . . . . 1.23 110.83 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG13 ' CE2' ' A' ' 74' ' ' PHE . 54.5 mt -103.86 103.0 14.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.242 0.544 . . . . 0.46000000000000002 109.751 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 67.6 mt -95.96 109.3 22.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.542 -0.91 . . . . 0.68999999999999995 108.542 172.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 39.5 t80 -95.38 136.72 35.39 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.801 -0.76 . . . . 0.58999999999999997 109.767 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.05 111.3 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.37 109.451 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.664 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -69.01 -56.7 8.63 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.204 -0.998 . . . . 0.46999999999999997 110.822 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.785 ' HB3' ' O ' ' A' ' 50' ' ' SER . 47.7 t -126.58 138.7 53.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.937 0.398 . . . . 1.23 110.598 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -88.89 -12.04 42.88 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.81999999999999995 108.624 172.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.64 -44.18 17.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.587 -1.188 . . . . 1.99 109.117 173.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 47' ' ' SER . 44.5 t -144.72 110.93 5.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 1.72 109.858 174.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.89 7.53 3.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 2.0899999999999999 111.441 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.33 -19.26 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.503 0.668 . . . . 2.8300000000000001 109.201 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HD2' ' O ' ' A' ' 50' ' ' SER . 90.5 m-85 -82.56 2.64 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 1.48 111.528 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 1.7 p-10 -60.09 139.14 57.67 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.047 0.451 . . . . 1.22 110.203 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.23 122.1 34.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.449 0.642 . . . . 1.8500000000000001 110.954 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 43' ' ' ILE . 98.2 t -79.03 114.26 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.317 -0.856 . . . . 1.0800000000000001 108.996 171.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 42' ' ' ILE . 6.5 mp -78.77 -55.39 5.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.728 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -158.65 148.51 19.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.73 -0.668 . . . . 1.3100000000000001 110.019 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.599 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 6.7 p -134.98 119.4 17.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.0900000000000001 109.858 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.17 114.71 46.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.652 -0.704 . . . . 1.22 110.337 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 5.0 mp -101.45 112.84 25.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 1.3400000000000001 110.618 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.86 103.97 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.71999999999999997 109.902 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.51 123.66 7.63 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 119.041 -0.866 . . . . 0.41999999999999998 112.438 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -102.66 166.59 6.35 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 CA-C-N 120.648 2.224 . . . . 0.55000000000000004 110.466 -16.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.24 61.42 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.392 -0.523 . . . . 0.94999999999999996 110.884 -176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.18 162.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.867 2.378 . . . . 0.69999999999999996 112.757 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.46 133.39 55.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.562 -0.745 . . . . 0.40999999999999998 110.998 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.34 162.23 9.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.167 -0.773 . . . . 0.33000000000000002 111.167 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.6 ttp180 -86.43 111.09 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.436 0.636 . . . . 2.7799999999999998 110.815 -177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -104.33 128.16 52.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.62 109.827 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.6 ttt -115.81 109.27 17.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.56 -0.533 . . . . 1.8 109.56 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -124.92 160.41 28.92 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.927 0.394 . . . . 0.37 110.249 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 25' ' ' GLU . 54.6 t -103.78 110.72 30.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.05 -0.523 . . . . 1.1200000000000001 109.884 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.75 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.7 t80 -96.65 121.0 38.0 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.174 -0.676 . . . . 0.44 109.174 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 27.2 mt-30 -131.19 148.17 52.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 1.1399999999999999 110.916 -176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.92 147.11 26.18 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.424 -0.954 . . . . 0.56000000000000005 108.424 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 4.8 t70 -68.92 -163.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.918 0.326 . . . . 2.1299999999999999 110.706 -176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 141.27 84.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 121.981 -0.449 . . . . 0.46000000000000002 110.616 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 84' ' ' ILE . 33.4 Cg_endo -64.9 156.71 60.71 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 122.887 2.391 . . . . 0.53000000000000003 111.52 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 m-20 -50.42 111.45 2.19 Favored Pre-proline 0 N--CA 1.468 0.433 0 O-C-N 123.379 0.424 . . . . 2.1899999999999999 111.249 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.29 -35.74 71.9 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.661 2.24 . . . . 0.54000000000000004 111.821 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.49 -15.76 66.52 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.89 -0.596 . . . . 0.51000000000000001 112.857 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 55' ' ' GLN . 49.8 mt -95.95 -17.62 20.89 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.466 -0.431 . . . . 1.6000000000000001 111.07 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 79' ' ' PRO . 56.4 mt -83.43 108.26 12.61 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.099 -0.704 . . . . 0.52000000000000002 109.099 173.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 7.5 Cg_exo -77.09 161.86 32.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.69 2.927 . . . . 0.81000000000000005 113.276 -170.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -47.61 -45.56 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.822 -1.081 . . . . 2.29 111.446 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 1.25 112.483 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.838 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 65.4 m-20 -106.49 -14.74 14.98 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.363 0.505 . . . . 1.9399999999999999 112.363 -172.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.49 91.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.145 0.498 . . . . 0.54000000000000004 110.677 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.46 40.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.949 -0.569 . . . . 0.56000000000000005 109.731 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.63 -160.36 9.57 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 119.935 -1.126 . . . . 0.62 113.604 -171.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.66 124.4 54.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.356 . . . . 1.23 110.98 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.5 144.92 50.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 0.63 110.259 176.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 t -93.91 129.69 43.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.228 -0.442 . . . . 0.35999999999999999 110.722 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 111' ' ' TYR . 3.9 p -105.36 108.89 26.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.932 -1.136 . . . . 0.59999999999999998 107.932 170.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -112.46 126.81 55.72 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.492 0.663 . . . . 1.21 111.509 -172.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.66 108.55 20.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.731 -1.122 . . . . 0.33000000000000002 109.351 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.6 p -105.57 141.62 36.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.954 -0.566 . . . . 1.4199999999999999 109.998 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 59.7 m -108.47 110.86 22.47 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.166 -0.47 . . . . 1.3200000000000001 110.201 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -87.03 119.93 27.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.654 . . . . 0.5 110.63 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CE1' HD23 ' A' ' 34' ' ' LEU . 12.3 t80 -130.84 126.02 35.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.817 -0.808 . . . . 0.72999999999999998 108.817 173.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 36' ' ' GLU . 35.0 mmt180 65.21 15.34 9.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 122.596 0.358 . . . . 2.4500000000000002 110.833 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.82 -5.53 72.94 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.549 -0.62 . . . . 0.56999999999999995 111.549 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -114.17 131.63 56.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.97 0.414 . . . . 1.3100000000000001 110.239 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.8 mt-10 -90.02 116.84 28.36 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.157 -0.474 . . . . 1.5900000000000001 109.978 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' A' ' 151' ' ' ILE . 32.9 p90 -94.96 -5.17 45.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.056 -0.52 . . . . 0.31 112.198 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 tt -155.28 149.51 11.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.849 0.356 . . . . 0.37 110.082 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -143.98 113.06 6.79 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.786 -0.643 . . . . 1.1399999999999999 109.861 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 69.9 t -89.86 103.2 13.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.386 -0.37 . . . . 0.38 110.297 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.84 102.56 2.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.775 -0.726 . . . . 0.27000000000000002 112.548 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' HG13 ' A' ' 95' ' ' VAL . 8.1 m-85 -98.23 124.49 42.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.896 0.379 . . . . 0.40000000000000002 110.483 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -87.11 115.17 24.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.181 -0.463 . . . . 0.78000000000000003 110.779 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 139' ' ' ILE . 69.9 t -98.52 127.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.154 -0.475 . . . . 1.1899999999999999 110.503 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -96.21 111.09 23.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.175 -0.676 . . . . 1.6299999999999999 109.175 174.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 135' ' ' LEU . 10.4 m-80 -100.51 108.43 20.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.286 0.565 . . . . 0.94999999999999996 109.688 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.99 144.65 33.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.133 -0.939 . . . . 1.97 109.033 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 67.3 m-85 -56.81 156.57 6.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.339 0.59 . . . . 0.68999999999999995 112.419 -172.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 14.7 p -81.0 -29.64 35.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.327 -0.851 . . . . 0.83999999999999997 110.395 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 37.2 mt-10 -87.95 131.48 34.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.501 -0.772 . . . . 2.2400000000000002 110.236 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.1 m -57.48 -35.83 70.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.447 0.467 . . . . 1.4099999999999999 110.6 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.92 -45.34 71.15 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.847 -0.615 . . . . 2.21 111.415 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -81.81 -17.73 46.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.826 0.346 . . . . 0.90000000000000002 110.807 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 59.6 mtp180 -79.32 -37.71 36.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.266 -0.425 . . . . 2.0299999999999998 110.407 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.23 -37.27 61.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.556 . . . . 2.8399999999999999 110.63 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -137.44 86.01 20.17 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.131 0.491 . . . . 2.1899999999999999 110.823 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.516 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 65.5 Cg_exo -50.78 121.77 8.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.922 2.415 . . . . 1.24 111.877 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 24.9 Cg_exo -65.05 163.81 27.3 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.998 2.465 . . . . 1.1899999999999999 111.794 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.31 -37.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 2.1600000000000001 111.693 -176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 51.5 mmtt -124.5 127.39 25.25 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 1.96 110.226 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.643 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 22.9 Cg_endo -61.23 161.18 23.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.038 2.492 . . . . 0.70999999999999996 112.881 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -131.52 118.77 20.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 1.28 109.983 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 77.1 m-85 -78.74 -16.16 57.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.971 -0.559 . . . . 0.5 111.295 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.5 t -89.78 -10.55 45.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.11 -0.496 . . . . 1.46 110.581 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.5 mmtp -116.97 5.4 12.87 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.538 0.685 . . . . 1.8700000000000001 109.701 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.6 tp -95.91 127.44 41.93 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.841 -1.072 . . . . 0.79000000000000004 110.313 -173.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.5 tt0 -100.23 128.73 46.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.61 -0.515 . . . . 1.6299999999999999 109.61 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.556 HH21 ' HE1' ' A' ' 22' ' ' PHE . 4.7 ptm85 -99.82 107.22 19.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.258 0.551 . . . . 2.8199999999999998 110.83 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 t30 -99.5 110.16 22.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.114 -0.948 . . . . 0.83999999999999997 109.435 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 113' ' ' VAL . 20.0 mt -89.62 117.02 32.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.896 -0.593 . . . . 0.47999999999999998 110.411 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.4 mt -76.45 82.0 3.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 0.98999999999999999 110.675 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.58 -10.53 59.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.611 0.72 . . . . 0.55000000000000004 109.88 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 m -71.49 -21.31 61.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.923 -1.035 . . . . 1.4199999999999999 110.809 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -128.64 83.4 66.28 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 1.9099999999999999 110.62 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.88 109.0 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.216 2.611 . . . . 0.66000000000000003 111.709 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -76.0 82.33 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.329 -0.619 . . . . 3.1499999999999999 109.329 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.36 104.2 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.542 0.687 . . . . 1.1399999999999999 110.923 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.0 m -111.89 115.5 29.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.74 -0.663 . . . . 0.56000000000000005 109.529 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -114.63 137.04 52.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.502 0.667 . . . . 3.0 110.548 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.62 159.48 17.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.875 -1.057 . . . . 0.46000000000000002 110.573 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -97.37 110.51 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.377 -0.601 . . . . 3.1400000000000001 109.377 174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 106' ' ' PHE . 25.6 pt -123.14 -177.28 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.894 -0.41 . . . . 0.64000000000000001 109.894 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -111.58 118.29 35.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.408 -0.59 . . . . 1.78 109.408 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.541 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 13.8 m95 -83.68 -16.38 45.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.539 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.44 168.26 10.31 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.969 -1.014 . . . . 2.3199999999999998 109.338 -170.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.48 71.72 10.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.516 0.674 . . . . 2.4900000000000002 110.875 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.012 -0.994 . . . . 2.5699999999999998 109.518 176.059 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.84 0.352 . . . . 2.96 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -63.05 118.52 7.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.283 0.563 . . . . 1.48 111.054 -173.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 38.7 mttm -103.23 -7.13 21.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.656 -0.702 . . . . 0.97999999999999998 110.908 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -146.9 120.32 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.393 -0.966 . . . . 0.45000000000000001 108.393 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -127.47 112.08 14.55 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.959 -0.564 . . . . 1.3899999999999999 110.443 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 64.3 t -68.71 114.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.991 -0.55 . . . . 1.3200000000000001 110.027 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -90.85 -67.73 0.83 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.917 -0.583 . . . . 0.95999999999999996 110.385 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -103.72 104.8 14.87 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.502 0.667 . . . . 1.47 110.836 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.8 p -103.14 104.51 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.911 -1.04 . . . . 1.01 108.668 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -114.24 148.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.121 0.486 . . . . 1.54 111.019 -172.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.43 113.08 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.686 -0.688 . . . . 0.91000000000000003 110.541 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.676 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -97.16 -177.78 3.96 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.828 -1.175 . . . . 1.1799999999999999 107.828 173.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 73.04 -16.06 0.49 Allowed 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.277 0.56 . . . . 2.73 111.065 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 25.6 t30 -85.4 123.94 72.31 Favored Pre-proline 0 C--N 1.309 -1.184 0 O-C-N 121.923 -0.486 . . . . 1.8799999999999999 110.937 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ASN . 18.0 Cg_endo -99.44 143.12 3.31 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.616 -0.993 . . . . 0.59999999999999998 112.782 -7.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 66.6 m -152.33 162.9 25.26 Favored Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 122.361 -0.212 . . . . 0.77000000000000002 111.413 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.8 Cg_exo -51.91 147.8 24.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.124 2.549 . . . . 0.82999999999999996 113.508 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.731 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 17.1 t80 -60.57 -33.05 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.40999999999999998 113.117 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -75.79 -0.46 21.13 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.44 0.533 . . . . 0.65000000000000002 112.44 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -94.96 148.11 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.672 -0.862 . . . . 2.0699999999999998 108.672 175.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.3 Cg_exo -64.95 141.41 70.64 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.553 2.169 . . . . 0.62 113.377 -174.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.8 m-85 -61.66 115.15 3.72 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.141 -0.689 . . . . 0.57999999999999996 109.141 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 9.7 tt0 -111.21 101.19 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.215 0.531 . . . . 1.4099999999999999 111.389 -173.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.4 148.46 32.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.994 -0.548 . . . . 0.5 110.256 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.82 ' HB3' HG12 ' A' ' 10' ' ' VAL . 41.3 tt0 -117.33 99.28 6.91 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.736 -0.839 . . . . 1.98 108.736 174.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 59.4 mt -91.62 105.24 16.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.099 -0.955 . . . . 0.35999999999999999 110.931 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.7 m -99.0 105.16 17.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.469 -0.567 . . . . 0.46000000000000002 109.469 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 35.9 p90 -121.93 137.13 54.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.815 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.1 tt0 -105.74 118.99 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 110.05 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 57.4 m -75.31 111.0 10.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.676 -0.693 . . . . 0.51000000000000001 109.136 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 2' ' ' ALA . 36.0 mt -73.02 -23.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.803 -0.814 . . . . 0.56999999999999995 108.803 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 45.2 mt-10 -138.36 164.84 28.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.752 -1.113 . . . . 1.8300000000000001 109.686 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -80.15 131.3 35.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.125 -0.695 . . . . 2.1800000000000002 109.125 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 65' ' ' VAL . 11.3 mt -99.43 134.39 42.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.059 -0.656 . . . . 1.52 110.808 -173.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -91.89 -32.14 15.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.959 -0.564 . . . . 1.55 110.98 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -93.11 177.87 5.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.254 -0.43 . . . . 2.9500000000000002 110.644 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -74.9 138.93 42.75 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.718 -0.475 . . . . 1.8799999999999999 109.718 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 HG11 ' A' ' 65' ' ' VAL . 15.1 tp -95.15 118.48 32.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.087 -0.708 . . . . 1.3200000000000001 109.087 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HA ' HD13 ' A' ' 61' ' ' LEU . 25.0 tt0 -99.54 121.19 40.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.34 -0.391 . . . . 0.92000000000000004 111.075 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.457 ' O ' ' HA ' ' A' ' 59' ' ' SER . 88.5 m95 -112.78 110.5 20.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.435 -0.348 . . . . 0.42999999999999999 110.081 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 16.8 mttp -108.27 137.16 46.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.408 . . . . 1.23 111.453 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 7.5 mt -105.18 104.02 16.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.457 -0.571 . . . . 0.46000000000000002 109.457 168.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 56' ' ' VAL . 64.0 mt -98.55 109.36 23.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.636 -0.711 . . . . 0.68999999999999995 109.56 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -93.91 131.12 39.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.039 -0.528 . . . . 0.58999999999999997 109.855 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG22 ' A' ' 93' ' ' THR . 87.9 t -60.43 108.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.609 -0.515 . . . . 0.37 109.609 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.626 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -61.35 -49.73 74.32 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.521 -0.847 . . . . 0.46999999999999997 111.315 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.597 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 14.5 m -135.03 126.2 28.03 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.713 -0.477 . . . . 1.23 109.713 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.5 -13.23 59.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.575 -0.898 . . . . 0.81999999999999995 108.575 170.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.69 -46.05 59.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.035 -0.984 . . . . 1.99 108.853 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.598 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 17.7 m -139.17 98.22 3.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.543 -0.91 . . . . 1.72 108.543 170.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 pm0 -70.5 -3.64 18.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.929 -0.578 . . . . 2.0899999999999999 111.557 -170.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -68.18 -7.51 30.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.311 0.577 . . . . 2.8300000000000001 110.127 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 24.9 m-85 -93.44 22.75 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.773 -0.649 . . . . 1.48 110.736 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 5.1 p-10 -62.48 144.36 56.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.007 0.432 . . . . 1.22 110.53 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -132.07 138.23 48.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.038 -0.528 . . . . 1.8500000000000001 110.701 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 43' ' ' ILE . 53.8 t -87.4 118.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.421 -0.585 . . . . 1.0800000000000001 109.421 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 74.3 mt -72.86 -53.68 10.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.234 -0.439 . . . . 1.05 110.985 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -158.51 158.92 34.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.03 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 13.1 p -131.82 114.39 14.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.952 -0.567 . . . . 1.0900000000000001 109.594 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.21 110.64 28.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 1.22 110.41 -175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 39' ' ' GLU . 4.0 mm? -97.34 119.81 36.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.422 -0.808 . . . . 1.3400000000000001 109.979 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.66 97.02 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 119.631 -0.827 . . . . 0.71999999999999997 110.101 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.59 146.08 16.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.256 -0.884 . . . . 0.41999999999999998 112.149 166.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 43.0 Cg_endo -90.26 154.53 27.82 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.685 -1.798 . . . . 0.55000000000000004 108.138 -16.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.615 HG11 HD22 ' A' ' 38' ' ' LEU . 3.8 p -112.64 107.04 55.25 Favored Pre-proline 0 C--N 1.304 -1.402 0 C-N-CA 119.018 -1.073 . . . . 0.94999999999999996 110.567 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.97 155.83 67.5 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.438 2.759 . . . . 0.69999999999999996 113.441 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -58.47 127.05 30.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.232 -0.895 . . . . 0.40999999999999998 110.74 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.34 166.32 11.42 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.657 -0.782 . . . . 0.33000000000000002 111.936 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.9 ttp180 -82.35 115.02 21.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.163 0.506 . . . . 2.7799999999999998 110.661 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -107.01 153.07 23.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.423 -0.808 . . . . 0.62 109.254 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -140.25 99.87 3.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.373 -0.376 . . . . 1.8 110.021 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 7.1 p90 -119.79 157.69 28.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 -178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.68 120.89 55.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.141 0.496 . . . . 1.1200000000000001 110.008 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -95.77 123.65 39.44 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.712 -0.847 . . . . 0.44 108.712 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.0 mt-30 -128.22 135.72 50.08 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.825 -0.435 . . . . 1.1399999999999999 109.825 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -139.35 134.45 32.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.287 -0.415 . . . . 0.56000000000000005 110.239 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.95 171.71 2.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.227 -0.442 . . . . 2.1299999999999999 111.507 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -59.51 128.2 85.71 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.701 -0.682 . . . . 0.46000000000000002 111.207 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 40.6 Cg_exo -57.95 158.09 22.35 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 123.012 2.474 . . . . 0.53000000000000003 112.041 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.73 112.05 4.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 2.1899999999999999 110.592 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.2 -19.61 66.12 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.027 2.485 . . . . 0.54000000000000004 111.863 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.44 -16.63 77.43 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.079 -0.582 . . . . 0.51000000000000001 112.223 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 53' ' ' TYR . 13.8 mt -94.52 -25.09 16.99 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 122.753 -0.263 . . . . 1.6000000000000001 111.43 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 57.0 mt -78.76 118.11 70.49 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.819 -0.438 . . . . 0.52000000000000002 109.819 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 88' ' ' ASP . 21.3 Cg_exo -66.47 161.26 41.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 123.626 2.884 . . . . 0.81000000000000005 113.494 -172.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 130' ' ' PRO . 19.1 t70 -56.97 -58.16 9.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.791 -1.095 . . . . 2.29 111.86 -176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.09 -18.06 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.981 0.419 . . . . 1.25 110.771 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.605 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 8.8 t70 -81.49 -28.34 34.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 1.9399999999999999 110.846 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -67.12 -23.91 65.87 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.13 -0.487 . . . . 0.54000000000000004 111.246 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.25 40.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.539 0.685 . . . . 0.56000000000000005 109.335 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.42 -155.29 7.94 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.47 -0.871 . . . . 0.62 112.547 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.86 125.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.499 0.666 . . . . 1.23 111.516 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.2 m -122.78 166.83 14.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.25 -1.389 . . . . 0.63 107.25 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' HB ' HG21 ' A' ' 45' ' ' VAL . 17.2 t -116.74 139.65 42.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 121.511 -0.743 . . . . 0.35999999999999999 111.044 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 111' ' ' TYR . 6.3 p -115.22 121.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.983 -0.747 . . . . 0.59999999999999998 108.983 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA2' ' A' ' 110' ' ' GLY . 48.0 mt -107.27 142.28 37.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 1.21 111.423 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.561 HG12 HG12 ' A' ' 42' ' ' ILE . 50.3 mt -121.22 104.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.37 -0.832 . . . . 0.33000000000000002 108.756 171.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -115.52 133.98 55.51 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.911 -0.586 . . . . 1.4199999999999999 109.893 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 36.0 t -110.25 128.58 55.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.307 0.575 . . . . 1.3200000000000001 110.251 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 3.0 m -108.19 134.13 51.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.17 -0.923 . . . . 0.5 111.195 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.461 ' CD1' ' HG2' ' A' ' 102' ' ' ARG . 33.7 t80 -138.47 130.77 28.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.346 -0.983 . . . . 0.72999999999999998 108.346 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' CD1' ' A' ' 101' ' ' TYR . 31.6 mmt180 67.97 13.87 9.24 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.194 0.309 . . . . 2.4500000000000002 111.187 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.82 2.71 84.03 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.669 -0.777 . . . . 0.56999999999999995 111.206 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -117.27 138.78 51.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.584 -0.525 . . . . 1.3100000000000001 109.584 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -95.99 123.79 39.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.913 0.387 . . . . 1.5900000000000001 110.71 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' HG12 ' A' ' 151' ' ' ILE . 38.3 p90 -104.49 -6.05 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.772 -0.649 . . . . 0.31 111.819 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -154.53 143.57 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.815 0.34 . . . . 0.37 110.262 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 2.4 tmm_? -141.66 110.28 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.086 -0.506 . . . . 1.1399999999999999 109.649 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 72.4 t -92.2 129.61 42.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.41 -0.814 . . . . 0.38 110.121 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -120.54 111.5 1.96 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.861 -0.685 . . . . 0.27000000000000002 112.305 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.2 m-85 -107.52 120.85 43.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.118 0.485 . . . . 0.40000000000000002 110.823 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -82.43 110.61 17.71 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.81 -0.632 . . . . 0.78000000000000003 110.044 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -96.11 120.09 45.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.05 0.453 . . . . 1.1899999999999999 110.098 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -91.78 114.37 26.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.642 -0.873 . . . . 1.6299999999999999 108.642 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 135' ' ' LEU . 36.6 m-80 -96.02 111.94 23.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.478 0.656 . . . . 0.94999999999999996 110.17 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.21 166.74 13.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.924 -1.035 . . . . 1.97 108.516 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 89.1 m-85 -77.92 152.55 33.18 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.372 -0.531 . . . . 0.68999999999999995 110.124 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 136' ' ' GLN . 25.3 p -78.93 -40.51 31.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.476 0.655 . . . . 0.83999999999999997 109.88 -178.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -75.25 127.99 34.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.062 -0.972 . . . . 2.2400000000000002 110.4 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 28.6 m -53.29 -39.49 64.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.549 -0.75 . . . . 1.4099999999999999 110.743 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.02 -42.81 95.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.954 -0.566 . . . . 2.21 111.222 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.16 -25.44 59.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.319 -0.401 . . . . 0.90000000000000002 110.469 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.22 -33.95 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.185 0.517 . . . . 2.0299999999999998 109.648 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.8 mm-40 -76.66 -35.28 58.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.393 -0.821 . . . . 2.8399999999999999 110.414 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -133.17 92.31 25.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.545 -0.298 . . . . 2.1899999999999999 111.168 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 38.0 Cg_exo -63.12 115.98 3.3 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.522 2.148 . . . . 1.24 111.262 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.5 Cg_exo -65.99 163.87 29.54 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.867 2.378 . . . . 1.1899999999999999 111.689 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -50.12 -35.18 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 123.502 0.501 . . . . 2.1600000000000001 112.105 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 71.7 mmtt -120.61 125.99 26.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.434 -0.348 . . . . 1.96 110.25 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 28.3 Cg_endo -61.23 153.58 64.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.722 2.281 . . . . 0.70999999999999996 111.745 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -124.17 118.77 27.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.133 0.492 . . . . 1.28 109.986 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.731 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 54.9 m-85 -77.14 -21.24 54.45 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.264 -0.88 . . . . 0.5 110.532 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t -82.56 -12.94 57.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 1.46 110.291 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 38.2 mmtm -115.56 20.5 14.67 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.971 -0.751 . . . . 1.8700000000000001 108.971 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 115' ' ' ASN . 4.4 tp -108.62 122.38 46.98 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.466 -0.788 . . . . 0.79000000000000004 110.395 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.565 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.04 118.01 36.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.08 -0.964 . . . . 1.6299999999999999 108.452 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.434 HH21 ' CG ' ' A' ' 13' ' ' ASP . 18.5 mtm180 -78.46 106.99 10.79 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.798 -0.445 . . . . 2.8199999999999998 109.798 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -98.94 90.15 4.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 0.83999999999999997 108.977 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 53.9 mt -78.35 118.45 25.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.673 -0.694 . . . . 0.47999999999999998 110.504 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.23 79.23 3.76 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.658 -0.701 . . . . 0.98999999999999999 110.619 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -13.5 61.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.648 -0.706 . . . . 0.55000000000000004 111.226 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -76.77 -13.45 60.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 1.4199999999999999 110.742 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -124.21 80.13 59.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 1.9099999999999999 109.737 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -91.72 113.63 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.808 2.339 . . . . 0.66000000000000003 112.009 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -77.05 84.81 3.56 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.469 -0.567 . . . . 3.1499999999999999 109.469 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.89 107.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.192 -0.458 . . . . 1.1399999999999999 110.214 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 m -121.61 108.18 13.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.56000000000000005 110.399 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 33.3 ptt180 -100.17 143.64 30.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 3.0 109.886 175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 41.5 m-85 -111.84 163.68 13.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.415 -0.811 . . . . 0.46000000000000002 110.704 -171.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -100.47 110.12 22.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.063 -0.517 . . . . 3.1400000000000001 110.045 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 106' ' ' PHE . 30.2 pt -130.32 173.51 14.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.264 -0.426 . . . . 0.64000000000000001 110.063 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -104.82 113.23 26.69 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.584 0.707 . . . . 1.78 110.364 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.455 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 6.6 m95 -79.57 -22.39 43.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.873 -1.158 . . . . 0.87 107.873 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.41 150.94 24.99 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.234 -1.803 . . . . 2.3199999999999998 108.513 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.7 72.42 9.5 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.156 0.979 . . . . 2.4900000000000002 112.247 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.121 -0.942 . . . . 2.5699999999999998 109.863 171.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.576 0.227 . . . . 2.96 110.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.2 128.78 45.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.48 110.788 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.79 -8.42 37.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.911 0.386 . . . . 0.97999999999999998 110.688 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.3 t -140.73 122.04 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.415 -0.587 . . . . 0.45000000000000001 109.415 176.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 31' ' ' ILE . 30.3 tp60 -121.19 102.85 8.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.722 -0.672 . . . . 1.3899999999999999 109.479 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 40.1 t -69.96 124.71 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -106.58 -64.9 1.13 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.202 -0.454 . . . . 0.95999999999999996 110.844 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 9.5 t30 -101.34 122.85 44.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.212 -0.449 . . . . 1.47 110.778 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.45 112.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.302 -0.629 . . . . 1.01 109.302 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 25' ' ' GLU . 3.0 p -130.83 131.23 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 120.956 0.407 . . . . 1.54 110.719 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.633 HG12 ' HB2' ' A' ' 141' ' ' ALA . 5.7 p -89.84 147.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.923 -0.58 . . . . 0.91000000000000003 109.931 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -131.75 173.66 10.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.931 -0.577 . . . . 1.1799999999999999 110.326 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.809 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.9 OUTLIER 73.33 8.05 5.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.914 -1.039 . . . . 2.73 109.865 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' OD1' HG13 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -86.68 133.53 39.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.706 -0.679 . . . . 1.8799999999999999 111.498 175.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 18.6 Cg_endo -98.62 148.3 5.3 Favored 'Cis proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.335 -1.11 . . . . 0.59999999999999998 111.614 -10.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.581 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 67.2 m -147.49 160.48 38.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 120.839 -0.344 . . . . 0.77000000000000002 111.172 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 134.64 29.61 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.234 2.622 . . . . 0.82999999999999996 112.399 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HE1' ' HG2' ' A' ' 79' ' ' PRO . 15.5 t80 -48.25 -27.22 2.34 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.535 1.309 . . . . 0.40999999999999998 114.535 -171.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -80.42 15.23 1.69 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.831 -0.543 . . . . 0.65000000000000002 111.167 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 16' ' ' SER . 26.7 p-10 -89.83 157.7 45.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.051 -0.522 . . . . 2.0699999999999998 109.679 171.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.04 158.41 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.607 2.205 . . . . 0.62 111.978 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 36.4 m-85 -79.97 109.91 14.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.155 -0.475 . . . . 0.57999999999999996 109.883 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.809 HE21 ' HB2' ' A' ' 13' ' ' ASP . 8.3 tt0 -103.43 114.38 28.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.189 -0.46 . . . . 1.4099999999999999 110.862 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 95.4 m-85 -123.38 130.5 52.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.912 -0.586 . . . . 0.5 111.125 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HB3' HG13 ' A' ' 10' ' ' VAL . 41.0 tt0 -99.95 94.47 6.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.995 . . . . 1.98 108.315 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.1 mt -97.69 117.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.508 -0.769 . . . . 0.35999999999999999 110.907 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.5 m -110.23 106.33 15.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.651 -0.704 . . . . 0.46000000000000002 110.111 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.656 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -120.96 135.74 55.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.369 -0.604 . . . . 0.28000000000000003 109.369 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.4 tt0 -105.64 118.24 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.626 -0.43 . . . . 0.77000000000000002 110.082 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 25.4 m -74.73 114.32 13.03 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 5' ' ' GLN . 50.2 mt -75.45 -23.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.464 -0.789 . . . . 0.56999999999999995 109.362 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 41.3 mt-10 -142.66 166.08 25.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.693 -1.139 . . . . 1.8300000000000001 109.207 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.26 120.97 26.5 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.735 -0.468 . . . . 2.1800000000000002 109.735 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.886 HD11 HG23 ' A' ' 65' ' ' VAL . 1.8 pp -99.66 135.56 40.9 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.494 -0.558 . . . . 1.52 109.494 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -100.36 -8.7 23.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.824 0.345 . . . . 1.55 111.543 -172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 9.4 mp0 -94.51 -168.85 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.582 -0.525 . . . . 2.9500000000000002 109.582 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -101.06 130.71 47.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.938 0.399 . . . . 1.8799999999999999 110.46 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 126.06 34.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.692 . . . . 1.3200000000000001 109.13 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.6 tt0 -97.11 122.23 39.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.92000000000000004 111.152 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 59' ' ' SER . 79.9 m95 -112.19 110.11 20.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.716 -0.846 . . . . 0.42999999999999999 108.716 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.544 ' HG3' ' HB2' ' A' ' 59' ' ' SER . 18.5 ttmt -123.54 136.94 54.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.368 -0.378 . . . . 1.23 111.2 -170.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -105.47 116.42 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.249 0.547 . . . . 0.46000000000000002 110.871 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 56' ' ' VAL . 62.7 mt -107.56 106.42 20.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.169 -0.923 . . . . 0.68999999999999995 108.891 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -94.78 128.98 41.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.631 -0.427 . . . . 0.58999999999999997 110.142 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' HB ' ' H ' ' A' ' 94' ' ' VAL . 65.8 t -64.91 106.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.556 . . . . 0.37 109.919 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.646 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -66.41 -51.2 44.72 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.606 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.619 ' HB3' ' O ' ' A' ' 50' ' ' SER . 44.0 t -122.95 134.26 54.35 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.794 0.33 . . . . 1.23 111.113 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.27 -18.04 35.13 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.441 -0.948 . . . . 0.81999999999999995 108.441 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.65 -45.24 79.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.632 -1.167 . . . . 1.99 109.029 171.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 47' ' ' SER . 41.1 t -151.15 109.67 3.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.687 -0.688 . . . . 1.72 109.682 173.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.8 4.71 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.712 -0.395 . . . . 2.0899999999999999 111.223 -172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.75 -17.56 64.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.585 0.707 . . . . 2.8300000000000001 109.491 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 13.1 m-85 -91.27 29.59 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.799 -1.091 . . . . 1.48 110.214 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.3 p30 -71.36 154.65 41.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 1.22 111.304 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -118.28 111.22 18.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.874 -0.603 . . . . 1.8500000000000001 110.239 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 43' ' ' ILE . 86.0 t -72.5 98.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.659 -0.867 . . . . 1.0800000000000001 108.659 168.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 79' ' ' PRO . 94.5 mt -72.1 -66.03 0.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 1.05 111.799 -171.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.99 149.72 48.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.208 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HG3' ' A' ' 41' ' ' LYS . 32.6 t -145.49 111.21 5.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.72 -0.844 . . . . 1.0900000000000001 108.72 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.1 m -106.13 141.42 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.94 -0.573 . . . . 1.22 110.895 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.0 mm? -115.08 116.66 28.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.705 -0.68 . . . . 1.3400000000000001 110.363 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.99 101.4 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 119.964 -0.694 . . . . 0.71999999999999997 109.759 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.17 121.84 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.534 -1.148 . . . . 0.41999999999999998 112.516 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 41.9 Cg_endo -100.27 167.83 8.79 Favored 'Cis proline' 0 N--CA 1.452 -0.937 0 CA-C-N 121.17 2.485 . . . . 0.55000000000000004 109.64 -16.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.886 HG23 HD11 ' A' ' 34' ' ' LEU . 1.5 t -107.96 112.28 61.78 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 119.072 -1.051 . . . . 0.94999999999999996 110.66 -175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.69 158.86 43.07 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.916 2.411 . . . . 0.69999999999999996 112.802 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.724 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -63.35 123.46 18.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.928 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 155.11 161.5 10.61 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.796 -0.921 . . . . 0.33000000000000002 110.796 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 29.4 ttp180 -87.44 107.57 18.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.044 0.449 . . . . 2.7799999999999998 110.347 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -98.42 146.31 25.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.755 -0.657 . . . . 0.62 110.516 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.9 ttm -131.16 101.15 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.189 -0.671 . . . . 1.8 109.189 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -119.26 145.43 46.1 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.933 0.397 . . . . 0.37 110.363 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' PHE . 46.7 t -97.35 103.37 14.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.993 -0.549 . . . . 1.1200000000000001 110.439 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 42' ' ' ILE . 2.8 t80 -78.62 134.06 37.22 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.955 -0.758 . . . . 0.44 108.955 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 54.8 mt-30 -134.43 119.27 18.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.409 -0.359 . . . . 1.1399999999999999 110.205 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . . . -113.19 157.47 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.168 -0.469 . . . . 0.56000000000000005 110.18 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -79.69 -176.63 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.817 0.341 . . . . 2.1299999999999999 110.736 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.33 127.62 78.21 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.425 -0.352 . . . . 0.46000000000000002 110.568 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 24.4 Cg_endo -62.41 130.36 29.87 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 123.104 2.536 . . . . 0.53000000000000003 112.173 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 40.0 t30 -46.74 119.25 5.5 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.648 -0.705 . . . . 2.1899999999999999 111.991 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 26.0 Cg_exo -64.91 -5.77 11.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.439 2.759 . . . . 0.54000000000000004 112.207 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.5 -15.59 75.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.076 -0.81 . . . . 0.51000000000000001 111.076 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 83' ' ' LEU . 4.4 mm? -97.6 -33.11 11.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.649 -0.276 . . . . 1.6000000000000001 110.741 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 43.9 mt -75.6 112.35 18.96 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-O 120.88 0.371 . . . . 0.52000000000000002 110.556 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.662 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.4 Cg_exo -70.46 161.6 45.45 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.859 3.039 . . . . 0.81000000000000005 112.245 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 21.0 m-20 -59.07 -50.29 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 2.29 110.752 -175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -34.1 76.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.515 -0.766 . . . . 1.25 111.622 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.662 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 76.3 m-20 -82.49 -25.41 33.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.519 -0.309 . . . . 1.9399999999999999 111.546 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.06 83.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.878 0.37 . . . . 0.54000000000000004 110.914 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 126' ' ' PRO . 4.1 t -88.54 41.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.486 -0.561 . . . . 0.56000000000000005 109.486 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -162.61 -133.23 1.44 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.963 -1.113 . . . . 0.62 113.456 -170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.51 141.38 28.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.197 0.523 . . . . 1.23 111.536 -172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.3 167.31 22.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.403 -0.962 . . . . 0.63 108.403 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' H ' ' HB ' ' A' ' 45' ' ' VAL . 15.9 t -124.69 129.59 73.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.125 -0.63 . . . . 0.35999999999999999 110.221 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 111' ' ' TYR . 7.7 p -101.41 115.66 43.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 0.59999999999999998 109.514 174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 37.0 mt -106.89 139.05 41.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.004 -0.544 . . . . 1.21 111.215 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 109' ' ' VAL . 65.6 mt -116.83 106.68 20.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.257 -0.883 . . . . 0.33000000000000002 109.17 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.2 p -101.97 135.8 42.91 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.771 -0.455 . . . . 1.4199999999999999 109.771 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 28.2 m -109.94 118.75 37.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.179 -0.464 . . . . 1.3200000000000001 110.117 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.6 m -104.73 130.57 52.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.625 . . . . 0.5 111.605 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 34' ' ' LEU . 11.5 t80 -134.13 131.62 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.841 -0.8 . . . . 0.72999999999999998 108.841 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 66.1 14.07 9.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.858 0.361 . . . . 2.4500000000000002 111.03 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.68 75.75 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.653 -0.784 . . . . 0.56999999999999995 111.451 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.32 120.11 33.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.804 -0.443 . . . . 1.3100000000000001 109.804 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 34.8 mt-10 -80.99 123.27 28.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 110.383 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.555 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 28.4 p90 -102.64 -10.2 19.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.975 0.731 . . . . 0.31 112.975 -171.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 tt -154.92 149.63 12.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.822 0.344 . . . . 0.37 110.58 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -134.2 118.48 17.68 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.95 -0.568 . . . . 1.1399999999999999 110.3 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 77.3 t -92.9 118.48 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.303 -0.408 . . . . 0.38 109.964 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.522 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -116.79 107.19 1.56 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.426 -0.892 . . . . 0.27000000000000002 112.935 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . 68.7 m-85 -101.68 133.96 45.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.601 -0.518 . . . . 0.40000000000000002 109.601 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.78 111.55 22.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.619 0.723 . . . . 0.78000000000000003 110.127 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 137' ' ' ARG . 85.4 t -88.34 128.0 40.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.082 -0.963 . . . . 1.1899999999999999 110.163 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.31 113.54 25.81 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.099 -0.704 . . . . 1.6299999999999999 109.099 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.466 ' HB3' HD21 ' A' ' 135' ' ' LEU . 92.0 m-20 -100.74 125.07 47.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 0.94999999999999996 111.447 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -139.53 146.75 40.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.562 -1.199 . . . . 1.97 108.32 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 83.2 m-85 -59.53 158.67 9.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.243 0.544 . . . . 0.68999999999999995 111.768 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 136' ' ' GLN . 23.8 p -80.02 -23.66 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.701 -0.681 . . . . 0.83999999999999997 110.664 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 38.9 mt-10 -106.76 139.55 41.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.243 -0.889 . . . . 2.2400000000000002 110.151 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.636 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 87.3 m -52.51 -48.89 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 1.4099999999999999 111.523 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -55.84 -41.78 74.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.499 . . . . 2.21 111.655 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.7 mt -74.82 -25.61 59.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.103 -0.499 . . . . 0.90000000000000002 110.931 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 75.6 mtp180 -74.0 -43.27 58.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 2.0299999999999998 110.122 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.5 mm-40 -70.51 -29.62 66.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.375 -0.83 . . . . 2.8399999999999999 110.236 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -127.34 74.49 77.49 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.393 -0.367 . . . . 2.1899999999999999 111.07 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' HG11 ' A' ' 90' ' ' VAL . 31.6 Cg_exo -61.32 117.66 4.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.223 1.948 . . . . 1.24 111.382 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 7.3 Cg_exo -76.14 163.6 32.57 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.321 2.681 . . . . 1.1899999999999999 111.743 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.25 -37.5 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 123.469 0.481 . . . . 2.1600000000000001 111.664 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 33.9 mmtp -113.03 112.08 50.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 1.96 109.651 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.583 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 12.4 Cg_endo -55.74 156.17 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.126 2.551 . . . . 0.70999999999999996 112.643 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.401 ' H ' ' HE2' ' A' ' 117' ' ' TYR . 21.3 m-20 -111.94 99.44 8.11 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.194 -0.912 . . . . 1.28 109.699 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -67.09 -27.03 67.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.5 109.807 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.9 m -78.26 -4.83 49.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.262 -0.881 . . . . 1.46 111.267 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 30.1 mmtp -126.97 9.2 6.83 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.057 0.456 . . . . 1.8700000000000001 109.802 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -95.81 127.29 41.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.719 -0.673 . . . . 0.79000000000000004 110.219 -173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.506 ' HB2' HG22 ' A' ' 118' ' ' THR . 19.8 tt0 -98.9 115.49 28.99 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.372 -0.603 . . . . 1.6299999999999999 109.372 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HG3' ' CG1' ' A' ' 113' ' ' VAL . 41.2 ttp180 -80.95 106.16 12.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.969 -0.559 . . . . 2.8199999999999998 110.297 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.7 t30 -103.45 100.72 10.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.551 0.691 . . . . 0.83999999999999997 109.591 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.518 HD12 ' ND2' ' A' ' 14' ' ' ASN . 10.1 mt -84.18 119.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.102 -0.954 . . . . 0.47999999999999998 109.919 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.93 89.84 4.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.98999999999999999 110.253 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.633 ' HB2' HG12 ' A' ' 11' ' ' VAL . . . -72.45 -18.82 61.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 0.55000000000000004 110.054 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 9.1 t -76.14 -9.45 58.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 1.4199999999999999 110.156 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -117.07 76.39 8.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.068 -0.716 . . . . 1.9099999999999999 109.068 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 142' ' ' SER . 19.5 Cg_endo -94.18 106.31 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.241 2.628 . . . . 0.66000000000000003 112.253 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 8.1 mmt180 -88.19 85.0 6.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.026 -0.534 . . . . 3.1499999999999999 110.765 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.7 p -89.82 104.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.315 0.578 . . . . 1.1399999999999999 109.869 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.4 m -122.55 108.39 13.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.853 -0.612 . . . . 0.56000000000000005 110.567 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 9.9 ptm180 -92.57 153.12 19.23 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.493 0.663 . . . . 3.0 110.85 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.27 168.59 9.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.775 -1.102 . . . . 0.46000000000000002 110.284 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -101.81 110.84 22.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.072 -0.513 . . . . 3.1400000000000001 109.931 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 20.4 pt -127.43 -179.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.64000000000000001 110.803 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -118.21 117.07 28.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.482 -0.781 . . . . 1.78 108.927 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -75.3 -17.25 60.32 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.162 -0.926 . . . . 0.87 110.789 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.04 166.63 21.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.487 -1.301 . . . . 2.3199999999999998 107.487 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.42 68.46 10.47 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.505 -0.878 . . . . 2.4900000000000002 109.799 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 . . . . . 0 C--O 1.246 0.897 0 CA-C-N 114.64 -1.164 . . . . 2.5699999999999998 109.111 177.128 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 111.491 0.182 . . . . 2.96 111.491 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 -70.89 0.55 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 112.155 0.428 . . . . 1.48 112.155 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.48 -8.58 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.894 -0.322 . . . . 0.97999999999999998 111.349 -175.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -143.62 129.19 15.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.45000000000000001 108.853 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -136.15 105.98 6.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.66 -0.7 . . . . 1.3899999999999999 110.227 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.62 128.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.409 -0.589 . . . . 1.3200000000000001 109.409 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -114.09 -64.68 1.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.085 -0.507 . . . . 0.95999999999999996 110.461 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 7.9 t30 -101.42 105.55 16.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.998 -0.546 . . . . 1.47 110.31 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 26' ' ' ILE . 5.8 p -126.6 99.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.986 0.898 . . . . 1.01 109.782 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.86 151.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.54 111.256 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 24' ' ' PHE . 8.1 t -99.91 143.06 14.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.9 -0.778 . . . . 0.91000000000000003 108.9 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 mp -123.74 154.02 40.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.1 0.476 . . . . 1.1799999999999999 111.275 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 78.22 -4.29 2.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 114.369 -1.287 . . . . 2.73 111.531 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -84.21 143.03 41.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 120.527 -0.469 . . . . 1.8799999999999999 110.291 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 77.1 Cg_endo -86.55 140.84 24.95 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.876 -1.302 . . . . 0.59999999999999998 113.411 -2.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.1 m -152.83 163.67 22.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.639 -0.71 . . . . 0.77000000000000002 110.499 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.4 Cg_exo -50.52 158.29 2.82 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.382 2.722 . . . . 0.82999999999999996 114.275 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 23.9 t80 -62.32 -25.67 68.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.421 -1.263 . . . . 0.40999999999999998 112.789 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 28.6 m-85 -79.55 -3.48 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.128 0.418 . . . . 0.65000000000000002 112.128 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.13 142.59 38.54 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.945 -0.761 . . . . 2.0699999999999998 108.945 173.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 14.6 Cg_exo -67.14 152.31 80.03 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.463 2.108 . . . . 0.62 112.702 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 51.8 m-85 -71.06 96.14 1.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.126 -0.694 . . . . 0.57999999999999996 109.126 169.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.3 tt0 -96.41 111.75 23.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.127 -0.942 . . . . 1.4099999999999999 111.222 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 11' ' ' VAL . 97.4 m-85 -118.52 141.81 48.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.727 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -111.04 103.77 12.27 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.84 -1.17 . . . . 1.98 107.84 172.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 9' ' ' VAL . 48.6 mt -107.33 108.54 25.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.513 -0.767 . . . . 0.35999999999999999 111.451 -174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 59.9 m -102.66 106.41 17.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.819 -0.628 . . . . 0.46000000000000002 109.556 170.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.56 135.65 53.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.303 -0.628 . . . . 0.28000000000000003 109.303 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 45.6 tt0 -102.79 113.65 27.25 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.081 0.467 . . . . 0.77000000000000002 109.873 -176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 35.7 m -75.67 115.44 15.36 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.896 -0.779 . . . . 0.51000000000000001 108.896 176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mt -77.69 -24.03 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.175 -0.676 . . . . 0.56999999999999995 109.175 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -144.22 179.0 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.096 -0.956 . . . . 1.8300000000000001 109.524 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 18.5 t70 -91.65 138.51 31.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.561 -0.29 . . . . 2.1800000000000002 110.464 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD21 ' HZ3' ' A' ' 153' ' ' TRP . 8.4 mp -105.22 131.21 52.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.381 -0.372 . . . . 1.52 110.207 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -81.97 -32.42 30.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 1.55 110.004 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 32.6 tt0 -89.04 162.82 15.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 2.9500000000000002 109.258 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 63' ' ' GLY . 11.3 p-10 -87.78 132.54 34.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.03 0.443 . . . . 1.8799999999999999 109.848 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.9 OUTLIER -81.99 126.04 31.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.889 -0.596 . . . . 1.3200000000000001 109.904 -174.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 41.8 tt0 -91.49 117.27 29.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.92000000000000004 111.335 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -103.15 109.15 20.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.613 -0.722 . . . . 0.42999999999999999 109.375 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 19.7 mttp -109.89 133.12 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.643 0.258 . . . . 1.23 110.977 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 97' ' ' ILE . 5.0 mt -104.35 92.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.118 -0.697 . . . . 0.46000000000000002 109.118 168.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . 60.4 mt -86.84 106.52 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.398 -0.819 . . . . 0.68999999999999995 109.112 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -91.17 130.11 37.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.306 -0.627 . . . . 0.58999999999999997 109.306 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' HG22 ' A' ' 93' ' ' THR . 86.1 t -60.4 113.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.513 . . . . 0.37 109.773 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -62.92 -54.29 34.48 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.132 -1.032 . . . . 0.46999999999999997 111.061 176.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.628 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 43.1 t -131.58 130.34 42.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 110.366 -0.235 . . . . 1.23 110.366 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -77.9 -15.96 58.6 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.06 -0.719 . . . . 0.81999999999999995 109.06 170.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.12 -49.17 29.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.076 -0.965 . . . . 1.99 108.542 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 47' ' ' SER . 70.2 m -140.1 104.04 4.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.471 -0.566 . . . . 1.72 109.471 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.04 4.5 8.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.377 0.51 . . . . 2.0899999999999999 112.377 -173.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -69.16 -5.39 22.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.326 0.584 . . . . 2.8300000000000001 110.164 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.598 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 21.8 m-85 -95.51 19.97 10.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.487 -0.779 . . . . 1.48 109.758 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -55.32 144.32 25.4 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.789 -0.641 . . . . 1.22 111.057 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' HB3' HD13 ' A' ' 83' ' ' LEU . 18.7 pt20 -140.41 114.28 8.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 110.716 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.9 p -78.11 119.14 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.257 0.551 . . . . 1.0800000000000001 109.675 175.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 97.8 mt -69.34 -62.87 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.585 -176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -139.24 146.76 40.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 110.598 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.471 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 2.6 p -121.04 109.3 14.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.279 -0.873 . . . . 1.0900000000000001 109.181 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -102.92 122.78 55.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.22 110.561 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.6 mm? -108.45 127.12 53.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.76 -0.655 . . . . 1.3400000000000001 109.906 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.81 98.64 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 119.647 -0.821 . . . . 0.71999999999999997 109.668 169.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 37' ' ' ASP . . . -107.35 134.49 12.23 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.922 -1.036 . . . . 0.41999999999999998 112.691 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.1 Cg_endo -87.23 165.62 46.26 Favored 'Cis proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.989 -1.671 . . . . 0.55000000000000004 108.693 -13.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 34' ' ' LEU . 2.8 p -119.86 99.85 48.96 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-O 122.219 1.009 . . . . 0.94999999999999996 110.153 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 4.1 Cg_endo -86.04 169.71 8.73 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.71 2.94 . . . . 0.69999999999999996 113.458 -171.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.74 131.48 49.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.217 -0.901 . . . . 0.40999999999999998 111.253 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.06 156.79 7.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.258 -0.737 . . . . 0.33000000000000002 111.258 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.8 ttt180 -88.5 98.65 11.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.436 0.636 . . . . 2.7799999999999998 109.937 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -89.8 117.93 29.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.141 -0.936 . . . . 0.62 110.892 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 45.0 ttp -103.69 101.77 11.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.038 -0.528 . . . . 1.8 110.023 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.44 141.53 51.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.111 0.481 . . . . 0.37 109.882 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.57 113.84 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.471 0.653 . . . . 1.1200000000000001 110.682 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -84.47 127.92 34.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.44 108.728 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.15 123.66 29.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 1.1399999999999999 110.316 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -124.71 149.09 47.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.551 . . . . 0.56000000000000005 109.757 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.28 -169.2 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.632 0.253 . . . . 2.1299999999999999 110.804 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . . . -71.68 125.69 91.66 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.536 -0.302 . . . . 0.46000000000000002 110.548 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 18' ' ' PHE . 19.8 Cg_endo -61.4 162.0 21.98 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.785 2.323 . . . . 0.53000000000000003 112.278 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -59.2 116.92 17.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 2.1899999999999999 111.317 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.91 -12.03 33.98 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.855 2.37 . . . . 0.54000000000000004 111.722 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.0 -14.48 62.61 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.51000000000000001 111.839 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 55' ' ' GLN . 12.9 mt -97.01 -29.49 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.877 -0.19 . . . . 1.6000000000000001 110.594 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 89' ' ' ALA . 42.8 mt -76.27 113.39 27.97 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 108.96 -0.756 . . . . 0.52000000000000002 108.96 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 1.114 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 58.6 Cg_endo -70.64 148.9 60.34 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.041 2.494 . . . . 0.81000000000000005 112.723 -171.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.6 -37.7 79.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.235 -0.893 . . . . 2.29 112.171 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.06 -22.23 39.43 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.455 0.539 . . . . 1.25 112.455 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 1.114 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 34.1 t70 -107.21 -18.51 13.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.537 0.569 . . . . 1.9399999999999999 112.537 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -58.4 -31.36 67.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.54000000000000004 111.722 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 126' ' ' PRO . 3.4 t -91.89 41.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.421 0.629 . . . . 0.56000000000000005 109.817 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.78 -135.27 2.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.637 -0.792 . . . . 0.62 112.739 -171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.67 128.36 73.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.329 0.585 . . . . 1.23 110.435 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.587 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.6 m -126.06 166.66 16.58 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.63 109.035 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 30.0 t -118.53 139.03 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 O-C-N 121.954 -0.466 . . . . 0.35999999999999999 110.516 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.09 108.27 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.331 -0.988 . . . . 0.59999999999999998 108.331 173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.7 pp -116.46 128.16 55.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.738 0.78 . . . . 1.21 111.928 -170.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 42' ' ' ILE . 60.2 mt -96.17 112.34 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.781 -1.1 . . . . 0.33000000000000002 109.806 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 p -101.62 133.84 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.079 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HB3' HD11 ' A' ' 38' ' ' LEU . 22.1 m -109.38 116.09 31.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.639 -0.504 . . . . 1.3200000000000001 109.639 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 2.9 m -105.12 136.63 44.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.685 -0.689 . . . . 0.5 111.622 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 46.7 t80 -141.5 130.21 22.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.8 -0.815 . . . . 0.72999999999999998 108.8 173.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 24.8 mmt180 65.43 17.56 11.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.615 0.366 . . . . 2.4500000000000002 111.177 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.68 4.47 82.72 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.56999999999999995 111.273 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.472 HE22 ' ND2' ' A' ' 152' ' ' ASN . 21.5 mt-30 -121.56 128.0 51.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.296 -0.452 . . . . 1.3100000000000001 110.033 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -83.71 131.98 34.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.907 -0.405 . . . . 1.5900000000000001 109.907 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' HB3' HG12 ' A' ' 151' ' ' ILE . 22.9 p90 -106.35 -10.79 16.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.48 -0.327 . . . . 0.31 111.858 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 7.4 tt -155.52 152.45 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.046 -0.353 . . . . 0.37 110.046 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 147' ' ' THR . 48.7 ttp180 -143.29 116.76 9.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.068 -0.514 . . . . 1.1399999999999999 110.029 177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 66.1 t -99.17 102.4 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.72 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 101.0 2.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.657 -0.783 . . . . 0.27000000000000002 112.766 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 18.1 m-85 -91.47 122.16 33.81 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.867 0.365 . . . . 0.40000000000000002 110.409 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.31 110.46 17.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.128 0.49 . . . . 0.78000000000000003 110.67 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 3.2 p -94.3 127.72 46.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.932 -0.577 . . . . 1.1899999999999999 109.962 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -101.08 124.22 46.45 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.403 -0.591 . . . . 1.6299999999999999 109.403 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -104.08 118.61 37.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.692 0.758 . . . . 0.94999999999999996 111.689 -173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -146.66 144.94 29.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.405 -1.27 . . . . 1.97 108.25 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 66.9 m-85 -63.43 164.56 9.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.995 0.426 . . . . 0.68999999999999995 111.489 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 136' ' ' GLN . 39.6 p -84.35 -28.81 26.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.645 0.736 . . . . 0.83999999999999997 109.287 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 34.7 mm-40 -82.39 132.19 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.678 -1.146 . . . . 2.2400000000000002 110.398 -175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 38.9 m -54.41 -47.3 72.92 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.369 0.418 . . . . 1.4099999999999999 110.352 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.11 -40.51 73.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.993 -0.549 . . . . 2.21 111.303 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.16 -19.29 54.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.75 -0.38 . . . . 0.90000000000000002 111.143 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 69.7 mtp180 -83.83 -36.35 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.882 0.373 . . . . 2.0299999999999998 110.048 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 120' ' ' THR . 42.5 mt-10 -58.96 -44.19 91.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.59 -0.732 . . . . 2.8399999999999999 110.225 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.9 p30 -140.81 92.37 8.83 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.634 -0.712 . . . . 2.1899999999999999 110.262 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.668 ' HB3' HG11 ' A' ' 90' ' ' VAL . 20.0 Cg_endo -61.87 116.27 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.181 1.921 . . . . 1.24 111.006 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.09 154.11 35.31 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.84 2.36 . . . . 1.1899999999999999 112.211 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 8.7 p -50.12 -36.52 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.731 -0.668 . . . . 2.1600000000000001 111.443 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 128' ' ' VAL . 68.4 mmtt -120.07 126.56 26.79 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 109.19 -0.671 . . . . 1.96 109.19 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.639 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 29.5 Cg_endo -61.45 159.66 30.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.349 2.699 . . . . 0.70999999999999996 113.662 -174.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.7 t70 -117.46 110.05 17.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.244 -0.889 . . . . 1.28 109.495 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 59.3 m-85 -77.31 -12.14 59.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.969 -0.56 . . . . 0.5 111.554 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 32.5 t -85.46 -17.53 36.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 1.46 111.529 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -124.98 1.01 7.99 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.287 0.565 . . . . 1.8700000000000001 110.371 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 35.3 tp -78.38 123.49 27.06 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.233 -0.894 . . . . 0.79000000000000004 109.493 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 118' ' ' THR . 24.2 tt0 -99.38 130.22 45.64 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 109.999 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 113' ' ' VAL . 20.3 mtm180 -91.85 108.05 19.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 2.8199999999999998 109.948 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 -97.5 89.2 4.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.456 0.646 . . . . 0.83999999999999997 109.488 174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.607 ' HA ' ' HA ' ' A' ' 113' ' ' VAL . 41.4 mt -73.39 115.78 14.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 109.887 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.31 88.84 2.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.074 -0.512 . . . . 0.98999999999999999 110.288 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.55 -10.31 59.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.521 0.677 . . . . 0.55000000000000004 110.179 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -84.76 -8.77 58.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.324 -0.853 . . . . 1.4199999999999999 109.637 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -123.91 78.29 57.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.951 -0.568 . . . . 1.9099999999999999 110.384 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 18.4 Cg_endo -93.38 111.37 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.481 2.787 . . . . 0.66000000000000003 112.166 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.92 83.5 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.564 -0.532 . . . . 3.1499999999999999 109.564 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.51 104.59 15.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.25 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.416 ' CB ' HH21 ' A' ' 108' ' ' ARG . 8.3 m -114.17 109.89 19.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.56000000000000005 109.769 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 20.5 ptp180 -98.68 150.06 22.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.918 -0.583 . . . . 3.0 110.111 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -120.32 151.14 39.64 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.128 -0.942 . . . . 0.46000000000000002 109.88 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -95.58 111.6 23.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.52 -0.548 . . . . 3.1400000000000001 109.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 106' ' ' PHE . 31.2 pt -122.02 -173.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.246 -0.433 . . . . 0.64000000000000001 110.12 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.472 ' ND2' HE22 ' A' ' 104' ' ' GLN . 7.7 p30 -111.36 116.76 31.5 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.601 -0.727 . . . . 1.78 109.657 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.524 ' HZ3' HD21 ' A' ' 34' ' ' LEU . 31.9 m95 -84.8 2.67 41.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.975 0.893 . . . . 0.87 108.758 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -116.26 -149.5 0.45 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.988 -1.46 . . . . 2.3199999999999998 108.484 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -122.68 72.92 1.1 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.169 -0.678 . . . . 2.4900000000000002 109.169 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.634 -0.712 . . . . 2.5699999999999998 109.587 -179.417 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.832 0.349 . . . . 2.96 111.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 31' ' ' ILE . . . -84.4 104.16 14.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.876 -0.416 . . . . 1.48 109.876 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.786 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -79.52 -17.51 53.9 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.724 -0.39 . . . . 0.97999999999999998 110.607 178.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 38' ' ' LEU . 4.7 t -140.82 125.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.45000000000000001 110.964 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -132.24 107.97 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 1.3899999999999999 109.516 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.2 t -66.23 134.99 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.063 -0.517 . . . . 1.3200000000000001 109.908 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -118.03 -62.91 1.49 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.95999999999999996 110.578 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 8.5 t30 -101.24 111.29 23.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.185 -0.461 . . . . 1.47 110.068 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -125.59 99.13 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 122.07 0.938 . . . . 1.01 110.311 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.1 t -109.79 132.26 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.136 -0.938 . . . . 1.54 110.728 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.7 m -89.69 143.82 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.685 -0.857 . . . . 0.91000000000000003 108.685 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.718 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.9 mp -124.07 156.42 36.6 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.518 -0.473 . . . . 1.1799999999999999 110.867 -175.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.752 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.5 OUTLIER 74.34 4.58 4.51 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 124.58 1.175 . . . . 2.73 110.023 177.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' ND2' ' HB ' ' A' ' 139' ' ' ILE . 40.3 t30 -83.35 133.98 46.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.567 -0.742 . . . . 1.8799999999999999 110.905 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 4.2 Cg_exo -82.38 147.63 65.63 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 124.16 -1.183 . . . . 0.59999999999999998 112.664 -5.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.752 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 8.1 t -144.73 150.54 47.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.017 -0.538 . . . . 0.77000000000000002 109.631 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 136' ' ' GLN . 87.2 Cg_exo -48.69 153.46 3.54 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.82 2.347 . . . . 0.82999999999999996 112.686 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.695 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 29.9 t80 -58.26 -27.44 64.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.067 -0.97 . . . . 0.40999999999999998 112.555 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HE2' ' HB2' ' A' ' 133' ' ' SER . 2.0 m-30 -76.7 -10.01 59.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.564 0.579 . . . . 0.65000000000000002 112.564 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.615 ' ND2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -81.66 140.54 47.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.93 -0.767 . . . . 2.0699999999999998 108.93 174.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.95 146.09 94.69 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.434 2.09 . . . . 0.62 112.427 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 24' ' ' PHE . 31.1 m-85 -64.56 99.74 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.853 -0.795 . . . . 0.57999999999999996 108.853 170.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 15.4 tt0 -99.9 107.88 19.99 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.1 -0.955 . . . . 1.4099999999999999 110.627 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 22' ' ' PHE . 97.7 m-85 -116.36 131.62 56.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.532 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 tt0 -101.04 95.33 6.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 69.6 mt -93.4 112.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.214 -0.903 . . . . 0.35999999999999999 111.281 -172.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.1 m -104.94 105.59 15.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.544 -0.753 . . . . 0.46000000000000002 109.527 173.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.6 p90 -119.84 137.64 53.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.515 -0.55 . . . . 0.28000000000000003 109.515 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.801 -0.636 . . . . 0.77000000000000002 109.966 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.0 t -81.19 109.29 15.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.109 -0.951 . . . . 0.51000000000000001 108.785 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 2' ' ' ALA . 20.4 mt -79.74 -11.9 13.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.656 -0.702 . . . . 0.56999999999999995 110.058 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 51.7 mt-10 -147.91 -177.6 5.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 1.8300000000000001 111.004 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -101.12 114.56 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.287 -0.635 . . . . 2.1800000000000002 109.287 175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.085 HD21 ' HB ' ' A' ' 65' ' ' VAL . 1.5 pp -94.49 132.97 38.59 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.474 -0.49 . . . . 1.52 111.673 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -74.06 -45.47 49.27 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.444 -0.798 . . . . 1.55 112.371 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 tp10 -86.18 -177.72 6.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.51 -0.552 . . . . 2.9500000000000002 109.51 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.26 136.05 33.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.385 -0.598 . . . . 1.8799999999999999 109.385 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' CD2' HG21 ' A' ' 4' ' ' VAL . 15.3 tp -82.54 123.96 29.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.834 -0.621 . . . . 1.3200000000000001 110.964 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.7 tt0 -94.58 116.0 28.24 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.904 0.383 . . . . 0.92000000000000004 111.766 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 59' ' ' SER . 76.3 m95 -109.84 117.52 34.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.002 -0.544 . . . . 0.42999999999999999 109.918 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 86.6 mttt -126.54 141.08 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.014 0.435 . . . . 1.23 111.464 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 97' ' ' ILE . 9.7 mt -105.02 107.6 22.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.934 -0.576 . . . . 0.46000000000000002 109.777 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 56' ' ' VAL . 3.1 mp -96.28 112.85 29.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.565 -0.531 . . . . 0.68999999999999995 109.565 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -98.99 133.33 43.41 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.093 -0.503 . . . . 0.58999999999999997 110.148 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 93' ' ' THR . 84.7 t -61.82 112.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -68.0 -63.2 3.76 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.62 -0.8 . . . . 0.46999999999999997 112.432 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 28.2 t -124.64 152.82 43.14 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 122.607 -0.349 . . . . 1.23 110.634 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -90.94 -21.83 21.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.704 -0.85 . . . . 0.81999999999999995 108.704 168.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.62 -45.99 18.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.035 -0.984 . . . . 1.99 110.173 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLU . 47.3 t -95.55 -47.89 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.958 0.408 . . . . 1.72 110.687 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' SER . 49.4 mt-10 66.75 -24.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.256 -0.884 . . . . 2.0899999999999999 111.641 -174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.5 tp10 -73.2 -8.87 57.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.548 0.689 . . . . 2.8300000000000001 109.564 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 11.2 m-85 -83.94 14.91 3.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.209 -0.905 . . . . 1.48 110.297 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.1 p-10 -58.39 133.75 56.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.507 -0.553 . . . . 1.22 109.507 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -129.99 123.32 30.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.824 -0.625 . . . . 1.8500000000000001 112.489 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.628 HG22 HG13 ' A' ' 43' ' ' ILE . 58.6 t -68.96 114.25 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.192 -0.913 . . . . 1.0800000000000001 109.25 169.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 77.3 mt -73.05 -52.67 13.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.685 -0.689 . . . . 1.05 110.901 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -158.23 165.41 34.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.821 -0.627 . . . . 1.3100000000000001 109.764 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 9.4 p -138.31 121.73 17.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.022 0.439 . . . . 1.0900000000000001 110.789 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.23 124.26 66.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.933 -0.576 . . . . 1.22 109.908 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 39' ' ' GLU . 2.3 mm? -110.75 133.27 53.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 110.1 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.77 102.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.492 0.663 . . . . 0.71999999999999997 109.881 171.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -107.4 116.94 5.09 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.676 -1.069 . . . . 0.41999999999999998 112.851 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 66.5 Cg_endo -99.68 168.41 9.44 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 CA-C-N 121.318 2.559 . . . . 0.55000000000000004 109.652 -14.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.085 ' HB ' HD21 ' A' ' 34' ' ' LEU . 2.1 t -106.78 109.43 63.1 Favored Pre-proline 0 C--N 1.318 -0.803 0 C-N-CA 119.146 -1.022 . . . . 0.94999999999999996 110.121 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -80.15 158.63 23.48 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.744 2.296 . . . . 0.69999999999999996 112.672 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -57.01 125.87 24.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.353 -0.839 . . . . 0.40999999999999998 111.42 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.36 9.54 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.809 -0.916 . . . . 0.33000000000000002 110.809 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.0 ttm180 -87.26 104.7 16.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.294 0.568 . . . . 2.7799999999999998 110.27 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.53 153.54 19.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.488 -0.778 . . . . 0.62 110.405 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.2 ttm -139.95 120.99 14.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.142 -0.481 . . . . 1.8 109.842 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -140.64 150.02 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.039 -0.356 . . . . 0.37 110.039 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.3 108.92 23.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.679 0.752 . . . . 1.1200000000000001 111.136 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -80.86 125.06 29.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.886 -1.052 . . . . 0.44 108.585 177.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -127.65 120.83 28.94 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.009 -0.367 . . . . 1.1399999999999999 110.009 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -123.34 120.02 31.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.167 -0.47 . . . . 0.56000000000000005 110.013 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.84 169.8 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.495 -0.321 . . . . 2.1299999999999999 110.863 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -44.99 123.02 4.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.46000000000000002 112.055 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HB2' HD11 ' A' ' 84' ' ' ILE . 77.5 Cg_exo -51.21 147.55 20.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.964 2.443 . . . . 0.53000000000000003 111.791 176.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -53.56 113.04 4.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 123.539 0.525 . . . . 2.1899999999999999 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.19 -15.91 52.42 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.223 2.615 . . . . 0.54000000000000004 112.193 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.45 -16.76 78.94 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.807 -0.711 . . . . 0.51000000000000001 111.893 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -99.67 -19.76 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.445 0.164 . . . . 1.6000000000000001 110.968 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 79' ' ' PRO . 58.0 mt -88.49 109.71 31.17 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.812 -0.44 . . . . 0.52000000000000002 109.812 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 88' ' ' ASP . 17.1 Cg_exo -69.74 160.24 50.44 Favored 'Trans proline' 0 CA--C 1.522 -0.09 0 C-N-CA 123.599 2.866 . . . . 0.81000000000000005 112.487 -176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -60.29 -42.56 95.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.813 -0.631 . . . . 2.29 111.707 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.01 -33.7 70.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 1.25 111.419 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.605 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 62.9 m-20 -88.91 -19.95 25.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.481 -0.327 . . . . 1.9399999999999999 111.64 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.22 81.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.54000000000000004 111.483 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.4 39.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.347 0.594 . . . . 0.56000000000000005 110.099 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.25 -170.84 17.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.62 113.21 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.531 ' HB ' ' ND2' ' A' ' 114' ' ' ASN . 7.1 p -89.77 137.16 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 1.23 111.082 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -135.05 164.47 27.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.514 -0.55 . . . . 0.63 109.514 176.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.01 136.37 40.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.872 -0.331 . . . . 0.35999999999999999 110.516 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.59 119.46 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.967 -0.753 . . . . 0.59999999999999998 108.967 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 26.5 mt -111.22 140.31 45.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.278 -172.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 42' ' ' ILE . 52.9 mt -116.16 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.955 -0.757 . . . . 0.33000000000000002 108.955 170.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 t -104.73 146.83 28.41 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.587 -0.523 . . . . 1.4199999999999999 109.587 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.82 120.58 37.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 1.3200000000000001 110.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.2 m -101.78 130.44 48.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.919 -0.582 . . . . 0.5 111.199 -175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 10.6 t80 -139.97 126.96 20.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.721 -0.844 . . . . 0.72999999999999998 108.721 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 33.1 mmt180 70.33 14.73 7.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 122.584 0.353 . . . . 2.4500000000000002 111.162 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.07 -6.89 82.46 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.836 -0.905 . . . . 0.56999999999999995 110.836 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.428 ' NE2' ' HB ' ' A' ' 151' ' ' ILE . 26.8 mt-30 -110.83 137.89 47.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.919 -0.64 . . . . 1.3100000000000001 109.85 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.07 134.99 33.62 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.7 -0.482 . . . . 1.5900000000000001 109.7 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -108.24 -13.83 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.655 0.264 . . . . 0.31 111.546 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 6.5 tt -155.34 147.27 12.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.24 -0.281 . . . . 0.37 110.24 176.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -143.08 110.99 5.96 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.968 -0.56 . . . . 1.1399999999999999 109.786 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.7 t -85.95 132.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.68 -0.691 . . . . 0.38 110.113 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.575 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . -124.38 116.31 2.76 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.523 -0.846 . . . . 0.27000000000000002 112.713 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.18 136.53 50.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.367 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -96.86 110.6 23.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.055 -0.521 . . . . 0.78000000000000003 109.934 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 137' ' ' ARG . 3.3 p -101.78 130.03 52.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.089 -0.505 . . . . 1.1899999999999999 110.949 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.531 ' ND2' ' HB ' ' A' ' 92' ' ' VAL . 18.0 m120 -97.48 118.72 34.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.885 -0.598 . . . . 1.6299999999999999 110.278 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 137' ' ' ARG . 23.7 m-80 -101.55 108.84 20.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.097 -0.501 . . . . 0.94999999999999996 110.001 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.26 149.5 49.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.975 -0.557 . . . . 1.97 109.709 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.705 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 91.0 m-85 -55.0 150.66 9.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.178 0.513 . . . . 0.68999999999999995 111.466 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.483 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 34.3 p -83.02 -22.78 33.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.109 0.957 . . . . 0.83999999999999997 108.694 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 1.3 mm-40 -87.86 122.05 31.02 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.924 -1.489 . . . . 2.2400000000000002 109.455 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.7 m -53.54 -39.63 64.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.341 0.591 . . . . 1.4099999999999999 110.017 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.2 -41.95 97.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 2.21 111.524 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.49 -23.95 39.78 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.481 -0.487 . . . . 0.90000000000000002 111.124 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 62.9 mtp180 -68.34 -37.25 80.33 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.473 0.654 . . . . 2.0299999999999998 109.339 174.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -75.24 -38.83 60.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.77 -1.105 . . . . 2.8399999999999999 110.87 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -133.42 84.02 47.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 121.053 -0.259 . . . . 2.1899999999999999 111.089 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 51.7 Cg_exo -56.69 116.21 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.943 1.762 . . . . 1.24 110.937 169.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 32.1 Cg_exo -62.88 166.9 13.02 Favored 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.277 2.651 . . . . 1.1899999999999999 111.19 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.0 p -33.33 -48.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 124.002 0.814 . . . . 2.1600000000000001 112.409 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -125.11 133.32 24.73 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.392 -0.596 . . . . 1.96 109.392 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.705 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 13.2 Cg_endo -56.06 170.11 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.159 2.573 . . . . 0.70999999999999996 112.473 176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.26 124.25 24.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.489 . . . . 1.28 110.859 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 53.3 m-85 -79.69 -13.47 59.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.063 -0.971 . . . . 0.5 111.219 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.471 ' HB2' ' HE2' ' A' ' 19' ' ' TYR . 33.5 t -89.36 -16.95 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 1.46 111.467 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 30.6 mmtp -110.79 9.83 22.6 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 108.566 -0.901 . . . . 1.8700000000000001 108.566 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 115' ' ' ASN . 14.6 tp -94.21 129.41 40.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.073 -1.422 . . . . 0.79000000000000004 109.55 -175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.483 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 1.3 tm0? -108.1 135.54 49.27 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.277 -0.638 . . . . 1.6299999999999999 109.277 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 18.4 mtm180 -103.97 106.79 17.41 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.895 -0.322 . . . . 2.8199999999999998 110.702 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 7.4 t30 -93.52 100.49 12.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.269 -0.641 . . . . 0.83999999999999997 109.269 173.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.459 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 69.0 mt -80.15 118.15 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.847 -0.615 . . . . 0.47999999999999998 110.715 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -81.12 91.11 6.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.311 -0.404 . . . . 0.98999999999999999 110.687 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.85 59.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.12 0.486 . . . . 0.55000000000000004 110.302 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 t -85.89 -1.07 56.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.855 -0.611 . . . . 1.4199999999999999 109.753 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -123.49 76.72 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.699 -0.682 . . . . 1.9099999999999999 109.618 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -91.67 106.9 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.059 2.506 . . . . 0.66000000000000003 112.526 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.453 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.1 tpm_? -81.33 82.83 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.282 0.563 . . . . 3.1499999999999999 109.518 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.67 107.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.441 0.639 . . . . 1.1399999999999999 110.203 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 m -127.9 108.77 10.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.946 -0.57 . . . . 0.56000000000000005 110.79 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 13.1 ptt180 -102.6 148.2 25.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.279 176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -115.18 154.11 29.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.275 -0.875 . . . . 0.46000000000000002 111.0 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -93.6 114.77 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.418 -0.586 . . . . 3.1400000000000001 109.418 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.428 ' HB ' ' NE2' ' A' ' 104' ' ' GLN . 32.8 pt -140.6 170.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.64000000000000001 110.58 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.29 117.19 30.96 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.351 -0.611 . . . . 1.78 109.351 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.431 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 6.4 m95 -87.06 -12.76 46.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.615 -0.721 . . . . 0.87 110.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.653 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 4.6 mm-40 -93.62 -153.38 0.36 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.151 -0.685 . . . . 2.3199999999999998 109.151 -167.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.38 71.66 0.94 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.872 -1.529 . . . . 2.4900000000000002 106.872 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 114.709 -1.132 . . . . 2.5699999999999998 110.454 -165.053 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.606 0.241 . . . . 2.96 111.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.67 125.4 29.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.057 0.456 . . . . 1.48 112.113 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -86.94 -17.49 33.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.478 -0.564 . . . . 0.97999999999999998 109.478 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 34' ' ' LEU . 2.1 t -139.62 125.65 22.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.406 -0.815 . . . . 0.45000000000000001 109.125 178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -128.37 109.85 11.81 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.34 -0.615 . . . . 1.3899999999999999 109.34 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 7.8 m -68.37 145.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.2 -0.667 . . . . 1.3200000000000001 109.2 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -123.98 -63.86 1.18 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.308 0.575 . . . . 0.95999999999999996 109.881 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 5.9 t30 -102.62 128.87 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.909 . . . . 1.47 110.168 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 7.7 p -144.14 122.03 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.287 0.565 . . . . 1.01 109.909 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 25' ' ' GLU . 4.7 p -136.83 143.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.001 -0.545 . . . . 1.54 110.412 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 139' ' ' ILE . 22.0 t -94.9 131.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.667 -0.494 . . . . 0.91000000000000003 109.667 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD11 ' HB2' ' A' ' 25' ' ' GLU . 1.9 mp -105.4 152.2 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.26 0.552 . . . . 1.1799999999999999 111.221 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.837 ' HB2' HE21 ' A' ' 23' ' ' GLN . 0.7 OUTLIER 69.92 23.21 5.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.513 -1.222 . . . . 2.73 109.861 177.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 42.5 t30 -96.18 129.29 34.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 1.8799999999999999 111.381 177.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 1.1 Cg_endo -91.36 148.73 16.99 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.724 -0.948 . . . . 0.59999999999999998 112.215 -8.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.6 m -153.03 165.73 16.98 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.681 -0.488 . . . . 0.77000000000000002 109.681 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -43.64 145.78 1.64 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.34 2.693 . . . . 0.82999999999999996 113.788 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 11.3 t80 -54.62 -36.35 64.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.67 -1.15 . . . . 0.40999999999999998 112.188 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 63.5 m-85 -77.63 4.8 10.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.01 0.433 . . . . 0.65000000000000002 111.634 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.35 131.27 30.12 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.879 -0.785 . . . . 2.0699999999999998 108.879 172.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 52.5 Cg_exo -53.93 144.9 54.15 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.48 2.787 . . . . 0.62 113.596 -172.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -75.82 101.33 5.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.68 -0.691 . . . . 0.57999999999999996 109.295 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.837 HE21 ' HB2' ' A' ' 13' ' ' ASP . 16.2 mt-30 -92.98 123.39 36.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 1.4099999999999999 110.429 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -125.18 113.7 18.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.975 0.417 . . . . 0.5 111.018 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -89.18 97.11 11.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.975 -1.12 . . . . 1.98 107.975 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -105.44 105.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.808 -1.087 . . . . 0.35999999999999999 110.979 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 21.4 m -95.25 105.31 17.25 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.31 -0.626 . . . . 0.46000000000000002 109.31 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 31.2 p90 -117.76 137.53 52.66 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.526 -0.546 . . . . 0.28000000000000003 109.526 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 52.1 tt0 -104.25 116.29 31.91 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.923 -0.581 . . . . 0.77000000000000002 110.487 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 62.4 m -75.35 105.75 6.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.716 -0.846 . . . . 0.51000000000000001 108.716 173.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 mt -69.48 -30.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.733 -0.84 . . . . 0.56999999999999995 108.733 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 6.4 mm-40 -131.61 170.92 14.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.235 -1.348 . . . . 1.8300000000000001 109.188 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.22 125.99 34.92 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.179 -0.674 . . . . 2.1800000000000002 109.179 173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.847 ' HB2' HG23 ' A' ' 65' ' ' VAL . 6.7 mp -91.82 136.79 32.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.731 -0.47 . . . . 1.52 109.731 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 m -86.77 -16.85 35.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 1.55 111.223 -174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 33.4 tt0 -109.38 164.75 12.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 109.857 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 7.5 p-10 -79.39 127.91 32.69 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.39 -0.596 . . . . 1.8799999999999999 109.39 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.574 ' HB2' HG21 ' A' ' 65' ' ' VAL . 15.2 tp -82.14 119.73 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.167 -0.47 . . . . 1.3200000000000001 110.647 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.9 tt0 -90.87 112.34 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.77 -0.65 . . . . 0.92000000000000004 111.052 -177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 60' ' ' VAL . 79.6 m95 -106.11 109.96 22.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.34 -0.985 . . . . 0.42999999999999999 108.34 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HG3' ' HB3' ' A' ' 59' ' ' SER . 29.9 ttmt -117.69 132.72 56.44 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.13 -0.322 . . . . 1.23 110.13 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 97' ' ' ILE . 4.8 mt -104.44 113.17 40.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 110.189 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.627 HD11 ' HD2' ' A' ' 41' ' ' LYS . 5.3 mp -105.41 111.7 35.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.347 -0.842 . . . . 0.68999999999999995 109.644 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' HE1' HG11 ' A' ' 113' ' ' VAL . 70.6 t80 -90.01 127.17 35.99 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.439 -0.948 . . . . 0.58999999999999997 108.439 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.649 ' HB ' HG22 ' A' ' 93' ' ' THR . 75.6 t -56.06 118.04 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.37 110.131 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -65.89 -52.02 41.18 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.515 -0.85 . . . . 0.46999999999999997 111.621 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.849 ' HG ' ' HD2' ' A' ' 53' ' ' TYR . 77.2 p -136.98 132.15 33.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 110.055 -0.35 . . . . 1.23 110.055 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -17.2 62.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.596 0.712 . . . . 0.81999999999999995 109.43 169.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -75.57 -49.83 17.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.774 -1.103 . . . . 1.99 111.237 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 52' ' ' GLU . 40.7 t -116.21 -39.43 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.375 -0.53 . . . . 1.72 111.779 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 70.81 -16.54 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.575 0.75 . . . . 2.0899999999999999 111.33 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 50' ' ' SER . 6.6 mm-40 -69.98 -10.02 57.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.775 0.798 . . . . 2.8300000000000001 109.787 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.849 ' HD2' ' HG ' ' A' ' 47' ' ' SER . 29.6 m-85 -91.97 15.86 12.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.84 -1.073 . . . . 1.48 110.218 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 8.6 p-10 -55.05 147.19 16.32 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.604 -0.725 . . . . 1.22 111.863 -176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 31.4 mt-30 -121.08 118.8 30.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 1.8500000000000001 110.819 -172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.04 104.97 8.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.342 -0.614 . . . . 1.0800000000000001 109.342 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.644 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 40.7 mt -74.66 -58.56 3.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.967 -0.561 . . . . 1.05 111.275 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -153.88 162.06 41.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.715 -0.675 . . . . 1.3100000000000001 109.254 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.669 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 19.6 p -151.31 117.22 5.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.447 -0.575 . . . . 1.0900000000000001 109.447 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 40' ' ' TRP . 18.4 m -104.61 132.65 50.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.904 -0.589 . . . . 1.22 110.601 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.5 mm? -113.25 104.98 12.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.953 -0.758 . . . . 1.3400000000000001 108.953 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.01 100.81 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.452 -0.899 . . . . 0.71999999999999997 109.675 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -105.63 117.88 5.63 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.266 -0.879 . . . . 0.41999999999999998 112.546 177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 66.3 Cg_endo -101.33 168.1 7.68 Favored 'Cis proline' 0 N--CA 1.446 -1.274 0 CA-C-N 119.589 1.694 . . . . 0.55000000000000004 110.616 -11.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -95.64 103.88 14.27 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.991 0.424 . . . . 0.94999999999999996 110.824 176.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 64' ' ' PRO . 2.4 Cg_endo -81.97 152.84 16.76 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.031 2.487 . . . . 0.69999999999999996 111.322 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -56.15 122.26 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.673 0.608 . . . . 0.40999999999999998 111.507 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 160.29 160.01 10.28 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.744 -0.942 . . . . 0.33000000000000002 110.744 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 38.1 ttm180 -89.64 108.15 19.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.311 0.556 . . . . 2.7799999999999998 110.118 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -102.76 120.4 40.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.705 -0.679 . . . . 0.62 110.724 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 46.0 ttm -102.46 96.84 7.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.165 -0.47 . . . . 1.8 109.809 175.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.74 144.76 44.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.16 0.505 . . . . 0.37 110.45 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -103.47 102.19 13.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.401 0.619 . . . . 1.1200000000000001 111.13 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -74.25 131.5 41.26 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.724 -0.843 . . . . 0.44 108.724 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -128.9 125.33 37.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 109.886 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -125.56 141.28 52.12 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.889 -0.596 . . . . 0.56000000000000005 110.239 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.2 -176.94 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 2.1299999999999999 111.51 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -82.32 126.21 74.74 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 116.034 -0.53 . . . . 0.46000000000000002 110.532 -178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.2 Cg_exo -59.47 158.66 26.4 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.03 2.487 . . . . 0.53000000000000003 112.442 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 83' ' ' LEU . 55.9 m-80 -58.23 124.73 72.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 2.1899999999999999 111.082 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 25.2 Cg_exo -65.12 -22.66 61.42 Favored 'Trans proline' 0 N--CA 1.466 -0.101 0 C-N-CA 122.891 2.394 . . . . 0.54000000000000004 112.198 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.57 74.45 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.89 -0.671 . . . . 0.51000000000000001 112.069 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.683 HD13 ' CB ' ' A' ' 80' ' ' ASN . 10.9 mp -87.44 -30.26 20.81 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.969 -0.382 . . . . 1.6000000000000001 109.969 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.9 mt -79.65 129.04 72.67 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.795 -0.638 . . . . 0.52000000000000002 109.868 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 96.8 Cg_endo -77.84 157.84 31.27 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.209 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -61.43 -42.12 98.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 2.29 111.901 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.98 -28.78 68.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.842 0.312 . . . . 1.25 111.842 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 12.6 t70 -77.95 -39.62 42.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.361 -0.381 . . . . 1.9399999999999999 111.558 -176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.73 -27.89 69.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.803 -0.635 . . . . 0.54000000000000004 112.273 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 130' ' ' PRO . 3.3 t -102.5 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.56000000000000005 110.181 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -150.51 -131.34 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.249 -0.977 . . . . 0.62 113.104 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.13 129.52 65.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.406 0.622 . . . . 1.23 110.626 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 45' ' ' VAL . 1.5 m -123.94 166.99 14.73 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.676 -0.861 . . . . 0.63 108.676 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.1 t -116.31 134.21 60.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 O-C-N 121.596 -0.69 . . . . 0.35999999999999999 110.413 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.31 108.38 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.257 -1.016 . . . . 0.59999999999999998 108.257 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.71 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.7 pp -120.23 135.84 54.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.568 0.699 . . . . 1.21 111.89 -170.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 42' ' ' ILE . 53.7 mt -104.58 112.67 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.019 -0.991 . . . . 0.33000000000000002 109.866 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 p -101.2 122.4 43.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.487 -0.56 . . . . 1.4199999999999999 109.487 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 15.6 t -102.32 118.59 37.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.227 0.536 . . . . 1.3200000000000001 109.846 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 9.3 m -100.23 132.49 45.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.189 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 36' ' ' GLU . 32.1 t80 -133.69 120.58 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.72999999999999998 109.44 172.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 36' ' ' GLU . 26.1 mmm180 65.29 28.01 11.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.8 0.44 . . . . 2.4500000000000002 111.322 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.44 7.1 88.02 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.029 -0.605 . . . . 0.56999999999999995 112.145 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -124.04 115.47 21.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.381 -0.6 . . . . 1.3100000000000001 109.381 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 3.3 mp0 -76.27 126.24 30.63 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.723 -0.391 . . . . 1.5900000000000001 110.348 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 38.9 p90 -104.54 -6.41 20.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.31 111.666 -175.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 9.0 tt -153.78 141.63 13.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.267 0.556 . . . . 0.37 110.659 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' HB2' ' HE2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -134.57 106.33 6.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 176.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 55.3 t -90.77 106.03 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.199 -0.455 . . . . 0.38 110.112 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -103.78 104.55 2.49 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.582 -0.818 . . . . 0.27000000000000002 112.711 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -97.45 124.62 41.71 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.587 -0.524 . . . . 0.40000000000000002 109.587 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -81.8 109.83 16.55 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.758 -0.46 . . . . 0.78000000000000003 109.758 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 137' ' ' ARG . 2.5 p -97.84 127.1 50.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 110.142 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -96.38 130.67 43.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.079 -0.51 . . . . 1.6299999999999999 109.816 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.522 ' HB3' HD21 ' A' ' 135' ' ' LEU . 76.2 m-20 -106.09 108.62 20.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.559 0.695 . . . . 0.94999999999999996 110.058 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -133.65 149.46 51.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.014 -0.994 . . . . 1.97 109.455 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 78.5 m-85 -61.96 153.71 28.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.006 0.431 . . . . 0.68999999999999995 110.885 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 136' ' ' GLN . 36.9 p -82.92 -23.56 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.606 0.717 . . . . 0.83999999999999997 109.525 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 47.1 mt-10 -99.18 127.91 45.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.534 -1.212 . . . . 2.2400000000000002 110.021 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 20.9 m -55.63 -40.29 71.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 1.4099999999999999 111.391 -176.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -58.79 -37.02 75.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.325 -0.398 . . . . 2.21 110.889 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.49 -24.45 53.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.147 0.498 . . . . 0.90000000000000002 110.263 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 65.6 mtp180 -80.35 -30.35 38.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.596 -0.729 . . . . 2.0299999999999998 110.49 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.9 mm-40 -65.6 -46.24 80.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.754 -0.657 . . . . 2.8399999999999999 110.372 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.83 84.28 38.7 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.311 0.576 . . . . 2.1899999999999999 110.76 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 54.4 Cg_exo -53.63 118.72 5.22 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.744 2.296 . . . . 1.24 111.825 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 37.4 Cg_exo -62.75 164.88 17.38 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.425 2.75 . . . . 1.1899999999999999 112.005 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 129' ' ' LYS . 11.1 p -50.6 -38.76 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 2.1600000000000001 111.55 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 128' ' ' VAL . 33.2 mmtp -119.82 131.07 24.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.536 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 25.5 Cg_endo -61.61 163.76 17.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.877 2.385 . . . . 0.70999999999999996 112.668 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.8 t0 -125.97 116.1 20.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 1.28 109.827 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.86 -27.03 44.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.054 -0.521 . . . . 0.5 110.594 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.1 m -78.26 -6.25 54.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 1.46 110.43 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.4 mmtt -119.54 4.52 11.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.613 -0.721 . . . . 1.8700000000000001 109.174 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 115' ' ' ASN . 10.3 tp -95.06 135.14 36.96 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.123 -0.944 . . . . 0.79000000000000004 110.45 -171.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.543 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.5 tt0 -111.67 127.14 55.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.616 -0.72 . . . . 1.6299999999999999 109.379 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 113' ' ' VAL . 5.1 ppt_? -84.81 110.71 19.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.778 0.799 . . . . 2.8199999999999998 109.906 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.0 t30 -99.02 91.99 5.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.616 -1.175 . . . . 0.83999999999999997 109.077 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.549 HG21 HG11 ' A' ' 11' ' ' VAL . 63.6 mt -77.46 120.69 28.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.824 -1.08 . . . . 0.47999999999999998 110.567 -175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.6 mt -78.01 84.14 4.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.184 0.516 . . . . 0.98999999999999999 110.259 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.77 -16.52 60.11 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.752 -0.833 . . . . 0.55000000000000004 108.752 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.9 m -76.01 -12.01 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.796 -1.093 . . . . 1.4199999999999999 110.165 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -127.8 79.18 74.03 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.458 -0.571 . . . . 1.9099999999999999 109.458 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -93.58 106.25 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.966 2.444 . . . . 0.66000000000000003 112.571 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 10.1 mmt180 -80.72 81.52 6.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.171 0.51 . . . . 3.1499999999999999 110.304 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.74 103.25 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.36 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -119.7 107.83 13.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.913 -0.585 . . . . 0.56000000000000005 109.571 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 31.4 ptt180 -99.38 147.46 25.21 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 120.274 -0.57 . . . . 3.0 109.504 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.515 ' HE2' ' HB2' ' A' ' 108' ' ' ARG . 35.2 m-85 -110.38 137.65 47.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.327 -0.852 . . . . 0.46000000000000002 109.91 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -79.41 109.86 14.17 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.329 -0.619 . . . . 3.1400000000000001 109.329 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 18.8 pt -125.68 -172.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.315 0.579 . . . . 0.64000000000000001 110.336 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.893 HD21 ' HA ' ' A' ' 155' ' ' ASP . 6.2 t30 -106.72 89.58 3.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.279 -0.873 . . . . 1.78 110.427 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -66.81 -48.48 68.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.986 0.898 . . . . 0.87 109.572 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -90.34 105.53 17.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.571 -1.195 . . . . 2.3199999999999998 107.886 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.893 ' HA ' HD21 ' A' ' 152' ' ' ASN . 32.0 t70 -74.63 72.79 1.97 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.006 0.816 . . . . 2.4900000000000002 111.502 -166.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.866 0 CA-C-N 114.913 -1.04 . . . . 2.5699999999999998 110.305 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.575 0.226 . . . . 2.96 111.005 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -78.83 139.1 38.42 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 121.095 -0.242 . . . . 1.48 110.373 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 153' ' ' TRP . 0.1 OUTLIER -100.44 -8.92 22.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.97999999999999998 109.954 175.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -141.36 116.71 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 109.043 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.15 107.11 11.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.426 -0.583 . . . . 1.3899999999999999 109.426 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 4.5 m -70.61 140.45 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.537 -0.542 . . . . 1.3200000000000001 109.537 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.44 -64.54 1.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.175 0.512 . . . . 0.95999999999999996 110.344 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 28.3 t-20 -103.26 101.83 11.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.627 -0.715 . . . . 1.47 110.787 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.62 116.3 52.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.197 0.522 . . . . 1.01 109.922 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.51 150.2 24.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.066 -0.515 . . . . 1.54 110.948 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.17 125.79 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.656 -0.702 . . . . 0.91000000000000003 109.952 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.708 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 3.0 mp -107.33 164.52 12.11 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.743 -0.466 . . . . 1.1799999999999999 109.743 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER 63.75 25.19 14.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.628 1.204 . . . . 2.73 109.117 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 17.0 t30 -114.42 128.04 26.23 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 113.552 -1.658 . . . . 1.8799999999999999 110.4 171.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HB3' ' HA ' ' A' ' 138' ' ' ASN . 2.5 Cg_endo -86.59 141.29 25.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.412 -1.078 . . . . 0.59999999999999998 112.081 -6.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 69.5 m -154.42 163.04 25.52 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.641 -0.254 . . . . 0.77000000000000002 110.526 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 80.6 Cg_exo -48.6 148.2 8.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.68 2.92 . . . . 0.82999999999999996 113.781 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 34.2 t80 -55.44 -34.55 64.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.382 -0.826 . . . . 0.40999999999999998 112.597 -176.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 51.2 m-85 -83.9 16.71 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.293 0.479 . . . . 0.65000000000000002 112.293 -175.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.85 156.82 36.83 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 107.764 -1.199 . . . . 2.0699999999999998 107.764 168.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.64 138.72 17.39 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.055 1.837 . . . . 0.62 112.66 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 47.0 m-85 -60.02 101.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.978 -0.749 . . . . 0.57999999999999996 108.978 171.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 5.4 tt0 -103.72 102.06 11.9 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 1.4099999999999999 110.771 -171.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 98.4 m-85 -113.89 137.96 50.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.5 111.04 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HG2' HG22 ' A' ' 73' ' ' VAL . 37.7 mt-10 -112.81 102.58 10.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.74 -0.837 . . . . 1.98 108.74 170.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 97' ' ' ILE . 59.4 mt -99.05 111.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.35999999999999999 111.508 -171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.6 m -98.11 106.16 18.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 0.46000000000000002 110.201 175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 p90 -121.14 136.45 54.97 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.559 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 31.5 tt0 -103.43 112.24 25.05 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.262 0.553 . . . . 0.77000000000000002 110.351 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 59.0 m -75.28 100.72 4.45 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.438 -0.801 . . . . 0.51000000000000001 108.954 176.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 2' ' ' ALA . 43.4 mt -63.29 -25.86 39.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.56999999999999995 110.032 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.591 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 22.9 tt0 -147.39 152.03 37.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.451 -0.944 . . . . 1.8300000000000001 108.451 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.81 140.64 45.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.543 . . . . 2.1800000000000002 110.431 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.32 136.3 39.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.732 -0.667 . . . . 1.52 110.159 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 p -92.87 -19.55 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.323 0.582 . . . . 1.55 109.866 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -96.6 178.84 5.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.388 -0.824 . . . . 2.9500000000000002 110.29 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -90.71 144.91 25.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.02 -0.536 . . . . 1.8799999999999999 110.021 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD12 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -101.35 119.98 39.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.769 -0.826 . . . . 1.3200000000000001 108.769 175.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 38.5 tt0 -89.22 113.9 25.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.92000000000000004 111.088 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.422 ' NE1' HD12 ' A' ' 38' ' ' LEU . 72.4 m95 -108.38 113.02 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.936 -1.135 . . . . 0.42999999999999999 107.936 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.632 ' CD ' ' HB3' ' A' ' 59' ' ' SER . 36.9 ttpt -126.96 140.86 52.01 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.162 -0.615 . . . . 1.23 110.881 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG13 ' CE2' ' A' ' 74' ' ' PHE . 30.4 mt -102.68 102.8 14.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.46000000000000002 109.545 177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 60.9 mt -98.35 106.64 19.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.313 -0.858 . . . . 0.68999999999999995 109.001 176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -91.88 128.02 37.56 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.615 -0.883 . . . . 0.58999999999999997 108.615 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 93' ' ' THR . 89.7 t -53.7 113.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.768 -0.456 . . . . 0.37 109.768 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' TYR . . . -65.97 -48.06 68.97 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.313 -0.946 . . . . 0.46999999999999997 111.629 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 28.8 t -142.56 134.98 27.79 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.598 0.237 . . . . 1.23 110.71 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.64 -22.0 47.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 109.56 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -66.65 -37.39 84.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.07 -0.968 . . . . 1.99 109.016 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 67.6 m -153.89 113.93 3.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.441 -0.799 . . . . 1.72 109.237 171.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.48 -3.59 18.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.827 0.346 . . . . 2.0899999999999999 111.305 -173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -71.18 -8.36 53.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.057 0.456 . . . . 2.8300000000000001 110.757 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 82.6 m-85 -85.47 11.69 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 1.48 110.391 175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.636 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 4.1 p-10 -50.52 139.64 15.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.402 0.62 . . . . 1.22 111.272 -175.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -123.27 128.21 49.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.358 -0.837 . . . . 1.8500000000000001 111.193 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.99 111.26 22.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.404 -0.816 . . . . 1.0800000000000001 110.257 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.26 -51.07 49.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.915 -0.584 . . . . 1.05 110.542 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -167.76 146.73 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.608 -0.723 . . . . 1.3100000000000001 109.607 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HB3' ' CD ' ' A' ' 41' ' ' LYS . 15.9 p -120.31 109.24 15.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.868 -0.79 . . . . 1.0900000000000001 108.868 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.45 122.96 55.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.562 0.696 . . . . 1.22 110.56 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 39' ' ' GLU . 2.7 mm? -103.81 128.56 51.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.408 -0.815 . . . . 1.3400000000000001 109.754 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.37 101.45 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.999 -0.68 . . . . 0.71999999999999997 109.753 171.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.25 120.36 6.31 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.473 -1.182 . . . . 0.41999999999999998 111.788 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 93.2 Cg_endo -102.29 166.43 6.69 Favored 'Cis proline' 0 N--CA 1.451 -0.978 0 CA-C-N 121.099 2.449 . . . . 0.55000000000000004 110.595 -13.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.17 59.67 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.354 -0.538 . . . . 0.94999999999999996 110.495 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.68 157.1 52.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.387 2.725 . . . . 0.69999999999999996 112.895 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -65.34 128.86 37.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.456 -0.793 . . . . 0.40999999999999998 110.948 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 30' ' ' CYS . . . 151.37 165.62 13.1 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.841 -0.695 . . . . 0.33000000000000002 111.85 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 18.5 ttm180 -86.59 99.22 11.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.462 0.649 . . . . 2.7799999999999998 110.059 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' THR . 65.9 m-70 -91.04 153.34 20.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.62 110.125 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -139.5 96.29 3.06 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.9 155.02 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.449 -0.341 . . . . 0.37 110.45 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.886 HG22 ' HG2' ' A' ' 25' ' ' GLU . 43.3 t -101.21 104.92 16.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.133 -0.485 . . . . 1.1200000000000001 110.303 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' CE2' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -87.56 111.51 21.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.128 -1.064 . . . . 0.44 108.128 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.9 tt0 -131.8 119.59 21.47 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.614 -0.721 . . . . 1.1399999999999999 110.181 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.99 152.3 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.611 -0.514 . . . . 0.56000000000000005 109.611 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.71 -166.25 0.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.786 0.326 . . . . 2.1299999999999999 111.65 -174.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 19' ' ' TYR . . . -75.57 128.36 84.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-O 120.728 0.299 . . . . 0.46000000000000002 110.735 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.86 157.45 48.08 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.602 2.202 . . . . 0.53000000000000003 112.192 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 50.2 t-20 -57.14 116.34 13.26 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.769 -0.65 . . . . 2.1899999999999999 110.826 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 80' ' ' ASN . 22.2 Cg_exo -67.58 -13.57 39.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.268 2.645 . . . . 0.54000000000000004 112.592 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.91 -16.53 76.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.537 -0.84 . . . . 0.51000000000000001 111.752 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 80' ' ' ASN . 10.9 mp -91.23 -26.19 19.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.534 0.207 . . . . 1.6000000000000001 110.685 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 65.7 mt -78.24 124.2 85.8 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.976 -0.379 . . . . 0.52000000000000002 109.976 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.749 ' HG2' ' HB3' ' A' ' 88' ' ' ASP . 95.5 Cg_endo -78.82 158.46 27.79 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.097 2.531 . . . . 0.81000000000000005 113.359 -171.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -50.66 -46.64 58.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.985 -1.007 . . . . 2.29 111.926 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.55 55.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 1.25 112.737 -172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.749 ' HB3' ' HG2' ' A' ' 85' ' ' PRO . 30.7 t70 -101.6 -26.04 13.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.989 0.366 . . . . 1.9399999999999999 111.989 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.98 -34.9 72.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.54000000000000004 111.188 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.67 40.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.217 0.532 . . . . 0.56000000000000005 109.71 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 -137.64 3.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.512 -0.851 . . . . 0.62 112.965 -172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.64 101.96 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.807 0.813 . . . . 1.23 110.932 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 45' ' ' VAL . 2.4 m -95.91 166.82 11.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.262 -0.881 . . . . 0.63 109.783 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 39.7 t -115.24 136.74 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 121.999 -0.438 . . . . 0.35999999999999999 110.202 177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 111' ' ' TYR . 4.1 p -116.04 110.86 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.436 -0.95 . . . . 0.59999999999999998 108.436 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -119.35 131.72 55.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.584 0.707 . . . . 1.21 111.914 -170.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 65.7 mt -99.21 113.12 33.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.979 -1.009 . . . . 0.33000000000000002 109.682 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.8 p -94.31 140.25 30.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.085 -0.507 . . . . 1.4199999999999999 110.222 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 10.4 m -120.66 116.57 25.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.149 -0.478 . . . . 1.3200000000000001 110.141 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.1 m -110.06 135.47 50.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.5 112.004 -173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 34.8 t80 -139.96 130.17 25.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.763 -0.829 . . . . 0.72999999999999998 108.763 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 40.4 mmt180 68.16 13.07 9.01 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.913 0.485 . . . . 2.4500000000000002 111.082 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.5 -4.58 82.39 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.415 -0.898 . . . . 0.56999999999999995 111.289 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 152' ' ' ASN . 27.0 mt-30 -112.48 144.2 42.34 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.751 -0.463 . . . . 1.3100000000000001 109.751 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.96 128.12 45.04 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.175 -0.306 . . . . 1.5900000000000001 110.175 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 32.4 p90 -103.35 -16.52 15.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.555 0.576 . . . . 0.31 112.555 -172.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 108' ' ' ARG . 7.5 tt -155.61 153.15 7.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.802 0.334 . . . . 0.37 110.425 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 107' ' ' ILE . 47.7 ttp180 -141.06 118.11 11.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.024 -0.535 . . . . 1.1399999999999999 109.932 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 49.3 t -93.43 109.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.147 -0.479 . . . . 0.38 111.027 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -103.03 112.32 4.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.726 -0.749 . . . . 0.27000000000000002 112.759 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 95' ' ' VAL . 25.9 m-85 -104.26 120.69 41.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.803 0.335 . . . . 0.40000000000000002 110.121 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -82.24 114.05 20.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.312 -0.404 . . . . 0.78000000000000003 110.165 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ILE . 2.6 p -98.71 123.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.395 0.617 . . . . 1.1899999999999999 110.819 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -88.09 112.71 22.96 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.079 -0.711 . . . . 1.6299999999999999 109.079 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -94.39 107.57 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.479 0.657 . . . . 0.94999999999999996 110.629 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -136.31 142.61 43.89 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.584 -1.189 . . . . 1.97 108.376 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -62.82 153.1 34.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.68999999999999995 111.031 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 15.2 p -78.44 -29.44 47.02 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.971 0.891 . . . . 0.83999999999999997 108.783 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 2.5 mm-40 -80.43 116.08 20.3 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.021 -1.445 . . . . 2.2400000000000002 108.856 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.583 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 17.0 m -56.65 -30.4 63.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.081 0.467 . . . . 1.4099999999999999 110.123 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.68 -43.22 97.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.533 -0.758 . . . . 2.21 111.28 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.61 -17.6 59.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.267 0.556 . . . . 0.90000000000000002 110.08 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -78.19 -23.51 47.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 2.0299999999999998 109.866 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 120' ' ' THR . 4.5 mm-40 -69.04 -42.54 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.766 -0.652 . . . . 2.8399999999999999 109.265 174.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -153.17 108.18 2.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 2.1899999999999999 111.353 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 37.1 Cg_exo -61.86 126.1 18.11 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.057 2.505 . . . . 1.24 111.671 175.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 23.6 Cg_exo -65.87 163.65 30.03 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.149 2.566 . . . . 1.1899999999999999 112.267 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.5 p -48.49 -41.42 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.9 -0.591 . . . . 2.1600000000000001 111.716 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.1 122.87 37.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.833 -0.802 . . . . 1.96 108.833 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.18 139.74 91.61 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.878 1.719 . . . . 0.70999999999999996 111.11 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 8.5 t70 -106.74 110.84 23.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.285 -0.416 . . . . 1.28 110.626 -171.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 70.6 m-85 -78.88 -27.84 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.669 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -78.83 -4.52 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.537 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 68.8 mmtt -123.6 10.48 9.08 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.394 -0.595 . . . . 1.8700000000000001 109.394 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 24.0 tp -97.33 132.9 42.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.284 -0.871 . . . . 0.79000000000000004 109.951 -174.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 5.3 tt0 -107.78 139.36 42.48 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.772 -0.455 . . . . 1.6299999999999999 109.772 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 137' ' ' ARG . 23.7 mtm180 -94.59 106.71 18.7 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.001 -0.545 . . . . 2.8199999999999998 109.978 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -94.82 86.5 4.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.013 -0.736 . . . . 0.83999999999999997 109.013 173.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.546 ' HB ' ' CG ' ' A' ' 14' ' ' ASN . 68.8 mt -73.51 124.26 30.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.224 -0.898 . . . . 0.47999999999999998 110.379 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.39 83.54 3.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.05 0.452 . . . . 0.98999999999999999 110.126 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.4 -16.94 47.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.832 -0.622 . . . . 0.55000000000000004 110.671 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 31.7 t -78.72 -12.48 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.037 -0.529 . . . . 1.4199999999999999 109.837 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -120.8 81.87 34.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 1.9099999999999999 110.52 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.9 106.68 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.281 1.987 . . . . 0.66000000000000003 111.974 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -86.05 100.55 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.177 -0.675 . . . . 3.1499999999999999 109.177 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -111.45 107.08 22.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.15 -0.477 . . . . 1.1399999999999999 111.24 -173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -101.41 110.54 22.57 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.251 -0.648 . . . . 0.56000000000000005 109.251 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 8.2 ptm180 -107.26 145.96 32.05 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.286 0.565 . . . . 3.0 110.553 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.28 157.57 27.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.025 -0.989 . . . . 0.46000000000000002 110.178 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -103.95 122.86 46.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.317 -0.623 . . . . 3.1400000000000001 109.317 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 106' ' ' PHE . 39.3 pt -136.06 -172.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.829 0.823 . . . . 0.64000000000000001 111.409 -174.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.449 ' H ' ' NE2' ' A' ' 104' ' ' GLN . 7.0 m-20 -95.54 112.6 24.29 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.138 -1.392 . . . . 1.78 109.915 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 3' ' ' LYS . 80.1 m95 -88.48 -22.37 23.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.416 0.627 . . . . 0.87 109.914 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -111.53 149.19 31.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.495 -0.775 . . . . 2.3199999999999998 109.181 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' C ' HD22 ' A' ' 156' ' ' ASN . 38.3 t70 -91.35 71.12 6.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.713 0.768 . . . . 2.4900000000000002 108.968 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.502 HD22 ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.863 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 109.669 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.085 -0.339 . . . . 2.96 110.085 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.88 -73.89 0.63 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.48 110.798 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.705 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -95.59 -27.85 15.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.089 0.403 . . . . 0.97999999999999998 112.089 -175.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 HD11 ' A' ' 34' ' ' LEU . 2.3 t -135.59 143.95 35.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 120.778 0.323 . . . . 0.45000000000000001 110.331 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -148.11 111.63 5.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.614 . . . . 1.3899999999999999 110.051 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 28' ' ' PHE . 60.5 t -73.11 125.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.578 -0.527 . . . . 1.3200000000000001 109.578 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -111.76 -60.09 1.9 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.687 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.0 t-20 -102.11 126.61 49.11 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.716 -0.475 . . . . 1.47 109.716 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.18 106.54 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.709 0.766 . . . . 1.01 110.086 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.19 136.29 33.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.545 -0.752 . . . . 1.54 110.518 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 139' ' ' ILE . 47.5 t -101.32 110.38 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.602 . . . . 0.91000000000000003 109.376 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.743 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 5.0 mp -101.46 154.69 18.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.0 0.428 . . . . 1.1799999999999999 110.821 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB2' HE21 ' A' ' 23' ' ' GLN . 6.4 t70 77.61 1.88 2.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.763 -1.108 . . . . 2.73 109.571 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' HA ' HH22 ' A' ' 137' ' ' ARG . 46.9 t30 -86.59 132.71 41.78 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.859 -1.064 . . . . 1.8799999999999999 110.415 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HB2' HE21 ' A' ' 136' ' ' GLN . 7.7 Cg_endo -95.52 151.32 10.05 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 125.08 -0.8 . . . . 0.59999999999999998 113.205 -6.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -154.17 163.09 25.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.77000000000000002 109.935 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.78 145.34 13.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.82999999999999996 111.994 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.723 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -57.58 -22.85 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.677 0.992 . . . . 0.40999999999999998 113.677 -173.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -72.9 4.53 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.991 -0.443 . . . . 0.65000000000000002 111.775 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.79 ' ND2' HH21 ' A' ' 137' ' ' ARG . 9.8 p-10 -83.22 164.89 43.76 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 116.162 -0.472 . . . . 2.0699999999999998 109.797 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 72.1 Cg_endo -86.51 144.5 7.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.896 1.731 . . . . 0.62 112.456 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 52.6 m-85 -70.93 97.68 1.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.512 -0.551 . . . . 0.57999999999999996 109.512 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.743 ' HG2' ' HB2' ' A' ' 12' ' ' LEU . 8.0 tt0 -98.97 106.47 18.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.916 . . . . 1.4099999999999999 110.68 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 22' ' ' PHE . 94.7 m-85 -115.05 137.91 51.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.781 -0.645 . . . . 0.5 110.82 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -100.97 100.54 11.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.381 -1.34 . . . . 1.98 107.381 172.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 97' ' ' ILE . 66.3 mt -101.14 103.19 14.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.997 -0.547 . . . . 0.35999999999999999 111.014 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 86.7 m -100.87 106.03 17.36 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.943 -0.571 . . . . 0.46000000000000002 109.869 173.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.8 p90 -118.82 139.27 51.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.243 -0.651 . . . . 0.28000000000000003 109.243 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.4 tt0 -108.22 121.66 45.34 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.057 -0.519 . . . . 0.77000000000000002 110.299 -175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 64.3 m -82.73 112.04 19.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.388 -0.824 . . . . 0.51000000000000001 109.492 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 31' ' ' ILE . 10.0 mt -75.85 -32.66 24.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.557 -0.905 . . . . 0.56999999999999995 108.557 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.705 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 39.3 mm-40 -126.81 174.74 8.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 108.28 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -94.76 139.2 31.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 101' ' ' TYR . 6.8 mp -97.4 139.07 33.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 1.52 110.376 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.3 t -90.76 -21.21 21.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.248 -0.433 . . . . 1.55 110.323 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 12.6 mm-40 -103.3 169.48 8.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.871 -0.604 . . . . 2.9500000000000002 110.343 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.41 143.85 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.116 -0.493 . . . . 1.8799999999999999 109.926 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.731 ' HB2' HG21 ' A' ' 65' ' ' VAL . 12.8 tp -98.03 122.8 41.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.94 -0.573 . . . . 1.3200000000000001 110.182 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 36.5 tt0 -98.93 113.97 26.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.343 -0.39 . . . . 0.92000000000000004 111.262 -175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 59' ' ' SER . 80.4 m95 -106.01 119.35 38.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.239 -0.437 . . . . 0.42999999999999999 109.888 174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HD3' HG11 ' A' ' 56' ' ' VAL . 81.4 mttt -120.28 144.99 47.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.954 0.407 . . . . 1.23 111.588 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 14.4 mt -104.59 99.39 8.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.869 -0.789 . . . . 0.46000000000000002 108.869 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 56' ' ' VAL . 56.5 mt -96.36 113.57 31.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.735 -0.666 . . . . 0.68999999999999995 109.281 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HE1' HG11 ' A' ' 113' ' ' VAL . 58.0 t80 -94.99 135.07 36.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.971 -0.559 . . . . 0.58999999999999997 109.994 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' ' HB ' ' A' ' 94' ' ' VAL . 60.2 t -72.4 101.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.135 -0.691 . . . . 0.37 109.135 173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.677 ' H ' ' HA ' ' A' ' 54' ' ' ASP . . . -54.83 -51.94 49.67 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.041 -0.6 . . . . 0.46999999999999997 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.644 ' HB2' ' HD3' ' A' ' 85' ' ' PRO . 40.5 t -134.72 138.61 44.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.676 0.274 . . . . 1.23 110.975 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -82.51 -20.6 36.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.757 -0.831 . . . . 0.81999999999999995 108.757 170.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB3' ' OG ' ' A' ' 47' ' ' SER . 34.7 tt0 -72.04 -40.8 68.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.734 -1.121 . . . . 1.99 109.239 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 47' ' ' SER . 38.8 m -147.48 107.25 3.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.525 -0.761 . . . . 1.72 109.448 173.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -68.98 -5.08 19.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.452 . . . . 2.0899999999999999 111.189 -175.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.18 -19.53 54.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.93 -0.577 . . . . 2.8300000000000001 110.488 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.458 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 60.8 m-85 -83.21 7.77 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 1.48 111.711 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 6.4 p-10 -62.06 145.33 53.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.111 0.481 . . . . 1.22 111.107 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.99 144.08 32.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.392 0.615 . . . . 1.8500000000000001 110.767 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 43' ' ' ILE . 44.6 t -96.11 117.6 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' HG3' ' A' ' 79' ' ' PRO . 9.0 mp -75.94 -42.47 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.0 -0.546 . . . . 1.05 111.435 -172.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -161.2 170.76 19.67 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.708 -0.397 . . . . 1.3100000000000001 110.612 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 10.0 p -146.48 119.98 9.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.894 -0.593 . . . . 1.0900000000000001 110.148 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.79 117.81 48.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.123 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' A' ' 39' ' ' GLU . 3.2 mm? -105.5 122.74 46.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 1.3400000000000001 110.446 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.23 101.54 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.908 -0.717 . . . . 0.71999999999999997 109.75 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 64' ' ' PRO . . . -106.17 120.34 6.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.813 -0.993 . . . . 0.41999999999999998 112.17 174.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 84.8 Cg_endo -99.57 167.52 9.58 Favored 'Cis proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.846 2.323 . . . . 0.55000000000000004 110.243 -14.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -101.84 110.53 62.36 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 120.584 -0.446 . . . . 0.94999999999999996 110.788 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CE1' ' A' ' 70' ' ' HIS . 11.0 Cg_endo -85.99 160.23 10.22 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.084 2.522 . . . . 0.69999999999999996 112.965 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -62.18 128.9 38.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 110.862 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.59 13.44 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.006 -0.838 . . . . 0.33000000000000002 111.006 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttm180 -84.3 113.81 21.4 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.06 0.457 . . . . 2.7799999999999998 110.433 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' CE1' ' HD2' ' A' ' 66' ' ' PRO . 84.9 m-70 -103.29 130.93 50.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.662 -0.699 . . . . 0.62 110.485 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.4 ttm -124.35 110.42 14.55 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.517 -0.549 . . . . 1.8 109.517 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -138.82 145.48 40.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.37 111.237 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.86 121.22 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.705 . . . . 1.1200000000000001 110.322 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -96.58 125.03 40.77 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.547 -0.908 . . . . 0.44 108.547 178.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' HD1' ' A' ' 74' ' ' PHE . 25.2 mt-30 -130.2 117.43 19.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.221 0.534 . . . . 1.1399999999999999 111.39 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -130.62 118.26 20.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.646 -0.707 . . . . 0.56000000000000005 109.84 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.6 m-20 -66.1 166.26 12.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.625 -0.261 . . . . 2.1299999999999999 111.567 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -41.29 135.82 1.81 Allowed Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 113.794 1.035 . . . . 0.46000000000000002 113.794 -172.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.631 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.0 Cg_exo -60.92 165.32 12.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.39 2.726 . . . . 0.53000000000000003 111.536 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.544 ' CB ' HD13 ' A' ' 83' ' ' LEU . 1.6 m-20 -57.84 112.77 5.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.375 -0.231 . . . . 2.1899999999999999 110.375 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.44 -27.24 47.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.899 2.399 . . . . 0.54000000000000004 112.166 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.61 -11.18 85.48 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.406 -0.678 . . . . 0.51000000000000001 111.406 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' A' ' 80' ' ' ASN . 11.1 mp -95.15 -15.02 23.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.941 -0.392 . . . . 1.6000000000000001 109.941 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 89' ' ' ALA . 33.3 mt -79.37 131.16 66.3 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.331 -0.395 . . . . 0.52000000000000002 110.111 176.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.682 ' CG ' ' HB3' ' A' ' 88' ' ' ASP . 11.7 Cg_endo -58.11 154.03 42.11 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 123.893 3.062 . . . . 0.81000000000000005 113.666 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.56 -37.48 59.93 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.358 -0.837 . . . . 2.29 111.023 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.43 -13.41 18.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.897 -0.321 . . . . 1.25 111.815 -173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.682 ' HB3' ' CG ' ' A' ' 85' ' ' PRO . 25.2 t70 -112.57 -8.31 13.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.751 0.31 . . . . 1.9399999999999999 111.745 -172.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 85' ' ' PRO . . . -61.85 -28.26 69.36 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.8 0.667 . . . . 0.54000000000000004 112.8 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 130' ' ' PRO . 23.0 t -101.05 44.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.696 0.76 . . . . 0.56000000000000005 109.925 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.96 -120.62 2.1 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 120.654 -0.784 . . . . 0.62 112.844 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.55 119.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.261 0.553 . . . . 1.23 110.889 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -118.84 167.76 11.41 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.048 -0.524 . . . . 0.63 109.924 179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 45' ' ' VAL . 23.6 t -118.07 129.61 74.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.675 -0.41 . . . . 0.35999999999999999 110.304 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.85 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.004 -1.11 . . . . 0.59999999999999998 108.004 170.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 3.5 pp -115.68 127.66 55.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.623 0.725 . . . . 1.21 111.81 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 26' ' ' ILE . 67.5 mt -95.77 99.82 9.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.981 -1.009 . . . . 0.33000000000000002 109.292 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -100.92 145.33 28.76 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.92 -0.77 . . . . 1.4199999999999999 108.92 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' SG ' ' HG ' ' A' ' 38' ' ' LEU . 12.3 t -120.14 120.93 37.63 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.212 0.53 . . . . 1.3200000000000001 110.674 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 7.2 m -93.17 125.31 37.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.038 -0.983 . . . . 0.5 111.029 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 34' ' ' LEU . 47.7 t80 -130.58 121.28 25.39 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.72999999999999998 108.883 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 36.7 mmt180 68.27 13.41 9.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.792 0.437 . . . . 2.4500000000000002 111.119 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.49 84.24 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.52 -1.032 . . . . 0.56999999999999995 110.52 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -112.39 116.85 30.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.765 -0.718 . . . . 1.3100000000000001 109.415 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.12 125.93 28.83 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.581 -0.526 . . . . 1.5900000000000001 109.581 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 43.9 p90 -106.29 -11.83 15.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.89 0.376 . . . . 0.31 111.407 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 5.4 tt -155.4 147.68 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.442 -0.345 . . . . 0.37 110.49 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 107' ' ' ILE . 41.0 ttp180 -144.19 108.68 4.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.758 -0.656 . . . . 1.1399999999999999 109.632 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 56.1 t -82.57 102.72 8.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.96 -0.564 . . . . 0.38 110.709 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -91.94 90.51 1.51 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.951 -0.642 . . . . 0.27000000000000002 112.351 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -90.36 124.35 34.85 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.838 -0.43 . . . . 0.40000000000000002 109.838 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.754 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 52.9 m-85 -85.53 119.15 25.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.057 0.456 . . . . 0.78000000000000003 110.25 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' HE1' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -94.26 118.01 39.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.443 -0.577 . . . . 1.1899999999999999 109.443 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 140' ' ' LEU . 7.9 t-20 -95.18 123.31 38.62 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.982 -0.747 . . . . 1.6299999999999999 108.982 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.718 HD22 HD11 ' A' ' 135' ' ' LEU . 10.0 m120 -96.32 107.14 19.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.819 -0.628 . . . . 0.94999999999999996 110.349 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 136' ' ' GLN . 21.8 mt-10 -141.24 137.3 32.46 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.558 -0.904 . . . . 1.97 108.558 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 96.8 m-85 -62.53 164.01 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.938 0.399 . . . . 0.68999999999999995 111.696 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.587 HG23 ' HB2' ' A' ' 136' ' ' GLN . 2.7 p -80.83 -21.99 40.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.44 0.638 . . . . 0.83999999999999997 110.345 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 53.5 mt-10 -97.58 130.97 44.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 110.462 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.9 m -54.99 -37.65 66.83 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.473 0.483 . . . . 1.4099999999999999 110.31 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -56.96 -48.34 78.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.703 -0.681 . . . . 2.21 111.079 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.6 -27.29 60.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.90000000000000002 111.138 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 66.7 mtp180 -68.72 -30.97 69.73 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.144 0.497 . . . . 2.0299999999999998 109.834 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -74.39 -39.91 62.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.566 -0.743 . . . . 2.8399999999999999 111.058 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -140.12 100.44 7.13 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 110.72 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 62.4 Cg_exo -55.87 122.57 11.99 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.924 1.749 . . . . 1.24 110.68 169.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 52.7 Cg_exo -57.0 165.86 4.63 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.229 2.619 . . . . 1.1899999999999999 111.463 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.78 -35.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 123.417 0.448 . . . . 2.1600000000000001 111.656 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -128.89 133.06 24.78 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.711 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 15.8 Cg_endo -54.54 154.53 19.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.159 1.906 . . . . 0.70999999999999996 111.933 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' H ' ' HE1' ' A' ' 117' ' ' TYR . 11.6 t70 -115.96 106.0 13.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.271 -0.64 . . . . 1.28 109.271 -175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 66.8 m-85 -70.06 -16.06 63.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.683 -0.69 . . . . 0.5 111.322 -171.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.7 m -88.87 -27.29 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.009 -0.541 . . . . 1.46 111.5 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 35.4 mmtm -98.59 -18.14 18.28 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.298 0.571 . . . . 1.8700000000000001 109.654 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 115' ' ' ASN . 2.2 tm? -71.03 109.46 5.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.68 -1.145 . . . . 0.79000000000000004 109.799 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' A' ' 118' ' ' THR . 51.1 tt0 -79.75 117.69 20.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.348 -0.842 . . . . 1.6299999999999999 109.805 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.969 HH11 HG13 ' A' ' 139' ' ' ILE . 15.1 ttp85 -77.42 109.77 11.61 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.527 -0.76 . . . . 2.8199999999999998 109.07 172.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 8.9 t30 -104.59 100.01 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.672 -0.492 . . . . 0.83999999999999997 109.672 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.969 HG13 HH11 ' A' ' 137' ' ' ARG . 57.7 mt -79.13 113.14 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.023 -0.535 . . . . 0.47999999999999998 110.107 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 114' ' ' ASN . 7.4 mp -68.88 85.47 0.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.98999999999999999 110.785 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.18 -17.66 48.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 109.573 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 7.4 t -79.33 -10.81 59.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.556 -0.747 . . . . 1.4199999999999999 109.524 174.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 140' ' ' LEU . 2.9 t-20 -121.57 74.86 34.05 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.779 -0.646 . . . . 1.9099999999999999 109.539 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 142' ' ' SER . 8.1 Cg_endo -86.53 106.07 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.733 2.289 . . . . 0.66000000000000003 112.105 -178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.754 ' HG3' ' HE1' ' A' ' 112' ' ' TYR . 6.1 mmm180 -90.32 79.84 6.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.365 0.602 . . . . 3.1499999999999999 110.311 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.44 104.25 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.029 -0.532 . . . . 1.1399999999999999 110.067 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 m -109.53 116.71 32.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.077 -0.511 . . . . 0.56000000000000005 110.137 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 19.3 ptt180 -109.11 148.65 30.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.401 0.62 . . . . 3.0 110.333 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -117.64 119.65 35.61 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.185 -0.916 . . . . 0.46000000000000002 110.528 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -73.73 111.49 8.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.865 0.364 . . . . 3.1400000000000001 110.274 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -132.88 -173.32 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.065 -0.516 . . . . 0.64000000000000001 109.869 -177.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.69 106.45 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.55 0.69 . . . . 1.78 110.514 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -73.54 -24.57 60.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.948 0.88 . . . . 0.87 109.008 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.59 146.67 24.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.026 -1.443 . . . . 2.3199999999999998 108.074 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.15 85.9 7.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.188 0.518 . . . . 2.4900000000000002 109.92 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.334 -0.848 . . . . 2.5699999999999998 110.096 179.777 . . . . . . . . 2 2 . 1 stop_ save_